text,title,id,project_number,terms,administration,organization,mechanism,year,award_amount,cong_dist,score
"Statistical Model Building for High Dimensional Biomedical Data    DESCRIPTION (provided by applicant):  Typical of current large-scale biomedical data is the feature of small number of observed samples and the widely observed sample heterogeneity. Identifying differentially expressed genes related to the sample phenotye (e.g., cancer disease development) and predicting sample phenotype based on the gene expressions are some central research questions in the microarray data analysis. Most existing statistical methods have ignored sample heterogeneity and thus loss power.       This project proposes to develop novel statistical methods that explicitly address the small sample size and sampe heterogeneity issues, and can be applied very generally. The usefulness of these methods will be shown with the large-scale biomedical data originating from the lung and kidney transplant research projects. The transplant projects aimed to improve the molecular diagnosis and therapy of lung/kidney allograft rejection by identifying molecular biomarkers to predict the allograft rejection for critical early treatment and rapid, noninvasive, and economical testing.       The specific aims are 1) Develop novel statistical methods for differential gene expression detection that explicitly model sample heterogeneity. 2) Develop novel statistical methods for classifying high-dimensional biomedical data and incorporating sample heterogeneity. 3) Develop novel statistical methods for jointly analyzing a set of genes (e.g., genes in a pathway). 4) Use the developed models and methods to answer research questions relevant to public health in the lung and kidney transplant projects; and implement and validate the proposed methods in user-friendly and well-documented software, and distribute them to the scientific community at no charge.       It is very important to identify new biomarkers of allograft rejection in lung and kidney transplant recipients. The rapid and reliable detection and prediction of rejection in easily obtainable body fluids may allow the rapid advancement of clinical interventional trials. We propose to study novel methods for analyzing the large-scale biomedical data to realize their full potential of molecular diagnosis and prognosis of transplant rejection prediction for critical early treatment.          ",Statistical Model Building for High Dimensional Biomedical Data,7858165,R01GM083345,"['Resources ', ' Research Resources ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Transplant Recipients ', ' transplant patient ', ' sound ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Technology ', ' Testing ', ' Transplantation ', ' transplant ', ' Universities ', ' Adopted ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Work ', ' Dimensions ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' interest ', ' kidney allograft ', ' renal allograft ', ' Body Fluids ', ' user friendly software ', ' user friendly computer software ', ' simulation ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cations ', ' Charge ', ' Relative (related person) ', ' Relative ', ' Statistical Methods ', ' Outcome Measure ', ' Modeling ', ' Sampling ', ' theories ', ' software development ', ' developing computer software ', ' develop software ', ' Genomics ', ' Communities ', ' cancer microarray ', ' predictive modeling ', ' computer based prediction ', ' design ', ' designing ', ' Outcome ', ' cancer type ', ' Coupled ', ' Early treatment ', ' early therapy ', ' early intervention ', ' user-friendly ', ' biomarker ', ' transplant database ', ' transplant data base ', ' biobank ', ' biorepository ', ' allograft rejection ', ' Data Analyses ', ' Data Analysis ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Effectiveness ', ' Address ', ' Data Set ', ' Dataset ', ' Data ', ' Detection ', ' Molecular Diagnosis ', ' Collection ', ' Oncogene Activation ', ' Tissue-Specific Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Characteristics ', ' Molecular ', ' Development ', ' developmental ', ' Experimental Designs ', ' Pathway interactions ', ' pathway ', ' Gene Expression ', ' Genes ', ' base ', ' method development ', ' Graft Rejection ', ' Transplantation Rejection ', ' Transplant Rejection ', ' improved ', ' Procedures ', ' Heterogeneity ', ' Algorithms ', ' Clinical ', ' Joints ', ' Articulation ', ' Kidney Transplantation ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Least-Squares Analysis ', ' Least-Squares Analyses ', ' Least Squares ', ' Individual ', ' Literature ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Sample Size ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Minnesota ', ' Statistical Models ', ' Probabilistic Models ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Patients ', ' Phenotype ', ' Probability ', ' outcome forecast ', ' Prognosis ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Proposals ', ' ']",NIGMS,UNIVERSITY OF MINNESOTA,R01,2010,253269,MN-05,0.0386714687053259
"Information Systems for Detecting and Managing Acute Kidney Injury    DESCRIPTION (provided by applicant):       Acute Kidney Injury (AKI) is a common complication among hospitalized patients and heralds a 3-5 fold increase in mortality, increased costs, and potential lifelong dependence on dialysis. While clinical decision support systems (CDSS) have previously assisted with the medical management of chronic kidney disease, there has been no validated approach for a CDSS to identify AKI and facilitate a medical intervention at an early stage. We propose to develop an AKI detection algorithm using laboratory and bedside measurements that are typically available in electronic medical records. We will validate the algorithm against the judgment of an expert nephrology review panel and use the latest published standards for AKI staging. As a second step, we plan to create models (using both traditional and machine learning approaches) that predict progression of AKI by incorporating comorbidities, admission diagnoses, and exposure to nephrotoxic therapies. Once the electronic criteria for early AKI are defined, we will build and evaluate a hospital-wide CDSS for managing early AKI. The goal is to prevent AKI progression and the associated complications of hypokalemia, acidemia, and medication toxicity.           Project Narrative: Hospitalized patients who develop impaired kidney function are at increased risk of dying or developing adverse events. Computerized systems of care are needed to quickly alert hospital care teams to which patients are developing kidney injury in order to tailor medications and other therapies.",Information Systems for Detecting and Managing Acute Kidney Injury,7925794,R01LM009965,"['Information Systems ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Investments ', ' Judgment ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Chronic Kidney Failure ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Laboratories ', ' Serum ', ' Blood Serum ', ' Failure (biologic function) ', ' failure ', ' FLR ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Renal function ', ' kidney function ', ' Individual ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Measurement ', ' Funding ', ' Maintenance ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mortality Vital Statistics ', ' Mortality ', ' Nephrology ', ' Patients ', ' Exposure to ', ' Staging ', ' Publishing ', ' Reaction Time ', ' psychomotor reaction time ', ' Response Time ', ' Response RT ', ' Research ', ' Rifles ', ' Risk ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Syndrome ', ' Time ', ' Urine ', ' Urine Urinary System ', ' Adopted ', ' Work ', ' Dependence ', ' Stream ', ' Pattern ', ' System ', ' LOINC Axis 4 System ', ' Clinical Decision Support Systems ', ' Consult ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' Performance ', ' cohort ', ' Toxic effect ', ' Toxicities ', ' Structure ', ' Capital ', ' Computerized Medical Record ', ' Electronic Medical Record ', ' Code ', ' Coding System ', ' Admission activity ', ' Admission ', ' Generic Drugs ', ' generic ', ' Nonproprietary Drugs ', ' Hospital Mortality ', ' Inhospital Mortality ', ' In-house Mortalities ', ' Decision Support Model ', ' Modeling ', ' Decision Support Systems ', ' response ', ' repository ', ' Adverse event ', ' Adverse Experience ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Documentation ', ' Comorbidity ', ' co-morbidity ', ' Complication ', ' cost ', ' care systems ', ' computerized ', ' computerized tools ', ' computational tools ', ' Computer Assisted ', ' computer aided ', ' Outcome ', ' Population ', ' prospective ', ' Early treatment ', ' early therapy ', ' early intervention ', ' Creatinine ', ' 2-amino-1,5-dihydro-1-methyl-4H-imidazol-4-one ', ' Provider ', ' Diagnosis ', ' Dialysis procedure ', ' dialysis therapy ', ' Dialysis ', ' Institution ', ' prevent ', ' preventing ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Electrolytes ', ' Electronics ', ' Address ', ' Dose ', ' Caring ', ' Data ', ' Detection ', ' Nephrotoxic ', ' Predictive Value ', ' Monitor ', ' Characteristics ', ' Process ', ' Guidelines ', ' Fluid Balance ', ' Output ', ' Injury ', ' Glomerular Filtration Rate ', ' base ', ' Goals ', ' improved ', ' Hospitals ', ' Algorithms ', ' Acute ', ' Chronic ', ' Clinical ', ' Phase ', ' Physiological ', ' Physiologic ', ' Medical ', ' Hypokalemia ', ' Hypopotassemia ', ' ']",NLM,VANDERBILT UNIVERSITY,R01,2010,330524,TN-05,0.16994534354426982
"A web hospital comparison tool for patients considering kidney transplantation an    DESCRIPTION (provided by applicant): This proposal addresses the need for objective hospital quality ranking tools that are relevant to patients' experiences and customizable to their individual conditions. This need is created by market changes where patients are increasingly being made aware of differences in quality between providers who will improve their odds at success. Medicare, state governments, insurers and several private companies offer information on hospital quality and cost across many conditions and incorporating a variety of data, process and outcomes quality indicators. However, according to investors, bankers, industry analysts and entrepreneurs, comparison tools are still at an embryonic stage. They suffer from limited specificity, low resolution, conflicts of interest and misfit in the patient information finding process. This leads to patient confusion and perceptions that information is meaningless for decision making. PickCare (tm) is a hospital comparison tool that will address gaps that exist in current hospital ranking systems using advanced statistical and econometric models that have never been applied in this space. In phase 1 we developed Pickcare v2.0 in kidney transplantation and showed that: 1) these models improve specificity through customization to patient factors that our analysis unearths are most important; 2) our models improve resolution by using an expanded history of risk factors; 3) the user interface tested with patients/ family communicates the system's improved resolution as differences across hospitals that patients can understand, and its specificity as a message of hope and alternatives. In phase 2 we will expand to Pickcare v3.0 to 1) accommodate user feedback from phase 1, 2) scale to accommodate more treatments beginning with dialysis and 3) further imbed the system in patients' information finding process. The deliverable of Phase 2 will be version 3 of Pickcare to be released on-line for kidney transplantation and tested internally with recruited patients for dialysis. A manuscript describing how the system influences patient choice in kidney transplantation based on analysis of on-line user data will also be submitted for publication.    PUBLIC HEALTH RELEVANCE: This proposal addresses the need for user-friendly web-based tools to help patients and their families choose between hospitals based on the quality of care they will receive. The tool is unique in that it is customized to patient conditions, it has high resolution to separate excellent, average and poor hospitals, it addresses patients' motivations to search for hospital information and builds trust by answering their questions independently of insurers or hospitals.           This proposal addresses the need for user-friendly web-based tools to help patients and their families choose between hospitals based on the quality of care they will receive. The tool is unique in that it is customized to patient conditions, it has high resolution to separate excellent, average and poor hospitals, it addresses patients' motivations to search for hospital information and builds trust by answering their questions independently of insurers or hospitals.",A web hospital comparison tool for patients considering kidney transplantation an,7921924,R44DK074209,"['Goals ', ' improved ', ' Health ', ' Medicare ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Recording of previous events ', ' History ', ' Hospitals ', ' Algorithms ', ' Clinical ', ' Phase ', ' Link ', ' Industry ', ' Insurance ', ' Insurance Carriers ', ' Insurers ', ' Kidney Transplantation ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Individual ', ' Trust ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Marketing ', ' Motivation ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Patients ', ' Perception ', ' Physicians ', ' Staging ', ' tool ', ' Publications ', ' Scientific Publication ', ' Recommendation ', ' Recruitment Activity ', ' recruit ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Risk Factors ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Specificity ', ' State Government ', ' Provincial Government ', ' statistics ', ' Testing ', ' Transplantation ', ' transplant ', ' frailty ', ' Clinic ', ' System ', ' LOINC Axis 4 System ', ' Quality Indicator ', ' preference ', ' Clinics and Hospitals ', ' Clinics or Hospitals ', ' experience ', ' success ', ' Risk Adjustment ', ' Manuscripts ', ' Case Mixes ', ' Conflict of Interest ', ' Measures ', ' Econometric Models ', ' Family member ', ' Healthcare ', ' health care ', ' Modeling ', ' Quality of Care ', ' QOC ', ' case control ', ' Cohort Studies ', ' Concurrent Studies ', ' cost ', ' Dialysis patients ', ' Outcome ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' user-friendly ', ' Confidential Information ', ' Confusion ', ' Mental Confusion ', ' Confusional State ', ' Cessation of life ', ' Death ', ' Decision Making ', ' Provider ', ' computerized data processing ', ' signal processing ', ' data processing ', ' Dialysis procedure ', ' dialysis therapy ', ' Dialysis ', ' Embryo ', ' Embryonic ', ' Address ', ' Data ', ' Resolution ', ' Process ', ' Family ', ' Feedback ', ' Advertising ', ' Affect ', ' Age ', ' base ', ' ']",NIDDK,"CULMINI, INC.",R44,2010,408212,CA-14,0.060371166221132505
"Statistical Model Building for High Dimensional Biomedical Data    DESCRIPTION (provided by applicant):  Typical of current large-scale biomedical data is the feature of small number of observed samples and the widely observed sample heterogeneity. Identifying differentially expressed genes related to the sample phenotye (e.g., cancer disease development) and predicting sample phenotype based on the gene expressions are some central research questions in the microarray data analysis. Most existing statistical methods have ignored sample heterogeneity and thus loss power.       This project proposes to develop novel statistical methods that explicitly address the small sample size and sampe heterogeneity issues, and can be applied very generally. The usefulness of these methods will be shown with the large-scale biomedical data originating from the lung and kidney transplant research projects. The transplant projects aimed to improve the molecular diagnosis and therapy of lung/kidney allograft rejection by identifying molecular biomarkers to predict the allograft rejection for critical early treatment and rapid, noninvasive, and economical testing.       The specific aims are 1) Develop novel statistical methods for differential gene expression detection that explicitly model sample heterogeneity. 2) Develop novel statistical methods for classifying high-dimensional biomedical data and incorporating sample heterogeneity. 3) Develop novel statistical methods for jointly analyzing a set of genes (e.g., genes in a pathway). 4) Use the developed models and methods to answer research questions relevant to public health in the lung and kidney transplant projects; and implement and validate the proposed methods in user-friendly and well-documented software, and distribute them to the scientific community at no charge.       It is very important to identify new biomarkers of allograft rejection in lung and kidney transplant recipients. The rapid and reliable detection and prediction of rejection in easily obtainable body fluids may allow the rapid advancement of clinical interventional trials. We propose to study novel methods for analyzing the large-scale biomedical data to realize their full potential of molecular diagnosis and prognosis of transplant rejection prediction for critical early treatment.          ",Statistical Model Building for High Dimensional Biomedical Data,8079474,R01GM083345,"['software development ', ' developing computer software ', ' develop software ', ' Statistical Models ', ' Probabilistic Models ', ' Experimental Designs ', ' user-friendly ', ' Probability ', ' Transplant Recipients ', ' transplant patient ', ' outcome forecast ', ' Prognosis ', ' Dimensions ', ' Charge ', ' Heterogeneity ', ' Research Proposals ', ' Outcome Measure ', ' Joints ', ' Articulation ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Data Analyses ', ' Data Analysis ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Data Set ', ' Dataset ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Pathway interactions ', ' pathway ', ' Testing ', ' sound ', ' Universities ', ' interest ', ' Literature ', ' Outcome ', ' Collection ', ' Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' public health medicine (field) ', ' Public Health ', ' simulation ', ' Sample Size ', ' Early treatment ', ' early therapy ', ' early intervention ', ' Sampling ', ' Coupled ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Adopted ', ' cancer type ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Development ', ' developmental ', ' Communities ', ' Algorithms ', ' base ', ' Address ', ' biomarker ', ' Detection ', ' Characteristics ', ' Procedures ', ' Statistical Methods ', ' Phenotype ', ' Data ', ' Relative (related person) ', ' Relative ', ' Gene Expression ', ' Work ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Patients ', ' Computer software ', ' computer program/software ', ' Software ', ' improved ', ' Modeling ', ' Research ', ' theories ', ' Genomics ', ' Transplantation ', ' transplant ', ' Individual ', ' Genes ', ' novel ', ' Molecular ', ' Clinical ', ' Effectiveness ', ' Lung diseases ', ' lung disorder ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' design ', ' designing ', ' Diagnosis ', ' Technology ', ' Resources ', ' Research Resources ', ' biobank ', ' biorepository ', ' Minnesota ', ' Tissue-Specific Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' cancer microarray ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' kidney allograft ', ' renal allograft ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Body Fluids ', ' Least-Squares Analysis ', ' Least-Squares Analyses ', ' Least Squares ', ' transplant database ', ' transplant data base ', ' Molecular Diagnosis ', ' Kidney Transplantation ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Cations ', ' predictive modeling ', ' computer based prediction ', ' allograft rejection ', ' Graft Rejection ', ' Transplantation Rejection ', ' Transplant Rejection ', ' Oncogene Activation ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' method development ', ' user friendly software ', ' user friendly computer software ', ' ']",NIGMS,UNIVERSITY OF MINNESOTA,R01,2011,250488,MN-05,0.0386714687053259
"ICP Elevation Alerting Based on a Predictive Model Hosting Platform    DESCRIPTION (provided by applicant): Recurring acute ICP elevations occur frequently and unpredictably among severe brain injury patients. ICP elevation can cause cerebral ischemia and lead to deadly brain herniation if untreated. Hence, prompt recognition and treatment of rising ICP are critical in managing severe brain injury patients. However, existing protocols in most neurocritical care units are reactive where bedside nurses, in response to simple threshold-crossing alarms, have to check numerical display of ICP on monitors to manually establish whether the alarm is a true one before initiating treatment. Acute ICP elevation is accompanied by distinctive ICP pulse morphological changes. By utilizing ICP pulse morphological metrics as input, we can accurately recognize precursors to ICP elevation to alert nurses and free them from a cognitively demanding process of establishing whether a consistent ICP elevation triggers the alarm. We therefore propose to deploy a previously developed accurate ICP elevation prediction model on an open-source model hosting platform to monitor continuous ICP signals and alert bedside nurses. Using this alerting system, we will further investigate the principal physiological abnormalities associated with acute ICP elevation showing different precursory ICP patterns prior to onset of elevation. We will pursue the following three aims: 1) To develop an alerting system for ICP elevation based on a model hosting platform; 2) To investigate whether the ICP alerting system helps nurses more efficiently manage ICP. 3) To detect consistent physiological abnormalities associated with acute ICP elevation.  Our long-term goal is to advance intensive care monitoring so that continuous signals from monitors are fully explored to integrate with the rest of clinical data in an electronic medical record (EMR) system to enhance clinical decision making. This project represents an effort piloting a platform-based approach towards overcoming translational barriers that impede the process of making advanced predictive analytics available at point of care. Therefore, broad impacts from this project are related to future efforts at leveraging this open model hosting platform to facilitate the translation of additional predictive models in other ICUs.      PUBLIC HEALTH RELEVANCE: Recurring acute intracranial pressure (ICP) elevation occurs frequently, up to more than 20 in a 12-hour nursing shift, and unpredictably among severe brain injury patients. These acute ICP elevations needs prompt treatment before they impair blood flow to the brain and cause deadly brain herniation. The present work is built upon our previously developed algorithm of detecting acute ICP elevation and an open software platform for hosting predictive algorithms to further develop and evaluate a real-time ICP elevation alerting system that will provide accurate alerts of impending ICP elevation. Rigorous human factor engineering principles and techniques will be adopted in developing this system and we will further leverage this real-time alerting system to investigate the principal physiological abnormalities that are associated with accurate ICP elevation.              Recurring acute intracranial pressure (ICP) elevation occurs frequently, up to more than 20 in a 12-hour nursing shift, and unpredictably among severe brain injury patients. These acute ICP elevations needs prompt treatment before they impair blood flow to the brain and cause deadly brain herniation. The present work is built upon our previously developed algorithm of detecting acute ICP elevation and an open software platform for hosting predictive algorithms to further develop and evaluate a real-time ICP elevation alerting system that will provide accurate alerts of impending ICP elevation. Rigorous human factor engineering principles and techniques will be adopted in developing this system and we will further leverage this real-time alerting system to investigate the principal physiological abnormalities that are associated with accurate ICP elevation.            ",ICP Elevation Alerting Based on a Predictive Model Hosting Platform,8222233,R01NS076738,"['Encephalon ', ' Brain Nervous System ', ' Brain ', ' Attention ', ' Adoption ', ' Algorithms ', ' History ', ' Recording of previous events ', ' Goals ', ' Future ', ' Engineering ', ' Mining ', ' Nurses ', ' Manuals ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Discipline of Nursing ', ' Subarachnoid Pressure ', ' Intracranial Pressure ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Rest ', ' Plumbing ', ' Play ', ' Patients ', ' Caring ', ' Dataset ', ' Data Set ', ' Physiologic ', ' Physiological ', ' Morphologic artifacts ', ' Artifacts ', ' Intensive Care ', ' Intracranial Pressure Increase ', ' Intracranial Pressure Elevation ', ' Elevated Intracranial Pressure ', ' Intracranial Hypertension ', ' improved ', ' base ', ' Translating ', ' computer program/software ', ' Software ', ' Computer software ', ' Work ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' Translations ', ' Time ', ' Testing ', ' Hour ', ' Clinical Decision Support Systems ', ' Event ', ' Nature ', ' Adopted ', ' Investigation ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Techniques ', ' brain lesion (from injury) ', ' brain damage ', ' Acquired brain injury ', ' Brain Injuries ', ' Pulse ', ' Physiologic pulse ', ' Blood flow ', ' Evaluation ', ' Trust ', ' Acute ', ' Metric ', ' response ', ' Modeling ', ' Cerebral Ischemia ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' point of care ', ' developmental ', ' Development ', ' designing ', ' design ', ' Process ', ' cost ', ' Clinical Data ', ' Monitor ', ' computer based prediction ', ' predictive modeling ', ' Data ', ' Detection ', ' usability ', ' open source ', ' clinical decision-making ', ' clinical applicability ', ' clinical application ', ' innovative ', ' innovate ', ' innovation ', ' ']",NINDS,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2012,429539,CA-33,0.035235093380457716
"ICP Elevation Alerting Based on a Predictive Model Hosting Platform    DESCRIPTION (provided by applicant): Recurring acute ICP elevations occur frequently and unpredictably among severe brain injury patients. ICP elevation can cause cerebral ischemia and lead to deadly brain herniation if untreated. Hence, prompt recognition and treatment of rising ICP are critical in managing severe brain injury patients. However, existing protocols in most neurocritical care units are reactive where bedside nurses, in response to simple threshold-crossing alarms, have to check numerical display of ICP on monitors to manually establish whether the alarm is a true one before initiating treatment. Acute ICP elevation is accompanied by distinctive ICP pulse morphological changes. By utilizing ICP pulse morphological metrics as input, we can accurately recognize precursors to ICP elevation to alert nurses and free them from a cognitively demanding process of establishing whether a consistent ICP elevation triggers the alarm. We therefore propose to deploy a previously developed accurate ICP elevation prediction model on an open-source model hosting platform to monitor continuous ICP signals and alert bedside nurses. Using this alerting system, we will further investigate the principal physiological abnormalities associated with acute ICP elevation showing different precursory ICP patterns prior to onset of elevation. We will pursue the following three aims: 1) To develop an alerting system for ICP elevation based on a model hosting platform; 2) To investigate whether the ICP alerting system helps nurses more efficiently manage ICP. 3) To detect consistent physiological abnormalities associated with acute ICP elevation.  Our long-term goal is to advance intensive care monitoring so that continuous signals from monitors are fully explored to integrate with the rest of clinical data in an electronic medical record (EMR) system to enhance clinical decision making. This project represents an effort piloting a platform-based approach towards overcoming translational barriers that impede the process of making advanced predictive analytics available at point of care. Therefore, broad impacts from this project are related to future efforts at leveraging this open model hosting platform to facilitate the translation of additional predictive models in other ICUs.        Recurring acute intracranial pressure (ICP) elevation occurs frequently, up to more than 20 in a 12-hour nursing shift, and unpredictably among severe brain injury patients. These acute ICP elevations needs prompt treatment before they impair blood flow to the brain and cause deadly brain herniation. The present work is built upon our previously developed algorithm of detecting acute ICP elevation and an open software platform for hosting predictive algorithms to further develop and evaluate a real-time ICP elevation alerting system that will provide accurate alerts of impending ICP elevation. Rigorous human factor engineering principles and techniques will be adopted in developing this system and we will further leverage this real-time alerting system to investigate the principal physiological abnormalities that are associated with accurate ICP elevation.            ",ICP Elevation Alerting Based on a Predictive Model Hosting Platform,8466387,R01NS076738,"['Adoption ', ' Algorithms ', ' Attention ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Engineering ', ' Future ', ' Goals ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Subarachnoid Pressure ', ' Intracranial Pressure ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Manuals ', ' Mining ', ' Nurses ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Discipline of Nursing ', ' Patients ', ' Play ', ' Plumbing ', ' Rest ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Testing ', ' Time ', ' Translating ', ' Translations ', ' Work ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' Artifacts ', ' Morphologic artifacts ', ' Intensive Care ', ' Dataset ', ' Data Set ', ' Caring ', ' Intracranial Pressure Increase ', ' Intracranial Pressure Elevation ', ' Elevated Intracranial Pressure ', ' Intracranial Hypertension ', ' base ', ' improved ', ' Acute ', ' Physiologic ', ' Physiological ', ' Evaluation ', ' Blood flow ', ' Trust ', ' brain lesion (from injury) ', ' brain damage ', ' Acquired brain injury ', ' Brain Injuries ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Pulse ', ' Physiologic pulse ', ' Adopted ', ' Investigation ', ' Hour ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Clinical Decision Support Systems ', ' interest ', ' Metric ', ' Modeling ', ' response ', ' Cerebral Ischemia ', ' Data ', ' Detection ', ' Clinical Data ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' point of care ', ' cost ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' clinical applicability ', ' clinical application ', ' open source ', ' usability ', ' clinical decision-making ', ' ']",NINDS,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2013,227168,CA-33,0.0413053686802712
"ICP Elevation Alerting Based on a Predictive Model Hosting Platform DESCRIPTION (provided by applicant): Recurring acute ICP elevations occur frequently and unpredictably among severe brain injury patients. ICP elevation can cause cerebral ischemia and lead to deadly brain herniation if untreated. Hence, prompt recognition and treatment of rising ICP are critical in managing severe brain injury patients. However, existing protocols in most neurocritical care units are reactive where bedside nurses, in response to simple threshold-crossing alarms, have to check numerical display of ICP on monitors to manually establish whether the alarm is a true one before initiating treatment. Acute ICP elevation is accompanied by distinctive ICP pulse morphological changes. By utilizing ICP pulse morphological metrics as input, we can accurately recognize precursors to ICP elevation to alert nurses and free them from a cognitively demanding process of establishing whether a consistent ICP elevation triggers the alarm. We therefore propose to deploy a previously developed accurate ICP elevation prediction model on an open-source model hosting platform to monitor continuous ICP signals and alert bedside nurses. Using this alerting system, we will further investigate the principal physiological abnormalities associated with acute ICP elevation showing different precursory ICP patterns prior to onset of elevation. We will pursue the following three aims: 1) To develop an alerting system for ICP elevation based on a model hosting platform; 2) To investigate whether the ICP alerting system helps nurses more efficiently manage ICP. 3) To detect consistent physiological abnormalities associated with acute ICP elevation. Our long-term goal is to advance intensive care monitoring so that continuous signals from monitors are fully explored to integrate with the rest of clinical data in an electronic medical record (EMR) system to enhance clinical decision making. This project represents an effort piloting a platform-based approach towards overcoming translational barriers that impede the process of making advanced predictive analytics available at point of care. Therefore, broad impacts from this project are related to future efforts at leveraging this open model hosting platform to facilitate the translation of additional predictive models in other ICUs. Recurring acute intracranial pressure (ICP) elevation occurs frequently, up to more than 20 in a 12-hour nursing shift, and unpredictably among severe brain injury patients. These acute ICP elevations needs prompt treatment before they impair blood flow to the brain and cause deadly brain herniation. The present work is built upon our previously developed algorithm of detecting acute ICP elevation and an open software platform for hosting predictive algorithms to further develop and evaluate a real-time ICP elevation alerting system that will provide accurate alerts of impending ICP elevation. Rigorous human factor engineering principles and techniques will be adopted in developing this system and we will further leverage this real-time alerting system to investigate the principal physiological abnormalities that are associated with accurate ICP elevation.",ICP Elevation Alerting Based on a Predictive Model Hosting Platform,8726550,R01NS076738,"['Adoption ', ' Algorithms ', ' Attention ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Engineering ', ' Future ', ' Goals ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Subarachnoid Pressure ', ' Intracranial Pressure ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Manuals ', ' Mining ', ' Nurses ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Discipline of Nursing ', ' Patients ', ' Play ', ' Plumbing ', ' Rest ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Testing ', ' Time ', ' Translating ', ' Translations ', ' Work ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' Artifacts ', ' Morphologic artifacts ', ' Intensive Care ', ' Dataset ', ' Data Set ', ' Caring ', ' Intracranial Pressure Increase ', ' Intracranial Pressure Elevation ', ' Elevated Intracranial Pressure ', ' Intracranial Hypertension ', ' base ', ' improved ', ' Acute ', ' Physiologic ', ' Physiological ', ' Evaluation ', ' Blood flow ', ' Trust ', ' brain lesion (from injury) ', ' brain damage ', ' Acquired brain injury ', ' Brain Injuries ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Pulse ', ' Physiologic pulse ', ' Adopted ', ' Investigation ', ' Hour ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Clinical Decision Support Systems ', ' interest ', ' Metric ', ' Modeling ', ' response ', ' Cerebral Ischemia ', ' Data ', ' Detection ', ' Clinical Data ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' point of care ', ' cost ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' clinical applicability ', ' clinical application ', ' open source ', ' usability ', ' clinical decision-making ', ' ']",NINDS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2013,182560,CA-12,0.0413053686802712
"ICP Elevation Alerting Based on a Predictive Model Hosting Platform DESCRIPTION (provided by applicant): Recurring acute ICP elevations occur frequently and unpredictably among severe brain injury patients. ICP elevation can cause cerebral ischemia and lead to deadly brain herniation if untreated. Hence, prompt recognition and treatment of rising ICP are critical in managing severe brain injury patients. However, existing protocols in most neurocritical care units are reactive where bedside nurses, in response to simple threshold-crossing alarms, have to check numerical display of ICP on monitors to manually establish whether the alarm is a true one before initiating treatment. Acute ICP elevation is accompanied by distinctive ICP pulse morphological changes. By utilizing ICP pulse morphological metrics as input, we can accurately recognize precursors to ICP elevation to alert nurses and free them from a cognitively demanding process of establishing whether a consistent ICP elevation triggers the alarm. We therefore propose to deploy a previously developed accurate ICP elevation prediction model on an open-source model hosting platform to monitor continuous ICP signals and alert bedside nurses. Using this alerting system, we will further investigate the principal physiological abnormalities associated with acute ICP elevation showing different precursory ICP patterns prior to onset of elevation. We will pursue the following three aims: 1) To develop an alerting system for ICP elevation based on a model hosting platform; 2) To investigate whether the ICP alerting system helps nurses more efficiently manage ICP. 3) To detect consistent physiological abnormalities associated with acute ICP elevation. Our long-term goal is to advance intensive care monitoring so that continuous signals from monitors are fully explored to integrate with the rest of clinical data in an electronic medical record (EMR) system to enhance clinical decision making. This project represents an effort piloting a platform-based approach towards overcoming translational barriers that impede the process of making advanced predictive analytics available at point of care. Therefore, broad impacts from this project are related to future efforts at leveraging this open model hosting platform to facilitate the translation of additional predictive models in other ICUs. Recurring acute intracranial pressure (ICP) elevation occurs frequently, up to more than 20 in a 12-hour nursing shift, and unpredictably among severe brain injury patients. These acute ICP elevations needs prompt treatment before they impair blood flow to the brain and cause deadly brain herniation. The present work is built upon our previously developed algorithm of detecting acute ICP elevation and an open software platform for hosting predictive algorithms to further develop and evaluate a real-time ICP elevation alerting system that will provide accurate alerts of impending ICP elevation. Rigorous human factor engineering principles and techniques will be adopted in developing this system and we will further leverage this real-time alerting system to investigate the principal physiological abnormalities that are associated with accurate ICP elevation.",ICP Elevation Alerting Based on a Predictive Model Hosting Platform,8732711,R01NS076738,"['Adoption ', ' Algorithms ', ' Attention ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Engineering ', ' Future ', ' Goals ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Subarachnoid Pressure ', ' Intracranial Pressure ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Manuals ', ' Mining ', ' Nurses ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Discipline of Nursing ', ' Patients ', ' Play ', ' Plumbing ', ' Rest ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Testing ', ' Time ', ' Translating ', ' Translations ', ' Work ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' Artifacts ', ' Morphologic artifacts ', ' Intensive Care ', ' Dataset ', ' Data Set ', ' Caring ', ' Intracranial Pressure Increase ', ' Intracranial Pressure Elevation ', ' Elevated Intracranial Pressure ', ' Intracranial Hypertension ', ' base ', ' improved ', ' Acute ', ' Physiologic ', ' Physiological ', ' Evaluation ', ' Blood flow ', ' Trust ', ' brain lesion (from injury) ', ' brain damage ', ' Acquired brain injury ', ' Brain Injuries ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Pulse ', ' Physiologic pulse ', ' Adopted ', ' Investigation ', ' Hour ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Clinical Decision Support Systems ', ' interest ', ' Metric ', ' Modeling ', ' response ', ' Cerebral Ischemia ', ' Data ', ' Detection ', ' Clinical Data ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' point of care ', ' cost ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' clinical applicability ', ' clinical application ', ' open source ', ' usability ', ' clinical decision-making ', ' Software Algorithm ', ' Algorithmic Tools ', ' Algorithmic Software ', ' ']",NINDS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2014,435641,CA-12,0.0413053686802712
"Predictive Model of Chronic Kidney Disease in a Hispanic Population     DESCRIPTION (provided by applicant): This career transition award will provide the applicant with protected research time to develop an independent research career in biomedical informatics. Dr. Starkey received his M.D. in 2003 from UT Southwestern, completed the NLM Biomedical Informatics Training Program post-doctoral fellowship in 2011 and earned a Ph.D. focusing on clinical informatics from the Clinical Sciences Degree Program at the University of Texas Medical Branch (UTMB) at Galveston in 2012. Dr. Starkey accepted a faculty position at the Institute for Translational Sciences at UTMB that is currently supporting his transition to independent investigator. Dr. Starkey will utilize the career transition award for novel applications of advanced machine learning methods to create predictive models of disease. Predictive models of disease allow for the stratification of risk and prevention of disease and have been successfully implemented in the assessment of cardiovascular disease risk. Predictive models of chronic kidney disease (CKD) are an active area of research since CKD is a risk factor for all-cause mortality, cardiovascular death and end-stage renal disease. However, there is not a single predictive model of CKD created for application to Hispanics and the external validity of existing models is poor. The objective of this project is to create predictive models of chronic kidney disease in a Hispanic population and quantify biomarkers of chronic kidney disease using multiple reaction monitoring (MRM) proteomics in this minority population. MRM proteomics will utilize the UTMB Novel Methodologies core and its array of resources to create an inter-institutional collaboration. Heterogeneous ensemble machine learning methods will be used to create the predictive model of chronic kidney disease in the Cameron County Hispanic Cohort (CCHC). Established in 2004, the CCHC is a random population sample in Brownsville, Texas created to evaluate the determinants of health in a US/Mexico border population that is primarily of Hispanic ethnicity. The CCHC has an extremely high prevalence of obesity and diabetes at 49.7% and 30.3%, respectively. Both obesity and diabetes are independent risk factors for the development of CKD and represent significant health disparities in the Hispanic population. Archived serum samples of CCHC participants and the CCHC database will be utilized to complete the following aims: 1) Create predictive models of CKD in a Hispanic population 2) Refine the predictive models by including clinical laboratory data and a selective reaction monitoring mass spectrometry panel of biomarkers. At the completion of this project, predictive models of CKD applicable to a Hispanic population will be created and MRM proteomics will demonstrate utility of biomarkers identified in other populations. The application of the results will be used to create clinical tools for CKD risk and guide future studies in this Hispanic population with health disparities. Importantly, it will provide a career transition for D. Starkey to demonstrate the knowledge gained during his training that results in impactful research and publications.              PROJECT NARRATIVE:  The proposed research is relevant to public health because it allows stratification of chronic kidney disease risk and quantifies biomarkers of chronic kidney disease in the Hispanic minority whom has significant health disparities with regard to kidney disease. The translation of selective reaction monitoring of biomarkers and development of heterogeneous ensemble machine learning methods for application to the prediction of chronic kidney disease in a minority population supports the NLM mission.",Predictive Model of Chronic Kidney Disease in a Hispanic Population,8700987,K22LM011869,"['Age ', ' Albumins ', ' Archives ', ' atherosclerotic vascular disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular system (all sites) ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardiovascular system ', ' Clinical Informatics ', ' Communities ', ' 2-amino-1,5-dihydro-1-methyl-4H-imidazol-4-one ', ' Creatinine ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' dialysis therapy ', ' Dialysis ', ' Dialysis procedure ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Faculty ', ' Fellowship ', ' Future ', ' Goals ', ' Health ', ' Hospitalization ', ' Household ', ' Incidence ', ' Institutes ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Chronic Kidney Failure ', ' Laboratories ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Mexico ', ' Mission ', ' Mortality ', ' Mortality Vital Statistics ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Probability ', ' Public Health ', ' public health medicine (field) ', ' Scientific Publication ', ' Publications ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Texas ', ' Time ', ' Training Programs ', ' Translations ', ' transplant ', ' Transplantation ', ' Universities ', ' Weight ', ' Work ', ' County ', ' forest ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Dataset ', ' Data Set ', ' career ', ' improved ', ' Area ', ' Clinical ', ' Medical ', ' Logistic Regressions ', ' Training ', ' Blood Serum ', ' Serum ', ' kidney function ', ' Renal function ', ' Individual ', ' Mexican ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Collaborations ', ' tool ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Investigation ', ' Reaction ', ' Visit ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' Postdoctoral Fellow ', ' cohort ', ' skills ', ' Disease Outcome ', ' novel ', ' Participant ', ' disease prevention ', ' disorder prevention ', ' disease risk ', ' disorder risk ', ' General Public ', ' General Population ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' Sampling ', ' Proteomics ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' health disparities ', ' health disparity ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' High Prevalence ', ' Stratification ', ' Career Transition Award ', ' Clinical Sciences ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Validation ', ' Monitor ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' urinary ', ' developmental ', ' Development ', ' biomed informatics ', ' biomedical informatics ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Minority ', ' cost-effective ', ' cost effective ', ' Population ', ' Prevalence ', ' prospective ', ' innovative ', ' innovate ', ' innovation ', ' medically underserved ', ' informatics training ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' multiple reaction monitoring ', ' screening ', ' ']",NLM,UNIVERSITY OF TEXAS MED BR GALVESTON,K22,2014,132121,TX-14,0.1516473655992275
"Predictive Model of Chronic Kidney Disease in a Hispanic Population DESCRIPTION (provided by applicant): This career transition award will provide the applicant with protected research time to develop an independent research career in biomedical informatics. Dr. Starkey received his M.D. in 2003 from UT Southwestern, completed the NLM Biomedical Informatics Training Program post-doctoral fellowship in 2011 and earned a Ph.D. focusing on clinical informatics from the Clinical Sciences Degree Program at the University of Texas Medical Branch (UTMB) at Galveston in 2012. Dr. Starkey accepted a faculty position at the Institute for Translational Sciences at UTMB that is currently supporting his transition to independent investigator. Dr. Starkey will utilize the career transition award for novel applications of advanced machine learning methods to create predictive models of disease. Predictive models of disease allow for the stratification of risk and prevention of disease and have been successfully implemented in the assessment of cardiovascular disease risk. Predictive models of chronic kidney disease (CKD) are an active area of research since CKD is a risk factor for all-cause mortality, cardiovascular death and end-stage renal disease. However, there is not a single predictive model of CKD created for application to Hispanics and the external validity of existing models is poor. The objective of this project is to create predictive models of chronic kidney disease in a Hispanic population and quantify biomarkers of chronic kidney disease using multiple reaction monitoring (MRM) proteomics in this minority population. MRM proteomics will utilize the UTMB Novel Methodologies core and its array of resources to create an inter-institutional collaboration. Heterogeneous ensemble machine learning methods will be used to create the predictive model of chronic kidney disease in the Cameron County Hispanic Cohort (CCHC). Established in 2004, the CCHC is a random population sample in Brownsville, Texas created to evaluate the determinants of health in a US/Mexico border population that is primarily of Hispanic ethnicity. The CCHC has an extremely high prevalence of obesity and diabetes at 49.7% and 30.3%, respectively. Both obesity and diabetes are independent risk factors for the development of CKD and represent significant health disparities in the Hispanic population. Archived serum samples of CCHC participants and the CCHC database will be utilized to complete the following aims: 1) Create predictive models of CKD in a Hispanic population 2) Refine the predictive models by including clinical laboratory data and a selective reaction monitoring mass spectrometry panel of biomarkers. At the completion of this project, predictive models of CKD applicable to a Hispanic population will be created and MRM proteomics will demonstrate utility of biomarkers identified in other populations. The application of the results will be used to create clinical tools for CKD risk and guide future studies in this Hispanic population with health disparities. Importantly, it will provide a career transition for D. Starkey to demonstrate the knowledge gained during his training that results in impactful research and publications. PROJECT NARRATIVE:  The proposed research is relevant to public health because it allows stratification of chronic kidney disease risk and quantifies biomarkers of chronic kidney disease in the Hispanic minority whom has significant health disparities with regard to kidney disease. The translation of selective reaction monitoring of biomarkers and development of heterogeneous ensemble machine learning methods for application to the prediction of chronic kidney disease in a minority population supports the NLM mission.",Predictive Model of Chronic Kidney Disease in a Hispanic Population,8929292,K22LM011869,"['Age ', ' Albumins ', ' Archives ', ' atherosclerotic vascular disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular system (all sites) ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardiovascular system ', ' Clinical Informatics ', ' Communities ', ' 2-amino-1,5-dihydro-1-methyl-4H-imidazol-4-one ', ' Creatinine ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' dialysis therapy ', ' Dialysis ', ' Dialysis procedure ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Faculty ', ' Fellowship ', ' Future ', ' Goals ', ' Health ', ' Hospitalization ', ' Household ', ' Incidence ', ' Institutes ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Chronic Kidney Failure ', ' Laboratories ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Mexico ', ' Mission ', ' Mortality ', ' Mortality Vital Statistics ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Probability ', ' Public Health ', ' public health medicine (field) ', ' Scientific Publication ', ' Publications ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Texas ', ' Time ', ' Training Programs ', ' Translations ', ' transplant ', ' Transplantation ', ' Universities ', ' Weight ', ' Work ', ' County ', ' forest ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Dataset ', ' Data Set ', ' career ', ' improved ', ' Area ', ' Clinical ', ' Medical ', ' Logistic Regressions ', ' Training ', ' Blood Serum ', ' Serum ', ' kidney function ', ' Renal function ', ' Individual ', ' Mexican ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Collaborations ', ' tool ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Investigation ', ' Reaction ', ' Visit ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' Postdoctoral Fellow ', ' cohort ', ' skills ', ' Disease Outcome ', ' novel ', ' Participant ', ' disease prevention ', ' disorder prevention ', ' disease risk ', ' disorder risk ', ' General Public ', ' General Population ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' Sampling ', ' Proteomics ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' health disparities ', ' health disparity ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' High Prevalence ', ' Stratification ', ' Career Transition Award ', ' Clinical Sciences ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Validation ', ' Monitor ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' urinary ', ' developmental ', ' Development ', ' biomed informatics ', ' biomedical informatics ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Minority ', ' cost-effective ', ' cost effective ', ' Population ', ' Prevalence ', ' prospective ', ' innovative ', ' innovate ', ' innovation ', ' medically underserved ', ' informatics training ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' multiple reaction monitoring ', ' screening ', ' ']",NLM,UNIVERSITY OF TEXAS MED BR GALVESTON,K22,2015,132348,TX-14,0.1516473655992275
"ICP Elevation Alerting Based on a Predictive Model Hosting Platform DESCRIPTION (provided by applicant): Recurring acute ICP elevations occur frequently and unpredictably among severe brain injury patients. ICP elevation can cause cerebral ischemia and lead to deadly brain herniation if untreated. Hence, prompt recognition and treatment of rising ICP are critical in managing severe brain injury patients. However, existing protocols in most neurocritical care units are reactive where bedside nurses, in response to simple threshold-crossing alarms, have to check numerical display of ICP on monitors to manually establish whether the alarm is a true one before initiating treatment. Acute ICP elevation is accompanied by distinctive ICP pulse morphological changes. By utilizing ICP pulse morphological metrics as input, we can accurately recognize precursors to ICP elevation to alert nurses and free them from a cognitively demanding process of establishing whether a consistent ICP elevation triggers the alarm. We therefore propose to deploy a previously developed accurate ICP elevation prediction model on an open-source model hosting platform to monitor continuous ICP signals and alert bedside nurses. Using this alerting system, we will further investigate the principal physiological abnormalities associated with acute ICP elevation showing different precursory ICP patterns prior to onset of elevation. We will pursue the following three aims: 1) To develop an alerting system for ICP elevation based on a model hosting platform; 2) To investigate whether the ICP alerting system helps nurses more efficiently manage ICP. 3) To detect consistent physiological abnormalities associated with acute ICP elevation. Our long-term goal is to advance intensive care monitoring so that continuous signals from monitors are fully explored to integrate with the rest of clinical data in an electronic medical record (EMR) system to enhance clinical decision making. This project represents an effort piloting a platform-based approach towards overcoming translational barriers that impede the process of making advanced predictive analytics available at point of care. Therefore, broad impacts from this project are related to future efforts at leveraging this open model hosting platform to facilitate the translation of additional predictive models in other ICUs. Recurring acute intracranial pressure (ICP) elevation occurs frequently, up to more than 20 in a 12-hour nursing shift, and unpredictably among severe brain injury patients. These acute ICP elevations needs prompt treatment before they impair blood flow to the brain and cause deadly brain herniation. The present work is built upon our previously developed algorithm of detecting acute ICP elevation and an open software platform for hosting predictive algorithms to further develop and evaluate a real-time ICP elevation alerting system that will provide accurate alerts of impending ICP elevation. Rigorous human factor engineering principles and techniques will be adopted in developing this system and we will further leverage this real-time alerting system to investigate the principal physiological abnormalities that are associated with accurate ICP elevation.",ICP Elevation Alerting Based on a Predictive Model Hosting Platform,8789794,R01NS076738,"['Adoption ', ' Algorithms ', ' Attention ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Engineering ', ' Future ', ' Goals ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Subarachnoid Pressure ', ' Intracranial Pressure ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Manuals ', ' Mining ', ' Nurses ', ' Nursing Profession ', ' Nursing Field ', ' Nursing ', ' Discipline of Nursing ', ' Patients ', ' Play ', ' Plumbing ', ' Rest ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Testing ', ' Time ', ' Translating ', ' Translations ', ' Work ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' Morphologic artifacts ', ' Artifacts ', ' Intensive Care ', ' Dataset ', ' Data Set ', ' Caring ', ' Intracranial Pressure Increase ', ' Intracranial Pressure Elevation ', ' Elevated Intracranial Pressure ', ' Intracranial Hypertension ', ' base ', ' improved ', ' Acute ', ' Physiologic ', ' Physiological ', ' Evaluation ', ' Blood flow ', ' Trust ', ' brain lesion (from injury) ', ' brain damage ', ' Acquired brain injury ', ' Brain Injuries ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Pulse ', ' Physiologic pulse ', ' Adopted ', ' Investigation ', ' Hour ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Clinical Decision Support Systems ', ' interest ', ' Modeling ', ' response ', ' Cerebral Ischemia ', ' Data ', ' Detection ', ' Clinical Data ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' point of care ', ' cost ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' clinical applicability ', ' clinical application ', ' open source ', ' usability ', ' clinical decision-making ', ' Software Algorithm ', ' Algorithmic Tools ', ' Algorithmic Software ', ' unique treatment ', ' targeted treatment ', ' tailored treatment ', ' individualized treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' ']",NINDS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2015,442019,CA-12,0.0413053686802712
"Promoting Utilization of Kidneys by Improving Patient Level Decision Making     DESCRIPTION (provided by applicant): Promoting Utilization of Kidneys by Improving Organ Acceptance Decision Making Only 15,652 of nearly 109,000 waitlisted patients for kidney transplant (KT) received one in 2014. More than six thousand died while waiting for a KT and more than two thousand became too sick to be transplanted. Patient survival, quality of life, and morbidity is significantly worse for those who remain on dialysis. The majority of kidneys that are transplanted are recovered from deceased donors. In 2014, while 12,664 kidneys were recovered for KT, 2,272 were discarded - most frequently due to being of marginal or low quality. Many of the discarded kidneys are believed to confer smaller survival gains than other procured kidneys. Previous studies show that the marginal kidneys offer survival benefits with respect to remaining on dialysis, but neglect quantification of these benefits to an individual patient. These studies ignore two major issues: (i) the low c-statistics of one and three year post-transplant patient and graft survival models; and (ii) dynamics of the organ offers and the current point based priority system for the waitlisted patients. Given these facts, from a decision maker's perspective, accepting or rejecting a low quality organ is not necessarily a well informed choice.  The proposed research takes a comprehensive approach in developing a survival model incorporating time on dialysis, recipient characteristics, transplant center characteristics, and donated kidney characteristics. It proposes to apply techniques from biostatistics and machine learning to improve model accuracy. The research further aims to quantify the dynamics of kidney availability of different quality organs, and model future kidney offers as a stochastic decision tree. The proposed computational engine for estimating the survival benefits of accepting or rejecting an offer will be transformative in clinical decision making. Moreover, th successful completion of the proposed research will provide a highly reliable approach to support kidney acceptance/rejection decisions. The research will be carried out by a trans- disciplinary team with expert knowledge in the transplant allocation system, decision methodologies, and clinical decision making. The research team will incorporate input from an external advisory board consisting of leaders and key stakeholders in kidney and pancreas transplant programs.   PUBLIC HEALTH RELEVANCE: The transplantation system in the United States discards hundreds of recovered kidneys annually. Many of the discarded kidneys are of marginal quality and are believed to confer smaller survival gains than other procured kidneys. The proposed research will take a comprehensive approach to accurately quantify patient survival and implications of accepting a kidney towards developing a decision support engine.  ",Promoting Utilization of Kidneys by Improving Patient Level Decision Making,9019712,R21DK108104,"['Accounting ', ' Affect ', ' Age ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Biopsy ', ' Blood Typing ', ' Blood Grouping ', ' Blood typing procedure ', ' Cause of Death ', ' Creatinine ', ' Death ', ' Cessation of life ', ' Decision Making ', ' Decision Trees ', ' diabetes ', ' Diabetes Mellitus ', ' dialysis therapy ', ' Dialysis ', ' Dialysis procedure ', ' Disorder ', ' Disease ', ' Elements ', ' Future ', ' Graft Survival ', ' Health ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' HCV infection ', ' Hepatitis C ', ' History ', ' Recording of previous events ', ' Leukocyte Antigens ', ' Human Leukocyte Antigens ', ' HL-A Antigens ', ' HLA Antigens ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' indexing ', ' Ischemia ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Kidney Transplantation ', ' Laterality ', ' Handedness ', ' Methodology ', ' Morbidity ', ' Morbidity - disease rate ', ' Pancreatic ', ' Pancreas ', ' Patients ', ' QOL ', ' Quality of life ', ' Registries ', ' Research ', ' Research Resources ', ' Resources ', ' statistics ', ' Time ', ' transplant ', ' Transplantation ', ' United States ', ' Waiting Lists ', ' Weight ', ' Measures ', ' Cost Savings ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Uncertainty ', ' doubt ', ' base ', ' Organ ', ' improved ', ' Chronic ', ' Blood Serum ', ' Serum ', ' Individual ', ' Ethnicity ', ' Ethnic Origin ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' transplant patient ', ' Transplant Recipients ', ' Knowledge ', ' programs ', ' Complex ', ' Techniques ', ' System ', ' Height ', ' Modeling ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' Address ', ' Data ', ' Organ Model ', ' Characteristics ', ' Process ', ' cost ', ' neglect ', ' time use ', ' clinical decision-making ', ' individual patient ', ' improved outcome ', ' survival outcome ', ' ']",NIDDK,NORTHWESTERN UNIVERSITY,R21,2016,189567,IL-07,0.23555140702429497
"Predictive Model of Chronic Kidney Disease in a Hispanic Population DESCRIPTION (provided by applicant): This career transition award will provide the applicant with protected research time to develop an independent research career in biomedical informatics. Dr. Starkey received his M.D. in 2003 from UT Southwestern, completed the NLM Biomedical Informatics Training Program post-doctoral fellowship in 2011 and earned a Ph.D. focusing on clinical informatics from the Clinical Sciences Degree Program at the University of Texas Medical Branch (UTMB) at Galveston in 2012. Dr. Starkey accepted a faculty position at the Institute for Translational Sciences at UTMB that is currently supporting his transition to independent investigator. Dr. Starkey will utilize the career transition award for novel applications of advanced machine learning methods to create predictive models of disease. Predictive models of disease allow for the stratification of risk and prevention of disease and have been successfully implemented in the assessment of cardiovascular disease risk. Predictive models of chronic kidney disease (CKD) are an active area of research since CKD is a risk factor for all-cause mortality, cardiovascular death and end-stage renal disease. However, there is not a single predictive model of CKD created for application to Hispanics and the external validity of existing models is poor. The objective of this project is to create predictive models of chronic kidney disease in a Hispanic population and quantify biomarkers of chronic kidney disease using multiple reaction monitoring (MRM) proteomics in this minority population. MRM proteomics will utilize the UTMB Novel Methodologies core and its array of resources to create an inter-institutional collaboration. Heterogeneous ensemble machine learning methods will be used to create the predictive model of chronic kidney disease in the Cameron County Hispanic Cohort (CCHC). Established in 2004, the CCHC is a random population sample in Brownsville, Texas created to evaluate the determinants of health in a US/Mexico border population that is primarily of Hispanic ethnicity. The CCHC has an extremely high prevalence of obesity and diabetes at 49.7% and 30.3%, respectively. Both obesity and diabetes are independent risk factors for the development of CKD and represent significant health disparities in the Hispanic population. Archived serum samples of CCHC participants and the CCHC database will be utilized to complete the following aims: 1) Create predictive models of CKD in a Hispanic population 2) Refine the predictive models by including clinical laboratory data and a selective reaction monitoring mass spectrometry panel of biomarkers. At the completion of this project, predictive models of CKD applicable to a Hispanic population will be created and MRM proteomics will demonstrate utility of biomarkers identified in other populations. The application of the results will be used to create clinical tools for CKD risk and guide future studies in this Hispanic population with health disparities. Importantly, it will provide a career transition for D. Starkey to demonstrate the knowledge gained during his training that results in impactful research and publications. PROJECT NARRATIVE:  The proposed research is relevant to public health because it allows stratification of chronic kidney disease risk and quantifies biomarkers of chronic kidney disease in the Hispanic minority whom has significant health disparities with regard to kidney disease. The translation of selective reaction monitoring of biomarkers and development of heterogeneous ensemble machine learning methods for application to the prediction of chronic kidney disease in a minority population supports the NLM mission.",Predictive Model of Chronic Kidney Disease in a Hispanic Population,9121614,K22LM011869,"['Age ', ' Albumins ', ' Archives ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' career transition ', ' career advancement ', ' Career Mobility ', ' Clinical Informatics ', ' Communities ', ' Creatinine ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' dialysis therapy ', ' Dialysis ', ' Dialysis procedure ', ' Disorder ', ' Disease ', ' Faculty ', ' Fellowship ', ' Future ', ' Goals ', ' Health ', ' Hospitalization ', ' Household ', ' Incidence ', ' Institutes ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Chronic Kidney Failure ', ' Laboratories ', ' Methods ', ' Methodology ', ' Mexico ', ' Mission ', ' mortality ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Probability ', ' Public Health ', ' Scientific Publication ', ' Publications ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Mass Spectrum Analysis ', ' Texas ', ' Time ', ' Training Programs ', ' Translations ', ' transplant ', ' Transplantation ', ' Universities ', ' Weight ', ' Work ', ' County ', ' forest ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Data Set ', ' Dataset ', ' career ', ' improved ', ' Area ', ' Clinical ', ' Medical ', ' Logistic Regressions ', ' Training ', ' Blood Serum ', ' Serum ', ' kidney function ', ' Renal function ', ' Individual ', ' Mexican ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Collaborations ', ' tool ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Investigation ', ' Reaction ', ' Visit ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' Postdoctoral Fellow ', ' cohort ', ' skills ', ' Disease Outcome ', ' novel ', ' Participant ', ' disease prevention ', ' disorder prevention ', ' disease risk ', ' disorder risk ', ' General Public ', ' General Population ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' Sampling ', ' Proteomics ', ' cardiovascular disease risk ', ' cardiovascular disorder risk ', ' disparity in health ', ' health disparity ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' High Prevalence ', ' Stratification ', ' Career Transition Award ', ' Clinical Sciences ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Validation ', ' Monitor ', ' Process ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' urinary ', ' developmental ', ' Development ', ' biomed informatics ', ' biomedical informatics ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Minority ', ' cost effective ', ' cost-effective ', ' Population ', ' Prevalence ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' medically underserved ', ' informatics training ', ' novel marker ', ' novel biomarker ', ' new marker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' multiple reaction monitoring ', ' screening ', ' learning strategy ', ' learning method ', ' learning activity ', ' inter-institutional ', ' Degree program ', ' biomarker development ', ' biomarker panel ', ' marker panel ', ' ']",NLM,UNIVERSITY OF TEXAS MED BR GALVESTON,K22,2016,135270,TX-14,0.1516473655992275
"Promoting Utilization of Kidneys by Improving Patient Level Decision Making     DESCRIPTION (provided by applicant): Promoting Utilization of Kidneys by Improving Organ Acceptance Decision Making Only 15,652 of nearly 109,000 waitlisted patients for kidney transplant (KT) received one in 2014. More than six thousand died while waiting for a KT and more than two thousand became too sick to be transplanted. Patient survival, quality of life, and morbidity is significantly worse for those who remain on dialysis. The majority of kidneys that are transplanted are recovered from deceased donors. In 2014, while 12,664 kidneys were recovered for KT, 2,272 were discarded - most frequently due to being of marginal or low quality. Many of the discarded kidneys are believed to confer smaller survival gains than other procured kidneys. Previous studies show that the marginal kidneys offer survival benefits with respect to remaining on dialysis, but neglect quantification of these benefits to an individual patient. These studies ignore two major issues: (i) the low c-statistics of one and three year post-transplant patient and graft survival models; and (ii) dynamics of the organ offers and the current point based priority system for the waitlisted patients. Given these facts, from a decision maker's perspective, accepting or rejecting a low quality organ is not necessarily a well informed choice.  The proposed research takes a comprehensive approach in developing a survival model incorporating time on dialysis, recipient characteristics, transplant center characteristics, and donated kidney characteristics. It proposes to apply techniques from biostatistics and machine learning to improve model accuracy. The research further aims to quantify the dynamics of kidney availability of different quality organs, and model future kidney offers as a stochastic decision tree. The proposed computational engine for estimating the survival benefits of accepting or rejecting an offer will be transformative in clinical decision making. Moreover, th successful completion of the proposed research will provide a highly reliable approach to support kidney acceptance/rejection decisions. The research will be carried out by a trans- disciplinary team with expert knowledge in the transplant allocation system, decision methodologies, and clinical decision making. The research team will incorporate input from an external advisory board consisting of leaders and key stakeholders in kidney and pancreas transplant programs. PUBLIC HEALTH RELEVANCE: The transplantation system in the United States discards hundreds of recovered kidneys annually. Many of the discarded kidneys are of marginal quality and are believed to confer smaller survival gains than other procured kidneys. The proposed research will take a comprehensive approach to accurately quantify patient survival and implications of accepting a kidney towards developing a decision support engine.  ",Promoting Utilization of Kidneys by Improving Patient Level Decision Making,9283528,R21DK108104,"['Affect ', ' ages ', ' Age ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Biopsy ', ' Blood Reticuloendothelial System ', ' Blood ', ' Cause of Death ', ' Creatinine ', ' Death ', ' Cessation of life ', ' Decision Making ', ' Decision Trees ', ' diabetes ', ' Diabetes Mellitus ', ' dialysis therapy ', ' Dialysis ', ' Dialysis procedure ', ' Disorder ', ' Disease ', ' Elements ', ' Future ', ' Graft Survival ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' non-A, non-B hepatitis ', ' non A, non B hepatitis ', ' hepatitis non A non B ', ' hep C ', ' Hepatitus C ', ' Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted ', ' Hepatitis C virus infection ', ' Hepatitis C virus ', ' HCV infection ', ' HCV ', ' Hepatitis C ', ' History ', ' Recording of previous events ', ' Leukocyte Antigens ', ' Human Leukocyte Antigens ', ' HL-A Antigens ', ' HLA Antigens ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Incentives ', ' indexing ', ' Ischemia ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Kidney Transplantation ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Handedness ', ' Laterality ', ' Methodology ', ' Morbidity - disease rate ', ' Morbidity ', ' Pancreas ', ' Pancreatic ', ' Patients ', ' Quality of life ', ' QOL ', ' Research ', ' Resources ', ' Research Resources ', ' statistics ', ' Time ', ' transplant ', ' Transplantation ', ' United States ', ' Waiting Lists ', ' Weight ', ' Measures ', ' Cost Savings ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' doubt ', ' Uncertainty ', ' base ', ' Organ ', ' improved ', ' Chronic ', ' Blood Serum ', ' Serum ', ' Individual ', ' Ethnicity ', ' Ethnic Origin ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Transplant Recipients ', ' transplant patient ', ' Knowledge ', ' programs ', ' Complex ', ' Techniques ', ' System ', ' Height ', ' Modeling ', ' End stage renal failure ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' Address ', ' Data ', ' Organ Model ', ' Characteristics ', ' Process ', ' cost ', ' neglect ', ' time use ', ' transplant registry ', ' public health relevance ', ' clinical decision-making ', ' individual patient ', ' improved outcome ', ' survival outcome ', ' ']",NIDDK,NORTHWESTERN UNIVERSITY,R21,2017,228085,IL-07,0.23555140702429497
"Developing and validating prognostic metabolomic signatures of diabetic kidney disease PROJECT SUMMARY/ABSTRACT Rationale. Diabetes is a leading cause of renal disease, accounting for 40% of the estimated 20 million US adult cases of chronic kidney disease. There is, however, substantial heterogeneity across diabetic patients with regards to development of kidney disease. Hence, there is an urgent need to identify prognostic biomarkers that can provide early and reliable evidence of future kidney disease, so that high-risk patients can receive optimal medical care. Existing clinical, proteomic and genomic markers do not consistently nor accurately predict kidney function decline. Metabolomics, a systematic evaluation of the end-products of cellular function in fluids, has the potential to inform physiological and pathological effects of chronic diseases. Metabolomic analysis combined with advanced quantitative methods could play a key role in building clinically useful prognostic signatures of diabetic kidney disease. Yet, development of computational methods with adequate rigor has lagged behind the technical capacity to perform large scale quantitative metabolomics. In this proposal we aim to address this computational gap in diabetic kidney disease research. Aims. We will implement rigorous computational methods to identify robust prognostic metabolite + clinical + genetic signatures of diabetic kidney disease progression. Specifically, we aim to (i) test the accuracy of previous signatures, and apply state-of-the-art analytic techniques and novel statistical methods to identify new multivariate metabolite sets for predicting kidney disease progression; (ii) quantify patterns of co-regulation of metabolites in diabetic kidney disease, and develop new tools in network biology to discover novel enzymes, proteins, metabolites, and molecular pathways which are implicated in diabetic kidney disease progression; (iii) test if these models can accurately predict kidney disease progression in independent prospective cohorts. Methods. Using clinical, genetic and metabolomic data from large prospective cohorts of > 1200 diverse, well- characterized patients with Type 2 diabetes, we will apply statistical methods for variable selection (e.g., penalized regression), and machine learning methods (e.g., random forest), which are known to perform well in the high-dimensional setting, to identify robust and parsimonious signatures of kidney disease progression. We will quantify inter-metabolite co-regulation patterns and infer biological pathways implicated in diabetic kidney disease. Throughout the modeling process, a rigorous training-validation paradigm will be adopted in order to improve reproducibility of models and reduce chance findings. Impact. A major product of this work will be the development of a clinically useful algorithm for identifying diabetic patients at high-risk for kidney function decline. Our findings will also provide insight into markers of renal dysfunction, and elucidate possible therapeutic targets for treating diabetic kidney disease, thus potentially informing the design of future clinical trials. PROJECT NARRATIVE Kidney disease, a major and common complication of diabetes, can lead to repeated hospitalizations and premature death. There is an urgent need to develop clinical tools that can provide early evidence that a given diabetic patient is likely to progress to kidney disease in the future. In this proposal, we will identify new urinary biomarkers and use novel statistical modeling methods to create a clinically useful algorithm for identifying diabetic patients at high-risk for kidney function decline, with the ultimate goal of improving disease management and reducing mortality rates for these patients.",Developing and validating prognostic metabolomic signatures of diabetic kidney disease,9306637,R01DK110541,"['Accounting ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Albuminuria ', ' Algorithms ', ' Biology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Clinical Trials ', ' co-morbidity ', ' Comorbidity ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Diabetic Kidney Disease ', ' Diabetic Nephropathy ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Enzyme Gene ', ' Enzymes ', ' Future ', ' Clinical genetics ', ' Medical Genetics ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Hospitalization ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Chronic Kidney Failure ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Methods ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' mortality ', ' Patients ', ' Play ', ' Publishing ', ' Recommendation ', ' Research ', ' Risk ', ' Sampling Studies ', ' Testing ', ' Urine Urinary System ', ' Urine ', ' Work ', ' forest ', ' health care ', ' Healthcare ', ' Dataset ', ' Data Set ', ' Caring ', ' improved ', ' Clinical ', ' prematurity ', ' premature ', ' Biological ', ' Physiologic ', ' Physiological ', ' Medical ', ' Link ', ' Evaluation ', ' prognostic ', ' Training ', ' kidney function ', ' Renal function ', ' insight ', ' diabetic ', ' Disease Progression ', ' Funding ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Collaborations ', ' Liquid substance ', ' liquid ', ' fluid ', ' tool ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Disease Management ', ' Disorder Management ', ' Chronic Kidney Insufficiency ', ' Chronic Renal Insufficiency ', ' Adopted ', ' Pattern ', ' Techniques ', ' American ', ' chemical association ', ' cohort ', ' novel ', ' Reporting ', ' Statistical Methods ', ' Regulation ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Genomics ', ' model development ', ' Bioinformatics ', ' Bio-Informatics ', ' nephrogenesis ', ' kidney development ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Address ', ' Data ', ' Prognostic Marker ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Reproducibility ', ' Validation ', ' Pathologic ', ' Molecular ', ' Process ', ' urinary ', ' developmental ', ' Development ', ' Pima Indian ', ' pathway ', ' Pathway interactions ', ' protein metabolite ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' open source ', ' therapeutic target ', ' network models ', ' high risk ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' diabetic patient ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' Patient risk ', ' learning strategy ', ' learning method ', ' learning activity ', ' genetic signature ', ' gene signatures ', ' biological heterogeneity ', ' genomic biomarker ', ' genomic marker ', ' metabolome ', ' metabonome ', ' prognostic signature ', ' prognostic profile ', ' predictive signature ', ' Longitudinal cohort ', ' Longterm cohort ', ' Long-term cohort ', ' Prospective cohort ', ' high dimensionality ', ' ']",NIDDK,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2017,340545,CA-52,0.16907537852350504
"A Novel Device for Optimal and Personalized Fluid Therapy in Septic Shock Patients Abstract Septic shock is a severe condition resulting in a critical reduction of organ perfusion with consequential and common stage 2 and 3 acute kidney injury (AKI) occurring in as many as 60% of patients and with an alarmingly high in-hospital co-morbid mortality rate of up to 70%. Current Surviving Sepsis Guidelines recommend early aggressive fluid resuscitation targeting mean arterial pressure (MAP 65 mmHg); however aggressive resuscitation commonly results in hypervolemia. Elevated intra-abdominal pressure (IAP), which occurs frequently in critically ill patients, is recognized as a vital parameter reflecting venous outflow that has wide-ranging physiologic effects including an association with AKI. Thus, abdominal perfusion pressure (APP=MAP-IAP) may provide the optimal target to guide hemodynamic support as it reflects both inflow (MAP) and outflow (IAP) perfusion. However, current methods of IAP measurement limit the validation of APP as a hemodynamic target as they are prone to (1) human error, limiting the reproducibility of measurements and (2) contamination resulting in catheter-associated urinary tract infections. Potrero Medical, Inc. has developed the Accuryn Monitoring System, which accurately, automatically and digitally extracts physiological data in real-time from the bladder, without the need for external equipment or manual manipulation. Accuryn received formal 510(k) clearance from the FDA for measurement of IAP, urine output and core temperature in April of 2016. In combination with MAP acquired through standard of care, Accuryn will enable APP-targeted hemodynamic resuscitation in septic shock patients. In this grant, the use of Accuryn to improve clinical outcomes in septic shock patients via both IAP monitoring and APP-targeted hemodynamic resuscitation will be validated. We plan to conduct a 24-month clinical trial with 200 septic shock patients divided among three groups: (1) Monitoring (normal IAP receiving MAP-targeted resuscitation), (2) Standard of Care MAP group (elevated IAP receiving MAP-targeted resuscitation), and (3) APP group (elevated IAP receiving APP 60 mmHg targeted resuscitation. The primary endpoint for comparison will be incidence or progression (defined by peak severity in creatinine and UO compared to baseline levels) of stage 2 and 3 AKI. Secondary endpoints include ICU- and hospital mortality, frequency and duration of RRT, urinary biomarker data, days on mechanical ventilation, mean duration of vasopressor support, and adverse events. Independent comparisons between these groups will (1) verify that elevated IAP during fluid resuscitation is correlated with AKI in septic shock patients and (2) validate that APP-guided fluid resuscitation reduces the incidence or progression of stage 2 and 3 AKI in septic shock patients compared to MAP-guided resuscitation. With this clinical study, we will validate the need for the Accuryn device to continuously measure IAP and target APP during resuscitation. The data collected from this grant will enable the design of a pivotal phase III clinical study defining APP- targeted hemodynamic support as the new standard of care for septic shock. Narrative Improving the resuscitation procedures in septic shock by (1) better gauging the patients volume status and (2) guiding hemodynamic support to individualized patient needs by a balanced, precision approach involving vasopressor support and targeted fluid expansion, may dramatically improve clinical outcomes including acute kidney injury. Potrero Medical intends use our Accuryn Monitoring System, to continuously measure intra- abdominal pressure (IAP) and apply the measure to target abdominal perfusion pressure (APP) during resuscitation to (1) verify the importance of IAP in the development of AKI in septic shock patients and (2) validate that APP-guided fluid resuscitation reduces the incidence or progression of AKI in septic shock patients compared to current standard care.",A Novel Device for Optimal and Personalized Fluid Therapy in Septic Shock Patients,9348493,R44GM123799,"['Abdominal ', ' Abdomen ', ' Adoption ', ' Awareness ', ' urinary bladder ', ' Bladder Urinary System ', ' Bladder ', ' Blood Pressure ', ' Blood Volume ', ' Clinical Study ', ' Clinical Research ', ' Clinical Trials ', ' co-morbidity ', ' Comorbidity ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Creatinine ', ' Critically Ill ', ' Critical Illness ', ' Death ', ' Cessation of life ', ' Equipment ', ' body fluid balance therapy ', ' Fluid Therapy ', ' Grant ', ' hemodynamics ', ' Hospitals ', ' Modern Man ', ' Human ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Incidence ', ' Joints ', ' Manuals ', ' Marketing ', ' Methods ', ' Mississippi ', ' mortality ', ' Patients ', ' Perfusion ', ' pressure ', ' Resuscitation ', ' Risk ', ' Septic Shock ', ' Employee Strikes ', ' Strikes ', ' Syndrome ', ' Temperature ', ' Testing ', ' Time ', ' Universities ', ' Urine Urinary System ', ' Urine ', ' vasopressor ', ' Vasopressor Agents ', ' Vasoconstrictors ', ' Vasoconstrictor Drugs ', ' Vasoactive Agonists ', ' Vasoconstrictor Agents ', ' Work ', ' Measures ', ' Inhospital Mortality ', ' In-house Mortalities ', ' Hospital Mortality ', ' Catheters ', ' Guidelines ', ' Organ ', ' improved ', ' Procedures ', ' mechanical respiratory assist ', ' Mechanical ventilation ', ' Clinical ', ' Phase ', ' Physiologic ', ' Physiological ', ' Medical ', ' Failure ', ' Measurement ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Collaborations ', ' Liquid substance ', ' liquid ', ' fluid ', ' Venous ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' abdominal pressure ', ' Frequencies ', ' Severities ', ' Protocols documentation ', ' Protocol ', ' System ', ' Fluid overload ', ' hypervolemia ', ' Equation ', ' Medical center ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' monitoring device ', ' novel ', ' Devices ', ' Adverse event ', ' Adverse Experience ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Consequentialism ', ' Address ', ' Data ', ' Intra-abdominal ', ' Reproducibility ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Patient-Focused Outcomes ', ' Validation ', ' Monitor ', ' urinary ', ' developmental ', ' Development ', ' Output ', ' digital ', ' designing ', ' design ', ' urinary tract catheter infection ', ' catheter associated urinary tract infection ', ' catheter associated UTI ', ' bloodstream infection ', ' blood infection ', ' Sepsis ', ' Outcome ', ' prospective ', ' patient population ', ' standard of care ', ' standard care ', ' standard treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' personalized approach ', ' tailored approach ', ' precision approach ', ' individualized approach ', ' Personalized medical approach ', ' ']",NIGMS,"POTRERO MEDICAL, INC.",R44,2017,1685221,CA-15,0.04185862447500626
"High content in vivo screening for acute kidney injury ameliorating drugs ABSTRACT In this application we will perform high throughput, high content, screening for small molecules that improve kidney regeneration after acute kidney injury (AKI). AKI presents a dire unmet medical need because of its high prevalence with long-term adverse health effects and life-threatening sequelae. Mortality is high and the only effective treatments are renal replacement therapies. The onset of the precipitating event is unpredictable, and in many instances once patients are admitted to the hospital, injury has already occurred. Improving recovery from injury therefore presents an attractive opportunity for intervention, but to date, no therapies are available that are effective if administered post injury. The vertebrate kidney has an innate ability to regenerate and follows a well-defined cellular mechanism that encompasses dedifferentiation of surviving renal tubule cells, proliferation of resulting progenitors, and repopulation of the denuded tubule. This sequence of events, together with their respective molecular markers, is conserved between humans, mouse, and zebrafish. During regeneration, transcription factors normally expressed during organogenesis (e.g.,lhx1a, pax2, and pax8) are reactivated. We previously demonstrated that small molecule-mediated augmentation of endogenous Lhx1a expression can ameliorate recovery in zebrafish and mouse models of AKI. Together these data support the overall hypothesis that augmentation by small molecules of cellular programs that drive kidney repair after injury represents a novel pharmacologic approach for the treatment of AKI and associated sequelae. Using a transgenic zebrafish line that expresses Lhx1a-EGFP we have developed an artificial intelligence-based, high-content assay to quantify lhx1a expression in the living embryo. Using multivariate analysis, the assay met accepted HTS assay performance standards and was validated in three-day variability studies and a small pilot library screen. We will perform a primary HTS of 50,000 compounds from the MLPCN collection. Prioritized hits will be subjected to a fully implemented, rigorous secondary assay paradigm encompassing kidney organ development, metabolic stability, in vivo efficacy, and activity profiling in a pathophysiological relevant AKI model. At the end of these studies we will have identified functionally and mechanistically characterized in vivo chemical probes to investigate the biology of kidney injury and regeneration, some of which are expected to have features that make them suitable for development into preclinical leads. NARRATIVE Acute kidney injury (AKI) presents a dire unmet medical need with unacceptably high mortality rates and a lack of therapeutic modalities. The vertebrate kidney has an innate ability to regenerate that can be enhanced by small molecules. In this proposal we will perform high-content, high throughput screening for kidney regeneration in zebrafish to discover novel chemical probes to investigate mechanisms of augmented kidney regeneration after injury.",High content in vivo screening for acute kidney injury ameliorating drugs,9262478,R01DK112652,"['Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biology ', ' Breeding ', ' Carboxylic Acids ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Embryonic ', ' Embryo ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Epithelial Cells ', ' Fibrosis ', ' Health ', ' Hospitals ', ' Modern Man ', ' Human ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Renal tubule structure ', ' renal tubule ', ' Kidney Tubules ', ' Libraries ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Microsomes ', ' mortality ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Patients ', ' Pharmacology ', ' Prodrugs ', ' Pro-Drugs ', ' Drug Precursors ', ' Natural regeneration ', ' regenerate ', ' Regeneration ', ' Specificity ', ' Stem cells ', ' Progenitor Cells ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Zebra Fish ', ' Zebra Danio ', ' Danio rerio ', ' Brachydanio rerio ', ' Zebrafish ', ' Generations ', ' Artifacts ', ' Morphologic artifacts ', ' Mediating ', ' Injury ', ' base ', ' improved ', ' Medical ', ' Kidney Replacement Therapy ', ' Renal Replacement Therapy ', ' Ensure ', ' Chemicals ', ' Evaluation ', ' kidney function ', ' Renal function ', ' Recovery ', ' Organogenesis ', ' analog ', ' Transgenes ', ' Therapeutic ', ' Metabolic ', ' Genetic ', ' Tubular formation ', ' Tubular ', ' Nature ', ' Life ', ' programs ', ' Complex ', ' Event ', ' Protocols documentation ', ' Protocol ', ' System ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' Cell Proliferation ', ' Cellular Proliferation ', ' Cell Multiplication ', ' Cell Growth in Number ', ' Performance ', ' small molecule libraries ', ' chemical library ', ' Transgenic Organisms ', ' transgenic ', ' Toxic effect ', ' Toxicities ', ' novel ', ' Modality ', ' Appearance ', ' organ regeneration ', ' Modeling ', ' response ', ' high throughput screening ', ' High Throughput Assay ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' small molecule ', ' Dose ', ' Data ', ' Detection ', ' High Prevalence ', ' Molecular Bank ', ' molecular library ', ' Reproducibility ', ' in vitro Assay ', ' in vivo ', ' Collection ', ' developmental ', ' Development ', ' preclinical ', ' pre-clinical ', ' mouse model ', ' murine model ', ' progenitor ', ' FDA approved ', ' effective therapy ', ' effective treatment ', ' molecular marker ', ' molecular biomarker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' kidney repair ', ' screening ', ' organ growth ', ' organ development ', ' ']",NIDDK,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2017,348188,PA-18,0.2064871036278161
"Discovery and characterization of novel ciliopathy protein complexes Abstract Ciliopathies are a collection of debilitating developmental disorders (e.g. Joubert syndrome, Meckel syndrome, Bardet-Biedl syndrome, orofaciodigital syndrome, polycystic kidney disease) which have no cures and limited but expensive treatments. Diagnosis and treatment is complicated due to ciliopathies causing multisystem pathologies and having large variance in their clinical presentations potentially resulting in neural tube defects, orofacial clefting, obesity, polycystic kidneys, retinal degeneration and in some cases, infant death. All ciliopathies are caused by dysfunctional cilia, the microtubule based organelle critical for cell-to-cell signaling, but currently there is limited understanding of the underlying molecular network responsible for proper cilia function. Recently, large-scale proteomic techniques have advanced where it is now possible to query the cell's molecular network and identify many new protein complexes. This proposal describes a research program that will 1) construct a ciliary complex map using proteomic techniques, 2) functionally characterize newly discovered ciliary complexes and 3) identify disruptions in complex assembly due to known ciliopathy mutations. Additional products of the proposed research will include a compendium of proteomic data on ciliated cells, statistical analysis tools for the discovery of protein complexes, functional characterization of critical ciliary processes and a more complete understanding of the underlying molecular network of ciliopathy disease states. This work aims to provide an important perspective of cilia biology in order to better understand the complex etiology and molecular causes of ciliopathies and potentially open new therapeutic avenues. Project Narrative Ciliopathies are a class of debilitating birth defects without known cures and limited but expensive treatments. Currently, we lack understanding of the underlying molecular network in ciliopathy patient cells and know even less about the causes of clinical presentations in ciliopathy patients. I propose to discover the differences in the molecular network between healthy cells and ciliopathy patient cells in an effort to better understand the molecular causes of clinical presentations possibly open new avenues for therapeutics.""""""",Discovery and characterization of novel ciliopathy protein complexes,9371331,K99HD092613,"['Congenital Malformation ', ' Congenital Deformity ', ' Congenital Defects ', ' Congenital Anatomical Abnormality ', ' Congenital Anatomic Abnormality ', ' Birth Defects ', ' Congenital Abnormality ', ' Affect ', ' Allelomorphs ', ' Alleles ', ' Biology ', ' Cell Body ', ' Cells ', ' Cilia ', ' Complement Proteins ', ' Complement ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Embryonic ', ' Embryo ', ' Exhibits ', ' Fractionation Radiotherapy ', ' FRACN ', ' Chemical Fractionation ', ' Fractionation ', ' Future ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Human ', ' Ion Exchange ', ' Polycystic Kidney Diseases ', ' Polycystic Kidney ', ' Maintenance ', ' Maps ', ' Mentors ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Structural Models ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Neural Tube Defects ', ' Neural Tube Developmental Defects ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Organelles ', ' Orofaciodigital Syndromes ', ' Pathology ', ' Patients ', ' Proteins ', ' Rana ', ' Frog ', ' Research ', ' Retinal Degeneration ', ' retinal degenerative diseases ', ' retinal degenerative ', ' retina degeneration ', ' degenerative retina diseases ', ' Role ', ' social role ', ' Sea Anemones ', ' Actiniaria ', ' Sea Urchins ', ' Echinoidea ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Syndrome ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Work ', ' Platanna ', ' Xenopus laevis ', ' Dataset ', ' Data Set ', ' base ', ' Clinical ', ' Biological ', ' Biochemical ', ' Link ', ' Training ', ' insight ', ' Therapeutic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Computational Biology ', ' computer biology ', ' programs ', ' Joubert syndrome ', ' cerebelloparenchymal disorder IV ', ' cerebellar vermis agenesis ', ' Joubert-Boltshauser syndrome ', ' Complex ', ' cell type ', ' Techniques ', ' Severity of illness ', ' disease severity ', ' infant death ', ' infantile death ', ' infant demise ', ' death in first year of life ', ' particle ', ' success ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' skills ', ' novel ', ' Bardet-Biedl Syndrome ', ' Bardet Biedel syndrome ', ' Regulation ', ' Property ', ' Proteomics ', ' Gene Transfer Techniques ', ' Transgenesis ', ' developmental disease/disorder ', ' developmental disorder ', ' Molecular Sieve Chromatography ', ' Size Exclusion Chromatography ', ' protein complex ', ' Alpha Cell ', ' -cell ', ' Glucagon Secreting Cell ', ' Glucagon Cell ', ' Structure of ciliary processes ', ' Ciliary Process ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Systems Biology ', ' Data ', ' Developmental Cell Biology ', ' in vivo ', ' Cilium Microtubule ', ' Collection ', ' Tissue Chip ', ' Tissue Arrays ', ' Tissue Microarray ', ' Molecular ', ' protein function ', ' developmental ', ' Development ', ' Flies ', ' fly ', ' clinically relevant ', ' clinical relevance ', ' human disease ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' loss of function ', ' ciliopathy ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' CRISPR/Cas system ', ' CRISPR ', ' in vivo imaging ', ' orofacial cleft ', ' orofacial clefting ', ' educational atmosphere ', ' university atmosphere ', ' training atmosphere ', ' school atmosphere ', ' learning environment ', ' learning atmosphere ', ' intellectual atmosphere ', ' educational environment ', ' education atmosphere ', ' collegiate atmosphere ', ' collegial atmosphere ', ' college atmosphere ', ' classroom environment ', ' ']",NICHD,"UNIVERSITY OF TEXAS, AUSTIN",K99,2017,100205,TX-10,0.05323049734211912
"Developing and validating prognostic metabolomic signatures of diabetic kidney disease PROJECT SUMMARY/ABSTRACT Rationale. Diabetes is a leading cause of renal disease, accounting for 40% of the estimated 20 million US adult cases of chronic kidney disease. There is, however, substantial heterogeneity across diabetic patients with regards to development of kidney disease. Hence, there is an urgent need to identify prognostic biomarkers that can provide early and reliable evidence of future kidney disease, so that high-risk patients can receive optimal medical care. Existing clinical, proteomic and genomic markers do not consistently nor accurately predict kidney function decline. Metabolomics, a systematic evaluation of the end-products of cellular function in fluids, has the potential to inform physiological and pathological effects of chronic diseases. Metabolomic analysis combined with advanced quantitative methods could play a key role in building clinically useful prognostic signatures of diabetic kidney disease. Yet, development of computational methods with adequate rigor has lagged behind the technical capacity to perform large scale quantitative metabolomics. In this proposal we aim to address this computational gap in diabetic kidney disease research. Aims. We will implement rigorous computational methods to identify robust prognostic metabolite + clinical + genetic signatures of diabetic kidney disease progression. Specifically, we aim to (i) test the accuracy of previous signatures, and apply state-of-the-art analytic techniques and novel statistical methods to identify new multivariate metabolite sets for predicting kidney disease progression; (ii) quantify patterns of co-regulation of metabolites in diabetic kidney disease, and develop new tools in network biology to discover novel enzymes, proteins, metabolites, and molecular pathways which are implicated in diabetic kidney disease progression; (iii) test if these models can accurately predict kidney disease progression in independent prospective cohorts. Methods. Using clinical, genetic and metabolomic data from large prospective cohorts of > 1200 diverse, well- characterized patients with Type 2 diabetes, we will apply statistical methods for variable selection (e.g., penalized regression), and machine learning methods (e.g., random forest), which are known to perform well in the high-dimensional setting, to identify robust and parsimonious signatures of kidney disease progression. We will quantify inter-metabolite co-regulation patterns and infer biological pathways implicated in diabetic kidney disease. Throughout the modeling process, a rigorous training-validation paradigm will be adopted in order to improve reproducibility of models and reduce chance findings. Impact. A major product of this work will be the development of a clinically useful algorithm for identifying diabetic patients at high-risk for kidney function decline. Our findings will also provide insight into markers of renal dysfunction, and elucidate possible therapeutic targets for treating diabetic kidney disease, thus potentially informing the design of future clinical trials. PROJECT NARRATIVE Kidney disease, a major and common complication of diabetes, can lead to repeated hospitalizations and premature death. There is an urgent need to develop clinical tools that can provide early evidence that a given diabetic patient is likely to progress to kidney disease in the future. In this proposal, we will identify new urinary biomarkers and use novel statistical modeling methods to create a clinically useful algorithm for identifying diabetic patients at high-risk for kidney function decline, with the ultimate goal of improving disease management and reducing mortality rates for these patients.",Developing and validating prognostic metabolomic signatures of diabetic kidney disease,9418599,R01DK110541,"['Accounting ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Albuminuria ', ' Algorithms ', ' Biology ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Chronic Disease ', ' chronic disorder ', ' Chronic Illness ', ' Clinical Trials ', ' Comorbidity ', ' co-morbidity ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Cessation of life ', ' Death ', ' Diabetes Mellitus ', ' diabetes ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Diabetic Nephropathy ', ' Diabetic Kidney Disease ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Enzymes ', ' Enzyme Gene ', ' Future ', ' Medical Genetics ', ' Clinical genetics ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Hospitalization ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Chronic Kidney Failure ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Methods ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' mortality ', ' Patients ', ' Play ', ' Publishing ', ' Recommendation ', ' Research ', ' Risk ', ' Sampling Studies ', ' Testing ', ' Urine ', ' Urine Urinary System ', ' Work ', ' forest ', ' Healthcare ', ' health care ', ' Data Set ', ' Dataset ', ' Caring ', ' improved ', ' Clinical ', ' prematurity ', ' premature ', ' Biological ', ' Physiologic ', ' Physiological ', ' Medical ', ' Link ', ' Evaluation ', ' prognostic ', ' Training ', ' kidney function ', ' Renal function ', ' insight ', ' diabetic ', ' Disease Progression ', ' Funding ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Collaborations ', ' Liquid substance ', ' liquid ', ' fluid ', ' tool ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Disease Management ', ' Disorder Management ', ' Chronic Kidney Insufficiency ', ' Chronic Renal Insufficiency ', ' Adopted ', ' Pattern ', ' Techniques ', ' American ', ' chemical association ', ' cohort ', ' novel ', ' Reporting ', ' Statistical Methods ', ' Regulation ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Genomics ', ' model development ', ' Bioinformatics ', ' Bio-Informatics ', ' nephrogenesis ', ' kidney development ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Address ', ' Data ', ' Prognostic Marker ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Reproducibility ', ' Validation ', ' Pathologic ', ' Molecular ', ' Process ', ' urinary ', ' developmental ', ' Development ', ' Pima Indian ', ' pathway ', ' Pathway interactions ', ' protein metabolite ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' prospective ', ' innovative ', ' innovate ', ' innovation ', ' open source ', ' therapeutic target ', ' network models ', ' high risk ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' diabetic patient ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' Patient risk ', ' learning method ', ' learning activity ', ' learning strategy ', ' gene signatures ', ' genetic signature ', ' biological heterogeneity ', ' genomic marker ', ' genomic biomarker ', ' metabonome ', ' metabolome ', ' prognostic profile ', ' prognostic signature ', ' predictive signature ', ' Longterm cohort ', ' Long-term cohort ', ' Longitudinal cohort ', ' Prospective cohort ', ' high dimensionality ', ' predictive assay ', ' predictive test ', ' ']",NIDDK,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2018,336980,CA-52,0.16907537852350504
"Nephrotic Syndrome Rare Disease Clinical Research Network II ABSTRACT Although patients with Nephrotic Syndrome (NS) present with shared clinical signs and symptoms (proteinuria, hypoalbuminemia, hyperlipidemia and edema), there is dramatic variability in prognosis and response to therapy, frustrating patients, families and their clinicians. Even within the histopathologic categories used in the current diagnostic approach (e.g. minimal change disease, focal segmental glomerulosclerosis), there is dramatic variability in disease progression and response to therapy, highlighting the underlying biological heterogeneity within the groups. Small studies with broad, clinical patient inclusion criteria have demonstrated that a subset of patients respond well to certain immunosuppressive medications, but accurate pre-treatment response of those individuals is not possible based on routine clinical parameters. This project will leverage the Nephrotic Syndrome Study Network (NEPTUNE) cohort study, a multi-center prospective study of over 600 patients with FSGS, MCD and MN with rich clinical data, kidney biopsy tissue and gene expression profiles. This study will leverage novel analysis tools to analyze the kidney tissue gene expression data to identify subgroups of patients with shared expression profiles. And, to combine this data with clinical characteristics and kidney biopsy pathology features to predict response to immunosuppressive therapy. It will utilize advanced analysis techniques which are ideal for rare disease when traditional statistical methods are not well equipped to identify relevant predictors from the large number of potential parameters across the genotype-phenotype continuum. The aims are: Aim 1: To utilize consensus non-negative matrix factorization (NMF) on glomerular and tubular genome wide mRNA expression data to identify functional subclasses of NEPTUNE participants. Aim 2: To utilize machine learning algorithms to identify predictors of response to initial immunosuppressive therapy from clinical characteristics, kidney biopsy pathology features and gene expression clusters. The objective is to improve the clinical care of patients with Nephrotic Syndrome by identifying novel, biologically-relevant predictors of treatment response. Risk stratification is useful not only to inform patients and clinicians who are making treatment decisions, but also allows stratification of patients at high risk of treatment failure into clinical trials of novel agents. LAY NARRATIVE Nephrotic Syndrome, caused by several rare kidney diseases, is characterized by an abnormal amount of protein in the urine, swelling and kidney failure. Patients affected by the syndrome suffer complications of the disease as well as the significant toxicity from the immunosuppressive therapy used to treat it, but their individual response to treatment and prognosis can vary markedly. This project aims to use clinical characteristics, gene expression levels from kidney biopsy tissue and pathology features from the kidney biopsy to quantify the likelihood that an individual person will fail to respond to immunosuppressive medications. This approach, if validated, may help to inform patients and clinicians about the risk of treatment failure.",Nephrotic Syndrome Rare Disease Clinical Research Network II,9716867,U54DK083912,"['Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Cohort Studies ', ' Concurrent Studies ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Edema ', ' Hydrops ', ' Dropsy ', ' Family ', ' Gene Expression ', ' Patient Care ', ' Patient Care Delivery ', ' Genotype ', ' Goals ', ' Recording of previous events ', ' History ', ' Hyperlipidemia ', ' Hyperlipemia ', ' Therapeutic immunosuppression ', ' immunosuppression therapy ', ' artificial immunosuppression ', ' Immunosuppressive Therapy ', ' Antirejection Therapy ', ' Anti-Rejection Therapy ', ' Immunosuppression ', ' immune suppression ', ' Immunosuppressive Effect ', ' Immunosuppression Effect ', ' Immunosuppressive Agents ', ' immunosuppressive ', ' Immunosuppressants ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Maps ', ' Persons ', ' Nephrotic Syndrome ', ' Parents ', ' Pathology ', ' Clinical Pathology ', ' Patients ', ' Phenotype ', ' outcome forecast ', ' Prognosis ', ' Prospective Studies ', ' Proteins ', ' Proteinuria ', ' Kidney Failure ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Risk ', ' Signs and Symptoms ', ' Diagnostic Findings ', ' Swelling ', ' Syndrome ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Urine ', ' Urine Urinary System ', ' therapy failure ', ' Treatment Failure ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Individual ', ' Hypoalbuminemia ', ' Disease Progression ', ' Tubular formation ', ' Tubular ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' Knowledge ', ' Focal Segmental Glomerulosclerosis ', ' Focal segmental glomerular sclerosis ', ' FSGS ', ' Techniques ', ' Disease remission ', ' Remission ', ' Toxic effect ', ' Toxicities ', ' Rare Diseases ', ' orphan disorder ', ' Rare Disorder ', ' Orphan Disease ', ' novel ', ' Participant ', ' Categories ', ' Statistical Methods ', ' response ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Investigational Therapies ', ' experimental therapeutics ', ' experimental therapeutic agents ', ' Investigational Treatments ', ' Experimental Therapies ', ' Data ', ' Prediction of Response to Therapy ', ' treatment response prediction ', ' treatment prediction ', ' therapy prediction ', ' predict treatment response ', ' predict therapy response ', ' predict therapeutic response ', ' Subgroup ', ' mRNA Expression ', ' Clinical Data ', ' Characteristics ', ' Molecular ', ' Process ', ' pathway ', ' Pathway interactions ', ' inclusion criteria ', ' high risk ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' new therapeutic target ', ' clinical care ', ' therapeutic response ', ' response to treatment ', ' treatment response ', ' genomewide ', ' genome scale ', ' genome-wide ', ' clinical practice ', ' response prediction ', ' predictor of response ', ' predictive response ', ' prediction of response ', ' predicting response ', ' gene signatures ', ' genetic signature ', ' biological heterogeneity ', ' stratified patient ', ' patient stratification ', ' patient subtypes ', ' patient subpopulations ', ' patient subgroups ', ' patient subsets ', ' Risk stratification ', ' Expression Profiling ', ' individualized response ', ' individual response ', ' Affect ', ' Algorithms ', ' Biology ', ' Biopsy ', ' Classification ', ' Systematics ', ' ']",NIDDK,UNIVERSITY OF MICHIGAN AT ANN ARBOR,U54,2018,71580,MI-12,0.15066481529936568
"A Deep Learning Model to Improve Pathologist Interpretation of Donor Kidney Biopsies PROJECT SUMMARY/ABSTRACT More people die every year from kidney disease than breast or prostate cancer. Kidney transplantation is life-saving but is limited by a shortage of organ donors and an unacceptably high donor organ discard rate. The decision to use or discard a donor kidney relies heavily on manual quantitation of key microscopic findings by pathologists. A major limitation of this microscopic examination is human variability and inefficiency in interpreting the findings, resulting in potentially healthy organs being deemed unsuitable for transplantation or potentially damaged organs being transplanted inappropriately. Our team developed the first Deep Learning model capable of automatically quantifying percent global glomerulosclerosis in whole slide images of donor kidney frozen section wedge biopsies. This innovative approach has the potential to transform donor kidney biopsy evaluation by improving pathologist efficiency, accuracy, and precision ultimately resulting in optimized donor organ utilization, diminished health care costs, and improved patient outcomes. The goal of this project is to establish our Deep Learning automated quantitative evaluation as the standard practice of donor kidney evaluation prior to transplantation. This will be achieved by assembling a team of expert kidney pathologists and computer scientists specializing in machine learning. The proposal will evaluate the accuracy and precision of the computerized approach to quantifying percent global glomerulosclerosis and compare these results with current standard of care pathologist evaluation. The feasibility of deploying the Deep Learning model to analyze whole slide images on the cloud will also be examined. The end product of this STTR will be a web-based platform to securely deploy Deep Learning image analysis as a tool to assist pathologists with donor kidney biopsy evaluation. PUBLIC HEALTH RELEVANCE STATEMENT Before a kidney can be transplanted, the tissue must be assessed under a microscope to ensure the organ is healthy enough for transplant. A major limitation of microscopic examination is human variability in interpreting the findings, resulting in healthy organs being deemed unsuitable for transplantation. This funding will support developing computer algorithms to assist pathologists in microscopic examination of donor kidney tissues, resulting in more consistent and objective biopsy interpretations, minimizing discard of potentially usable kidneys and optimizing organ placement for transplant.",A Deep Learning Model to Improve Pathologist Interpretation of Donor Kidney Biopsies,9678574,R41DK120253,"['Biopsy ', ' malignant breast neoplasm ', ' malignant breast tumor ', ' Breast Cancer ', ' Charge ', ' Computers ', ' Cessation of life ', ' Death ', ' Freezing ', ' Frozen Sections ', ' Freeze Sectioning ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Healthcare Systems ', ' Health Care Systems ', ' Medicare ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Human ', ' Modern Man ', ' Immunohistochemistry ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' Interobserver Variability ', ' Interobserver Variations ', ' Inter-Observer Variation ', ' Inter-Observer Variability ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Chronic Kidney Failure ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Kidney Transplantation ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Manuals ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Organ Donor ', ' Pathology ', ' Patients ', ' Personal Satisfaction ', ' wellbeing ', ' well-being ', ' Quantitative Evaluations ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Savings ', ' Computer software ', ' Software ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Transplantation ', ' transplant ', ' Universities ', ' Washington ', ' Work ', ' Measures ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Data Set ', ' Dataset ', ' Blinded ', ' Caring ', ' Sickness Cost ', ' Disease Costs ', ' Cost of Illness ', ' base ', ' glomerular sclerosis ', ' glomerulosclerosis ', ' Organ ', ' Microscope ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Chronic ', ' Clinical ', ' Microscopic ', ' Phase ', ' Ensure ', ' Evaluation ', ' Funding ', ' Transplanted tissue ', ' Graft Material ', ' Pathologist ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Malignant neoplasm of prostate ', ' Prostatic Cancer ', ' Prostate Cancer ', ' Prostate CA ', ' Malignant prostatic tumor ', ' Malignant Tumor of the Prostate ', ' Life ', ' Scientist ', ' Slide ', ' meetings ', ' Speed ', ' technological innovation ', ' Modeling ', ' software development ', ' developing computer software ', ' develop software ', ' Address ', ' Reproducibility ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Patient-Focused Outcomes ', ' STTR ', ' Small Business Technology Transfer Research ', ' Pathologic ', ' Process ', ' imaging ', ' Image ', ' digital ', ' computerized ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' computer aided ', ' Computer Assisted ', ' Outcome ', ' innovative ', ' innovate ', ' innovation ', ' computer algorithm ', ' Computational algorithm ', ' commercial application ', ' public health relevance ', ' standard of care ', ' clinical practice ', ' Secure ', ' cloud based ', ' learning network ', ' power analysis ', ' whole slide imaging ', ' deep learning ', ' ']",NIDDK,"NEWVENTUREIQ, LLC",R41,2018,214009,MO-01,0.15455137839899133
"A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles In the United States, 2.8 million people every year seek medical attention for traumatic brain injury (TBI), of which 80% are considered to have a mild TBI (i.e. concussion). Even in those with mild injuries, 10-20% of individuals will suffer long-term disability including seizures and emotional and behavioral issues. One of the primary challenges in TBI care is appropriately classifying this heterogeneous injury and identifying patients at risk for these chronic impairments. Conventional imaging studies, including magnetic resonance imaging (MRI) and computed tomography (CT), are commonly used to classify TBI, but do not reliably capture the full extent of the injury, particularly in those patients with mild injuries. Currently, there are few molecular markers to assist in the assessment of an individual's unique injury and subsequent recovery and biomarkers are desperately needed in the field that correlate with these varied endophenotypes, track the progress of the disease, and predict clinical outcomes. To address this challenge, we propose to develop a microchip-based platform that can be used to characterize TBI and its recovery using the RNA cargo found in brain-derived circulating extracellular vesicles (EVs), including exosomes. Unlike prior work that has mainly focused on single biomarkers, our approach measures a panel of circulating EV miRNA markers processed with machine learning algorithms, to more comprehensively capture the state of the injured and recovering brain. Our proposal combines surface marker-specific nanomagnetic isolation of brain-derived EVs from a variety of cell types, biomarker discovery using RNA sequencing, and machine learning processing of EV miRNA cargo to measure the state of injury and recovery in TBI. Nanoscale exosomes are known to shed from brain cells into the blood stream, carrying with them the molecular signatures that can be used to better diagnose and treat injuries, such as traumatic brain injury. We propose an innovative, clinically practical approach to probe the RNA contained within these nanoscale vesicles to better understand a patient's injury and recovery to better guide treatment. Our rapid and easily multiplexed platform has great potential for non-invasive diagnostics and monitoring of both secondary injury progression and drug efficacy, offers tremendous benefits for patients.",A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles,9630167,R21MH118170,"['Algorithms ', ' Archives ', ' Astrocytes ', ' astrocytic glia ', ' Astroglia ', ' Astrocytus ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Vessels ', ' vascular ', ' Blood Volume ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Brain Concussion ', ' concussion ', ' Commotio Cerebri ', ' Cerebral Concussion ', ' Calibration ', ' Cell Line ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Classification ', ' Systematics ', ' Color ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Elements ', ' Goals ', ' Gold ', ' Recording of previous events ', ' History ', ' Human ', ' Modern Man ', ' Inflammation ', ' Laboratories ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Methods ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Neurons ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Nucleic Acids ', ' Patients ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Production ', ' outcome forecast ', ' Prognosis ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA Probes ', ' RNA Gene Probes ', ' Seizures ', ' Technology ', ' Testing ', ' Time ', ' X-Ray Computed Tomography ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' United States ', ' Work ', ' Measures ', ' Blinded ', ' Caring ', ' Injury ', ' base ', ' improved ', ' Surface ', ' Chronic ', ' Clinical ', ' Evaluation ', ' prognostic ', ' disability ', ' Individual ', ' Recovery ', ' non-invasive diagnostic ', ' non-invasive diagnosis ', ' noninvasive diagnosis ', ' brain-injured ', ' brain damage ', ' Acquired brain injury ', ' Brain Injuries ', ' Vesicle ', ' Inflammatory ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Severities ', ' Stream ', ' cell type ', ' System ', ' Benchmarking ', ' Best Practice Analysis ', ' innovative technologies ', ' brain cell ', ' Performance ', ' drug efficacy ', ' technology development ', ' tech development ', ' Devices ', ' Sorting - Cell Movement ', ' sorting ', ' Emotional ', ' Modeling ', ' Sampling ', ' nucleic acid detection ', ' Traumatic Brain Injury ', ' traumatic brain damage ', ' Brain Trauma ', ' neuropathology ', ' microchip ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Car Phone ', ' Mobile Phones ', ' Address ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' wet brain ', ' Intracranial Edema ', ' Brain Swelling ', ' Brain Edema ', ' point of care ', ' Behavioral ', ' imaging ', ' Image ', ' nano magnetic ', ' nanomagnetic ', ' injury and repair ', ' cost ', ' injured ', ' digital ', ' Advanced Development ', ' designing ', ' design ', ' next generation ', ' nanometer sized ', ' nanometer scale ', ' nano scale ', ' nano meter sized ', ' nano meter scale ', ' nanoscale ', ' injury response ', ' response to injury ', ' Outcome ', ' prospective ', ' innovative ', ' innovate ', ' innovation ', ' Impairment ', ' endophenotype ', ' murine model ', ' mouse model ', ' medical attention ', ' molecular biomarker ', ' molecular marker ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' ratiometric ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' precision-based medicine ', ' precision medicine ', ' mild brain trauma ', ' mild TBI ', ' MTBI ', ' mild traumatic brain injury ', ' biomarker discovery ', ' exosome ', ' extracellular vesicles ', ' predictor of clinical outcome ', ' clinical outcome prediction ', ' predict clinical outcome ', ' microRNA markers ', ' miRNA markers ', ' miRNA biomarkers ', ' microRNA biomarkers ', ' imaging study ', ' manufacturability ', ' individualized response ', ' individual response ', ' ']",NIMH,UNIVERSITY OF PENNSYLVANIA,R21,2018,206809,PA-03,0.024048001331914613
"Development and Validation of Radiation-Free Pediatric Renal Function Quantification Project Abstract Motivation: Chronic kidney disease (CKD) affects more than 500 million people. Children commonly develop CKD from urinary obstructive diseases and nephrotoxic therapies, and then suffer severe growth failure, hyper- tension, cardiovascular risks, and neurocognitive decits, and eventually end-stage kidney disease. Accurate renal function quantication will improve clinical management of hydronephrosis (1 in 100 babies) and dos- ing/selection of chemotherapeutic regimens in oncology patients. Glomerular ltration rate (GFR), the biomarker of renal function, is derived from blood or urine tests. These tests only provide global GFR and are limited in accuracy, especially in children, and even more so in children with cancer. MRI offers superb anatomic delineation without ionizing radiation, and is thus ideal for pediatric kidney imaging. However, MRI has not been widely adopted for pediatric renal function evaluation due to lack of reliability and cumbersome workow. These hurdles stem from the fact that the critical components required for global and regional GFR calculation, including high spatiotemporal resolution, plasma ow and arterial input function, are difcult to obtain, and that accurate image segmentation of kidneys (cortex and medulla) is labor intensive. Additionally, although the same contrast agent injection can be used for obstruction evaluation, certain areas of the kidney suffer from signicant signal loss using standard MRI acquisition techniques due to high contrast agent concentrations. This project addresses these major challenges for automated comprehensive renal function evaluation in children. Approach: The project has three development aims, which are validated by clinical studies. Aim 1 will enable novel free-breathing time-resolved 3D dynamic contrast enhanced MRI that simultaneously provides accurate GFR calculation and renal plasma ow. This is achieved by incorporating self-navigated motion compensation, fast acquisition with parallel imaging and compressed sensing, and phase-contrast ow imaging. The second aim is to develop multiple new image analysis methods to extract GFR and renal plasma ow (RPF) that lever- age novel ow data of Aim 1, as well as automated new machine-learning image processing techniques for the segmentation of kidneys and ultimately global and regional GFR calculation. In Aim 3, we will develop and integrate ultrashort-echo-time techniques to address the MRI signal loss due to T2* effects from high contrast concentration for patients with obstruction, and further incorporate motion compensation and accelerated imag- ing methods to enable time-resolved high-resolution dynamic MRI for contrast washout kinetics analysis in the same MR exam. Aim 4 will determine the performance of these methods in a clinical setting. Signicance: This work will lead to robust, automated comprehensive pediatric renal MRI for safer and more accurate renal function evaluation in children. The techniques will facilitate widespread application in the com- munity setting and permit robust evaluation of renal function, for both children and adults. Project Narrative Kidney diseases in children often stem from blockages of the urinary tract or toxicity from medications, such as antibiotics or chemotherapies. Kidney function quantication is crucial for clinical management of these children. This work will develop accurate and automated pediatric MRI for quantication of kidney function and diagnosis of urinary tract obstruction.",Development and Validation of Radiation-Free Pediatric Renal Function Quantification,9501621,R01EB026136,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Age ', ' ages ', ' Aging ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Antibiotics ', ' Miscellaneous Antibiotic ', ' Antibiotic Drugs ', ' Antibiotic Agents ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cardiac Output ', ' heart output ', ' Child ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Clinical Research ', ' Clinical Study ', ' Contrast Media ', ' Radiopaque Media ', ' Contrast Drugs ', ' Contrast Agent ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Evolution ', ' Furosemide ', ' Fursemide ', ' Frusemid ', ' Gadolinium ', ' Gd element ', ' Glomerular Filtration Rate ', ' Gold ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Hydronephrosis ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' kidney cortex ', ' renal cortex ', ' kidney cortical portion ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Chronic Kidney Failure ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Kinetics ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Mainstreaming ', ' achievement Mainstream Education ', ' Educational Mainstreaming ', ' Manuals ', ' Methods ', ' Motion ', ' Motivation ', ' Obstruction ', ' Patients ', ' Perfusion ', ' Drug Kinetics ', ' Pharmacokinetics ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' pressure ', ' Ionizing radiation ', ' ionizing output ', ' Radiation-Ionizing Total ', ' Ionizing Electromagnetic Radiation ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Testing ', ' Time ', ' Urinary tract ', ' Urine ', ' Urine Urinary System ', ' Work ', ' Measures ', ' base ', ' image processing ', ' Obstructive Uropathy ', ' urinary tract obstruction ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' kidney imaging ', ' Area ', ' Clinical ', ' Phase ', ' urological ', ' urologic ', ' Renal Plasma Flow ', ' Compensation ', ' Financial compensation ', ' Evaluation ', ' Failure ', ' pediatric ', ' Childhood ', ' Blood flow ', ' kidney function ', ' Renal function ', ' Measurement ', ' Oncology Cancer ', ' oncology ', ' pediatric malignancy ', ' pediatric cancer ', ' children with cancer ', ' childhood malignancy ', ' child with cancer ', ' cancer in children ', ' cancer in a child ', ' Malignant childhood cancer ', ' Malignant Pediatric Tumor ', ' Malignant Pediatric Neoplasm ', ' Malignant Childhood Tumor ', ' Childhood Cancers ', ' Malignant Childhood Neoplasm ', ' Venous ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Adopted ', ' antimicrobial drug ', ' antimicrobial agent ', ' anti-microbial drug ', ' anti-microbial agent ', ' Protocols documentation ', ' Protocol ', ' Techniques ', ' experience ', ' Performance ', ' nephrotoxicity ', ' kidney toxicity ', ' Nephrotoxic ', ' Toxic effect ', ' Toxicities ', ' novel ', ' chemotherapeutic agent ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Radiation ', ' computerized data processing ', ' data processing ', ' End stage renal failure ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' imaging modality ', ' imaging method ', ' image-based method ', ' Address ', ' Data ', ' Reproducibility ', ' Resolution ', ' Clinical Management ', ' Validation ', ' urinary ', ' developmental ', ' Development ', ' Renal Blood Flow ', ' imaging ', ' Image ', ' reconstruction ', ' neurocognitive impairment ', ' neurocognitive decline ', ' IQ Deficit ', ' Neurocognitive Deficit ', ' imaging Segmentation ', ' data acquisition ', ' chemotherapy ', ' loss of function ', ' stem ', ' spatiotemporal ', ' community setting ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' Regimen ', ' four-dimensional imaging ', ' 4-D imaging ', ' 4D Imaging ', ' Cone ', ' contrast enhanced ', ' recruit ', ' Injections ', ' ']",NIBIB,STANFORD UNIVERSITY,R01,2018,683369,CA-18,0.08730528022376681
"Big data in acute renal rejection PROJECT SUMMARY  Background: Acute rejection of renal transplant, i.e., the immunological response of the human body to a foreign kidney, is the main cause of dysfunction in renal transplant patients, surpassing acute tubular necrosis (ATN) and immune drug toxicity. Over 650,000 patients in the US have end-stage renal disease and renal transplant offers the best outcome for these patients. However, 15%-27% of renal transplant patients have ARTR within 5 years, which if not detected and treated promptly, causes renal damage and leads to renal failure of the transplanted kidney. Currently, ARTR is initially evaluated using blood tests and urine sampling, e.g., plasma creatinine and creatinine clearance. However, these indices have low sensitivity, since a significant change in creatinine levels is only detectable after the loss of 60% of renal function. ARTR diagnosis requires renal biopsy (gold standard), which is invasive, takes a week for diagnosis, and costs up to $20,000. Further, needle biopsy is prone to over- or under-estimation of inflammation. The proposed study seeks to develop and validate a new noninvasive computer-aided diagnostic (CAD) software system that can provide highly accurate (over 97% accuracy) diagnosis of ARTR at an early stage by integrating laboratory-based biomarkers (e.g., creatinine clearance (CrCl) and serum plasma creatinine (SPCr)) with imaging-markers that will be extracted from either dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) or diffusion- weighted magnetic resonance imaging (DW-MRI).  Objective/Hypotheses: The primary objective of this proposal is to develop and validate a clinically usable system for the early detection of acute renal transplant rejection (ARTR) based on testing the following three hypotheses: (i) The perfusion of the contrast agent in the cortex of the rejected kidney is slower than the perfusion of the contrast agent in the non-rejected kidney; (ii) The estimated apparent diffusion coefficient (ADC) in the cortex of the rejected kidney is smaller than the estimated ADC in the cortex of the non-rejected kidney; and (iii) Fusing laboratory-based biomarkers (e.g., CrCl and SPCr) with imaging-markers that will lead to novel fused indices for distinguishing rejected versus non-rejected kidneys in clinical decision-making.  Specific Aims: (i) Develop a software CAD system for early detection of acute renal transplant rejection based on integrating/fusing the estimated physiological perfusion parameters from DCE-MRI data with laboratory-based biomarkers for both rejected and non-rejected transplanted kidneys; (ii) Develop a software CAD system for early detection of acute renal transplant rejection based on integrating/fusing the estimated physiological diffusion parameters from DW-MRI data with laboratory-based biomarkers for both rejected and non-rejected transplanted kidneys; and (iii) Evaluate the accuracy of the proposed image analysis software system with clinical data that will be collected at University of Louisville (Approved IRB # 16.0041), University of Michigan (Approved IRB # HUM00115031), and the collected MRI data at The Kidney transplant center at Mansoura University with local regulatory approval.  Study Design: We will develop the following image analysis techniques to accurately analyze both DCE- MRI and DW-MRI: (i) segmentation of the kidney object from the surrounding abdominal structures for either DCE-MRI or DW-MRI using appearance and prior shape models; (ii) a Laplace-based non-rigid registration approach to handle local deformations in the kidney region caused by physiological effects (e.g., intrinsic pulsatile effects, breathing, or transmitted effects from adjacent structures, such as the bowel) during the data collection; (iii) segmentation of the kidney cortex and generation of either the physiological perfusion parameters (e.g., wash-in slope, wash-out slope, time-to-peak, and peak value) or physiological diffusion parameters (e.g., ADC); (iv) classification of the acute rejection versus non-rejection kidney status and evaluating the method as a diagnostic test; and (v) depiction of parametric maps of the estimated perfusion or diffusion indices to help clinical visual assessment of the transplanted kidney. The MRI and clinical data will be obtained from patients who have undergone kidney transplantation from live donors, and are available to our research team via Dr. Beache and Dr. Dwyer (Radiology Department and The Kidney Transplant Center at the University of Louisville, respectively) and Dr. Samaniego-Picota (Director of the Kidney Transplant Program and the Transplant Ambulatory Care Unit at the University of Michigan). In addition to the data that will be collected at the University of Louisville and the University of Michigan, our group has access to MRI data that had been collected from an additional 100 subjects at Mansoura University Hospital, Egypt. This data is available to our group through Dr. Abou El-Ghar, one of the PI collaborators, and it will be used to test the proposed CAD system on the data collected from another geographical area. Our preliminary diagnostic results, based on analysis of DCE-MRI data from 54 independent in-vivo cases using leave-one-subject-out approach were 98% accurate (sensitivity = 100.00%, specificity = 96%, and Dice similarity coefficient (DSC) = 98%). Moreover, our preliminary results, based on the analysis of DW-MRI data from 75 independent in-vivo cases using leave-one-subject-out were 97% accurate (sensitivity = 98%, specificity = 96%, and DSC = 98%). These results demonstrate the potential of the proposed CAD system to complement current technologies such as nuclear imaging and ultrasonography to determine the type of kidney dysfunction post transplantation. PROJECT NARRATIVE Acute renal transplant rejection (ARTR), i.e., the immunological response of the human body to a foreign kidney, is the main cause of dysfunction in renal transplant patients, surpassing acute tubular necrosis and immune drug toxicity. Over 650,000 patients in the US have end-stage renal disease and renal transplant offers the best outcome for these patients. However, 15%-27% of renal transplant patients have ARTR within 5 years, which if not detected and treated promptly, causes renal damage and leads to renal failure of the transplanted kidney. Biopsy remains the gold standard for the assessment of renal transplant dysfunction but can lead to over- or under-estimation of the inflammation, and is used as a last resort due to invasiveness, high cost, and potential morbidity. The proposed study seeks to provide a new noninvasive computer-aided diagnostic (CAD) software system with the ability to make highly accurate diagnosis (>97% accuracy) at an early stage of ARTR by integrating laboratory-based biomarkers (e.g., creatinine clearance (CrCl) and serum plasma creatinine (SPCr)) with imaging-markers obtained from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) or diffusion-weighted magnetic resonance imaging (DW-MRI).",Big data in acute renal rejection,9590370,R15AI135924,"['Abdomen ', ' Abdominal ', ' Algorithms ', ' Ambulatory Care ', ' outpatient treatment ', ' Outpatient Care ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Biopsy ', ' Needle biopsy procedure ', ' needle biopsy ', ' Classification ', ' Systematics ', ' Complement ', ' Complement Proteins ', ' Contrast Media ', ' Radiopaque Media ', ' Contrast Drugs ', ' Contrast Agent ', ' Creatinine ', ' Data Collection ', ' Diagnosis ', ' Diffusion ', ' Drug toxicity ', ' Egypt ', ' Geographic Locations ', ' geographic site ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Gold ', ' Graft Rejection ', ' Transplantation Rejection ', ' Transplant Rejection ', ' Blood Tests ', ' Hematology Testing ', ' Hematological Tests ', ' Hematologic Tests ', ' University Hospitals ', ' indexing ', ' Inflammation ', ' Intestines ', ' bowel ', ' Intestinal ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' kidney cortex ', ' renal cortex ', ' kidney cortical portion ', ' Kidney Transplantation ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Acute Kidney Tubular Necrosis ', ' acute tubular necrosis ', ' Lower Nephron Nephrosis ', ' Acute Renal Failure with Tubular Necrosis ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Maps ', ' Methods ', ' Michigan ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Morbidity - disease rate ', ' Morbidity ', ' Patients ', ' Perfusion ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Radiology Specialty ', ' Radiology ', ' General Radiology ', ' Kidney Failure ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Resort ', ' Computer software ', ' Software ', ' Specificity ', ' Systems Analysis ', ' Systems Analyses ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Transplantation ', ' transplant ', ' Ultrasonography ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Universities ', ' Urine ', ' Urine Urinary System ', ' Generations ', ' Diagnostic tests ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Acute ', ' Clinical ', ' Physiologic ', ' Physiological ', ' kidney function ', ' Renal function ', ' Visual ', ' Human Figure ', ' Human body ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Shapes ', ' tool ', ' Diagnostic ', ' Creatinine clearance measurement ', ' Creatinine Clearance ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Transplant Recipients ', ' transplant patient ', ' programs ', ' Immune ', ' Immunes ', ' Techniques ', ' System ', ' Early Diagnosis ', ' early detection ', ' diagnostic accuracy ', ' Accuracy of Diagnosis ', ' Structure ', ' novel ', ' Appearance ', ' Modeling ', ' Sampling ', ' Diffusion Magnetic Resonance Imaging ', ' diffusion tensor imaging ', ' dMRI ', ' Diffusion-weighted Magnetic Resonance Imaging ', ' Diffusion weighted imaging ', ' Diffusion Weighted MRI ', ' Diffusion MRI ', ' DWI-MRI ', ' DWI (diffusion weighted imaging) ', ' End stage renal failure ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' Data ', ' Detection ', ' in vivo ', ' Clinical Data ', ' Collection ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Patient-Focused Outcomes ', ' cost ', ' software systems ', ' computer aided ', ' Computer Assisted ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' clinical decision-making ', ' IRBs ', ' IRB ', ' Institutional Review Boards ', ' BigData ', ' Big Data ', ' accurate diagnosis ', ' contrast enhanced ', ' imaging marker ', ' imaging biomarker ', ' clinically useful biomarkers ', ' clinical biomarkers ', ' MRI biomarker ', ' magnetic resonance imaging biomarker ', ' nuclear imaging ', ' transplant centers ', ' ']",NIAID,UNIVERSITY OF LOUISVILLE,R15,2018,454648,KY-03,0.18943450978315385
"A Novel Device for Optimal and Personalized Fluid Therapy in Septic Shock Patients Abstract Septic shock is a severe condition resulting in a critical reduction of organ perfusion with consequential and common stage 2 and 3 acute kidney injury (AKI) occurring in as many as 60% of patients and with an alarmingly high in-hospital co-morbid mortality rate of up to 70%. Current Surviving Sepsis Guidelines recommend early aggressive fluid resuscitation targeting mean arterial pressure (MAP 65 mmHg); however aggressive resuscitation commonly results in hypervolemia. Elevated intra-abdominal pressure (IAP), which occurs frequently in critically ill patients, is recognized as a vital parameter reflecting venous outflow that has wide-ranging physiologic effects including an association with AKI. Thus, abdominal perfusion pressure (APP=MAP-IAP) may provide the optimal target to guide hemodynamic support as it reflects both inflow (MAP) and outflow (IAP) perfusion. However, current methods of IAP measurement limit the validation of APP as a hemodynamic target as they are prone to (1) human error, limiting the reproducibility of measurements and (2) contamination resulting in catheter-associated urinary tract infections. Potrero Medical, Inc. has developed the Accuryn Monitoring System, which accurately, automatically and digitally extracts physiological data in real-time from the bladder, without the need for external equipment or manual manipulation. Accuryn received formal 510(k) clearance from the FDA for measurement of IAP, urine output and core temperature in April of 2016. In combination with MAP acquired through standard of care, Accuryn will enable APP-targeted hemodynamic resuscitation in septic shock patients. In this grant, the use of Accuryn to improve clinical outcomes in septic shock patients via both IAP monitoring and APP-targeted hemodynamic resuscitation will be validated. We plan to conduct a 24-month clinical trial with 200 septic shock patients divided among three groups: (1) Monitoring (normal IAP receiving MAP-targeted resuscitation), (2) Standard of Care MAP group (elevated IAP receiving MAP-targeted resuscitation), and (3) APP group (elevated IAP receiving APP 60 mmHg targeted resuscitation. The primary endpoint for comparison will be incidence or progression (defined by peak severity in creatinine and UO compared to baseline levels) of stage 2 and 3 AKI. Secondary endpoints include ICU- and hospital mortality, frequency and duration of RRT, urinary biomarker data, days on mechanical ventilation, mean duration of vasopressor support, and adverse events. Independent comparisons between these groups will (1) verify that elevated IAP during fluid resuscitation is correlated with AKI in septic shock patients and (2) validate that APP-guided fluid resuscitation reduces the incidence or progression of stage 2 and 3 AKI in septic shock patients compared to MAP-guided resuscitation. With this clinical study, we will validate the need for the Accuryn device to continuously measure IAP and target APP during resuscitation. The data collected from this grant will enable the design of a pivotal phase III clinical study defining APP- targeted hemodynamic support as the new standard of care for septic shock. Narrative Improving the resuscitation procedures in septic shock by (1) better gauging the patients volume status and (2) guiding hemodynamic support to individualized patient needs by a balanced, precision approach involving vasopressor support and targeted fluid expansion, may dramatically improve clinical outcomes including acute kidney injury. Potrero Medical intends use our Accuryn Monitoring System, to continuously measure intra- abdominal pressure (IAP) and apply the measure to target abdominal perfusion pressure (APP) during resuscitation to (1) verify the importance of IAP in the development of AKI in septic shock patients and (2) validate that APP-guided fluid resuscitation reduces the incidence or progression of AKI in septic shock patients compared to current standard care.",A Novel Device for Optimal and Personalized Fluid Therapy in Septic Shock Patients,9554957,R44GM123799,"['Abdomen ', ' Abdominal ', ' Adoption ', ' Awareness ', ' Bladder ', ' urinary bladder ', ' Bladder Urinary System ', ' Blood Pressure ', ' Blood Volume ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Comorbidity ', ' co-morbidity ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Creatinine ', ' Critical Illness ', ' Critically Ill ', ' Cessation of life ', ' Death ', ' Equipment ', ' Fluid Therapy ', ' body fluid balance therapy ', ' Grant ', ' hemodynamics ', ' Hospitals ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Incidence ', ' Joints ', ' Manuals ', ' Marketing ', ' Methods ', ' Mississippi ', ' mortality ', ' Patients ', ' Perfusion ', ' pressure ', ' Resuscitation ', ' Risk ', ' Septic Shock ', ' Syndrome ', ' Temperature ', ' Testing ', ' Time ', ' Universities ', ' Urine ', ' Urine Urinary System ', ' Vasoconstrictor Agents ', ' vasopressor ', ' Vasopressor Agents ', ' Vasoconstrictors ', ' Vasoconstrictor Drugs ', ' Vasoactive Agonists ', ' Work ', ' Measures ', ' Hospital Mortality ', ' Inhospital Mortality ', ' In-house Mortalities ', ' Catheters ', ' Guidelines ', ' Organ ', ' improved ', ' Procedures ', ' mechanical respiratory assist ', ' Mechanical ventilation ', ' Clinical ', ' Phase ', ' Physiologic ', ' Physiological ', ' Medical ', ' Failure ', ' Measurement ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Collaborations ', ' Liquid substance ', ' liquid ', ' fluid ', ' Venous ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' abdominal pressure ', ' Frequencies ', ' Severities ', ' Protocols documentation ', ' Protocol ', ' System ', ' Fluid overload ', ' hypervolemia ', ' Equation ', ' Medical center ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' monitoring device ', ' novel ', ' Devices ', ' Adverse event ', ' Adverse Experience ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Consequentialism ', ' Address ', ' Data ', ' Intra-abdominal ', ' Reproducibility ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Patient-Focused Outcomes ', ' Validation ', ' Monitor ', ' urinary ', ' developmental ', ' Development ', ' Output ', ' digital ', ' designing ', ' design ', ' urinary tract catheter infection ', ' catheter associated urinary tract infection ', ' catheter associated UTI ', ' bloodstream infection ', ' blood infection ', ' Sepsis ', ' Outcome ', ' prospective ', ' patient population ', ' standard of care ', ' standard treatment ', ' standard care ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' tailored approach ', ' precision approach ', ' individualized approach ', ' Personalized medical approach ', ' personalized approach ', ' human error ', ' secondary end point ', ' secondary endpoint ', ' primary end point ', ' primary endpoint ', ' ']",NIGMS,"POTRERO MEDICAL, INC.",R44,2018,1224065,CA-15,0.04185862447500626
"Extracellular Vesicles as a Link Between Placental and Renal Dysfunction in Preeclampsia PROJECT SUMMARY Preeclampsia (PE) is a devastating hypertensive disorder of pregnancy that is a leading cause of maternal and fetal mortality and morbidity worldwide. It affects 2-10% of women and accounts for 16% of maternal deaths related to childbirth in developed countries. PE is difficult to study because it is a multifactorial disorder with varying molecular mechanisms associated with the development of the spectrum of clinical symptoms associated with early onset, late onset, and severe PE. A personalized medicine approach applied to dissecting the underlying mechanisms of PE may be beneficial to reduce clinical incidence of this devastating syndrome. The placenta plays a key role in the development of PE, leading to widespread maternal endothelial dysfunction, hypertension, and systemic multi-organ failure in PE. Extracellular vesicles (EVs) containing protein, RNA, and lipid cargo are continuously extruded from the placenta, and are capable of interacting with maternal organs including the kidney. PE is primarily associated with placental and renal dysfunction, and PE is the most common cause of acute kidney injury during pregnancy. However, no studies have investigated the potential of placenta-derived RNA cargo as a link between placental and renal dysfunction in PE. Urinary EVs are derived from multiple tissue types and represent a trove of biomarkers that are increasingly being utilized to diagnose renal disorders. Further, urine samples can be obtained throughout pregnancy non-invasively and could potentially be utilized to identify biomarkers related to placental dysfunction in PE. In the proposed research, during the mentored phase, cutting-edge RNA-Seq technology coupled with computational biological and machine learning approaches will be applied to profile the transcriptome of urinary EVs in women with PE compared to normal pregnancy. Preliminary data indicates that it is possible to isolate and profile the transcriptome of urinary EVs from maternal urine throughout normal gestation, and that placenta-derived and placenta-specific mRNA and miRNA can be detected within the urinary EV population. This presents a novel technique that has potential to identify biomarkers as well as provide information on placental dysfunction in PE in a non-invasive manner. During the independent phase, the candidate will utilize an in vitro approach to investigate the effect of uptake of placenta-derived EVs with miRNA cargo associated with PE on the function of proximal tubule epithelial cells and cortical collecting duct cells. These two renal-specific cell types are involved in tubular reabsorption in the nephron, a process that is compromised leading to increased excretion of protein in the urine in some preeclamptic pregnancies. This proposal is multidisciplinary, utilizing basic biology, clinical research, and high-performance computing applied to investigating placental dysfunction in PE. These experiments are significant because they will generate novel information on the role of placenta- derived EVs in renal dysfunction in PE, as well as point the way towards preventative and therapeutic targets that may be transformative and clinically relevant. PROJECT NARRATIVE The proposed research will examine the transcriptome of urinary extracellular vesicles obtained non-invasively as a source of placenta-derived nucleic acids reflective of the development of preeclampsia (PE), and will con- duct in vitro experiments to determine the role of placental extracellular vesicles in renal dysfunction in PE.",Extracellular Vesicles as a Link Between Placental and Renal Dysfunction in Preeclampsia,9583334,K99HD096125,"['Affect ', ' Biology ', ' Blood Circulation ', ' Circulation ', ' Bloodstream ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Cells ', ' Cell Body ', ' Chromosomes ', ' Clinical Research ', ' Clinical Study ', ' Developing Countries ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Epithelial Cells ', ' Gestational Age ', ' Fetal Age ', ' Chronologic Fetal Maturity ', ' Goals ', ' Human ', ' Modern Man ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Immunohistochemistry ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' In Vitro ', ' Incidence ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Libraries ', ' Lipids ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Maternal Mortality ', ' maternal death ', ' Mentors ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Nephrons ', ' Uriniferous Tube ', ' Nucleic Acids ', ' Pathology ', ' Placenta ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Play ', ' Pre-Eclampsia ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pregnancy ', ' Gestation ', ' Proteins ', ' Proteinuria ', ' Research ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' Messenger RNA ', ' mRNA ', ' Role ', ' social role ', ' Stress ', ' Syndrome ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Urine ', ' Urine Urinary System ', ' Woman ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Population Heterogeneity ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' pregnancy disorder ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' Injury ', ' Organ ', ' improved ', ' Clinical ', ' prematurity ', ' premature ', ' Phase ', ' Biological ', ' Link ', ' excretion ', ' Excretory function ', ' Failure ', ' Oxygen Deficiency ', ' Hypoxic ', ' Hypoxia ', ' uptake ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' Industrialized Nations ', ' Industrialized Countries ', ' Developed Nations ', ' Developed Countries ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Tubular formation ', ' Tubular ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Source ', ' cell type ', ' Techniques ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' Stillbirth ', ' High Performance Computing ', ' high-end computing ', ' novel ', ' Pathogenesis ', ' Sampling ', ' response ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Childbirth ', ' child birth ', ' prevent ', ' preventing ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Small RNA ', ' Fetal Mortality Statistics ', ' Fetal Mortality ', ' Data ', ' Disease Pathway ', ' Ductal Epithelial Cell ', ' Ductal Cell ', ' Transcript ', ' Pathologic ', ' Characteristics ', ' Molecular ', ' Process ', ' urinary ', ' developmental ', ' Development ', ' early onset ', ' neonatal morbidity ', ' Population ', ' Coupled ', ' innovative ', ' innovate ', ' innovation ', ' transcriptomics ', ' clinical relevance ', ' clinically relevant ', ' multidisciplinary ', ' maternal serum ', ' therapeutic target ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' biorepository ', ' biobank ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' endothelial dysfunction ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' global transcription profile ', ' global gene expression ', ' transcriptome ', ' symptom comorbidity ', ' symptom association ', ' cooccuring symptom ', ' concurrent symptom ', ' comorbid symptom ', ' associated symptom ', ' extracellular vesicles ', ' experimental research ', ' experiment ', ' experimental study ', ' Molecular Disease ', ' ']",NICHD,UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,K99,2018,104534,IL-13,0.0302676147727873
"A Machine Learning Alternative to Beamforming to Improve Ultrasound Image Quality for Interventional Access to the Kidney Project Summary  Despite the widespread prevalence of ultrasound imaging in hospitals today, the clinical utility of ultrasound guidance is severely hampered by clutter and reverberation artifacts that obscure structures of interest and com- plicate anatomical measurements. Clutter is particularly problematic in overweight and obese individuals, who account for 78.6 million adults and 12.8 million children in North America. Similarly, interventional procedures of- ten require insertion of one or more metal tools, which generate reverberation artifacts that obfuscate instrument location, orientation, and geometry, while obscuring nearby tissues, thus additionally hampering ultrasound im- age quality. Although artifacts are problematic, ultrasound continues to persist primarily because of its greatest strengths (i.e., mobility, cost, non-ionizing radiation, real-time visualization, and multiplanar views) in comparison to existing image-guidance options, but it would be signicantly more useful without problematic artifacts.  Our long-term project goal is to use state-of-the-art machine learning techniques to provide interventional radiologists with artifact-free ultrasound-based images. We will initially develop a new framework alternative to the ultrasound beamforming process that removes needle tip reverberations and acoustic clutter caused by multipath scattering in near-eld tissues when guiding needles to the kidney to enable removal of painful kidney stones. Our rst aim will test convolutional neural networks (CNNs) that input raw channel data and output human readable images with no artifacts caused by multipath scattering and reverberations. A secondary goal of the CNNs is to learn the minimum number of parameters required to create these new CNN-based images. Our second aim will validate the trained algorithms with ultrasound data from experimental phantom and ex vivo tissue. Our third aim will extend our evaluation to ultrasound images of in vivo porcine kidneys. This work is the rst to propose bypassing the entire beamforming process and replacing it with machine learning and computer vision techniques to remove traditionally problematic noise artifacts and create a fundamentally new type of artifact-free, high-contrast, high-resolution, ultrasound-based image for guiding interventional procedures.  This work combines the expertise of an imaging scientist, a computer scientist, and an interventional ra- diologist to explore an untapped, understudied area that is only recently made feasible through improvements in computing power, advances in computer vision capabilities, and new knowledge about dominant sources of image degradation. Translation to in vivo cases is enabled by our clinical collaboration with the Department of Radiology at the Johns Hopkins Hospital. With support from the NIH Trailblazer Award, our team will be the rst to develop these tools and capabilities to eliminate noise artifacts in interventional ultrasound, opening the door to a new paradigm in ultrasound image formation, which will directly benet millions of patients with clearer, easier-to-interpret ultrasound images. Subsequent R01 funding will customize our innovation to addi- tional application-specic ultrasound procedures (e.g., breast biopsies, cancer detection, autonomous surgery). Project Narrative Artifacts in ultrasound images, specically artifacts caused by multipath scattering and acoustic reverberations (which occur when imaging through the abdominal tissue of overweight and obese patients or visualizing metallic surgical tools), remain as a major clinical challenge. There are no existing solutions to eliminate these artifacts based on today's signal processing techniques. The goal of this project is to step away from conventional signal processing models and instead learn from raw data examples with state-of-the-art machine learning techniques that differentiate artifacts from true signals, and thereby deliver clearer, easier-to-interpret images.",A Machine Learning Alternative to Beamforming to Improve Ultrasound Image Quality for Interventional Access to the Kidney,9600285,R21EB025621,"['Abdomen ', ' Abdominal ', ' Acoustics ', ' Acoustic ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Age ', ' ages ', ' Algorithms ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Architecture ', ' Engineering / Architecture ', ' Award ', ' Back ', ' Dorsum ', ' Biopsy ', ' Child ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Computer Vision Systems ', ' computer vision ', ' Computers ', ' Cyst ', ' Diagnosis ', ' Elements ', ' Environment ', ' Fatty Liver ', ' hepatic steatosis ', ' Liver Steatosis ', ' Goals ', ' Hospitals ', ' Human ', ' Modern Man ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Kidney Calculi ', ' Renal Stone ', ' Renal Calculi ', ' Kidney Stones ', ' Learning ', ' Liver diseases ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Metals ', ' Methods ', ' Methodology ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Needles ', ' Noise ', ' North America ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Pain ', ' Painful ', ' Patients ', ' Nonionizing Radiation ', ' Radiation-Non-Ionizing Total ', ' Nonionizing Electromagnetic Radiation ', ' Non-Ionizing Radiation ', ' Non-Ionizing Electromagnetic Radiation ', ' Radiology Specialty ', ' Radiology ', ' General Radiology ', ' Retroperitoneal Space ', ' Retroperitoneum ', ' Retroperitoneal Cavity ', ' Retroperitoneal ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Computer software ', ' Software ', ' Surgical Instruments ', ' Family suidae ', ' suid ', ' porcine ', ' Swine ', ' Suidae ', ' Pigs ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Translations ', ' Ultrasonography ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' United States ', ' Work ', ' Measures ', ' Morphologic artifacts ', ' Artifacts ', ' Custom ', ' Visualization ', ' Imagery ', ' base ', ' improved ', ' Procedures ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Interventional Ultrasound ', ' Interventional Ultrasonography ', ' Evaluation ', ' Training ', ' Individual ', ' Measurement ', ' Funding ', ' radiologist ', ' Collaborations ', ' Imaging Phantoms ', ' tool ', ' instrument ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Scientist ', ' Source ', ' Techniques ', ' Location ', ' Overweight ', ' Over weight ', ' fetal ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' interest ', ' Biological Neural Networks ', ' neural network ', ' Structure ', ' novel ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Bypass ', ' Modeling ', ' Readability ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Image-Guided Surgery ', ' surgical imaging ', ' intraoperative imaging ', ' intra-operative imaging ', ' Thick ', ' Thickness ', ' Data ', ' Resolution ', ' in vivo ', ' Cancer Detection ', ' Process ', ' Cardiac ', ' imaging ', ' Image ', ' Output ', ' cost ', ' image guided intervention ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' clinical effect ', ' Network-based ', ' lenses ', ' lens ', ' Geometry ', ' signal processing ', ' image guidance ', ' image guided ', ' Breast biopsy ', ' metallicity ', ' imaging scientist ', ' deep learning ', ' ']",NIBIB,JOHNS HOPKINS UNIVERSITY,R21,2018,194115,MD-07,0.10676809805586455
"High content in vivo screening for acute kidney injury ameliorating drugs ABSTRACT In this application we will perform high throughput, high content, screening for small molecules that improve kidney regeneration after acute kidney injury (AKI). AKI presents a dire unmet medical need because of its high prevalence with long-term adverse health effects and life-threatening sequelae. Mortality is high and the only effective treatments are renal replacement therapies. The onset of the precipitating event is unpredictable, and in many instances once patients are admitted to the hospital, injury has already occurred. Improving recovery from injury therefore presents an attractive opportunity for intervention, but to date, no therapies are available that are effective if administered post injury. The vertebrate kidney has an innate ability to regenerate and follows a well-defined cellular mechanism that encompasses dedifferentiation of surviving renal tubule cells, proliferation of resulting progenitors, and repopulation of the denuded tubule. This sequence of events, together with their respective molecular markers, is conserved between humans, mouse, and zebrafish. During regeneration, transcription factors normally expressed during organogenesis (e.g.,lhx1a, pax2, and pax8) are reactivated. We previously demonstrated that small molecule-mediated augmentation of endogenous Lhx1a expression can ameliorate recovery in zebrafish and mouse models of AKI. Together these data support the overall hypothesis that augmentation by small molecules of cellular programs that drive kidney repair after injury represents a novel pharmacologic approach for the treatment of AKI and associated sequelae. Using a transgenic zebrafish line that expresses Lhx1a-EGFP we have developed an artificial intelligence-based, high-content assay to quantify lhx1a expression in the living embryo. Using multivariate analysis, the assay met accepted HTS assay performance standards and was validated in three-day variability studies and a small pilot library screen. We will perform a primary HTS of 50,000 compounds from the MLPCN collection. Prioritized hits will be subjected to a fully implemented, rigorous secondary assay paradigm encompassing kidney organ development, metabolic stability, in vivo efficacy, and activity profiling in a pathophysiological relevant AKI model. At the end of these studies we will have identified functionally and mechanistically characterized in vivo chemical probes to investigate the biology of kidney injury and regeneration, some of which are expected to have features that make them suitable for development into preclinical leads. NARRATIVE Acute kidney injury (AKI) presents a dire unmet medical need with unacceptably high mortality rates and a lack of therapeutic modalities. The vertebrate kidney has an innate ability to regenerate that can be enhanced by small molecules. In this proposal we will perform high-content, high throughput screening for kidney regeneration in zebrafish to discover novel chemical probes to investigate mechanisms of augmented kidney regeneration after injury.",High content in vivo screening for acute kidney injury ameliorating drugs,9406857,R01DK112652,"['Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' Breeding ', ' Carboxylic Acids ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Embryo ', ' Embryonic ', ' Embryonic Development ', ' Embryogenesis ', ' Embryo Development ', ' Epithelial Cells ', ' Fibrosis ', ' Health ', ' Hospitals ', ' Human ', ' Modern Man ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Renal tubule structure ', ' renal tubule ', ' Kidney Tubules ', ' Libraries ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' Microsomes ', ' mortality ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Patients ', ' Pharmacology ', ' Prodrugs ', ' Pro-Drugs ', ' Drug Precursors ', ' Natural regeneration ', ' regenerate ', ' Regeneration ', ' Specificity ', ' Stem cells ', ' Progenitor Cells ', ' Testing ', ' transcription factor ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' Zebrafish ', ' Zebra Fish ', ' Zebra Danio ', ' Danio rerio ', ' Brachydanio rerio ', ' Generations ', ' Morphologic artifacts ', ' Artifacts ', ' Mediating ', ' Injury ', ' base ', ' improved ', ' Medical ', ' Kidney Replacement Therapy ', ' Renal Replacement Therapy ', ' Ensure ', ' Chemicals ', ' Evaluation ', ' kidney function ', ' Renal function ', ' Recovery ', ' Organogenesis ', ' analog ', ' Transgenes ', ' Therapeutic ', ' Metabolic ', ' Genetic ', ' Tubular formation ', ' Tubular ', ' Nature ', ' Life ', ' programs ', ' Complex ', ' Event ', ' Protocols documentation ', ' Protocol ', ' System ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' Cell Proliferation ', ' Cellular Proliferation ', ' Cell Multiplication ', ' Cell Growth in Number ', ' Performance ', ' small molecule libraries ', ' chemical library ', ' Transgenic Organisms ', ' transgenic ', ' Toxic effect ', ' Toxicities ', ' novel ', ' Modality ', ' Appearance ', ' organ regeneration ', ' Modeling ', ' response ', ' high throughput screening ', ' High Throughput Assay ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' small molecule ', ' Dose ', ' Data ', ' Detection ', ' High Prevalence ', ' Molecular Bank ', ' molecular library ', ' Reproducibility ', ' in vitro Assay ', ' in vivo ', ' Collection ', ' developmental ', ' Development ', ' preclinical ', ' pre-clinical ', ' murine model ', ' mouse model ', ' progenitor ', ' FDA approved ', ' effective treatment ', ' effective therapy ', ' molecular biomarker ', ' molecular marker ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' kidney repair ', ' screening ', ' organ development ', ' organ growth ', ' ']",NIDDK,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2018,351001,PA-18,0.2064871036278161
"Integrative Molecular Epidemiology Approach to Identify Nephrotic Syndrome Subgroups ABSTRACT Although patients with Nephrotic Syndrome (NS) present with shared clinical signs and symptoms (proteinuria, hypoalbuminemia, hyperlipidemia and edema), there is dramatic variability in prognosis and response to therapy, frustrating patients, families and their clinicians. Even within the histopathologic categories used in the current diagnostic approach (e.g. minimal change disease, focal segmental glomerulosclerosis), there is dramatic variability in disease progression and response to therapy, highlighting the underlying biological heterogeneity within the groups. Small studies with broad, clinical patient inclusion criteria have demonstrated that a subset of patients respond well to anti-TNF therapy, but accurate pre-treatment response of those individuals is not possible based on routine clinical parameters. This project will leverage the Nephrotic Syndrome Study Network (NEPTUNE) cohort study, a multi-center prospective study of 600 patients with FSGS, MCD and MN with rich clinical data, kidney biopsy tissue and gene expression profiles. This study will leverage the kidney tissue gene expression data to identify a subgroup of patients with TNF-alpha pathway activation, assess associated clinical outcomes and identify non- molecular predictors of the subgroup. The aims are:  Aim 1: To identify a subgroup of Nephrotic Syndrome patients with homogeneous activation of the  TNF-alpha transcriptional pathway.  Aim 2: To compare molecular subgroups with conventional clinical-pathologic classification in  clinical outcome prediction.  Aim 3: To identify non-invasive markers (e.g. demographics, blood and urine markers), standard  pathology features and novel pathologic biopsy descriptors associated with the TNF-alpha subgroup. To accomplish this project, the applicant will pursue formal training in systems biology, genetic epidemiology and bioinformatics. She will be mentored by a multi-disciplinary team with expertise in systems biology, epidemiology and bioinformatics. The long term objective is to improve the clinical care of patients with Nephrotic Syndrome by improved understanding of the underlying biology, identifying novel biomarkers and potential therapeutic targets for future validation in animal models and mechanistic-based interventional clinical trials. PROJECT NARRATIVE Nephrotic Syndrome, caused by several rare kidney diseases, is characterized by an abnormal amount of protein in the urine, swelling and kidney failure. Patients affected by the syndrome suffer complications of the disease as well as the toxicity of the immunosuppressive therapy used to treat it, but their individual presentations, response to treatment and prognosis can vary markedly. This project aims to use gene expression levels from kidney biopsy tissue to identify the subgroup patients most likely to respond to TNF- alpha blocking medications, an approach which, if validated, may help to inform targeted therapy selections for these patients.",Integrative Molecular Epidemiology Approach to Identify Nephrotic Syndrome Subgroups,9431752,K08DK115891,"['Affect ', ' Award ', ' Biology ', ' Biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Classification ', ' Systematics ', ' Clinical Trials ', ' Cohort Studies ', ' Concurrent Studies ', ' Complement ', ' Complement Proteins ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Edema ', ' Hydrops ', ' Dropsy ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Family ', ' Future ', ' Gene Expression ', ' Patient Care ', ' Patient Care Delivery ', ' Genotype ', ' Membranous Glomerulonephritis ', ' Membranous Nephropathy ', ' Membranous Glomerulopathy ', ' Membranous Glomerulonephropathy ', ' Extramembranous Glomerulopathy ', ' Grant ', ' Heterogeneity ', ' Hyperlipidemia ', ' Hyperlipemia ', ' Therapeutic immunosuppression ', ' immunosuppression therapy ', ' artificial immunosuppression ', ' Immunosuppressive Therapy ', ' Antirejection Therapy ', ' Anti-Rejection Therapy ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Kidney Diseases ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Glomerulus ', ' renal glomerulus ', ' kidney glomeruli ', ' Malpighian Tuft ', ' Leadership ', ' Mentors ', ' Nephrotic Syndrome ', ' Pathology ', ' Patients ', ' Phenotype ', ' Probability ', ' outcome forecast ', ' Prognosis ', ' Prospective Studies ', ' Proteins ', ' Proteinuria ', ' Publications ', ' Scientific Publication ', ' Kidney Failure ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Resources ', ' Research Resources ', ' Signs and Symptoms ', ' Diagnostic Findings ', ' Swelling ', ' Syndrome ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Urine ', ' Urine Urinary System ', ' Work ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Histologically ', ' Histologic ', ' Molecular Epidemiology ', ' Training ', ' Individual ', ' Hypoalbuminemia ', ' Disease Progression ', ' Patient Selection ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Renal Glomerular Diseases and Syndromes ', ' Glomerular disease ', ' Renal glomerular syndrome ', ' Renal glomerular disorder ', ' Renal glomerular disease or syndrome ', ' Renal glomerular disease ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' anti-TNF-alpha therapy ', ' anti-TNF therapy ', ' Anti-Tumor Necrosis Factor Therapy ', ' Descriptor ', ' Genetic ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Focal Segmental Glomerulosclerosis ', ' Focal segmental glomerular sclerosis ', ' FSGS ', ' Complex ', ' Clinical Course of Disease ', ' Techniques ', ' System ', ' cohort ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Toxic effect ', ' Toxicities ', ' Histopathology ', ' skills ', ' novel ', ' Participant ', ' member ', ' Categories ', ' Positioning Attribute ', ' Position ', ' TNF gene ', ' Tumor Necrosis Factor-alpha ', ' Tumor Necrosis Factor ', ' TNF ', ' TNFA ', ' TNF- ', ' TNF Alpha ', ' TNF A ', ' TNF ', ' Monocyte-Derived TNF ', ' Macrophage-Derived TNF ', ' Cachectin ', ' response ', ' genetic epidemiology ', ' genetic epidemiologic study ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Bioinformatics ', ' Bio-Informatics ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Systems Biology ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Prediction of Response to Therapy ', ' treatment response prediction ', ' treatment prediction ', ' therapy prediction ', ' predict treatment response ', ' predict therapy response ', ' predict therapeutic response ', ' Subgroup ', ' Clinical Data ', ' Observational research ', ' Observation study ', ' Observation research ', ' Observational Study ', ' Validation ', ' Pathologic ', ' Characteristics ', ' Molecular ', ' pathway ', ' Pathway interactions ', ' Outcome ', ' multidisciplinary ', ' inclusion criteria ', ' demographics ', ' therapeutic target ', ' clinical epidemiology ', ' clinical care ', ' therapeutic response ', ' response to treatment ', ' treatment response ', ' novel biomarker ', ' new marker ', ' novel marker ', ' clinical practice ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' biological heterogeneity ', ' predictors of outcomes ', ' predictive outcomes ', ' outcome prediction ', ' patient subtypes ', ' patient subpopulations ', ' patient subgroups ', ' patient subsets ', ' predictor of clinical outcome ', ' clinical outcome prediction ', ' predict clinical outcome ', ' Prospective cohort study ', ' Expression Profiling ', ' Molecular Disease ', ' responsive patient ', ' patient response ', ' ']",NIDDK,UNIVERSITY OF MICHIGAN AT ANN ARBOR,K08,2018,170193,MI-12,0.11701062357598033
"Early Identification of Acute Kidney Injury Using Deep Recurrent Neural Nets, Presented with Probable Etiology Abstract Significance: In this SBIR project we propose to develop Previse, a novel, software-based clinical decision support (CDS) system for predicting acute kidney injury (AKI), and attributing AKI to one of several causal mechanisms (etiologies). Previse will use machine learning methods and information drawn from the electronic health record (EHR) to identify the early signs of acute kidney injury. By doing so before the clinical syndrome of AKI is fully developed, Previse will give clinicians the time to intervene with the goals of preventing further kidney damage, and decreasing the sequelae of AKI. Combining this prediction module with a second module that suggests the underlying causes responsible for an incipient or full AKI, Previse will enable clinicians to make earlier and better-informed treatment decisions for AKI patients. Research Question: Can a machine- learning-based CDS predict the development and progression of AKI in hospitalized patients 72 hours in advance of KDIGO stage 2 or 3, with performance providing an area under the receiver operating characteristic curve (AUROC) of at least 0.85? Is it possible to use a Bayesian model to infer the cause of AKI with high accuracy (AUROC  0.75)? Prior work: We have developed a prototype version of the Previse system which predicts AKI up to 72 hours in advance of KDIGO stage 2 or 3 criteria, with an AUROC near 0.70. We have previously developed machine-learning-based predictive tools for sepsis, in-hospital mortality, and other adverse patient events with performance significantly improved over commonly used rules-based scoring systems. Specific Aims: To predict the onset of chart-abstracted KDIGO stage 2 or 3 AKI in retrospective data, 72 hours in advance (Aim 1); to use data drawn from the EHR to identify the cause of AKI at time of onset with high accuracy, and to present this causal inference, its likelihood, and relevant evidence supporting it in a human-interpretable fashion (Aim 2). Methods: We will predict the onset of AKI using a deep, recurrent neural network (RNN). This expressive, nonlinear classifier will incorporate time-series information in the qualitative portions of the EHR and will also incorporate features derived from text components, such as radiology reports. Labeling AUROC of 0.85 or higher at 72 hours pre-KDIGO AKI will constitute success in Aim 1. In Aim 2, we will train a dynamic Bayesian network to identify the cause of AKI. We will train this system using semi-supervised methods, where the causes of a set of AKI examples will be hand-annotated by clinician experts; these examples will be split into two groups, with some used for training and the remainder for testing. Aim 2 will be successful if this training results in etiology identification accuracy of at least 0.75 in the test set. Future Directions: Following the proposed work, the combined Previse system will be deployed for prospective studies at partner hospitals. Narrative Acute kidney injury (AKI) affects approximately 7% of all hospitalized patients each year in the United States, causing short-term and lasting harm, including increased risk of mortality. However, the existing tools for acute kidney injury detection have failed to offer significant anticipation of full-blown AKI, or to provide the insight into the AKIs root cause, which are needed to make an impact on patient outcomes. We will develop Previse, a machine-learning-based prediction system that continuously monitors for incipient AKI and offers clinicians probable root causes of AKI.","Early Identification of Acute Kidney Injury Using Deep Recurrent Neural Nets, Presented with Probable Etiology",9621546,R43AA027674,"['Affect ', ' Clinical Trials ', ' Diagnosis ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Fatigue ', ' Lack of Energy ', ' Future ', ' Goals ', ' Hand ', ' Hospitals ', ' Human ', ' Modern Man ', ' Inpatients ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Methods ', ' mortality ', ' Patients ', ' Physical Examination ', ' Medical Inspection ', ' Prospective Studies ', ' Radiology Specialty ', ' Radiology ', ' General Radiology ', ' Receiver Operating Characteristics ', ' Receiver Operator Characteristics ', ' Recurrence ', ' Recurrent ', ' Research ', ' Risk ', ' Computer software ', ' Software ', ' Supervision ', ' Syndrome ', ' Testing ', ' Time ', ' United States ', ' Work ', ' Hospital Mortality ', ' Inhospital Mortality ', ' In-house Mortalities ', ' Risk Assessment ', ' Data Set ', ' Dataset ', ' Injury to Kidney ', ' base ', ' Label ', ' improved ', ' Area ', ' Clinical ', ' Phase ', ' Series ', ' Hospitalization cost ', ' Hospital Costs ', ' Training ', ' kidney function ', ' Renal function ', ' insight ', ' Measurement ', ' root ', ' Plant Roots ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Therapeutic ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Diagnostic Procedure ', ' Diagnostic Technique ', ' Diagnostic Method ', ' Hour ', ' Event ', ' System ', ' Clinical Decision Support Systems ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' experience ', ' Performance ', ' rapid diagnosis ', ' success ', ' relating to nervous system ', ' neural ', ' Head Start Program ', ' Head Start ', ' novel ', ' Reporting ', ' Admission activity ', ' Admission ', ' Early identification ', ' prevent ', ' preventing ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Address ', ' Data ', ' Detection ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Patient-Focused Outcomes ', ' Small Business Innovation Research ', ' SBIR ', ' Small Business Innovation Research Grant ', ' Monitor ', ' trend ', ' Process ', ' Text ', ' developmental ', ' Development ', ' Electronic Health Record ', ' Bayesian computation ', ' Bayesian Networks ', ' computer based statistical methods ', ' bloodstream infection ', ' blood infection ', ' Sepsis ', ' prototype ', ' effective treatment ', ' effective therapy ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' Bayesian Modeling ', ' Patient risk ', ' learning method ', ' learning activity ', ' learning strategy ', ' improved outcome ', ' predictive tools ', ' experimental research ', ' experiment ', ' experimental study ', ' imaging study ', ' clinical decision support ', ' over-treatment ', ' overtreatment ', ' recurrent neural network ', ' ']",NIAAA,"DASCENA, INC.",R43,2018,349320,CA-15,0.13856798438851337
"Discovery and characterization of novel ciliopathy protein complexes Abstract Ciliopathies are a collection of debilitating developmental disorders (e.g. Joubert syndrome, Meckel syndrome, Bardet-Biedl syndrome, orofaciodigital syndrome, polycystic kidney disease) which have no cures and limited but expensive treatments. Diagnosis and treatment is complicated due to ciliopathies causing multisystem pathologies and having large variance in their clinical presentations potentially resulting in neural tube defects, orofacial clefting, obesity, polycystic kidneys, retinal degeneration and in some cases, infant death. All ciliopathies are caused by dysfunctional cilia, the microtubule based organelle critical for cell-to-cell signaling, but currently there is limited understanding of the underlying molecular network responsible for proper cilia function. Recently, large-scale proteomic techniques have advanced where it is now possible to query the cell's molecular network and identify many new protein complexes. This proposal describes a research program that will 1) construct a ciliary complex map using proteomic techniques, 2) functionally characterize newly discovered ciliary complexes and 3) identify disruptions in complex assembly due to known ciliopathy mutations. Additional products of the proposed research will include a compendium of proteomic data on ciliated cells, statistical analysis tools for the discovery of protein complexes, functional characterization of critical ciliary processes and a more complete understanding of the underlying molecular network of ciliopathy disease states. This work aims to provide an important perspective of cilia biology in order to better understand the complex etiology and molecular causes of ciliopathies and potentially open new therapeutic avenues. Project Narrative Ciliopathies are a class of debilitating birth defects without known cures and limited but expensive treatments. Currently, we lack understanding of the underlying molecular network in ciliopathy patient cells and know even less about the causes of clinical presentations in ciliopathy patients. I propose to discover the differences in the molecular network between healthy cells and ciliopathy patient cells in an effort to better understand the molecular causes of clinical presentations possibly open new avenues for therapeutics.""""""",Discovery and characterization of novel ciliopathy protein complexes,9565420,K99HD092613,"['Congenital Abnormality ', ' Congenital Malformation ', ' Congenital Deformity ', ' Congenital Defects ', ' Congenital Anatomical Abnormality ', ' Congenital Anatomic Abnormality ', ' Birth Defects ', ' Affect ', ' Alleles ', ' Allelomorphs ', ' Biology ', ' Cells ', ' Cell Body ', ' Cilia ', ' Complement ', ' Complement Proteins ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Statistical Data Interpretation ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Embryo ', ' Embryonic ', ' Exhibits ', ' Fractionation ', ' Fractionation Radiotherapy ', ' FRACN ', ' Chemical Fractionation ', ' Future ', ' Recording of previous events ', ' History ', ' Human ', ' Modern Man ', ' Ion Exchange ', ' Polycystic Kidney Diseases ', ' Polycystic Kidney ', ' Maintenance ', ' Maps ', ' Mentors ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Structural Models ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Neural Tube Defects ', ' Neural Tube Developmental Defects ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Organelles ', ' Orofaciodigital Syndromes ', ' Pathology ', ' Patients ', ' Proteins ', ' Rana ', ' Frog ', ' Research ', ' Retinal Degeneration ', ' retinal degenerative diseases ', ' retinal degenerative ', ' retina degeneration ', ' degenerative retina diseases ', ' Role ', ' social role ', ' Sea Anemones ', ' Actiniaria ', ' Sea Urchins ', ' Echinoidea ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Mass Spectrum Analysis ', ' Mass Spectrum Analyses ', ' Mass Spectrum ', ' Mass Spectroscopy ', ' Mass Spectrometry ', ' Mass Photometry/Spectrum Analysis ', ' Syndrome ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Work ', ' Xenopus laevis ', ' Platanna ', ' Data Set ', ' Dataset ', ' base ', ' Clinical ', ' Biological ', ' Biochemical ', ' Link ', ' Training ', ' insight ', ' Therapeutic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Computational Biology ', ' computer biology ', ' programs ', ' Joubert syndrome ', ' cerebelloparenchymal disorder IV ', ' cerebellar vermis agenesis ', ' Joubert-Boltshauser syndrome ', ' Complex ', ' cell type ', ' Techniques ', ' Severity of illness ', ' disease severity ', ' infant death ', ' infantile death ', ' infant demise ', ' death in first year of life ', ' particle ', ' success ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' skills ', ' novel ', ' Bardet-Biedl Syndrome ', ' Bardet Biedel syndrome ', ' Regulation ', ' Property ', ' Proteomics ', ' Gene Transfer Techniques ', ' Transgenesis ', ' developmental disease ', ' developmental disorder ', ' Molecular Sieve Chromatography ', ' Size Exclusion Chromatography ', ' protein complex ', ' Structure of ciliary processes ', ' Ciliary Process ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Systems Biology ', ' Data ', ' Developmental Cell Biology ', ' in vivo ', ' Cilium Microtubule ', ' Collection ', ' Tissue Chip ', ' Tissue Arrays ', ' Tissue Microarray ', ' Molecular ', ' protein function ', ' developmental ', ' Development ', ' Flies ', ' fly ', ' clinical relevance ', ' clinically relevant ', ' human disease ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' loss of function ', ' ciliopathy ', ' CRISPR/Cas system ', ' CRISPR ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' imaging in vivo ', ' in vivo imaging ', ' orofacial clefting ', ' orofacial cleft ', ' university atmosphere ', ' training atmosphere ', ' school atmosphere ', ' learning environment ', ' learning atmosphere ', ' intellectual atmosphere ', ' educational environment ', ' education atmosphere ', ' collegiate atmosphere ', ' collegial atmosphere ', ' college atmosphere ', ' classroom environment ', ' educational atmosphere ', ' ']",NICHD,"UNIVERSITY OF TEXAS, AUSTIN",K99,2018,100205,TX-10,0.05323049734211912
"Measuring post-arrest neurologic injury via nanofluidic assay of brain-derived exosomal RNA Out-of-hospital cardiac arrest (OHCA) strikes over 300,000 people in the US annually. Between 30-50% of OHCA survivors experience some degree of long-term neurologic injury, from mild cognitive defects to severe disability. These injuries are the result of a complex set of ischemia-reperfusion phenomena, known as the post-cardiac arrest syndrome (PCAS), that occurs over the first few days after resuscitation. Prognostication during this critical period, and prediction of neurologic disability, remains an enormous challenge. Serologic markers of brain injury, such as nerve-specific enolase or S100-B, have been tested extensively but have limited predictive value. Quantifying PCAS injury during clinical care has remained a key knowledge gap; with more accurate injury measurement, clinicians would be better able to tailor patient care appropriately by adjusting the intensity of brain-protective therapies including targeted temperature management. Our team has developed a novel approach to injury assessment that applies nanofluidic technology to isolate and analyze brain-derived extracellular vesicles (EVs) from serum, small circulating bodies that represent their cells of origin and are released into the blood in greater quantity when cells are damaged or die. Exosomes carry a collection of microRNA (miRNA) species that can be measured and sequenced, allowing for precise analysis of a transcriptome of brain injury. When we coupled brain-derived exosomal miRNA analysis with machine learning techniques, we demonstrated that exosomal measurement predicted injury severity after traumatic brain injury. We now seek to apply this technology to post-arrest neurologic assessment; we hypothesize that serial EV sampling will allow for more precise measurement of PCAS-related brain injury. We will perform serial blood sampling of adult (age>17 y) non-traumatic resuscitated OHCA patients (0,6,12,24 h post-arrest) as well as from a negative control set of patients with myocardial infarction and positive control set of patients with significant cerebrovascular accident. We will characterize brain-derived miRNA species from both cohorts, first in a derivation group (n=10) and then a validation group (n=40) for each cohort. We will collect demographic and clinical outcome data, including neurologic status at discharge and at 90 d via modified Rankin Scale (mRS), dichotomized into good (mRS 0-2) or poor (mRS 3-6) outcome. A machine learning algorithm will be applied to the derivation group to develop an injury predictive tool, which will then be tested in the validation group. We hypothesize that (1) EV-derived miRNA will identify OHCA patients with brain injury at discharge compared to negative controls and (2) miRNA analysis will discriminate between OHCA patients with good or bad outcomes. Finally, we will apply the predictive tool across 4 timepoints in the OHCA cohort, hypothesizing that more injured patients will show a more significant injury miRNA pattern among earlier timepoints. If successful, this strategy could be coupled to post-arrest trials that require real-time neurologic injury evaluation, and could enable clinicians to tailor care to improve long-term neurologic outcomes. NARRATIVE Out-of-hospital cardiac arrest afflicts >300,000 people in the U.S. each year. Many resuscitated victims die before hospital discharge or suffer enduring neurologic disabilities from ischemia-reperfusion injury, yet our ability to quantitatively measure these injuries during critical care are limited. We propose to test a novel diagnostic approach to address this, using nanofluidic technology to isolate and characterize brain-derived microRNAs from a cohort of initial survivors of cardiac arrest, compared to a control cohort of patients with myocardial infarction (negative control) and a cohort of patients with stroke (positive control).",Measuring post-arrest neurologic injury via nanofluidic assay of brain-derived exosomal RNA,9824489,R21NS109763,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Age ', ' ages ', ' Epitopes ', ' Binding Determinants ', ' Antigenic Determinants ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biomedical Engineering ', ' bioengineering ', ' bio-engineers ', ' bio-engineered ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Circulation ', ' Circulation ', ' Bloodstream ', ' Blood - brain barrier anatomy ', ' Hemato-Encephalic Barrier ', ' Blood-Brain Barrier ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Cell Body ', ' Cells ', ' Clinical Study ', ' Clinical Research ', ' Concurrent Studies ', ' Cohort Studies ', ' Critical Care ', ' Discriminant Analyses ', ' Discriminant Analysis ', ' Exhibits ', ' Patient Care Delivery ', ' Patient Care ', ' Cardiac Arrest ', ' Asystole ', ' Heart Arrest ', ' Hospitals ', ' Ischemia ', ' Learning ', ' Morbidity ', ' Morbidity - disease rate ', ' Mothers ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' Nerve ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neurons ', ' Nucleic Acids ', ' Patients ', ' phosphoglycerate hydro lyase ', ' phosphoglycerate dehydratase ', ' Phosphopyruvate Hydratase ', ' 2-Phospho-D-glycerate hydro-lyase ', ' 2-Phospho-D-Glycerate Hydrolase ', ' enolase ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' QOL ', ' Quality of life ', ' reperfusion ', ' Reperfusion Therapy ', ' Reperfusion Damage ', ' Ischemia-Reperfusion Injury ', ' Reperfusion Injury ', ' Research ', ' Resuscitation ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Stroke ', ' Syndrome ', ' Technology ', ' Temperature ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Work ', ' Glutamate Receptor ', ' Measures ', ' Inhospital Mortality ', ' In-house Mortalities ', ' Hospital Mortality ', ' Caring ', ' Acute myocardial infarction ', ' Acute myocardial infarct ', ' Injury ', ' base ', ' species difference ', ' Blood specimen ', ' Blood Sample ', ' improved ', ' Surface ', ' Acute ', ' Clinical ', ' Neurologic ', ' Neurological ', ' Survivors ', ' GLAST Protein ', ' Glutamate-Aspartate Transporter ', ' GLAST ', ' Evaluation ', ' prognostic ', ' Serum ', ' Blood Serum ', ' disability ', ' Individual ', ' Measurement ', ' Brain Injuries ', ' brain-injured ', ' brain damage ', ' Acquired brain injury ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Investigation ', ' Severities ', ' Complex ', ' cell type ', ' Pattern ', ' Techniques ', ' Neurologic Deficit ', ' Medical center ', ' experience ', ' cell injury ', ' cell damage ', ' Cellular injury ', ' cohort ', ' Cognitive deficits ', ' cognitive defects ', ' Neurological status ', ' Neurologic status ', ' Nervous System Trauma ', ' neurotrauma ', ' Neurological trauma ', ' Neurological Injury ', ' Neurological Damage ', ' Nervous System damage ', ' Nervous System Injuries ', ' Sampling ', ' Traumatic Brain Injury ', ' traumatic brain damage ', ' Brain Trauma ', ' Neural Cell Adhesion Molecule L1 ', ' Neural Adhesion Molecule L1 ', ' Nerve Growth Factor-Inducible Large External Glycoprotein ', ' NILE Protein ', ' NILE Glycoprotein ', ' NGF-Inducible Glycoprotein ', ' L1CAM ', ' L1 Cell Adhesion Molecule ', ' F11 Glycoprotein ', ' Cell Surface Glycoprotein L1 ', ' CamL1 Gene Product ', ' CALL protein ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' fluidic ', ' Microfluidics ', ' Diameter ', ' Caliber ', ' CD81 gene ', ' TSPAN28 ', ' TAPA1 ', ' TAPA-1 ', ' CD81 ', ' Address ', ' Data ', ' Predictive Value ', ' Research Infrastructure ', ' Clinical Data ', ' Collection ', ' Transcript ', ' Validation ', ' Derivation procedure ', ' Derivation ', ' Development ', ' developmental ', ' injured ', ' Neuronal Injury ', ' neuron injury ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' nanoscale ', ' nanometer sized ', ' nanometer scale ', ' nano scale ', ' nano meter sized ', ' nano meter scale ', ' nanofluidic ', ' nano fluidic ', ' Outcome ', ' Neurological outcome ', ' Neurologic outcome ', ' prospective ', ' Coupled ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' multidisciplinary ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' critical period ', ' clinical care ', ' serological marker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' transcriptome ', ' global transcription profile ', ' global gene expression ', ' improved outcome ', ' predictive tools ', ' microvesicles ', ' exosome ', ' extracellular vesicles ', ' machine learning algorithm ', ' out-of-hospital cardiac arrest ', ' ']",NINDS,UNIVERSITY OF PENNSYLVANIA,R21,2019,442750,PA-03,0.01779439751731
"2019 STONE LAB SCIENTIFIC SYMPOSIUM: THINKING OUTSIDE THE BOX FOR KIDNEY STONE DISEASE 2019 STONE LAB SCIENTIFIC SYMPOSIUM: THINKING OUTSIDE THE BOX FOR KIDNEY STONE DISEASE  PROJECT SUMMARY/ABSTRACT A 1.5-day symposium, StoneLab will be held December 6-7, 2019 at AUA Headquarters in Linthicum, Maryland, near BWI Airport. The novel StoneLab Symposium will be a meeting where kidney stone researchers can come together with experts in biomedical engineering, physics, chemistry, artificial intelligence, medical device design and development. We plan to encourage researchers to think outside the box in the search for advances in kidney stone treatment. The target audience for this meeting includes: urologists, nephrologists, basic scientists, early-career investigators, residents, research fellows, and project management members of urology research teams in the area of nephrolithiasis and related technology development. It is essential that the urology community, and especially trainees, early-career physician- scientists, and researchers be provided with accessible opportunities to gain understanding of new knowledge and recent advances in not only their own fields, but in related fields that they may not otherwise be aware of, and leverage this for new research frameworks that can help improve the treatment of kidney stone disease. A critical aspect of the StoneLab Sympoisum is the delivery of talks from outside the normal realm of kidney stone research by leading basic scientists, followed by discussions led by kidney stone researchers and surgeons. The intent of these discussions is to spur the development of collaborations and the generation of new ideas and avenues for exploration. Another goal of the meeting is to help identify future funding needs and growth areas for kidney stone research. The R13 support requested in this application will encourage early investigators to participate in the workshop and stimulate their development as researchers and surgeon- scientists. This symposium will have a major impact by bringing together premier kidney stone researchers, along with experts in nephrology, biomedical engineering, physics, chemistry, artificial intelligence, and medical device design and development, to explore solutions for the most pressing translational science issues facing kidney stone researchers today. The Principal Investigator (PI), Carolyn J.M. Best, PhD, is AUA Director of Research. The Program Planning Committee consists of a diverse multidisciplinary team of distinguished scientists and urologists, most of whom also serve in leadership roles of several AUA-affiliated subspecialty societies: Khurshid Ghani, MD, MS (Chair); Ben H. Chew, MD, MSc (Co-Chair); Thomas Chi, MD; Benjamin Canales, MD, MPH; Gary Curhan, MD, ScD; Amy Krambeck, MD; Dirk Lange, PhD; Manoj Monga, MD, FACS; Kristina Penniston, PhD,RD; and Aria Olumi, MD (ex-officio). 2019 STONE LAB SCIENTIFIC SYMPOSIUM: THINKING OUTSIDE THE BOX FOR KIDNEY STONE DISEASE  PROJECT NARRATIVE/PUBLIC HEALTH RELEVANCE STATEMENT This application seeks support to enable the American Urological Association (AUA) to invite early-career investigators (and late-stage trainees) to participate in a novel interdisciplinary symposium where premier kidney stone researchers, along with experts in nephrology, can come together with experts in biomedical engineering, physics, chemistry, artificial intelligence, and medical device design and development with the aim of thinking outside the box in the search for advances in kidney stone treatment. This meeting will explore solutions for the most pressing translational science issues facing kidney stone researchers today, research in interdisciplinary fields that might be leveraged for new research to improve treatment of kidney stone disease, and help identify future funding needs and growth areas for kidney stone research. A critical aspect of the StoneLab Sympoisum is the delivery of talks from outside the normal realm of kidney stone research by leading basic scientists, followed by discussions led by kidney stone researchers and surgeons with the intent to spur the development of collaborations and the generation of new ideas and avenues for exploration.",2019 STONE LAB SCIENTIFIC SYMPOSIUM: THINKING OUTSIDE THE BOX FOR KIDNEY STONE DISEASE,9914630,U13DK124023,"['Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Award ', ' Awareness ', ' Biology ', ' Biomedical Engineering ', ' bioengineering ', ' bio-engineers ', ' bio-engineered ', ' Chemistry ', ' Communities ', ' Disorder ', ' Disease ', ' Engineering ', ' Future ', ' Goals ', ' Grant ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Renal Stone ', ' Renal Calculi ', ' Kidney Stones ', ' Kidney Calculi ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Leadership ', ' Maryland ', ' Medical Device Designs ', ' Methodology ', ' Miniaturisations ', ' Miniaturization ', ' Nephrology ', ' North America ', ' optical ', ' Optics ', ' Physicians ', ' Physics ', ' Privatization ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Remote Operation (Robotics) ', ' Robotics ', ' social role ', ' Role ', ' Science ', ' Societies ', ' Specialty ', ' medical specialties ', ' Technology ', ' Travel ', ' United States ', ' Urology ', ' Generations ', ' symposia ', ' summit ', ' convention ', ' conference ', ' symposium ', ' career ', ' improved ', ' Area ', ' Medical ', ' urologic ', ' urological ', ' Discipline ', ' Educational workshop ', ' Workshop ', ' Fostering ', ' Development Plans ', ' Funding ', ' Urologist ', ' Collaborations ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Nephrolithiasis ', ' Renal\xa0lithiasis ', ' Scientist ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' interest ', ' meetings ', ' Surgeon ', ' American ', ' technology development ', ' tech development ', ' novel ', ' member ', ' Basic Science ', ' Basic Research ', ' career development ', ' Genomics ', ' Device or Instrument Development ', ' instrument development ', ' device development ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Translational Research ', ' translation research ', ' Translational Science ', ' Principal Investigator ', ' Development ', ' developmental ', ' next generation ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' multidisciplinary ', ' public health relevance ', ' next generation sequencing ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' Big Data ', ' BigData ', ' Big Data Methods ', ' Big Data Tools ', ' Big Data Analytics ', ' ']",NIDDK,AMERICAN UROLOGICAL ASSOCIATION,U13,2019,10000,MD-02,0.21769544102377464
"Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery PROJECT SUMMARY In the United States over 500,000 cardiac surgeries are performed annually. Postoperative acute kidney injury (AKI) occurs in ~20% of cardiac surgical patients. Several cohort and registry studies have reported that AKI defined by rise in serum creatinine after cardiac surgery associates with development of chronic kidney disease and cardiovascular events. However, it is unclear which patients will develop long-term adverse kidney events, adverse cardiovascular events, or both. In recent years blood and urine AKI biomarkers have been identified that reflect different aspects of AKI biology and that detect serum creatinine defined AKI earlier than rise in serum creatinine or detect subclinical AKI that is not revealed by traditional serum creatinine assessment. Clinical outcomes and biomarker research has focused mainly on detecting cardiac surgery- associated AKI itself, but not on predicting which patients are at greatest risk for long-term adverse kidney and cardiovascular outcomes after AKI. The central hypothesis of this proposal is that perioperative blood and urine AKI biomarkers significantly associate with increased long-term (2 to 5 years) postoperative major adverse kidney events (MAKE) and major adverse cardiovascular events (MACE). MAKE is defined as the composite of dialysis, death, renal hospitalization, or  30 day postoperative eGFR decline >25% from preoperative baseline. MACE is defined as the composite of death or hospitalizations for heart failure, myocardial infarction, coronary revascularization, arrhythmia, or stroke. We propose a prospective observational cohort study of 610 patients undergoing cardiac surgery at UT Southwestern Medical Center who will be followed for a minimum of 2 years and up to 5 years following cardiac surgery. Based on preliminary data we will assess plasma NT-pro- B-type natriuretic peptide, plasma intact fibroblast growth factor 23, serum cystatin C, urine TIMP-2*IGFBP7, and urine Kidney Injury Molecule-1 AKI biomarkers preoperatively and at 5 postoperative time points. This proposal will address three specific aims: 1) To determine the association between in-hospital AKI biomarkers and occurrence of MAKE during long-term follow-up; 2) To determine the association between in-hospital AKI biomarkers and occurrence of MACE during long-term follow-up; and 3) To develop clinical prediction models for long-term MAKE and MACE after cardiac surgery. In addition to traditional regression modeling, we will use machine learning that leverages detailed perioperative data including time-varying intraoperative and intensive care unit clinical data and blood and urine AKI biomarker data to create high performing prediction models. Our proposal is significant because knowing what blood and urine AKI biomarkers and clinical parameters accurately predict long-term major adverse kidney and cardiovascular outcomes after cardiac surgery provides the foundation for clinical trials that will identify effective short and long-term interventions for patients at highest risk. Our proposal is innovative because clinical and biomarker data has not been leveraged in this way to predict long-term MAKE and MACE after cardiac surgery. PROJECT NARRATIVE The proposed research is relevant to public health because combining blood and urine acute kidney injury biomarkers and clinical data to identify cardiac surgical patients at highest risk for long-term major adverse kidney and cardiovascular outcomes will allow interventional studies to better individualize clinical management to prevent these outcomes. While acute kidney injury after cardiac surgery is associated with increased long-term adverse kidney and cardiovascular outcomes (~25% incidence), it remains unclear which patients with postoperative acute kidney injury are at highest risk. Thus, the proposed research is relevant to the NIH's mission to develop fundamental knowledge that can be applied to enhancing health, lengthening life, and reducing illness and disability.",Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery,9800334,R01HL148448,"['Anesthesiology ', ' Angiotensin-Converting Enzyme Inhibitors ', ' Kininase II Inhibitors ', ' Kininase II Antagonists ', ' Angiotensin-Converting Enzyme Antagonists ', ' Angiotensin I-Converting Enzyme Inhibitors ', ' ACE Inhibitors ', ' Arrhythmia ', ' Heart Arrhythmias ', ' Cardiac Arrhythmia ', ' Biology ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cardiology ', ' Cardiopulmonary Bypass ', ' heart bypass ', ' Heart-Lung Bypass ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Clinical Informatics ', ' Clinical Trials ', ' Concurrent Studies ', ' Cohort Studies ', ' Creatinine ', ' Death ', ' Cessation of life ', ' dialysis therapy ', ' Dialysis ', ' Dialysis procedure ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Foundations ', ' Foxes ', ' Future ', ' Goals ', ' Grant ', ' Health ', ' cardiac failure ', ' Heart failure ', ' heart surgery ', ' Heart Surgical Procedures ', ' Cardiac Surgical Procedures ', ' Cardiac Surgery ', ' Cardiac Surgery procedures ', ' hemodynamics ', ' Hospital Admission ', ' Hospitalization ', ' Hospitals ', ' Incidence ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Information Systems ', ' Intensive Care Units ', ' interventions research ', ' interventional study ', ' interventional research ', ' intervention research ', ' Intervention Studies ', ' intra-operative care ', ' Peroperative Care ', ' Intraoperative Care ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Chronic Kidney Failure ', ' Literature ', ' Methods ', ' Mission ', ' mortality ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Nephrology ', ' Patients ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Postoperative ', ' Post-Operative ', ' Postoperative Period ', ' Prospective Studies ', ' Public Health ', ' Publishing ', ' Questionnaires ', ' Angiotensin Receptor ', ' Records ', ' Registries ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Regression Analysis ', ' Research ', ' Risk ', ' Sensitivity and Specificity ', ' cerebrovascular accident ', ' cerebral vascular accident ', ' brain attack ', ' Cerebrovascular Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebral Stroke ', ' Brain Vascular Accident ', ' Apoplexy ', ' Stroke ', ' Time ', ' United States ', ' Urine Urinary System ', ' Urine ', ' brain Natriuretic factor ', ' Type-B Natriuretic Peptide ', ' Nesiritide ', ' Natriuretic Factor-32 ', ' Brain Natriuretic Peptide-32 ', ' BNP-32 ', ' BNP Gene Product ', ' Brain natriuretic peptide ', ' post-gamma-protein ', ' cystatin C ', ' post gamma-globulins ', ' Measures ', ' base ', ' Transfusion ', ' Clinical ', ' Medical ', ' Serum ', ' Blood Serum ', ' disability ', ' Renal function ', ' kidney function ', ' Databases ', ' data base ', ' Data Bases ', ' Measurement ', ' Funding ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Life ', ' Hour ', ' Event ', ' Source ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Medical center ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' cohort ', ' rat KIM-1 protein ', ' renal KIM-1 ', ' kidney injury molecule 1 ', ' novel ', ' health record ', ' Reporting ', ' Modeling ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' fibroblast growth factor 23 ', ' FGF23 gene product ', ' preventing ', ' prevent ', ' Address ', ' Dose ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' Clinical Data ', ' Clinical Management ', ' Enrollment ', ' enroll ', ' Longterm Follow-up ', ' longterm followup ', ' long-term followup ', ' Long-term Follow-up ', ' Perioperative ', ' Coronary ', ' Cardiac ', ' Development ', ' developmental ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' design ', ' designing ', ' Outcome ', ' Computational Science ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' multidisciplinary ', ' high risk ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' biobank ', ' biorepository ', ' Cardiac rehabilitation ', ' cardiac rehab ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' clinical biomarkers ', ' clinically useful biomarkers ', ' outcome prediction ', ' predictors of outcomes ', ' predictive outcomes ', ' Prospective cohort study ', ' ']",NHLBI,UT SOUTHWESTERN MEDICAL CENTER,R01,2019,802772,TX-30,0.0957863801598272
"High content in vivo screening for acute kidney injury ameliorating drugs ABSTRACT In this application we will perform high throughput, high content, screening for small molecules that improve kidney regeneration after acute kidney injury (AKI). AKI presents a dire unmet medical need because of its high prevalence with long-term adverse health effects and life-threatening sequelae. Mortality is high and the only effective treatments are renal replacement therapies. The onset of the precipitating event is unpredictable, and in many instances once patients are admitted to the hospital, injury has already occurred. Improving recovery from injury therefore presents an attractive opportunity for intervention, but to date, no therapies are available that are effective if administered post injury. The vertebrate kidney has an innate ability to regenerate and follows a well-defined cellular mechanism that encompasses dedifferentiation of surviving renal tubule cells, proliferation of resulting progenitors, and repopulation of the denuded tubule. This sequence of events, together with their respective molecular markers, is conserved between humans, mouse, and zebrafish. During regeneration, transcription factors normally expressed during organogenesis (e.g.,lhx1a, pax2, and pax8) are reactivated. We previously demonstrated that small molecule-mediated augmentation of endogenous Lhx1a expression can ameliorate recovery in zebrafish and mouse models of AKI. Together these data support the overall hypothesis that augmentation by small molecules of cellular programs that drive kidney repair after injury represents a novel pharmacologic approach for the treatment of AKI and associated sequelae. Using a transgenic zebrafish line that expresses Lhx1a-EGFP we have developed an artificial intelligence-based, high-content assay to quantify lhx1a expression in the living embryo. Using multivariate analysis, the assay met accepted HTS assay performance standards and was validated in three-day variability studies and a small pilot library screen. We will perform a primary HTS of 50,000 compounds from the MLPCN collection. Prioritized hits will be subjected to a fully implemented, rigorous secondary assay paradigm encompassing kidney organ development, metabolic stability, in vivo efficacy, and activity profiling in a pathophysiological relevant AKI model. At the end of these studies we will have identified functionally and mechanistically characterized in vivo chemical probes to investigate the biology of kidney injury and regeneration, some of which are expected to have features that make them suitable for development into preclinical leads. NARRATIVE Acute kidney injury (AKI) presents a dire unmet medical need with unacceptably high mortality rates and a lack of therapeutic modalities. The vertebrate kidney has an innate ability to regenerate that can be enhanced by small molecules. In this proposal we will perform high-content, high throughput screening for kidney regeneration in zebrafish to discover novel chemical probes to investigate mechanisms of augmented kidney regeneration after injury.",High content in vivo screening for acute kidney injury ameliorating drugs,9613245,R01DK112652,"['improved ', ' Medical ', ' Renal Replacement Therapy ', ' Kidney Replacement Therapy ', ' Ensure ', ' Chemicals ', ' Evaluation ', ' Renal function ', ' kidney function ', ' Recovery ', ' Organogenesis ', ' analog ', ' Transgenes ', ' Therapeutic ', ' Metabolic ', ' Genetic ', ' Tubular formation ', ' Tubular ', ' Nature ', ' Life ', ' programs ', ' Complex ', ' Event ', ' Protocols documentation ', ' Protocol ', ' System ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' Cell Proliferation ', ' Cellular Proliferation ', ' Cell Multiplication ', ' Cell Growth in Number ', ' Performance ', ' small molecule libraries ', ' chemical library ', ' Transgenic Organisms ', ' transgenic ', ' Toxic effect ', ' Toxicities ', ' novel ', ' Modality ', ' Appearance ', ' organ regeneration ', ' Modeling ', ' response ', ' high throughput screening ', ' High Throughput Assay ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' small molecule ', ' Dose ', ' Data ', ' Detection ', ' High Prevalence ', ' Molecular Bank ', ' molecular library ', ' Reproducibility ', ' in vitro Assay ', ' in vivo ', ' Collection ', ' Development ', ' developmental ', ' pre-clinical ', ' preclinical ', ' mouse model ', ' murine model ', ' progenitor ', ' FDA approved ', ' effective therapy ', ' effective treatment ', ' molecular marker ', ' molecular biomarker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' kidney repair ', ' screening ', ' organ growth ', ' organ development ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' Breeding ', ' Carboxylic Acids ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Embryonic ', ' Embryo ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Epithelial Cells ', ' Fibrosis ', ' Health ', ' Hospitals ', ' Modern Man ', ' Human ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' renal tubule ', ' Kidney Tubules ', ' Renal tubule structure ', ' Libraries ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' Microsomes ', ' mortality ', ' Multivariate Analyses ', ' Multivariate Analysis ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Patients ', ' Pharmacology ', ' Pro-Drugs ', ' Drug Precursors ', ' Prodrugs ', ' regenerate ', ' Regeneration ', ' Natural regeneration ', ' Specificity ', ' Progenitor Cells ', ' Stem cells ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Zebra Fish ', ' Zebra Danio ', ' Danio rerio ', ' Brachydanio rerio ', ' Zebrafish ', ' Generations ', ' Artifacts ', ' Morphologic artifacts ', ' Mediating ', ' Injury ', ' base ', ' ']",NIDDK,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2019,352125,PA-18,0.2064871036278161
"Artificial intelligence-enabled, real-time communication software for optimizing clinical decision making during the allocation, procurement, and transplantation of donated organs Project Abstract for HealthTech Solutions Kidney transplantation is a clinically effective and cost-effective treatment for patients suffering from end-stage renal disease (ESRD) and diabetes. Twenty-two patients die each day waiting for a transplant and 30% of all deaths in the US could be prevented by organ transplant. Despite the obvious clinical and cost-effective advantages of kidney transplantation, there has been a decades-long rise in the kidney discard rate from 5.1% in 1988 to 19.2% in 2015. During a successful Phase I grant and to address the need for a dedicated communications system to help improve transplant patient outcomes and achieve greater donated organ utilization, HealthTech Solutions (HTS), Inc. developed a proprietary mobile application for secure team communication tailored specifically for kidney transplant teams. To further improve communication efficiency and augment critical decision making in healthcare, specifically for surgeons, HTS will employ machine learning (ML) powered clinical decision support. Clinical decision support (CDS) may significantly increase access, increase quality, and reduce the cost of kidney transplantation. The proposed project is designed to further test and quantify the improvement of the donor management, coordination process, and kidney utilization outcomes using the companys CDS and communication infrastructure for medical team communication. The aims are; 1) Develop CDS models specifically for transplant professionals aimed at improving decision times and decision confidence. Develop the CDS infrastructure capable of handling medical data and serving insights safely, securely, and rapidly; 2) Asses usability by working with a test group to exceed usability criteria and ensure that CDS meets clinician needs through user feedback iterations. Verification of utility from a diversified testing group (n=10) that represent every type of professional involved in transplant cases. 3) Measure the effects of TXP Chat enhanced with CDS after live clinical implementation in the kidney offer and procurement processes for more than 3,000 offers (1,500 with CDS and 1,500 control) over a period of 365 days with multiple partner institutions (n=3). TXP Chat and CDS will demonstrate to be reliable, secure, trustworthy and useful by the clinical/technical community, increase kidney acceptance practices resulting in an increase in kidney transplants, reduction in cold ischemic time, and reduction in time from offer to transplant. Ultimately, these metrics have been demonstrated in the literature to improve patient outcomes, reduce expensive chronic treatment costs (e.g. dialysis), reduce patient deaths from lack of kidney availability, and significantly improve human health and productivity. Study results will be disseminated via publication in a peer-reviewed journal. Aim 1 will lay the foundation for further development to enable wider CDS in the Phase IIB. Aim 2 will prove physician support and steady adoption trend as we roll into commercialization. Aim 3 will provide multi-center pilot study data used to prove increased efficiency of the process in terms of time, money, and total number of kidneys transplanted. Project Narrative Despite the obvious clinical and cost-effectiveness advantages of kidney transplantation for many patients, nearly 1 in 5 kidneys authorized for donation are discarded. This project addresses the need for an efficient communications software technology enhanced with clinical decision support tailored for organ procurement organizations and transplant centers. Combined with enhanced communication efficiency, clinical decision support powered by machine learning may significantly improve donated kidney utilization and increase the number of viable, but currently unused organs that could otherwise be successfully transplanted, reducing waste and saving lives.","Artificial intelligence-enabled, real-time communication software for optimizing clinical decision making during the allocation, procurement, and transplantation of donated organs",9845904,R44LM012575,"['Adoption ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Communication ', ' Communities ', ' cost effectiveness ', ' Death ', ' Cessation of life ', ' Decision Making ', ' dialysis therapy ', ' Dialysis ', ' Dialysis procedure ', ' Feedback ', ' Foundations ', ' Renal Diabetes ', ' Renal Glycosuria ', ' Goals ', ' Grant ', ' Health ', ' Modern Man ', ' Human ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' kidney tx ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Kidney Transplantation ', ' Literature ', ' Multiple Partners ', ' Organ Procurements ', ' organ xenograft ', ' organ graft ', ' organ allograft ', ' Organ Transplants ', ' Grafting Procedure ', ' Organ Transplantation ', ' Patients ', ' Peer Review ', ' Physicians ', ' pilot study ', ' Pilot Projects ', ' Privatization ', ' Productivity ', ' Scientific Publication ', ' Publications ', ' Savings ', ' Software ', ' Computer software ', ' Survey Instrument ', ' Surveys ', ' Technology ', ' Phone ', ' Telephone ', ' Testing ', ' Time ', ' transplant ', ' Transplantation ', ' waitlist ', ' Waiting Lists ', ' Work ', ' Measures ', ' Tissue Transplantation ', ' health care ', ' Healthcare ', ' Decision Support Model ', ' Treatment Cost ', ' Journals ', ' Magazine ', ' Organ ', ' improved ', ' Chronic ', ' Clinical ', ' Phase ', ' Medical ', ' Ensure ', ' Evaluation ', ' insight ', ' wasting ', ' satisfaction ', ' Asses ', ' Equus asinus ', ' Donkey ', ' Transplanted tissue ', ' Graft Material ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Transplant Recipients ', ' transplant patient ', ' Life ', ' Hour ', ' System ', ' burnout ', ' burn-out ', ' Surgeon ', ' experience ', ' Performance ', ' cohesion ', ' Reporting ', ' Positioning Attribute ', ' Position ', ' response ', ' Enhancement Technology ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' Institution ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' Direct Costs ', ' Patient-Focused Outcomes ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' transmission process ', ' Transmission ', ' trend ', ' Process ', ' Development ', ' developmental ', ' cost ', ' design ', ' designing ', ' Clinical effectiveness ', ' Outcome ', ' cost effective ', ' usability ', ' commercial application ', ' commercialization ', ' effective therapy ', ' effective treatment ', ' clinical decision-making ', ' Secure ', ' operation ', ' mobile application ', ' mobile app ', ' transplant centers ', ' clinical decision support ', ' clinical implementation ', ' Infrastructure ', ' ']",NLM,ORGANIZER,R44,2019,512863,IA-02,0.1930198988985972
"Quantitative Renal Imaging for Kidney Diseases Contrast Enhanced Magnetic Resonance Angiography (CEMRA) with gadolinium (Gd) provides high resolution visualization of the vascular compartment, but is rarely used in patients with advanced chronic kidney disease (CKD) (estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73m2) due to the risk of nephrogenic systemic fibrosis (NSF). There is thus an unmet need to develop MRI techniques that can both replace Gd and provide new insights into the etiology and severity of CKD.  PI Sridhar and his team at Northeastern University (NEU) have developed a new technique, Quantitative Ultra-short Time-to-Echo Contrast-Enhanced (QUTE-CE) MRI, leads to quantifiable positive contrast images of the vasculature with unprecedented clarity and definition. QUTE-CE is particularly optimal using Ferumoxytol (Feraheme), an FDA approved iron-oxide nanopharmaceutical, that is already routinely used for iron-deficient anemia therapy in CKD patients. Under an ongoing clinical trial (NCT03266848) we have demonstrated QUTE- CE MRI for renal and cerebral imaging in humans at 3T.  This R21 project will develop the QUTE-CE MRI method for kidney imaging in patients with both normal kidney function as well as with CKD. We propose to scan 25 total patients (10 in Year 1 and 15 in Year 2) who are already scheduled to receive ferumoxytol infusion for iron-deficiency anemia therapy. The specific aims of this project are summarized below. Specific Aim 1: Renal Vascular Angiograms of CKD Patients. These studies will be conducted at NEU and Massachusetts General Hospital (MGH) using Siemens Prisma MRI scanners. Three tasks will be pursued to develop the optimizing protocol. Task 1: Develop a robust QUTE-CE imaging protocol. Task 2: Implement a robust methodology for accounting for B1 inhomogeneity. Task 3: Develop a robust trajectory for improved image reconstruction including motion correction. We hypothesize that QUTE-CE MRI will lead to high resolution angiograms that will allow for the safe diagnosis of existing pathologies such as renal artery stenosis in addition to the novel identification of kidney micro-vascular disease. Specific Aim 2: Obtain quantitative renal blood volume (RBV) maps and develop machine learning algorithms (MLA) to better understand the severity of kidney disease. The renal angiograms will be analyzed to obtain renal blood volume (RBV) maps. The RBV maps will be analyzed in terms of Machine-Learning algorithms (MLA) to explore whether we can identify common etiologies of CKD as well as estimate the severity of kidney disease. The MLA will enable organ segmentation, automatized renal parenchyma volumetry, as well as automated extraction and labeling of lesions. The MLA results will be compared with radiological scoring, estimated GFR, and degree of albuminuria. We hypothesize that the absolute RBV maps will enable quantitative monitoring of blood volume in cortex and medulla, and that RBV could be a surrogate parameter for renal microvascular rarefaction, a central mechanism in CKD initiation and progression. PROJECT NARRATIVE TITLE: Quantitative Renal Imaging for Kidney Disease This project will develop a quantitative magnetic resonance imaging technique QUTE-CE MRI for studies of chronic kidney disease (CKD). The QUTE-CE MRI methodology provides very clear and high resolution angiographic images of vasculature using a safe and clinically approved nanoparticle contrast agent, that will transform standard of care by enabling diagnostic imaging for a large population of patients with CKD who cannot be imaged with the current gadolinium contrast agent due to its toxicity.",Quantitative Renal Imaging for Kidney Diseases,9824779,R21DK118449,"['Accounting ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Albuminuria ', ' Algorithms ', ' Anemia ', ' Angiography ', ' angiographic imaging ', ' Angiogram ', ' Arteries ', ' Blood Vessels ', ' vascular ', ' Blood Volume ', ' Systematics ', ' Classification ', ' Clinical Study ', ' Clinical Research ', ' Clinical Trials ', ' Radiopaque Media ', ' Contrast Drugs ', ' Contrast Agent ', ' Contrast Media ', ' Cyst ', ' Diagnosis ', ' Diagnostic Imaging ', ' Gd element ', ' Gadolinium ', ' Glomerular Filtration Rate ', ' Hospitals ', ' General Hospitals ', ' Modern Man ', ' Human ', ' image generation ', ' image construction ', ' image reconstruction ', ' Iodine ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Chronic Kidney Failure ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Maps ', ' Massachusetts ', ' Methods ', ' Methodology ', ' Motion ', ' Nephrology ', ' Pathology ', ' Patients ', ' Proteinuria ', ' Public Health ', ' Radiology ', ' General Radiology ', ' Radiology Specialty ', ' Renal Artery Stenosis ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Kidney Failure ', ' Research ', ' Risk ', ' Software ', ' Computer software ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' United States ', ' Universities ', ' Veins ', ' red iron oxide ', ' ferric oxide ', ' colcothar ', ' Fe oxide ', ' iron oxide ', ' Imaging Technics ', ' Imaging Procedures ', ' Imaging Techniques ', ' Schedule ', ' prisma ', ' Iron deficiency anemia ', ' Imagery ', ' Visualization ', ' Organ ', ' Label ', ' improved ', ' kidney imaging ', ' Clinical ', ' prognostic ', ' Lesion ', ' Renal function ', ' kidney function ', ' insight ', ' Cerebrum ', ' cerebral ', ' Disease Progression ', ' Magnetic Resonance Angiography ', ' MRI Angiography ', ' Radiation Toxicity ', ' radiation poisoning ', ' Radiotoxicity ', ' Acute Radiation Syndrome ', ' Iron ', ' Fe element ', ' instrument ', ' Diagnostic ', ' Severities ', ' Scanning ', ' Protocols documentation ', ' Protocol ', ' Techniques ', ' Medical center ', ' Infusion procedures ', ' Infusion ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' kidney vascular structure ', ' renovascular ', ' kidney vascular ', ' Renal vessels ', ' Renal Vascular ', ' Toxic effect ', ' Toxicities ', ' expectation ', ' novel ', ' Modeling ', ' imaging method ', ' image-based method ', ' imaging modality ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Address ', ' ferumoxytol ', ' Feraheme ', ' Resolution ', ' Monitor ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' nanodrug ', ' nanopharmaceutical ', ' nano drug ', ' nanoparticle ', ' nanosized particle ', ' nano-sized particle ', ' nano particle ', ' Population ', ' multidisciplinary ', ' high risk ', ' FDA approved ', ' patient population ', ' standard of care ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Microvascular Dysfunction ', ' small vessel disease ', ' microvascular disease ', ' microvascular complications ', ' contrast enhanced ', ' Gaussian model ', ' Gaussianity model ', ' Gaussianity ', ' Gaussian statistics ', ' Magnetic nanoparticles ', ' contrast imaging ', ' clinical imaging ', ' nuclear imaging ', ' machine learning algorithm ', ' Nephrogenic Systemic Fibrosis\xa0 ', ' kidney biopsy ', ' renal biopsy ', ' ']",NIDDK,NORTHEASTERN UNIVERSITY,R21,2019,220889,MA-07,0.12272298555535655
"Development and Validation of Radiation-Free Pediatric Renal Function Quantification Project Abstract Motivation: Chronic kidney disease (CKD) affects more than 500 million people. Children commonly develop CKD from urinary obstructive diseases and nephrotoxic therapies, and then suffer severe growth failure,  hypertension, cardiovascular risks, and neurocognitive deficits, and eventually end-stage kidney disease. Accurate renal function quantification will improve clinical management of hydronephrosis (1 in 100 babies) and  dosing/selection of chemotherapeutic regimens in oncology patients. Glomerular filtration rate (GFR), the biomarker of renal function, is derived from blood or urine tests. These tests only provide global GFR and are limited in accuracy, especially in children, and even more so in children with cancer. MRI offers superb anatomic delineation without ionizing radiation, and is thus ideal for pediatric kidney imaging. However, MRI has not been widely adopted for pediatric renal function evaluation due to lack of reliability and cumbersome workflow. These hurdles stem from the fact that the critical components required for global and regional GFR calculation, including high spatiotemporal resolution, plasma flow and arterial input function, are difficult to obtain, and that accurate image segmentation of kidneys (cortex and medulla) is labor intensive. Additionally, although the same contrast agent injection can be used for obstruction evaluation, certain areas of the kidney suffer from significant signal loss using standard MRI acquisition techniques due to high contrast agent concentrations. This project addresses these major challenges for automated comprehensive renal function evaluation in children. Approach: The project has three development aims, which are validated by clinical studies. Aim 1 will enable novel free-breathing time-resolved 3D dynamic contrast enhanced MRI that simultaneously provides accurate GFR calculation and renal plasma flow. This is achieved by incorporating self-navigated motion compensation, fast acquisition with parallel imaging and compressed sensing, and phase-contrast flow imaging. The second aim is to develop multiple new image analysis methods to extract GFR and renal plasma flow (RPF) that  leverage novel flow data of Aim 1, as well as automated new machine-learning image processing techniques for the segmentation of kidneys and ultimately global and regional GFR calculation. In Aim 3, we will develop and integrate ultrashort-echo-time techniques to address the MRI signal loss due to T2* effects from high contrast concentration for patients with obstruction, and further incorporate motion compensation and accelerated  imaging methods to enable time-resolved high-resolution dynamic MRI for contrast washout kinetics analysis in the same MR exam. Aim 4 will determine the performance of these methods in a clinical setting. Significance: This work will lead to robust, automated comprehensive pediatric renal MRI for safer and more accurate renal function evaluation in children. The techniques will facilitate widespread application in the com- munity setting and permit robust evaluation of renal function, for both children and adults. Project Narrative Kidney diseases in children often stem from blockages of the urinary tract or toxicity from medications, such as antibiotics or chemotherapies. Kidney function quantification is crucial for clinical management of these children. This work will develop accurate and automated pediatric MRI for quantification of kidney function and diagnosis of urinary tract obstruction.",Development and Validation of Radiation-Free Pediatric Renal Function Quantification,9677647,R01EB026136,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Antibiotics ', ' Miscellaneous Antibiotic ', ' Antibiotic Drugs ', ' Antibiotic Agents ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cardiac Output ', ' heart output ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Clinical Study ', ' Clinical Research ', ' Radiopaque Media ', ' Contrast Drugs ', ' Contrast Agent ', ' Contrast Media ', ' Diagnosis ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Evolution ', ' Glomerular Filtration Rate ', ' Gold ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Hydronephrosis ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' renal cortex ', ' kidney cortical portion ', ' kidney cortex ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Chronic Kidney Failure ', ' Kinetics ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' achievement Mainstream Education ', ' Educational Mainstreaming ', ' Mainstreaming ', ' Manuals ', ' Methods ', ' Motion ', ' Motivation ', ' Obstruction ', ' Patients ', ' Perfusion ', ' Pharmacokinetics ', ' Drug Kinetics ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' pressure ', ' ionizing output ', ' Radiation-Ionizing Total ', ' Ionizing Electromagnetic Radiation ', ' Ionizing radiation ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Testing ', ' Time ', ' Urinary tract ', ' Urine Urinary System ', ' Urine ', ' Work ', ' Measures ', ' base ', ' image processing ', ' urinary tract obstruction ', ' Obstructive Uropathy ', ' improved ', ' Image Analysis ', ' image evaluation ', ' Image Analyses ', ' kidney imaging ', ' Area ', ' Clinical ', ' Phase ', ' urologic ', ' urological ', ' Renal Plasma Flow ', ' Financial compensation ', ' Compensation ', ' Evaluation ', ' Failure ', ' Childhood ', ' pediatric ', ' Blood flow ', ' Reflux ', ' Renal function ', ' kidney function ', ' Measurement ', ' oncology ', ' Oncology Cancer ', ' Malignant Childhood Neoplasm ', ' pediatric malignancy ', ' pediatric cancer ', ' children with cancer ', ' childhood malignancy ', ' child with cancer ', ' cancer in children ', ' cancer in a child ', ' Malignant childhood cancer ', ' Malignant Pediatric Tumor ', ' Malignant Pediatric Neoplasm ', ' Malignant Childhood Tumor ', ' Childhood Cancers ', ' Venous ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Adopted ', ' antimicrobial drug ', ' antimicrobial agent ', ' anti-microbial drug ', ' anti-microbial agent ', ' Protocols documentation ', ' Protocol ', ' Techniques ', ' 3-Dimensional ', ' 3D ', ' 3-D ', ' experience ', ' Performance ', ' nephrotoxicity ', ' kidney toxicity ', ' Nephrotoxic ', ' Toxic effect ', ' Toxicities ', ' novel ', ' chemotherapeutic agent ', ' cardiovascular risk factor ', ' cardiovascular risk ', ' Radiation ', ' data processing ', ' computerized data processing ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' imaging method ', ' image-based method ', ' imaging modality ', ' Address ', ' Dose ', ' Data ', ' Reproducibility ', ' Resolution ', ' Clinical Management ', ' Validation ', ' urinary ', ' Development ', ' developmental ', ' Renal Blood Flow ', ' Image ', ' imaging ', ' reconstruction ', ' Neurocognitive Deficit ', ' neurocognitive impairment ', ' neurocognitive decline ', ' IQ Deficit ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Consumption ', ' imaging Segmentation ', ' data acquisition ', ' chemotherapy ', ' loss of function ', ' stem ', ' spatiotemporal ', ' community setting ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Regimen ', ' 4D Imaging ', ' four-dimensional imaging ', ' 4-D imaging ', ' Cone ', ' contrast enhanced ', ' recruit ', ' Injections ', ' automated analysis ', ' ']",NIBIB,STANFORD UNIVERSITY,R01,2019,665614,CA-18,0.08507986593957383
"Integrative Molecular Epidemiology Approach to Identify Nephrotic Syndrome Subgroups ABSTRACT Although patients with Nephrotic Syndrome (NS) present with shared clinical signs and symptoms (proteinuria, hypoalbuminemia, hyperlipidemia and edema), there is dramatic variability in prognosis and response to therapy, frustrating patients, families and their clinicians. Even within the histopathologic categories used in the current diagnostic approach (e.g. minimal change disease, focal segmental glomerulosclerosis), there is dramatic variability in disease progression and response to therapy, highlighting the underlying biological heterogeneity within the groups. Small studies with broad, clinical patient inclusion criteria have demonstrated that a subset of patients respond well to anti-TNF therapy, but accurate pre-treatment response of those individuals is not possible based on routine clinical parameters. This project will leverage the Nephrotic Syndrome Study Network (NEPTUNE) cohort study, a multi-center prospective study of 600 patients with FSGS, MCD and MN with rich clinical data, kidney biopsy tissue and gene expression profiles. This study will leverage the kidney tissue gene expression data to identify a subgroup of patients with TNF-alpha pathway activation, assess associated clinical outcomes and identify non- molecular predictors of the subgroup. The aims are:  Aim 1: To identify a subgroup of Nephrotic Syndrome patients with homogeneous activation of the  TNF-alpha transcriptional pathway.  Aim 2: To compare molecular subgroups with conventional clinical-pathologic classification in  clinical outcome prediction.  Aim 3: To identify non-invasive markers (e.g. demographics, blood and urine markers), standard  pathology features and novel pathologic biopsy descriptors associated with the TNF-alpha subgroup. To accomplish this project, the applicant will pursue formal training in systems biology, genetic epidemiology and bioinformatics. She will be mentored by a multi-disciplinary team with expertise in systems biology, epidemiology and bioinformatics. The long term objective is to improve the clinical care of patients with Nephrotic Syndrome by improved understanding of the underlying biology, identifying novel biomarkers and potential therapeutic targets for future validation in animal models and mechanistic-based interventional clinical trials. PROJECT NARRATIVE Nephrotic Syndrome, caused by several rare kidney diseases, is characterized by an abnormal amount of protein in the urine, swelling and kidney failure. Patients affected by the syndrome suffer complications of the disease as well as the toxicity of the immunosuppressive therapy used to treat it, but their individual presentations, response to treatment and prognosis can vary markedly. This project aims to use gene expression levels from kidney biopsy tissue to identify the subgroup patients most likely to respond to TNF- alpha blocking medications, an approach which, if validated, may help to inform targeted therapy selections for these patients.",Integrative Molecular Epidemiology Approach to Identify Nephrotic Syndrome Subgroups,9672412,K08DK115891,"['Affect ', ' Award ', ' Biology ', ' Biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Systematics ', ' Classification ', ' Clinical Trials ', ' Concurrent Studies ', ' Cohort Studies ', ' Complement Proteins ', ' Complement ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Hydrops ', ' Dropsy ', ' Edema ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Family ', ' Future ', ' Gene Expression ', ' Patient Care Delivery ', ' Patient Care ', ' Genotype ', ' Membranous Nephropathy ', ' Membranous Glomerulopathy ', ' Membranous Glomerulonephropathy ', ' Extramembranous Glomerulopathy ', ' Membranous Glomerulonephritis ', ' Grant ', ' Heterogeneity ', ' Hyperlipemia ', ' Hyperlipidemia ', ' immunosuppression therapy ', ' artificial immunosuppression ', ' Immunosuppressive Therapy ', ' Antirejection Therapy ', ' Anti-Rejection Therapy ', ' Therapeutic immunosuppression ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' renal glomerulus ', ' kidney glomeruli ', ' Malpighian Tuft ', ' Kidney Glomerulus ', ' Leadership ', ' Mentors ', ' Nephrotic Syndrome ', ' Pathology ', ' Patients ', ' Phenotype ', ' Probability ', ' Prognosis ', ' outcome forecast ', ' Prospective Studies ', ' Proteins ', ' Proteinuria ', ' Scientific Publication ', ' Publications ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Kidney Failure ', ' Research Resources ', ' Resources ', ' Diagnostic Findings ', ' Signs and Symptoms ', ' Swelling ', ' Syndrome ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Urine Urinary System ', ' Urine ', ' Work ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Histologic ', ' Histologically ', ' Molecular Epidemiology ', ' Training ', ' Individual ', ' Hypoalbuminemia ', ' Disease Progression ', ' Patient Selection ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Renal glomerular disease ', ' Renal glomerular syndrome ', ' Renal glomerular disorder ', ' Renal glomerular disease or syndrome ', ' Renal Glomerular Diseases and Syndromes ', ' Glomerular disease ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Anti-Tumor Necrosis Factor Therapy ', ' anti-TNF-alpha therapy ', ' anti-TNF therapy ', ' Descriptor ', ' Genetic ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Focal Segmental Glomerulosclerosis ', ' Focal segmental glomerular sclerosis ', ' FSGS ', ' Complex ', ' Clinical Course of Disease ', ' Techniques ', ' cohort ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' Toxic effect ', ' Toxicities ', ' Histopathology ', ' Structure ', ' skills ', ' novel ', ' Participant ', ' member ', ' Categories ', ' Positioning Attribute ', ' Position ', ' TNF gene ', ' Tumor Necrosis Factor-alpha ', ' Tumor Necrosis Factor ', ' TNF ', ' TNFA ', ' TNF- ', ' TNF Alpha ', ' TNF A ', ' TNF ', ' Monocyte-Derived TNF ', ' Macrophage-Derived TNF ', ' Cachectin ', ' (TNF)- ', ' response ', ' genetic epidemiology ', ' genetic epidemiologic study ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Bioinformatics ', ' Bio-Informatics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Systems Biology ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Prediction of Response to Therapy ', ' treatment response prediction ', ' treatment prediction ', ' therapy prediction ', ' predict treatment response ', ' predict therapy response ', ' predict therapeutic response ', ' Subgroup ', ' Clinical Data ', ' Observational Study ', ' Observational research ', ' Observation study ', ' Observation research ', ' Validation ', ' Pathologic ', ' Characteristics ', ' Molecular ', ' Pathway interactions ', ' pathway ', ' Outcome ', ' multidisciplinary ', ' inclusion criteria ', ' demographics ', ' therapeutic target ', ' clinical epidemiology ', ' clinical care ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' novel marker ', ' novel biomarker ', ' new marker ', ' clinical practice ', ' biological systems ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' biological heterogeneity ', ' outcome prediction ', ' predictors of outcomes ', ' predictive outcomes ', ' patient subsets ', ' patient subtypes ', ' patient subpopulations ', ' patient subgroups ', ' predict clinical outcome ', ' predictor of clinical outcome ', ' clinical outcome prediction ', ' Prospective cohort study ', ' Expression Profiling ', ' Molecular Disease ', ' patient response ', ' responsive patient ', ' kidney biopsy ', ' renal biopsy ', ' ']",NIDDK,UNIVERSITY OF MICHIGAN AT ANN ARBOR,K08,2019,169110,MI-12,0.11701062357598033
"Extracellular Vesicles as a Link Between Placental and Renal Dysfunction in Preeclampsia PROJECT SUMMARY Preeclampsia (PE) is a devastating hypertensive disorder of pregnancy that is a leading cause of maternal and fetal mortality and morbidity worldwide. It affects 2-10% of women and accounts for 16% of maternal deaths related to childbirth in developed countries. PE is difficult to study because it is a multifactorial disorder with varying molecular mechanisms associated with the development of the spectrum of clinical symptoms associated with early onset, late onset, and severe PE. A personalized medicine approach applied to dissecting the underlying mechanisms of PE may be beneficial to reduce clinical incidence of this devastating syndrome. The placenta plays a key role in the development of PE, leading to widespread maternal endothelial dysfunction, hypertension, and systemic multi-organ failure in PE. Extracellular vesicles (EVs) containing protein, RNA, and lipid cargo are continuously extruded from the placenta, and are capable of interacting with maternal organs including the kidney. PE is primarily associated with placental and renal dysfunction, and PE is the most common cause of acute kidney injury during pregnancy. However, no studies have investigated the potential of placenta-derived RNA cargo as a link between placental and renal dysfunction in PE. Urinary EVs are derived from multiple tissue types and represent a trove of biomarkers that are increasingly being utilized to diagnose renal disorders. Further, urine samples can be obtained throughout pregnancy non-invasively and could potentially be utilized to identify biomarkers related to placental dysfunction in PE. In the proposed research, during the mentored phase, cutting-edge RNA-Seq technology coupled with computational biological and machine learning approaches will be applied to profile the transcriptome of urinary EVs in women with PE compared to normal pregnancy. Preliminary data indicates that it is possible to isolate and profile the transcriptome of urinary EVs from maternal urine throughout normal gestation, and that placenta-derived and placenta-specific mRNA and miRNA can be detected within the urinary EV population. This presents a novel technique that has potential to identify biomarkers as well as provide information on placental dysfunction in PE in a non-invasive manner. During the independent phase, the candidate will utilize an in vitro approach to investigate the effect of uptake of placenta-derived EVs with miRNA cargo associated with PE on the function of proximal tubule epithelial cells and cortical collecting duct cells. These two renal-specific cell types are involved in tubular reabsorption in the nephron, a process that is compromised leading to increased excretion of protein in the urine in some preeclamptic pregnancies. This proposal is multidisciplinary, utilizing basic biology, clinical research, and high-performance computing applied to investigating placental dysfunction in PE. These experiments are significant because they will generate novel information on the role of placenta- derived EVs in renal dysfunction in PE, as well as point the way towards preventative and therapeutic targets that may be transformative and clinically relevant. PROJECT NARRATIVE The proposed research will examine the transcriptome of urinary extracellular vesicles obtained non-invasively as a source of placenta-derived nucleic acids reflective of the development of preeclampsia (PE), and will con- duct in vitro experiments to determine the role of placental extracellular vesicles in renal dysfunction in PE.",Extracellular Vesicles as a Link Between Placental and Renal Dysfunction in Preeclampsia,9974957,K99HD096125,"['Affect ', ' Biology ', ' Blood Circulation ', ' Circulation ', ' Bloodstream ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Cell Body ', ' Cells ', ' Chromosomes ', ' Clinical Study ', ' Clinical Research ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Countries ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Epithelial Cells ', ' Fetal Age ', ' Chronologic Fetal Maturity ', ' Gestational Age ', ' Goals ', ' Modern Man ', ' Human ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry ', ' In Vitro ', ' Incidence ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' Libraries ', ' Lipids ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' maternal death ', ' Maternal Mortality ', ' Mentors ', ' Methods ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Uriniferous Tube ', ' Nephrons ', ' Nucleic Acids ', ' Pathology ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta ', ' Play ', ' pregnancy toxemia/hypertension ', ' Proteinuria-Edema-Hypertension Gestosis ', ' Pregnancy Toxemias ', ' Preeclampsia ', ' EPH Gestosis ', ' Pre-Eclampsia ', ' Gestation ', ' Pregnancy ', ' Proteins ', ' Proteinuria ', ' Research ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' mRNA ', ' Messenger RNA ', ' social role ', ' Role ', ' Stress ', ' Syndrome ', ' Technology ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Urine Urinary System ', ' Urine ', ' Woman ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' pregnancy disorder ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Injury ', ' Organ ', ' improved ', ' Clinical ', ' premature ', ' prematurity ', ' Phase ', ' Biological ', ' Link ', ' Excretory function ', ' excretion ', ' Failure ', ' Hypoxia ', ' Oxygen Deficiency ', ' Hypoxic ', ' uptake ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Developed Countries ', ' Industrialized Nations ', ' Industrialized Countries ', ' Developed Nations ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Tubular formation ', ' Tubular ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Source ', ' cell type ', ' Techniques ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' stillbirth ', ' stillborn ', ' High Performance Computing ', ' high-end computing ', ' novel ', ' Pathogenesis ', ' Sampling ', ' response ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Childbirth ', ' child birth ', ' preventing ', ' prevent ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Small RNA ', ' Fetal Mortality Statistics ', ' Fetal Mortality ', ' Data ', ' Disease Pathway ', ' Ductal Epithelial Cell ', ' Ductal Cell ', ' Transcript ', ' Pathologic ', ' Characteristics ', ' Molecular ', ' Process ', ' urinary ', ' Development ', ' developmental ', ' early onset ', ' neonatal morbidity ', ' Population ', ' Coupled ', ' innovation ', ' innovative ', ' innovate ', ' transcriptomics ', ' clinically relevant ', ' clinical relevance ', ' multidisciplinary ', ' maternal serum ', ' therapeutic target ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' biobank ', ' biorepository ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' endothelial dysfunction ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' transcriptome ', ' global transcription profile ', ' global gene expression ', ' associated symptom ', ' symptom comorbidity ', ' symptom association ', ' cooccuring symptom ', ' concurrent symptom ', ' comorbid symptom ', ' extracellular vesicles ', ' experimental study ', ' experimental research ', ' experiment ', ' Molecular Disease ', ' kidney dysfunction ', ' renal dysfunction ', ' ']",NICHD,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",K99,2019,104534,CA-52,0.0302676147727873
"Low- and Zero-dose Contrast-enhanced MRI Using Deep Learning Project Summary Motivation: Gadolinium-based contrast agents (GBCAs) are used in approximately a third of all MRI scans. The unique relaxation parameters of GBCAs create indispensable image contrast for a wide range of clinical applications, such as angiography and tumor detection. However, the usage of GBCAs has been linked to the development of nephrogenic systemic fibrosis (NSF). NSF can be painful, cause severe disability, and even death. The risk of developing NSF prevents millions of patients with advanced chronic kidney disease (CKD) from receiving contrast-enhanced MRI exams. The recent identification of gadolinium deposition within the brain and body has raised additional safety concerns about the usage of GBCAs. Studies have demonstrated increased signal intensity on the unenhanced T1-weighted MR images that is correlated with previous GBCA exposure, and this gadolinium retention is independent of renal function. While initial reports focused on linear GBCAs, more recent reports show that gadolinium deposition occurs with macrocyclic GBCAs as well, albeit at lower levels. FDA has recently issued warnings about gadolinium retention following contrast-enhanced MRI, and required GBCA manufacturers to conduct human and animal studies to further assess the safety of these contrast agents. This project addresses these concerns by developing low-dose and zero-dose contrast-enhanced MRI using artificial intelligence (AI) and deep learning (DL). Approach: This fast-track project has two phases and three aims. Aim 1 (Phase I) is to develop a DL method that can synthesize full-dose contrast-enhanced MR images using pre-contrast images and contrast-enhanced images acquired with only 10% of standard GBCA dose. A software infrastructure will be constructed to seamlessly integrate the DL software between MR scanners and PACS. Aim 2 (Phase II) is to develop a DL method that can synthesize full-dose contrast-enhanced MR images using GBCA-free acquisitions with different image contrast. In Aim 3 (Phase II), we will clinically validate and evaluate both low-dose and zero-dose DL methods, including on patients with mild- to-moderate CKD. Non-inferiority tests and diagnostic performance of the synthesized full-dose images compared to the true full-dose images will be performed. Significance: This work will lead to safer contrast-enhanced MRI. The low-dose and zero-dose contrast-enhanced MRI method will benefit not only millions of patients with advanced CKD, who cannot currently undergo contrast-enhanced MRI, but many more patients with normal kidney function, who are at the risk of gadolinium retention after contrast-enhanced MRI. Project Narrative Gadolinium-based contrast agents (GBCAs) are widely used in MRI exams to create indispensable image contrast for monitoring treatment and investigating pathology and function. However, the usage of GBCAs has been linked to the development of nephrogenic systemic fibrosis, preventing patients with advanced chronic kidney disease from receiving contrast-enhanced MRI exams, as well as potential gadolinium deposition in the body and brain for patients with normal kidney function. This project aims to address these problems by developing and validating low-dose and zero-dose contrast-enhanced MRI using deep learning. !",Low- and Zero-dose Contrast-enhanced MRI Using Deep Learning,9776655,R44EB027560,"['Affect ', ' Angiography ', ' angiographic imaging ', ' Angiogram ', ' Animals ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Clinical Study ', ' Clinical Research ', ' Radiopaque Media ', ' Contrast Drugs ', ' Contrast Agent ', ' Contrast Media ', ' Death ', ' Cessation of life ', ' Gd element ', ' Gadolinium ', ' Goals ', ' Hospitals ', ' Modern Man ', ' Human ', ' Image Enhancement ', ' image generation ', ' image construction ', ' image reconstruction ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Chronic Kidney Failure ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Medical Imaging ', ' Methods ', ' Motivation ', ' Painful ', ' Pain ', ' Pathology ', ' Patients ', ' Relaxation ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Kidney Failure ', ' Research ', ' Risk ', ' Safety ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Software ', ' Computer software ', ' Software Verification ', ' Software Validation ', ' Testing ', ' Work ', ' Dataset ', ' Data Set ', ' base ', ' Clinical ', ' Phase ', ' Link ', ' Evaluation ', ' Training ', ' disability ', ' Renal function ', ' kidney function ', ' Deposition ', ' Deposit ', ' Diagnostic ', ' System ', ' experience ', ' Performance ', ' Reporting ', ' Modeling ', ' software development ', ' developing computer software ', ' develop software ', ' MRI Scans ', ' Magnetic Resonance Imaging Scan ', ' Manufacturer Name ', ' Manufacturer ', ' preventing ', ' prevent ', ' Address ', ' Dose ', ' Detection ', ' Small Business Innovation Research Grant ', ' Small Business Innovation Research ', ' SBIR ', ' Monitor ', ' Development ', ' developmental ', ' Health Professional ', ' Healthcare professional ', ' Health Care Professional ', ' Image ', ' imaging ', ' clinical application ', ' clinical applicability ', ' tumor ', ' contrast enhanced ', ' contrast imaging ', ' learning strategy ', ' learning method ', ' learning activity ', ' deep learning ', ' Infrastructure ', ' convolutional neural network ', ' convolutional neural nets ', ' ConvNet ', ' deep learning algorithm ', ' Nephrogenic Systemic Fibrosis\xa0 ', ' ']",NIBIB,"SUBTLE MEDICAL, INC.",R44,2019,185379,CA-18,0.03764938747015583
"Machine Learning and Network Science for Predicting Kidney Transplant Survival  Chronic kidney disease affects about 10% of adults in the United States and 7-12% of the population worldwide. It may lead to irreversible loss of kidney function, known as end-stage renal disease (ESRD). For patients with ESRD, kidney transplantation is the preferred treatment compared to dialysis in terms of patient survival, quality of life and cost. Despite the advantages of kidney transplants, most patients with ESRD are treated with dialysis primarily because there exist an insufficient number of compatible donors for patients. The human leukocyte antigens (HLAs) of the organ donor and recipient are known to be a significant contributing factor to transplanted organ survival times due to immunogenicity, the immune response of the recipient to the transplanted organ. Mismatches between donor and recipient HLAs are associated with shorter survival times; however, it is extremely rare to identify donors that have a perfect match with recipients, so most transplants involve mismatched HLAs. Our main objective is to accurately predict survival times for kidney transplants by incorporating both data- driven models of HLA compatibility based on outcomes of past transplants and biologically-driven models of HLA immunogenicity. Accurate prediction of survival times can improve patient transplant outcomes by enabling more efficient allocation of donors and recipients, particularly by reducing the number of repeat transplants due to graft failure with a poorly matched donor. We propose to estimate HLA compatibilities using high-dimensional variable selection techniques applied to outcomes of past transplants and through a novel donor-recipient latent space model for the HLA compatibility network. We then propose to incorporate these predicted compatibilities along with biologically-driven models of HLA immunogenicity using amino acid sequences and epitopes into a multi-task classification-based survival prediction algorithm. Our proposed approach for learning integrated data- and biologically-driven models of transplant survival generalizes broadly to organ transplantation (liver, heart, pancreas, lungs) and possibly to bone marrow transplantation. Finding better methods for human leukocyte antigen (HLA) matching between donor and recipient may redefine and improve clinical outcomes for organ and tissue transplants. In fact, new approach may revolutionize the selection of donors with recipients, thereby producing significantly improved long-term organ and tissue transplant survivals.",Machine Learning and Network Science for Predicting Kidney Transplant Survival ,9916110,R01LM013311,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Amino Acid Sequence ', ' protein sequence ', ' Primary Protein Structure ', ' Epitopes ', ' Binding Determinants ', ' Antigenic Determinants ', ' Antigens ', ' immunogen ', ' ATGN ', ' Anus ', ' Anal ', ' Bone Marrow Transplantation ', ' Marrow Transplantation ', ' Bone Marrow Transplant ', ' Bone Marrow Grafting ', ' Systematics ', ' Classification ', ' dialysis therapy ', ' Dialysis ', ' Dialysis procedure ', ' Heart ', ' Leukocyte Antigens ', ' Human Leukocyte Antigens ', ' HL-A Antigens ', ' HLA Antigens ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Chronic Kidney Failure ', ' kidney tx ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Kidney Transplantation ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Methods ', ' Organ Donor ', ' Organ Survival ', ' organ xenograft ', ' organ graft ', ' organ allograft ', ' Organ Transplants ', ' Grafting Procedure ', ' Organ Transplantation ', ' Pancreatic ', ' Pancreas ', ' Patients ', ' Plants ', ' QOL ', ' Quality of life ', ' Research ', ' Science ', ' Time ', ' transplant ', ' Transplantation ', ' United States ', ' Tissue Transplantation ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Renal function ', ' kidney function ', ' Space Models ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Transplanted tissue ', ' Graft Material ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Transplant Recipients ', ' transplant patient ', ' Techniques ', ' hazard ', ' novel ', ' Modeling ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' Donor Selection ', ' Donor Screening ', ' Data ', ' cost ', ' immunogenicity ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Outcome ', ' Population ', ' multitask ', ' multi-task ', ' graft failure ', ' learning network ', ' discrete time ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' survival prediction ', ' predictor of survival ', ' predict survival ', ' high dimensionality ', ' human model ', ' transplant model ', ' ']",NLM,UNIVERSITY OF TOLEDO,R01,2019,274577,OH-09,0.1316692082596502
"Developing and validating prognostic metabolomic signatures of diabetic kidney disease PROJECT SUMMARY/ABSTRACT Rationale. Diabetes is a leading cause of renal disease, accounting for 40% of the estimated 20 million US adult cases of chronic kidney disease. There is, however, substantial heterogeneity across diabetic patients with regards to development of kidney disease. Hence, there is an urgent need to identify prognostic biomarkers that can provide early and reliable evidence of future kidney disease, so that high-risk patients can receive optimal medical care. Existing clinical, proteomic and genomic markers do not consistently nor accurately predict kidney function decline. Metabolomics, a systematic evaluation of the end-products of cellular function in fluids, has the potential to inform physiological and pathological effects of chronic diseases. Metabolomic analysis combined with advanced quantitative methods could play a key role in building clinically useful prognostic signatures of diabetic kidney disease. Yet, development of computational methods with adequate rigor has lagged behind the technical capacity to perform large scale quantitative metabolomics. In this proposal we aim to address this computational gap in diabetic kidney disease research. Aims. We will implement rigorous computational methods to identify robust prognostic metabolite + clinical + genetic signatures of diabetic kidney disease progression. Specifically, we aim to (i) test the accuracy of previous signatures, and apply state-of-the-art analytic techniques and novel statistical methods to identify new multivariate metabolite sets for predicting kidney disease progression; (ii) quantify patterns of co-regulation of metabolites in diabetic kidney disease, and develop new tools in network biology to discover novel enzymes, proteins, metabolites, and molecular pathways which are implicated in diabetic kidney disease progression; (iii) test if these models can accurately predict kidney disease progression in independent prospective cohorts. Methods. Using clinical, genetic and metabolomic data from large prospective cohorts of > 1200 diverse, well- characterized patients with Type 2 diabetes, we will apply statistical methods for variable selection (e.g., penalized regression), and machine learning methods (e.g., random forest), which are known to perform well in the high-dimensional setting, to identify robust and parsimonious signatures of kidney disease progression. We will quantify inter-metabolite co-regulation patterns and infer biological pathways implicated in diabetic kidney disease. Throughout the modeling process, a rigorous training-validation paradigm will be adopted in order to improve reproducibility of models and reduce chance findings. Impact. A major product of this work will be the development of a clinically useful algorithm for identifying diabetic patients at high-risk for kidney function decline. Our findings will also provide insight into markers of renal dysfunction, and elucidate possible therapeutic targets for treating diabetic kidney disease, thus potentially informing the design of future clinical trials. PROJECT NARRATIVE Kidney disease, a major and common complication of diabetes, can lead to repeated hospitalizations and premature death. There is an urgent need to develop clinical tools that can provide early evidence that a given diabetic patient is likely to progress to kidney disease in the future. In this proposal, we will identify new urinary biomarkers and use novel statistical modeling methods to create a clinically useful algorithm for identifying diabetic patients at high-risk for kidney function decline, with the ultimate goal of improving disease management and reducing mortality rates for these patients.",Developing and validating prognostic metabolomic signatures of diabetic kidney disease,9695208,R01DK110541,"['Accounting ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Albuminuria ', ' Algorithms ', ' Biology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Clinical Trials ', ' co-morbidity ', ' Comorbidity ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Diabetic Kidney Disease ', ' Diabetic Nephropathy ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Enzyme Gene ', ' Enzymes ', ' Future ', ' Clinical genetics ', ' Medical Genetics ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Hospital Admission ', ' Hospitalization ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Chronic Kidney Failure ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' mortality ', ' Patients ', ' Play ', ' Publishing ', ' Recommendation ', ' Research ', ' Risk ', ' Sampling Studies ', ' Testing ', ' Urine Urinary System ', ' Urine ', ' Work ', ' health care ', ' Healthcare ', ' Dataset ', ' Data Set ', ' Caring ', ' improved ', ' Clinical ', ' premature ', ' prematurity ', ' Biological ', ' Physiological ', ' Physiologic ', ' Medical ', ' Link ', ' Evaluation ', ' prognostic ', ' Training ', ' Renal function ', ' kidney function ', ' insight ', ' diabetic ', ' Disease Progression ', ' Funding ', ' Collaborations ', ' Liquid substance ', ' liquid ', ' fluid ', ' tool ', ' Complications of Diabetes Mellitus ', ' Diabetic Complications ', ' Diabetes-Related Complications ', ' Diabetes Complications ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Disease Management ', ' Disorder Management ', ' Chronic Kidney Insufficiency ', ' Chronic Renal Insufficiency ', ' Adopted ', ' Pattern ', ' Techniques ', ' American ', ' chemical association ', ' cohort ', ' novel ', ' Reporting ', ' Statistical Methods ', ' Regulation ', ' Modeling ', ' Sampling ', ' Proteomics ', ' Genomics ', ' model development ', ' Bioinformatics ', ' Bio-Informatics ', ' kidney development ', ' nephrogenesis ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' Address ', ' Data ', ' Prognostic Marker ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Reproducibility ', ' Validation ', ' Pathologic ', ' Molecular ', ' Process ', ' urinary ', ' Development ', ' developmental ', ' Pima Indian ', ' Pathway interactions ', ' pathway ', ' protein metabolite ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' design ', ' designing ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' open source ', ' therapeutic target ', ' network models ', ' high risk ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' diabetic patient ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' learning strategy ', ' learning method ', ' learning activity ', ' genetic signature ', ' gene signatures ', ' biological heterogeneity ', ' genomic biomarker ', ' genomic marker ', ' metabolome ', ' metabonome ', ' prognostic signature ', ' prognostic profile ', ' predictive signature ', ' Longitudinal cohort ', ' Longterm cohort ', ' Long-term cohort ', ' Prospective cohort ', ' high dimensionality ', ' predictive test ', ' predictive assay ', ' random forest ', ' bioinformatics tool ', ' bio-informatics tool ', ' multidimensional data ', ' high dimensional data ', ' kidney dysfunction ', ' renal dysfunction ', ' Type 2 diabetic ', ' Type II diabetic ', ' ']",NIDDK,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2019,335803,CA-52,0.16907537852350504
"Identifying Personalized Risk of Acute Kidney Injury with Machine Learning PROJECT SUMMARY/ABSTRACT Acute Kidney Injury (AKI) is a common and highly lethal health problem, affecting 10-15% of all hospitalized patients and >50% of patients in intensive care units (ICUs). It has been shown that a small increase in serum creatinine (SCr) of 0.5 mg/dl was associated with a 6.5-fold increase in the odds of death, a 3.5-day increase in length of stay, and nearly $7,500 in excess hospital costs. Unfortunately, no specific treatment exists to cure AKI once it has developed. The ability to predict AKI in hospitalized patients would provide clinicians the opportunity to modify care pathways and implement interventions, which could in turn prevent AKI and yield better outcomes. Although electronic medical record (EMR) based monitoring systems for AKI have led to expedited interventions and may increase the percentage of patients returning to baseline kidney function, most of these systems are reactive rather than proactive, with little or no contribution to AKI prevention. Moreover, our current knowledge of AKI risk factors is far from complete, especially in the ICU and general inpatient populations, characterized by numerous deficiencies and systematic failings that may be avoidable To transform the reactive AKI care to proactive and personalized care, early identification of high risk patients and better understanding of individual modifiable risk factors for AKI is the key. In Aim 1, to discover novel risk factors predictive of AKI, we propose to develop an ensemble multi-view feature selection framework to simultaneously consider the differences and interrelations between feature spaces and obtain robust knowledge by synthesizing findings from diverse patient populations across multiple institutions in nine US states. In Aim 2, to discover general modifiable causes of AKI to help physicians design more effective AKI prevention policies, we propose to develop a novel multi-cause inference method to identify causal relationships between modifiable factors and AKI for susceptible patient subgroups. In Aim 3, to explain what caused AKI in individual patients to support physicians in designing personalized AKI intervention, we propose to develop a new causal explanation method by integrating causal inference and case based reasoning to quantify patient-level causal significance of modifiable factors. The proposed study will have a significant clinical impact by not only expanding the capacity of clinicians to identify high risk patients for AKI early and advancing the general knowledge on causal and modifiable risk factors for AKI but also supporting personalized AKI intervention with suggestions on potential patient-specific actionable items. The work will not only advance AKI but also the machine learning and clinical research informatics community and the methodology developed is generalizable to other clinical domains. PROJECT NARRATIVE The proposed research is to identify clinical risk factors of acute kidney injury (AKI) in hospitalized patients from electronic medical records (EMRs) with machine learning. AKI risk factors discovered from EMR of diverse populations from multiple institutions across nine US states will be reliable and robust and can assist clinicians in providing proactive and personalized care to high-risk patients.",Identifying Personalized Risk of Acute Kidney Injury with Machine Learning,9819327,R01DK116986,"['Affect ', ' Elderly ', ' senior citizen ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Algorithms ', ' inhibitor/antagonist ', ' inhibitor ', ' Clinical Study ', ' Clinical Research ', ' Communities ', ' Creatinine ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' Diagnosis ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Patient Care Delivery ', ' Patient Care ', ' geographic site ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Geographic Locations ', ' Health ', ' Heterogeneity ', ' Hospitals ', ' Incidence ', ' Inpatients ', ' Intensive Care Units ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' Learning ', ' hospital stay ', ' hospital length of stay ', ' hospital days ', ' Number of Days in Hospital ', ' Length of Stay ', ' Methods ', ' Methodology ', ' Patients ', ' Physicians ', ' Physiology ', ' Research ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Suggestion ', ' Time ', ' Work ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' Inhospital Mortality ', ' In-house Mortalities ', ' Hospital Mortality ', ' Outcomes Research ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Risk Assessment ', ' Caring ', ' injury prevention ', ' Injury to Kidney ', ' base ', ' improved ', ' Clinical ', ' Series ', ' Hospital Costs ', ' Hospitalization cost ', ' Link ', ' Serum ', ' Blood Serum ', ' Renal function ', ' kidney function ', ' Individual ', ' Policies ', ' Exposure to ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Life ', ' Event ', ' Pattern ', ' System ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' acute kidney injury ', ' Informatics ', ' nephrotoxicity ', ' kidney toxicity ', ' Nephrotoxic ', ' novel ', ' adjudication ', ' adjudicative process and procedure ', ' Predictive Factor ', ' Early identification ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Institution ', ' preventing ', ' prevent ', ' US State ', ' Geographic state ', ' Health system ', ' Data ', ' Clinical Data ', ' Patient-Focused Outcomes ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Monitor ', ' Myocardial ', ' Pathway interactions ', ' pathway ', ' design ', ' designing ', ' Sepsis ', ' bloodstream infection ', ' blood infection ', ' Outcome ', ' Population ', ' case-based ', ' modifiable risk ', ' high risk ', ' patient population ', ' clinical risk ', ' clinical predictors ', ' personalized care ', ' personalized patient care ', ' individualized patient care ', ' individualized care ', ' Precision care ', ' individual patient ', ' patient subsets ', ' patient subtypes ', ' patient subpopulations ', ' patient subgroups ', ' high dimensionality ', ' machine learning algorithm ', ' mortality risk ', ' death risk ', ' ']",NIDDK,UNIVERSITY OF KANSAS MEDICAL CENTER,R01,2019,512304,KS-03,0.10904054565217873
"A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles In the United States, 2.8 million people every year seek medical attention for traumatic brain injury (TBI), of which 80% are considered to have a mild TBI (i.e. concussion). Even in those with mild injuries, 10-20% of individuals will suffer long-term disability including seizures and emotional and behavioral issues. One of the primary challenges in TBI care is appropriately classifying this heterogeneous injury and identifying patients at risk for these chronic impairments. Conventional imaging studies, including magnetic resonance imaging (MRI) and computed tomography (CT), are commonly used to classify TBI, but do not reliably capture the full extent of the injury, particularly in those patients with mild injuries. Currently, there are few molecular markers to assist in the assessment of an individual's unique injury and subsequent recovery and biomarkers are desperately needed in the field that correlate with these varied endophenotypes, track the progress of the disease, and predict clinical outcomes. To address this challenge, we propose to develop a microchip-based platform that can be used to characterize TBI and its recovery using the RNA cargo found in brain-derived circulating extracellular vesicles (EVs), including exosomes. Unlike prior work that has mainly focused on single biomarkers, our approach measures a panel of circulating EV miRNA markers processed with machine learning algorithms, to more comprehensively capture the state of the injured and recovering brain. Our proposal combines surface marker-specific nanomagnetic isolation of brain-derived EVs from a variety of cell types, biomarker discovery using RNA sequencing, and machine learning processing of EV miRNA cargo to measure the state of injury and recovery in TBI. Nanoscale exosomes are known to shed from brain cells into the blood stream, carrying with them the molecular signatures that can be used to better diagnose and treat injuries, such as traumatic brain injury. We propose an innovative, clinically practical approach to probe the RNA contained within these nanoscale vesicles to better understand a patient's injury and recovery to better guide treatment. Our rapid and easily multiplexed platform has great potential for non-invasive diagnostics and monitoring of both secondary injury progression and drug efficacy, offers tremendous benefits for patients.",A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles,9788528,R21MH118170,"['Archives ', ' Astrocytes ', ' astrocytic glia ', ' Astroglia ', ' Astrocytus ', ' Axon ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Vessels ', ' vascular ', ' Blood Volume ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Brain Concussion ', ' concussion ', ' Commotio Cerebri ', ' Cerebral Concussion ', ' Calibration ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Systematics ', ' Classification ', ' Color ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Elements ', ' Goals ', ' Gold ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Human ', ' Inflammation ', ' Laboratories ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Methods ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neurons ', ' Nucleic Acids ', ' Patients ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Production ', ' Prognosis ', ' outcome forecast ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' RNA Gene Probes ', ' RNA Probes ', ' Seizures ', ' Technology ', ' Testing ', ' Time ', ' computerized tomography ', ' computerized axial tomography ', ' computed axial tomography ', ' catscan ', ' Xray Computed Tomography ', ' X-Ray Computerized Tomography ', ' X-Ray CAT Scan ', ' Tomodensitometry ', ' EMI scan ', ' Computed Tomography ', ' CT scan ', ' CT imaging ', ' CT X Ray ', ' CAT scan ', ' X-Ray Computed Tomography ', ' United States ', ' Work ', ' Measures ', ' Blinded ', ' Caring ', ' Injury ', ' base ', ' improved ', ' Surface ', ' Chronic ', ' Clinical ', ' Evaluation ', ' prognostic ', ' disability ', ' Individual ', ' Recovery ', ' noninvasive diagnosis ', ' noninvasive diagnostic ', ' non-invasive diagnostic ', ' non-invasive diagnosis ', ' Brain Injuries ', ' brain-injured ', ' brain damage ', ' Acquired brain injury ', ' Vesicle ', ' Inflammatory ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Severities ', ' Stream ', ' cell type ', ' System ', ' Benchmarking ', ' Best Practice Analysis ', ' innovative technologies ', ' brain cell ', ' Performance ', ' drug efficacy ', ' technology development ', ' tech development ', ' Devices ', ' Sorting - Cell Movement ', ' sorting ', ' Emotional ', ' Modeling ', ' Sampling ', ' nucleic acid detection ', ' Traumatic Brain Injury ', ' traumatic brain damage ', ' Brain Trauma ', ' neuropathology ', ' microchip ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Car Phone ', ' Mobile Phones ', ' Address ', ' Data ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' research clinical testing ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' Monitor ', ' Process ', ' Development ', ' developmental ', ' Brain Edema ', ' wet brain ', ' Intracranial Edema ', ' Brain Swelling ', ' point of care ', ' Behavioral ', ' Image ', ' imaging ', ' nanomagnetic ', ' nano magnetic ', ' injury and repair ', ' cost ', ' injured ', ' digital ', ' Advanced Development ', ' design ', ' designing ', ' next generation ', ' nanoscale ', ' nanometer sized ', ' nanometer scale ', ' nano scale ', ' nano meter sized ', ' nano meter scale ', ' response to injury ', ' injury response ', ' Outcome ', ' prospective ', ' innovation ', ' innovative ', ' innovate ', ' Impairment ', ' endophenotype ', ' mouse model ', ' murine model ', ' medical attention ', ' molecular marker ', ' molecular biomarker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' ratiometric ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' precision medicine ', ' precision-based medicine ', ' mild traumatic brain injury ', ' mild brain trauma ', ' mild TBI ', ' MTBI ', ' biomarker discovery ', ' exosome ', ' extracellular vesicles ', ' predict clinical outcome ', ' predictor of clinical outcome ', ' clinical outcome prediction ', ' microRNA biomarkers ', ' microRNA markers ', ' miRNA markers ', ' miRNA biomarkers ', ' imaging study ', ' manufacturability ', ' individual response ', ' individualized response ', ' machine learning algorithm ', ' ']",NIMH,UNIVERSITY OF PENNSYLVANIA,R21,2019,207338,PA-03,0.024048001331914613
"Single Cell Analysis of Kidney Transplant Antibody Mediated Rejection PROJECT SUMMARY/ABSTRACT Kidney transplantation offers the greatest survival advantage to patients with end stage kidney disease and is vastly more cost effective than dialysis. Long-term survival of kidney transplants has not improved in recent decades. Antibody mediated rejection (AMR) has been identified as a major cause of transplant failure. Currently, management of patients with AMR is inconsistent among centers and frequently fails. We hypothesize that the cell types and cell states unique to AMR can be resolved by single cell RNA sequencing (scRNA-seq) of biopsy samples taken from patients at the time of diagnosis. This approach uses an unsupervised framework for dissecting transcriptional heterogeneity within complex tissues such as the kidney. This allows for the interrogation of cell states and subpopulations using an unbiased clustering approach that is independent of previous knowledge and can provide unprecedented resolution. To test our hypothesis we propose the following aims: In Aim 1, we will perform scRNA-seq of 40 research biopsy cores (20 AMR and 20 non-AMR). From this data we will identify genes expressed in endothelial cells and antibody secreting cells that define AMR specific phenotypes. We have demonstrated feasibility of this approach by generating single cell data from human biopsy samples as outlined in the research plan. For Aim 2, we will use immunohistochemistry to validate these AMR specific markers on a set of independent tissue samples. For Aim 3, we will use publicly available Affymetrix microarray datasets from kidney transplant biopsies with associated outcomes data to determine which cell types are associated with allograft outcome. This proposal logically builds on the principal investigators previous research experience and clinical training. To date he has been working full time in clinical transplantation and continuing his research endeavors on an out of hours basis. Despite this his research output and experience continue to grow and he has recently published a report on the first successful application of this technology to human kidney biopsy tissue (co-first author). This proposal now focuses on expanding his scientific skills by attaining additional knowledge and practical research experience in single cell methods, bioinformatics and immunology. The career development goals will be achieved through a multi-faceted approach involving mentoring by Dr. Benjamin Humphreys and an advisory committee consisting of Drs. Barbara Murphy (transplant genomics), Phil Payne (biomedical informatics and translational science), Rob Mitra (single cell applications) and Paul Allen (translational immunology), didactic coursework, scientific investigation, and training in scientific communication and research ethics. This work will take place in Washington University which has a rich history of mentoring successful physician-scientists. Successful completion of this career development award will result in a better understanding of AMR, result in the principal investigators transition to an independent physician- scientist, and provide a solid foundation from which he will apply for RO1-level funding. PROJECT NARRATIVE Antibody mediated rejection is a major cause of kidney transplant failure. The pathophysiology of antibody mediated rejection is poorly understood and current treatment strategies frequently fail. Successful completion of this project has the potential to identify new markers of disease and novel targets for treatment.",Single Cell Analysis of Kidney Transplant Antibody Mediated Rejection,9721353,K08DK120953,"['Antibodies ', ' Archives ', ' Arteritis ', ' B-Lymphocytes ', ' B-cell ', ' B-Cells ', ' B cells ', ' B cell ', ' B blood cells ', ' Biopsy ', ' Cell Viability ', ' Cell Survival ', ' Cell Body ', ' Cells ', ' Diagnosis ', ' dialysis therapy ', ' Dialysis ', ' Dialysis procedure ', ' Disorder ', ' Disease ', ' Endothelium ', ' Foundations ', ' Future ', ' Gene Expression ', ' Genes ', ' Goals ', ' Heterogeneity ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Human ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' kidney tx ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Kidney Transplantation ', ' Masks ', ' Mentors ', ' Methods ', ' Patients ', ' Phenotype ', ' Physicians ', ' pilot study ', ' Pilot Projects ', ' plasmocyte ', ' Plasmacytes ', ' Blood Plasma Cell ', ' Plasma Cells ', ' Publishing ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Staining method ', ' Stains ', ' Technology ', ' Testing ', ' Urothromboplastin ', ' Tissue Thromboplastin ', ' Tissue Factor Procoagulant ', ' Tissue Factor ', ' Prothrombinase ', ' Glomerular Procoagulant Activity ', ' Factor III ', ' Coagulin ', ' Coagulation Factor III ', ' CD142 Antigens ', ' Blood Coagulation Factor III ', ' Thromboplastin ', ' Time ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' transplant ', ' Transplantation ', ' Universities ', ' Washington ', ' Work ', ' Antibody-Secreting Cells ', ' Immunoglobulin-Secreting Cells ', ' Mediating ', ' Dataset ', ' Data Set ', ' Immunology ', ' Advisory Committees ', ' advisory team ', ' Task Forces ', ' base ', ' career ', ' improved ', ' Solid ', ' Clinical ', ' Histologic ', ' Histologically ', ' Link ', ' prognostic ', ' Training ', ' Endothelial Cells ', ' Failure ', ' Bayesian Method ', ' Bayesian posterior distribution ', ' Bayesian classification procedure ', ' Bayesian classification method ', ' Bayesian approaches ', ' Bayesian Statistical Method ', ' Bayesian Methodology ', ' Measurement ', ' Funding ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Immune response ', ' immunoresponse ', ' host response ', ' Immunological response ', ' Inflammatory ', ' tool ', ' Diagnostic ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Scientist ', ' Investigation ', ' Hour ', ' Complex ', ' Event ', ' Source ', ' cell type ', ' Allografting ', ' experience ', ' human data ', ' single cell analysis ', ' diagnostic accuracy ', ' Accuracy of Diagnosis ', ' Biopsy Specimen ', ' Biopsy Sample ', ' skills ', ' novel ', ' Reporting ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' FYN gene ', ' SYN protein ', ' SYN gene ', ' SLK protein ', ' SLK gene ', ' FYN oncogene related to SRC, FGR, YES ', ' FYN ', ' Research Ethics ', ' Sampling ', ' career development ', ' Genomics ', ' Bioinformatics ', ' Bio-Informatics ', ' B-Cell Activation ', ' Molecular Interaction ', ' Binding ', ' protein expression ', ' fluidic ', ' Microfluidics ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' Tissue Sample ', ' Core Needle Biopsy ', ' Core Biopsy ', ' Candidate Disease Gene ', ' Candidate Gene ', ' IGFBP3 gene ', ' IGFBP3 ', ' IBP3 ', ' Data ', ' Disease Marker ', ' Reproducibility ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Resolution ', ' Retrieval ', ' in vivo ', ' Communication Research ', ' Patient-Focused Outcomes ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Translational Research ', ' translation research ', ' Translational Science ', ' Principal Investigator ', ' Output ', ' belimumab ', ' Benlysta ', ' biomedical informatics ', ' biomed informatics ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' Outcome ', ' cost effective ', ' Population ', ' transcriptomics ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' treatment strategy ', ' novel marker ', ' novel biomarker ', ' new marker ', ' TNFRSF17 gene ', ' tumor necrosis factor receptor superfamily, member 17 ', ' TNFRSF17 ', ' BCMA protein ', ' BCMA gene ', ' BCM protein ', ' BCM gene ', ' B-Cell Maturation Factor ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' XBP1 gene ', ' XBP1 ', ' experimental study ', ' experimental research ', ' experiment ', ' single-cell RNA sequencing ', ' single cell RNA-seq ', ' scRNA-seq ', ' random forest ', ' kidney biopsy ', ' renal biopsy ', ' ']",NIDDK,WASHINGTON UNIVERSITY,K08,2019,165758,MO-01,0.1378357981313671
"Leveraging Artificial-Intelligence to Profile and Enhance Phenotypic Plasticity for Second Injury Prevention: An Innovative Precision Medicine Platform to Revolutionize Injury Care Project Summary/Abstract The best predictor of future injury is previous injury. Unfortunately, this has not changed in a quarter century, despite the introduction of evidence-based medicine and the associated revisions to post-injury treatment and care. Nearly nine million sports-related injuries occur annually, and the majority of these require medical treatment and/or clinical intervention prior to clearance for the athlete to return to play (RTP). Even with formal care, injured athletes are two- to four times (in extreme cases 100 times) more likely to suffer a second injury for up to two years after RTP. This is even more alarming given that 65% of initial sports-related injuries affect children and young adults (ages 5-24 years), setting them up for a lifetime of negative health outcomes. These data implicate the initial injury event as the tipping point for a post-injury cascade of negative sequelae exposing athletes to more physical and psychological pain, higher medical costs and greater risk of severe long-term negative health throughout their life. Thus, an urgent need exists to revolutionize the current standard of post- injury care through better identification and targeting of deficits that underlie second injury risk to enable everyone to stay physically active and healthy for their whole lives. To address this need, we propose a pioneering approach that capitalizes on the biological concept of Phenotypic Plasticity (PP) to quantify an athletes functional adaptability across different performance environments. Here PP is computed based on both intrinsic and extrinsic factors that reflect the functional movement capability of the athlete. The overall objective of this proposal is, therefore, to develop a generalizable PP-based precision sports medicine approach for second injury prevention through the development of a systematic bioinformatics-driven approach for PP profile construction, and the training of genetic fuzzy artificial intelligence to establish treatment type and magnitude for precision enhancement of PP. The result of the proposed work will be a generalizable PP-based precision sports medicine approach via two expected outcomes: (1) a formalized phenotypic precision medicine approach to objectively quantify behavioral plasticity, and (2) the successful implementation of a platform leveraging genetic fuzzy artificial intelligence integrated with mixed reality for performance prediction. This platform will support delivery of personalized treatments for PP enhancement. These objectives are the critical first step for the development of a generalizable precision medicine approach that will revolutionize rehabilitation and finally stem the tide of second injury in sport. This contribution will be significant to push back against the initial injury tipping point and, in doing so, create a pathway for injured athletes to return safely to physical activity and to maintain a long-term healthy lifestyle. Project Narrative The proposed research is relevant to public health because the proposed platform will lead to fewer young men and women who suffer from second injury and the negative effects that lead to poorer long-term health. The project is relevant to NIHs mission because the knowledge gained will be used to optimize new precision assessment and treatment strategies to prevent injury, and this will enhance health and reduce the burden of athletic injury.",Leveraging Artificial-Intelligence to Profile and Enhance Phenotypic Plasticity for Second Injury Prevention: An Innovative Precision Medicine Platform to Revolutionize Injury Care,9723527,R21EB027865,"['Affect ', ' Age ', ' ages ', ' Algorithms ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Athletic Injuries ', ' Sports Injuries ', ' Back ', ' Dorsum ', ' Behavior ', ' Behavioral Sciences ', ' Biology ', ' Biomedical Engineering ', ' bioengineering ', ' bio-engineers ', ' bio-engineered ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Disorder ', ' Disease ', ' Elements ', ' Environment ', ' Future ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Health ', ' indexing ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Methods ', ' Mission ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' body movement ', ' Movement ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' living system ', ' Organism ', ' Painful ', ' Pain ', ' Phenotype ', ' Play ', ' Public Health ', ' rehabilitative therapy ', ' rehabilitative ', ' Rehabilitation ', ' Medical Rehabilitation ', ' Rehabilitation therapy ', ' Research ', ' Risk ', ' Specialty ', ' medical specialties ', ' Sports ', ' Sports Medicine ', ' Stress ', ' Technology ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' Work ', ' Measures ', ' medical costs ', ' Medical Care Costs ', ' Caring ', ' injury prevention ', ' Custom ', ' Injury ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Physiological ', ' Physiologic ', ' Medical ', ' psychologic ', ' psychological ', ' Series ', ' Randomized Clinical Trials ', ' Training ', ' Physical activity ', ' Individual ', ' Recovery ', ' young adult ', ' young adulthood ', ' adult youth ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Genetic ', ' light weight ', ' lightweight ', ' Morphology ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Evidence Based Medicine ', ' Knowledge ', ' Life ', ' programs ', ' Dimensions ', ' Complex ', ' Event ', ' System ', ' Services ', ' behavior prediction ', ' behavioral prediction ', ' Performance ', ' success ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Pharmacogenomics ', ' Bioinformatics ', ' Bio-Informatics ', ' Tissue Sample ', ' preventing ', ' prevent ', ' Address ', ' fitness ', ' Data ', ' Motor ', ' Molecular ', ' Development ', ' developmental ', ' Behavioral ', ' Pathway interactions ', ' pathway ', ' environmental change ', ' injured ', ' Behavioral Model ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' stem ', ' evidence base ', ' treatment strategy ', ' complex biological systems ', ' young man ', ' adolescent men ', ' adolescent man ', ' young woman ', ' adolescent women ', ' adolescent woman ', ' Combinatorial Optimization ', ' precision medicine ', ' precision-based medicine ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' precision genetics ', ' personalized genetics ', ' Precision therapeutics ', ' precision treatment ', ' precision therapies ', ' healthy lifestyle ', ' healthy life-style ', ' Genomic approach ', ' genomic strategy ', ' genomic effort ', ' behavioral plasticity ', ' mixed reality ', ' multimodal data ', ' multi-modal data ', ' ']",NIBIB,UNIV OF NORTH CAROLINA CHAPEL HILL,R21,2019,326700,NC-04,0.011773487032144444
"A Machine Learning Alternative to Beamforming to Improve Ultrasound Image Quality for Interventional Access to the Kidney Project Summary  Despite the widespread prevalence of ultrasound imaging in hospitals today, the clinical utility of ultrasound guidance is severely hampered by clutter and reverberation artifacts that obscure structures of interest and com- plicate anatomical measurements. Clutter is particularly problematic in overweight and obese individuals, who account for 78.6 million adults and 12.8 million children in North America. Similarly, interventional procedures of- ten require insertion of one or more metal tools, which generate reverberation artifacts that obfuscate instrument location, orientation, and geometry, while obscuring nearby tissues, thus additionally hampering ultrasound im- age quality. Although artifacts are problematic, ultrasound continues to persist primarily because of its greatest strengths (i.e., mobility, cost, non-ionizing radiation, real-time visualization, and multiplanar views) in comparison to existing image-guidance options, but it would be signicantly more useful without problematic artifacts.  Our long-term project goal is to use state-of-the-art machine learning techniques to provide interventional radiologists with artifact-free ultrasound-based images. We will initially develop a new framework alternative to the ultrasound beamforming process that removes needle tip reverberations and acoustic clutter caused by multipath scattering in near-eld tissues when guiding needles to the kidney to enable removal of painful kidney stones. Our rst aim will test convolutional neural networks (CNNs) that input raw channel data and output human readable images with no artifacts caused by multipath scattering and reverberations. A secondary goal of the CNNs is to learn the minimum number of parameters required to create these new CNN-based images. Our second aim will validate the trained algorithms with ultrasound data from experimental phantom and ex vivo tissue. Our third aim will extend our evaluation to ultrasound images of in vivo porcine kidneys. This work is the rst to propose bypassing the entire beamforming process and replacing it with machine learning and computer vision techniques to remove traditionally problematic noise artifacts and create a fundamentally new type of artifact-free, high-contrast, high-resolution, ultrasound-based image for guiding interventional procedures.  This work combines the expertise of an imaging scientist, a computer scientist, and an interventional ra- diologist to explore an untapped, understudied area that is only recently made feasible through improvements in computing power, advances in computer vision capabilities, and new knowledge about dominant sources of image degradation. Translation to in vivo cases is enabled by our clinical collaboration with the Department of Radiology at the Johns Hopkins Hospital. With support from the NIH Trailblazer Award, our team will be the rst to develop these tools and capabilities to eliminate noise artifacts in interventional ultrasound, opening the door to a new paradigm in ultrasound image formation, which will directly benet millions of patients with clearer, easier-to-interpret ultrasound images. Subsequent R01 funding will customize our innovation to addi- tional application-specic ultrasound procedures (e.g., breast biopsies, cancer detection, autonomous surgery). Project Narrative Artifacts in ultrasound images, specically artifacts caused by multipath scattering and acoustic reverberations (which occur when imaging through the abdominal tissue of overweight and obese patients or visualizing metallic surgical tools), remain as a major clinical challenge. There are no existing solutions to eliminate these artifacts based on today's signal processing techniques. The goal of this project is to step away from conventional signal processing models and instead learn from raw data examples with state-of-the-art machine learning techniques that differentiate artifacts from true signals, and thereby deliver clearer, easier-to-interpret images.",A Machine Learning Alternative to Beamforming to Improve Ultrasound Image Quality for Interventional Access to the Kidney,9748523,R21EB025621,"['Abdomen ', ' Abdominal ', ' Acoustics ', ' Acoustic ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Age ', ' ages ', ' Algorithms ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Architecture ', ' Engineering / Architecture ', ' Award ', ' Back ', ' Dorsum ', ' Biopsy ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' computer vision ', ' Computer Vision Systems ', ' Computers ', ' Cyst ', ' Diagnosis ', ' Elements ', ' Environment ', ' hepatic steatosis ', ' Liver Steatosis ', ' Fatty Liver ', ' Goals ', ' Hospitals ', ' Modern Man ', ' Human ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' Renal Stone ', ' Renal Calculi ', ' Kidney Stones ', ' Kidney Calculi ', ' Learning ', ' liver disorder ', ' hepatopathy ', ' hepatic disease ', ' Hepatic Disorder ', ' Liver diseases ', ' Metals ', ' Methods ', ' Methodology ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Needles ', ' Noise ', ' North America ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Painful ', ' Pain ', ' Patients ', ' Radiation-Non-Ionizing Total ', ' Nonionizing Electromagnetic Radiation ', ' Non-Ionizing Radiation ', ' Non-Ionizing Electromagnetic Radiation ', ' Nonionizing Radiation ', ' Radiology ', ' General Radiology ', ' Radiology Specialty ', ' Retroperitoneum ', ' Retroperitoneal Cavity ', ' Retroperitoneal ', ' Retroperitoneal Space ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Software ', ' Computer software ', ' Surgical Instruments ', ' suid ', ' porcine ', ' Swine ', ' Suidae ', ' Pigs ', ' Family suidae ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' Translations ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' United States ', ' Work ', ' Measures ', ' Artifacts ', ' Morphologic artifacts ', ' Custom ', ' Imagery ', ' Visualization ', ' base ', ' improved ', ' Procedures ', ' Area ', ' Clinical ', ' Variant ', ' Variation ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Interventional Ultrasonography ', ' Interventional Ultrasound ', ' Evaluation ', ' Training ', ' Individual ', ' Measurement ', ' Funding ', ' radiologist ', ' Collaborations ', ' Imaging Phantoms ', ' tool ', ' instrument ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Scientist ', ' Source ', ' Techniques ', ' Location ', ' Overweight ', ' Over weight ', ' fetal ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' interest ', ' Structure ', ' novel ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Bypass ', ' Modeling ', ' Readability ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Image-Guided Surgery ', ' surgical imaging ', ' intraoperative imaging ', ' intra-operative imaging ', ' Thickness ', ' Thick ', ' Data ', ' Resolution ', ' in vivo ', ' Cancer Detection ', ' Process ', ' Cardiac ', ' Image ', ' imaging ', ' Output ', ' cost ', ' image guided intervention ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' clinical effect ', ' Network-based ', ' lens ', ' lenses ', ' Geometry ', ' signal processing ', ' image guided ', ' image guidance ', ' Breast biopsy ', ' metallicity ', ' imaging scientist ', ' deep learning ', ' convolutional neural network ', ' convolutional neural nets ', ' ConvNet ', ' machine learning algorithm ', ' ']",NIBIB,JOHNS HOPKINS UNIVERSITY,R21,2019,195128,MD-07,0.10676809805586455
"A new approach to predict graft outcome from histology in children undergoing kidney transplantation using machine learning methods Abstract Although the overall renal graft survival has dramatically improved over the last several decades, almost half of pediatric patients lose their transplant within 10 years. Epidemiology, immunology and histology are all key elements in understanding post-transplant complications and in predicting clinical outcomes, however accurate prediction of transplant outcomes remains challenging and understudied among pediatric kidney transplant recipients. Machine learning technology is rapidly advancing and has demonstrated remarkable predictive accuracy surpassing classical predictive models in several biomedical applications. The goal of this research proposal is to develop machine learning methods to improve prediction of transplant outcomes through analysis of histology, assemble data sufficient to describe the incidence of different types of rejection and histological findings on pediatric kidney transplant biopsies, and to assess their impact on graft outcome. To achieve these goals, we will assemble an international multicenter cohort of over 700 pediatric kidney transplant recipients and develop and validate machine-learning models combining clinical, immunological and histological data for predicting short-term pediatric graft outcomes. This study will enable accurate, reproducible, and standardized assessment of histopathological findings in pediatric transplant recipients and provide a new method to predict graft outcome. This will pave the way to future large, prospective study assessing the feasibility and potential impact of machine-learning methods in transplant biopsy analysis, with the goal of improving clinical management and resource utilization by identifying patients with high risk of graft loss. Finally, this study will provide critical information for efficient and effective design of clinical trials focused on improving outcomes of pediatric kidney transplant recipients, with an emphasis on individualized treatment. Project Narrative: Accurate prediction of graft outcome in pediatric kidney transplant patients is critical to individualize patients' management and treatment and to design efficient and effective clinical trials focused on improving outcomes of these patients. Our long-term goal is to improve the assessment of histopathological findings in pediatric transplant recipients and create a new systematic methodology to predict graft outcomes that can be applied nationally and internationally. The goal of this research proposal is to develop machine learning methods to improve prediction of transplant outcomes through analysis of histology, assemble data sufficient to describe the incidence of different types of rejection and histological findings on pediatric kidney transplant biopsies, and to assess their impact on graft outcome.",A new approach to predict graft outcome from histology in children undergoing kidney transplantation using machine learning methods,9808911,R21DK122229,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Antibodies ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Biopsy ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Systematics ', ' Classification ', ' Clinical Trials ', ' Elements ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Europe ', ' Future ', ' Goals ', ' Transplantation Rejection ', ' Transplant Rejection ', ' Graft Rejection ', ' Graft Survival ', ' Histology ', ' Modern Man ', ' Human ', ' Incidence ', ' Interobserver Variations ', ' Inter-Observer Variation ', ' Inter-Observer Variability ', ' Interobserver Variability ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' kidney tx ', ' Renal Transplants ', ' Renal Transplantation ', ' Kidney Transplants ', ' Kidney Grafting ', ' Kidney Transplantation ', ' Manuals ', ' Methods ', ' Methodology ', ' Pathology ', ' Patients ', ' Prospective Studies ', ' Research Proposals ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' Standardization ', ' Technology ', ' Time ', ' transplant ', ' Transplantation ', ' United States ', ' Dataset ', ' Data Set ', ' Immunology ', ' base ', ' improved ', ' Acute ', ' Chronic ', ' Clinical ', ' Histologic ', ' Histologically ', ' Renal Replacement Therapy ', ' Kidney Replacement Therapy ', ' Childhood ', ' pediatric ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Therapeutic ', ' Pathologist ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Transplant Recipients ', ' transplant patient ', ' programs ', ' Event ', ' Scanning ', ' Techniques ', ' American ', ' cohort ', ' Reporting ', ' Pathology Report ', ' Modeling ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Histopathologic Grade ', ' Histologic Grade ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' Address ', ' Data ', ' International ', ' Multi-Institutional Clinical Trial ', ' Multisite clinical trial ', ' Multisite clinical study ', ' Multicenter clinical trial ', ' Multicenter clinical study ', ' Multi-site clinical trial ', ' Multi-site clinical study ', ' Multi-center clinical trial ', ' Multi-center clinical study ', ' Reproducibility ', ' Clinical Management ', ' Clinical Trials Design ', ' Patient-Focused Outcomes ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Risk Estimate ', ' Update ', ' Pathologic ', ' Immunologics ', ' Immunologically ', ' Immunological ', ' Immunologic ', ' Immunochemical Immunologic ', ' Modification ', ' Development ', ' developmental ', ' Image ', ' imaging ', ' digital ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' design ', ' designing ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Outcome ', ' Prevalence ', ' multidisciplinary ', ' transplantation medicine ', ' transplant medicine ', ' high risk ', ' risk benefit ratio ', ' allograft rejection ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' pediatric patients ', ' child patients ', ' learning strategy ', ' learning method ', ' learning activity ', ' personalized management ', ' precision management ', ' personalized disease management ', ' personalized clinical management ', ' individualized patient management ', ' individualized management ', ' improved outcome ', ' predict clinical outcome ', ' predictor of clinical outcome ', ' clinical outcome prediction ', ' Retrospective cohort ', ' transplant centers ', ' Infrastructure ', ' convolutional neural network ', ' convolutional neural nets ', ' ConvNet ', ' Pediatric cohort ', ' post-transplant ', ' posttransplantation ', ' posttransplant ', ' post-transplantation ', ' ']",NIDDK,EMORY UNIVERSITY,R21,2019,269258,GA-05,0.11968963525426282
"Adiposity-obesity-related subgroups discovery and metabolomics analysis for chronic kidney disease Project Summary Chronic kidney disease (CKD) is prevalent in the U.S. population and is a major cause of end-stage renal disease (ESRD), cardiovascular disease morbidity, and mortality. Current gaps exist in characterizing the heterogeneity of CKD population. Obesity further increases the risks of adverse outcomes among people with impaired kidney function. However, the mechanism between obesity and CKD is not fully understood, and numerous studies have observed obesity paradox or survival advantage being associated with higher body fat among advanced CKD patients. In this context, the Chronic Renal Insufficiency Cohort (CRIC) Study provides an ideal opportunity to study the mechanism of CKD with its rich clinical information and population characteristics, as well as its availability of non-targeted high-dimensional metabolomics data. To better understand the adiposity-obesity-related (AOR) mechanisms of CKD and to discover novel biomarkers, we propose to identify distinct subgroups based on AOR attributes and to perform metabolomics analysis on the identified subgroups and CKD outcomes. The overall goal of this research and the training plan is to execute three studies as the subjects of a doctoral dissertation in metabolomics analysis and CKD epidemiology. First, in Aim 1, we will identify latent AOR subgroups in the CRIC CKD population using the data-driven approach of consensus clustering. We will also evaluate the utility and the independent risk discrimination performance of the AOR subgroups with key CKD outcomes (CKD progression, CVD, and death), using Cox regression model with adjustment for known CKD risk factors. Next, in Aim 2, we will perform metabolomics analysis and identify metabolites and metabolomic patterns that are associated with the different AOR subgroups. In response to the statistical challenges in analyzing the high-dimensional metabolomics data, we will implement both the machine learning random-forest algorithm and the conventional univariate and multivariate regression analysis. Finally, in Aim 3, we will investigate the relationship between CKD outcomes and the metabolites and metabolomic patterns identified in Aim 2, using Cox regression model, extended by pathway analysis and mediation analysis. Mining high-dimensional metabolomics data with AOR phenotypes in the CRIC Study holds promise to expand our knowledge of pathophysiology and molecular characterization of CKD. Future studies can be built upon these findings to improve more effective and personalized CKD management in the setting of the obesity epidemic. A rigorous curriculum including didactic and experiential learning in biomedical data mining, statistics, and advanced epidemiology will round out the applicant's training, preparing her to be an independent and collaborative investigator and a kidney disease epidemiologist at the completion of his PhD. Project Narrative Chronic kidney disease (CKD) and its risk factors of obesity, diabetes, and hypertension are prevalent in the United States. To better understand the mechanism between adiposity-obesity-related CKD mechanism, the proposed research will implement machine learning algorithms, and identify distinct patient subgroups and discover novel CKD biomarkers, using the clinical and high-dimensional metabolomics data from a diverse cohort of CKD patients. The findings of our study hold promise to expand our knowledge of pathophysiology and molecular characterization of CKD, and facilitate personalized disease management.",Adiposity-obesity-related subgroups discovery and metabolomics analysis for chronic kidney disease,9834239,F31DK122683,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Affect ', ' Albuminuria ', ' Algorithms ', ' Blood Pressure ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Concurrent Studies ', ' Cohort Studies ', ' lesson plans ', ' Curriculum ', ' Educational Curriculum ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' Cognitive Discrimination ', ' Discrimination ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Fats ', ' Fatty acid glycerol esters ', ' Future ', ' Glomerular Filtration Rate ', ' Dextrose ', ' D-Glucose ', ' Glucose ', ' Goals ', ' hemoglobin A1c ', ' Hemoglobin A(1) ', ' HbA1c ', ' HbA1 ', ' Hb A1c ', ' Hb A1a+b ', ' Hb A1 ', ' Glycohemoglobin A ', ' Glycosylated hemoglobin A ', ' Heterogeneity ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' insulin resistant ', ' Insulin Resistance ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' renal disorder ', ' kidney disorder ', ' Renal Disease ', ' Nephropathy ', ' Kidney Diseases ', ' chronic kidney disease ', ' Chronic Renal Failure ', ' Chronic Renal Disease ', ' Chronic Kidney Failure ', ' Kynurenine ', ' Methods ', ' Mining ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Multivariate Analyses ', ' Multivariate Analysis ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patients ', ' Phenotype ', ' Population Characteristics ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Regression Analysis ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' statistics ', ' Levotryptophan ', ' L-Tryptophan ', ' Tryptophan ', ' United States ', ' Weight ', ' tropomyosin binding protein troponin T ', ' Troponin T ', ' Outcome Assessment ', ' base ', ' improved ', ' Clinical ', ' Training ', ' Renal function ', ' kidney function ', ' Measurement ', ' Disease Progression ', ' Active Learning ', ' Experiential Learning ', ' Cooperative Learning ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Metabolic ', ' tool ', ' Body fat ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' Knowledge ', ' Disease Management ', ' Disorder Management ', ' Chronic Kidney Insufficiency ', ' Chronic Renal Insufficiency ', ' Pattern ', ' Techniques ', ' Height ', ' Performance ', ' cohort ', ' Disease Outcome ', ' novel ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' response ', ' fibroblast growth factor 23 ', ' FGF23 gene product ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' End stage renal failure ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' datamining ', ' data mining ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' PTH gene ', ' parathormone ', ' Parathyroid Hormone ', ' Parathyrin ', ' Data ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Research Training ', ' Subgroup ', ' Epidemiologist ', ' Characteristics ', ' Molecular ', ' Pathway interactions ', ' pathway ', ' Population ', ' Impairment ', ' population based ', ' novel marker ', ' novel biomarker ', ' new marker ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' adverse outcome ', ' adverse consequence ', ' Patient risk ', ' targeted biomarker ', ' personalized management ', ' precision management ', ' personalized disease management ', ' personalized clinical management ', ' individualized patient management ', ' individualized management ', ' patient subsets ', ' patient subtypes ', ' patient subpopulations ', ' patient subgroups ', ' high dimensionality ', ' preservation ', ' random forest ', ' machine learning algorithm ', ' multidimensional data ', ' high dimensional data ', ' Obesity Epidemic ', ' ']",NIDDK,UNIVERSITY OF PENNSYLVANIA,F31,2019,45016,PA-03,0.07815903712809812
"In-Office, Ultrasound-Based Breakage and Removal of Urinary stones OVERALL SUMMARY  The main focus of this Program Project Grant is to discover the foundational and translational knowledge needed to create an office-based handheld ultrasound device to target, detach, break, and expel stones and stone fragments from the urinary space to facilitate natural clearance. This system will obviate costly and inefficient emergency department visits that typically include repetitive exposure to ionizing radiation from diagnostic imaging, and will significantly reduce the often lengthy (days to weeks) wait time patients must endure before procedures for stone removal can be scheduled and performed. As the proposed therapy system is entirely noninvasive, patients will be treated on an outpatient basis. Further, as the system is designed to efficiently and painlessly break stones of any size and expel the fragments from the kidney, the treatment of both symptomatic and asymptomatic stones using this technology will reduce the high retreatment and stone event recurrence rates associated with current surgical interventions for stone removal.  In this effort, we will combine stone breakage by burst wave lithotripsy (BWL), clearance of fragments by ultrasonic propulsion (UP), and stone-specific ultrasound imaging (S-mode) into an integrated system in which exposure strategies are adapted during treatment in response to real-time acoustic feedback to enhance comminution efficiency and patient safety. We will tailor treatment by investigating numerically and in lab tests the primary mechanisms - cavitation and elastic waves - involved in the comminution process over a broad parameter space. We will develop acoustics-based feedback including model- based, machine learning and passive acoustic mapping (PAM) of the bubble field to signal the need to adjust the energy output. We will investigate the morphological and functional response of the kidney in living animals and in ex vivo perfused porcine kidneys, and pursue tissue protective treatment strategies such as power ramping.  These studies will include the first in-human test of BWL in which we will compare the comminution effectiveness and safety of treatment with and without adaptive output control in response to acoustic feedback. In addition, we will conduct a randomized controlled trial of the benefits and risks of fragmenting and expelling symptomatic and asymptomatic stones in the clinic. Toward application of the system for use in humans, we will refine and validate the use of UP and S-mode together to improve stone and fragment detection. With our eye on the future of stone management, we will develop and validate in vivo an extracorporeal acoustic tractor beam to grasp and carry fragments through the complex three- dimensional path of the urinary space and out of the kidney. OVERALL NARRATIVE Urinary stone disease, which affects 1 in 11 Americans, is one of the most painful diseases and also the costliest non-malignant urologic disease, because current management is limited to observation for the stone to pass or performing surgery. The main focus of this Program Project Grant is to discover the foundational and translational knowledge needed to create an office-based, handheld ultrasound device to target, detach, break, and expel stones and stone fragments from the urinary space to facilitate natural clearance. This system will obviate costly and temporizing emergency department visits and radiation exposing imaging while the patient waits in pain for days to weeks for the stone to pass or be surgically removed.","In-Office, Ultrasound-Based Breakage and Removal of Urinary stones",9791705,P01DK043881,"['Acoustics ', ' Acoustic ', ' Affect ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Animals ', ' Calibration ', ' Diagnostic Imaging ', ' Disorder ', ' Disease ', ' Engineering ', ' Eyeball ', ' Eye ', ' Feedback ', ' Foundations ', ' bone fracture ', ' Fracture ', ' Future ', ' Health ', ' Modern Man ', ' Human ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' Litholapaxy ', ' Lithotripsy ', ' Methodology ', ' Out-patients ', ' Outpatients ', ' Painful ', ' Pain ', ' Patients ', ' Productivity ', ' Scientific Publication ', ' Publications ', ' ionizing output ', ' Radiation-Ionizing Total ', ' Ionizing Electromagnetic Radiation ', ' Ionizing radiation ', ' Ramp ', ' Recurrent ', ' Recurrence ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Safety ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' suid ', ' porcine ', ' Swine ', ' Suidae ', ' Pigs ', ' Family suidae ', ' Technology ', ' Testing ', ' Time ', ' Body Tissues ', ' Tissues ', ' ultrasound scanning ', ' ultrasound imaging ', ' ultrasound ', ' sound measurement ', ' sonography ', ' sonogram ', ' diagnostic ultrasound ', ' Ultrasound Test ', ' Ultrasound Medical Imaging ', ' Ultrasound Diagnosis ', ' Ultrasonogram ', ' Ultrasonic Imaging ', ' Medical Ultrasound ', ' Echotomography ', ' Echography ', ' Ultrasonography ', ' Urolith ', ' Urinary Tract Stones ', ' Urinary Stones ', ' Urinary Calculi ', ' urinary tract disorder ', ' Urological Disorders ', ' Urological Diseases ', ' Urologic Disorder ', ' Urinary Tract Diseases ', ' Urologic Diseases ', ' Measures ', ' Schedule ', ' Dataset ', ' Data Set ', ' calcification ', ' Calcified ', ' base ', ' improved ', ' Procedures ', ' Clinical ', ' Ensure ', ' grasp ', ' Grips ', "" Bowman's space "", ' Urinary Space ', ' Painless ', ' not painful ', ' nonpainful ', ' non-painful ', ' Sample Size ', ' Collaborations ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Exposure to ', ' Morphology ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Retreatment ', ' re-treatment ', ' Knowledge ', ' programs ', ' Dimensions ', ' Complex ', ' Event ', ' Clinic ', ' Techniques ', ' System ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' American ', ' success ', ' Structure ', ' simulation ', ' Benefits and Risks ', ' Modality ', ' Devices ', ' Reporting ', ' Excision ', ' resection ', ' Surgical Removal ', ' Removal ', ' Extirpation ', ' Abscission ', ' Statistical Methods ', ' Modeling ', ' response ', ' patient safety ', ' Effectiveness ', ' Address ', ' Ultrasonics ', ' Ultrasonic ', ' Biostatistics Core ', ' Data ', ' Detection ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' NIDDK ', ' Program Research Project Grants ', ' Research Program Projects ', ' Program Project Grant ', ' P01 Program ', ' P01 Mechanism ', ' Renal Tissue ', ' in vivo ', ' Non-Malignant ', ' nonmalignant ', ' Tissue Model ', ' Monitor ', ' Process ', ' Image ', ' imaging ', ' safety study ', ' Output ', ' cost ', ' design ', ' designing ', ' next generation ', ' treatment strategy ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' biomechanical model ', ' biomechanical simulation ', ' biomechanical modeling ', ' biomechanic simulation ', ' biomechanic modeling ', ' Radiation exposure ', ' experimental study ', ' experimental research ', ' experiment ', ' Wait Time ', ' first-in-human ', ' first in man ', ' ']",NIDDK,UNIVERSITY OF WASHINGTON,P01,2019,1619137,WA-07,0.08013196363928765
"Artificial Intelligence-Based Approaches for Renal Structure Characterization in Computed Tomography Images ABSTRACT The goal of this R03 Small Grant Program for NIDDK is to provide additional funding for Dr. Kline to expand upon his work on his K award and apply his expertise to new image acquisitions and problems related to renal imaging. Dr. Klines work has piqued the interest of many internal and external investigators and has led to recent collaborations with Drs. Rule, Denic, and Kim. Together with Dr. Erickson, this new research team has prepared this R03 proposal which takes advantage of the unique expertise of each team member. The focus of this proposal is to bridge the gap between microscopic observations and those assessable non-invasively by radiological imaging. To do this, we have established a unique dataset of renal CT imaging data and corresponding biopsy measured nephron densities. We have also generated a large database of gold-standard segmentation data of kidneys, cortical regions, and medullary pyramids. Using this existing data, we propose to: (i) develop tools for segmentation of kidneys, segmentation of individual medullary pyramids, and imputing missing parts of the kidneys outside of the imaged field-of-view in the CT image, and (ii) to establish imaging biomarkers of early CKD, and correlate macroscopic imaging findings to underlying microscopic structure. This research will be facilitated by Mayo Clinics outstanding clinical and research environment dedicated to improving patient care, as well as the Aging Kidney Anatomy Study (PI: Rule), which led to the generation of this unique and well characterized dataset. Dr. Klines background in imaging technologies and image processing makes him particularly well suited to perform this research. In addition to the above aims, near the end of this research project Dr. Kline will submit a highly competitive R01 application expanding upon the findings from this research proposal. This proposal will lead to vast improvements to current analysis workflows, as well as an improved understanding of the prognostic power of renal imaging biomarkers. Obtaining this R03 Award will greatly facilitate Dr. Klines transition into a prosperous independent researcher focused on developing novel imaging technologies and image analysis techniques for abdominal organ pathologies. Narrative Non-invasive methods for characterizing micro-structural changes of the kidney during aging as well as in health and disease are currently not possible. This research program proposes to use our existing database of renal imaging and renal biopsy data to bridge the gap between macroscopic radiological findings on computed tomography images to those assessable in microscopic images of renal biopsies. This program will develop new automated methods for performing measurements on the images, as well as use machine/deep learning methods to search for new imaging biomarkers that relate to nephron density and size, as well as establish their usefulness for early chronic kidney disease detection and transplant planning.",Artificial Intelligence-Based Approaches for Renal Structure Characterization in Computed Tomography Images,10040835,R03DK125632,"['Abdomen ', ' Abdominal ', ' Affect ', ' Aging ', ' Albuminuria ', ' Anatomy ', ' Anatomic ', ' Anatomic Sites ', ' Anatomic structures ', ' Anatomical Sciences ', ' Arteries ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Award ', ' Biopsy ', ' Clinical Research ', ' Clinical Study ', ' Communities ', ' Computer Vision Systems ', ' computer vision ', ' Disease ', ' Disorder ', ' Environment ', ' Fibrosis ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Gold ', ' Grant ', ' Health ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Polycystic Kidney Diseases ', ' Polycystic Kidney ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Methods ', ' Nephrons ', ' Uriniferous Tube ', ' Pathology ', ' Patients ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Research Proposals ', ' Resources ', ' Research Resources ', ' Risk ', ' Semantics ', ' Surveys ', ' Survey Instrument ', ' Technology ', ' Time ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' Transplantation ', ' transplant ', ' Work ', ' Generations ', ' Measures ', ' Autosomal Dominant Polycystic Kidney ', ' ADPKD ', ' Adult Polycystic Kidney Disease ', ' Autosomal Dominant Polycystic Kidney Disease ', ' Dominant Polycystic Kidney Disease ', ' Dataset ', ' Data Set ', ' base ', ' density ', ' image processing ', ' Organ ', ' improved ', ' Image Analyses ', ' image evaluation ', ' image interpretation ', ' Image Analysis ', ' Area ', ' Microscopic ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' Funding ', ' R-Series Research Projects ', ' R01 Mechanism ', ' R01 Program ', ' Research Grants ', ' Research Projects ', ' Research Project Grants ', ' Liver Cyst ', ' Hepatic Cyst ', ' Collaborations ', ' Tubular ', ' Tubular formation ', ' tool ', ' machine learned ', ' Machine Learning ', ' programs ', ' Hour ', ' Scanning ', ' Clinic ', ' Techniques ', ' interest ', ' Visit ', ' Services ', ' early detection ', ' Early Diagnosis ', ' interstitial ', ' Structure ', ' novel ', ' member ', ' Pathologic Constriction ', ' Pathological Constriction ', ' Stenosis ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Radiologic Finding ', ' Data ', ' Detection ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' Reproducibility ', ' Career Development Awards ', ' Career Development Awards and Programs ', ' Career Development Programs K-Series ', ' K-Awards ', ' Research Career Program ', ' K-Series Research Career Programs ', ' Clinical Evaluation ', ' Clinical Testing ', ' clinical test ', ' research clinical testing ', ' developmental ', ' Development ', ' Renal Blood Flow ', ' imaging ', ' Image ', ' Outcome ', ' Imaging technology ', ' graft failure ', ' clinical practice ', ' clinical decision-making ', ' noninvasive imaging ', ' non-invasive imaging ', ' precision-based medicine ', ' precision medicine ', ' prognostic ability ', ' prognostic power ', ' prognostic utility ', ' prognostic value ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' learning activity ', ' learning method ', ' learning strategy ', ' early biomarkers ', ' early detection markers ', ' early detection biomarkers ', ' microscope imaging ', ' microscopy imaging ', ' microscopic imaging ', ' individualized clinical decision ', ' individualized decision ', ' personalized clinical decision ', ' personalized data-driven decision ', ' personalized decision ', ' radiologic imaging ', ' radiological imaging ', ' novel imaging technology ', ' deep learning ', ' automated image analysis ', ' automated analysis ', ' renal biopsy ', ' kidney biopsy ', ' live kidney donor ', ' living kidney donor ', ' Patient imaging ', ' auto-segmentation ', ' automatic segmentation ', ' autosegmentation ', ' automated segmentation ', ' ']",NIDDK,MAYO CLINIC ROCHESTER,R03,2020,113350,MN-01,0.13684818519079045
"Development and Validation of Radiation-Free Pediatric Renal Function Quantification Project Abstract Motivation: Chronic kidney disease (CKD) affects more than 500 million people. Children commonly develop CKD from urinary obstructive diseases and nephrotoxic therapies, and then suffer severe growth failure,  hypertension, cardiovascular risks, and neurocognitive deficits, and eventually end-stage kidney disease. Accurate renal function quantification will improve clinical management of hydronephrosis (1 in 100 babies) and  dosing/selection of chemotherapeutic regimens in oncology patients. Glomerular filtration rate (GFR), the biomarker of renal function, is derived from blood or urine tests. These tests only provide global GFR and are limited in accuracy, especially in children, and even more so in children with cancer. MRI offers superb anatomic delineation without ionizing radiation, and is thus ideal for pediatric kidney imaging. However, MRI has not been widely adopted for pediatric renal function evaluation due to lack of reliability and cumbersome workflow. These hurdles stem from the fact that the critical components required for global and regional GFR calculation, including high spatiotemporal resolution, plasma flow and arterial input function, are difficult to obtain, and that accurate image segmentation of kidneys (cortex and medulla) is labor intensive. Additionally, although the same contrast agent injection can be used for obstruction evaluation, certain areas of the kidney suffer from significant signal loss using standard MRI acquisition techniques due to high contrast agent concentrations. This project addresses these major challenges for automated comprehensive renal function evaluation in children. Approach: The project has three development aims, which are validated by clinical studies. Aim 1 will enable novel free-breathing time-resolved 3D dynamic contrast enhanced MRI that simultaneously provides accurate GFR calculation and renal plasma flow. This is achieved by incorporating self-navigated motion compensation, fast acquisition with parallel imaging and compressed sensing, and phase-contrast flow imaging. The second aim is to develop multiple new image analysis methods to extract GFR and renal plasma flow (RPF) that  leverage novel flow data of Aim 1, as well as automated new machine-learning image processing techniques for the segmentation of kidneys and ultimately global and regional GFR calculation. In Aim 3, we will develop and integrate ultrashort-echo-time techniques to address the MRI signal loss due to T2* effects from high contrast concentration for patients with obstruction, and further incorporate motion compensation and accelerated  imaging methods to enable time-resolved high-resolution dynamic MRI for contrast washout kinetics analysis in the same MR exam. Aim 4 will determine the performance of these methods in a clinical setting. Significance: This work will lead to robust, automated comprehensive pediatric renal MRI for safer and more accurate renal function evaluation in children. The techniques will facilitate widespread application in the com- munity setting and permit robust evaluation of renal function, for both children and adults. Project Narrative Kidney diseases in children often stem from blockages of the urinary tract or toxicity from medications, such as antibiotics or chemotherapies. Kidney function quantification is crucial for clinical management of these children. This work will develop accurate and automated pediatric MRI for quantification of kidney function and diagnosis of urinary tract obstruction.",Development and Validation of Radiation-Free Pediatric Renal Function Quantification,9852445,R01EB026136,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Anatomy ', ' Anatomic ', ' Anatomic Sites ', ' Anatomic structures ', ' Anatomical Sciences ', ' Antibiotics ', ' Antibiotic Agents ', ' Antibiotic Drugs ', ' Miscellaneous Antibiotic ', ' Breathing ', ' Respiratory Aspiration ', ' Respiratory Inspiration ', ' inspiration ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cardiac Output ', ' heart output ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Clinical Research ', ' Clinical Study ', ' Contrast Media ', ' Contrast Agent ', ' Contrast Drugs ', ' Radiopaque Media ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Evolution ', ' Glomerular Filtration Rate ', ' Gold ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Hydronephrosis ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' kidney cortex ', ' kidney cortical portion ', ' renal cortex ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Kinetics ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Mainstreaming ', ' Educational Mainstreaming ', ' achievement Mainstream Education ', ' Manuals ', ' Methods ', ' Motion ', ' Motivation ', ' Obstruction ', ' Patients ', ' Perfusion ', ' Drug Kinetics ', ' Pharmacokinetics ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' pressure ', ' Ionizing radiation ', ' Ionizing Electromagnetic Radiation ', ' Radiation-Ionizing Total ', ' ionizing output ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Testing ', ' Time ', ' Urinary tract ', ' Urine ', ' Urine Urinary System ', ' Work ', ' Measures ', ' base ', ' image processing ', ' Obstructive Uropathy ', ' urinary tract obstruction ', ' improved ', ' Image Analyses ', ' image evaluation ', ' image interpretation ', ' Image Analysis ', ' kidney imaging ', ' Area ', ' Clinical ', ' Phase ', ' urological ', ' urologic ', ' Renal Plasma Flow ', ' Compensation ', ' Financial compensation ', ' Evaluation ', ' Failure ', ' pediatric ', ' Childhood ', ' Blood flow ', ' Reflux ', ' kidney function ', ' Renal function ', ' Measurement ', ' Oncology Cancer ', ' Oncology ', ' Childhood Cancers ', ' Malignant Childhood Tumor ', ' Malignant Pediatric Neoplasm ', ' Malignant Pediatric Tumor ', ' Malignant childhood cancer ', ' cancer in a child ', ' cancer in children ', ' child with cancer ', ' childhood malignancy ', ' children with cancer ', ' pediatric cancer ', ' pediatric malignancy ', ' Malignant Childhood Neoplasm ', ' Venous ', ' machine learned ', ' Machine Learning ', ' Functional MRI ', ' fMRI ', ' Functional Magnetic Resonance Imaging ', ' Adopted ', ' anti-microbial agent ', ' anti-microbial drug ', ' antimicrobial agent ', ' antimicrobial drug ', ' Protocol ', ' Protocols documentation ', ' Techniques ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' experience ', ' Performance ', ' Nephrotoxic ', ' kidney toxicity ', ' nephrotoxicity ', ' Toxicities ', ' Toxic effect ', ' novel ', ' chemotherapeutic agent ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' Radiation ', ' data processing ', ' computerized data processing ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Address ', ' Dose ', ' Data ', ' Reproducibility ', ' Resolution ', ' Clinical Management ', ' Validation ', ' urinary ', ' developmental ', ' Development ', ' Renal Blood Flow ', ' imaging ', ' Image ', ' reconstruction ', ' IQ Deficit ', ' intelligence quotient deficit ', ' neurocognitive decline ', ' neurocognitive impairment ', ' Neurocognitive Deficit ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Consumption ', ' imaging Segmentation ', ' data acquisition ', ' chemotherapy ', ' loss of function ', ' stem ', ' spatiotemporal ', ' community setting ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' Regimen ', ' 4-D imaging ', ' four-dimensional imaging ', ' 4D Imaging ', ' Cone ', ' contrast enhanced ', ' recruit ', ' Injections ', ' automated analysis ', ' ']",NIBIB,STANFORD UNIVERSITY,R01,2020,662001,CA-18,0.08507986593957383
"Leveraging Artificial-Intelligence to Profile and Enhance Phenotypic Plasticity for Second Injury Prevention: An Innovative Precision Medicine Platform to Revolutionize Injury Care Project Summary/Abstract The best predictor of future injury is previous injury. Unfortunately, this has not changed in a quarter century, despite the introduction of evidence-based medicine and the associated revisions to post-injury treatment and care. Nearly nine million sports-related injuries occur annually, and the majority of these require medical treatment and/or clinical intervention prior to clearance for the athlete to return to play (RTP). Even with formal care, injured athletes are two- to four times (in extreme cases 100 times) more likely to suffer a second injury for up to two years after RTP. This is even more alarming given that 65% of initial sports-related injuries affect children and young adults (ages 5-24 years), setting them up for a lifetime of negative health outcomes. These data implicate the initial injury event as the tipping point for a post-injury cascade of negative sequelae exposing athletes to more physical and psychological pain, higher medical costs and greater risk of severe long-term negative health throughout their life. Thus, an urgent need exists to revolutionize the current standard of post- injury care through better identification and targeting of deficits that underlie second injury risk to enable everyone to stay physically active and healthy for their whole lives. To address this need, we propose a pioneering approach that capitalizes on the biological concept of Phenotypic Plasticity (PP) to quantify an athletes functional adaptability across different performance environments. Here PP is computed based on both intrinsic and extrinsic factors that reflect the functional movement capability of the athlete. The overall objective of this proposal is, therefore, to develop a generalizable PP-based precision sports medicine approach for second injury prevention through the development of a systematic bioinformatics-driven approach for PP profile construction, and the training of genetic fuzzy artificial intelligence to establish treatment type and magnitude for precision enhancement of PP. The result of the proposed work will be a generalizable PP-based precision sports medicine approach via two expected outcomes: (1) a formalized phenotypic precision medicine approach to objectively quantify behavioral plasticity, and (2) the successful implementation of a platform leveraging genetic fuzzy artificial intelligence integrated with mixed reality for performance prediction. This platform will support delivery of personalized treatments for PP enhancement. These objectives are the critical first step for the development of a generalizable precision medicine approach that will revolutionize rehabilitation and finally stem the tide of second injury in sport. This contribution will be significant to push back against the initial injury tipping point and, in doing so, create a pathway for injured athletes to return safely to physical activity and to maintain a long-term healthy lifestyle. Project Narrative The proposed research is relevant to public health because the proposed platform will lead to fewer young men and women who suffer from second injury and the negative effects that lead to poorer long-term health. The project is relevant to NIHs mission because the knowledge gained will be used to optimize new precision assessment and treatment strategies to prevent injury, and this will enhance health and reduce the burden of athletic injury.",Leveraging Artificial-Intelligence to Profile and Enhance Phenotypic Plasticity for Second Injury Prevention: An Innovative Precision Medicine Platform to Revolutionize Injury Care,9989850,R21EB027865,"['Affect ', ' Age ', ' ages ', ' Algorithms ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Athletic Injuries ', ' Sports Injuries ', ' Back ', ' Dorsum ', ' Behavior ', ' Behavioral Sciences ', ' Biology ', ' Biomedical Engineering ', ' bio-engineered ', ' bio-engineers ', ' bioengineering ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Disease ', ' Disorder ', ' Elements ', ' Environment ', ' Future ', ' Genetic Markers ', ' genetic biomarker ', ' Genotype ', ' Goals ', ' Health ', ' indexing ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Methods ', ' Mission ', ' Biological Models ', ' Biologic Models ', ' Model System ', ' Movement ', ' body movement ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Organism ', ' living system ', ' Pain ', ' Painful ', ' Phenotype ', ' Play ', ' Public Health ', ' Rehabilitation therapy ', ' Medical Rehabilitation ', ' Rehabilitation ', ' rehab therapy ', ' rehabilitative ', ' rehabilitative therapy ', ' Research ', ' Risk ', ' medical specialties ', ' Specialty ', ' Sports ', ' Sports Medicine ', ' Stress ', ' Technology ', ' Time ', ' Treatment Protocols ', ' Treatment Regimen ', ' Treatment Schedule ', ' Work ', ' Measures ', ' medical costs ', ' Medical Care Costs ', ' Caring ', ' injury prevention ', ' Custom ', ' injuries ', ' Injury ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Physiologic ', ' Physiological ', ' Medical ', ' psychological ', ' psychologic ', ' Series ', ' Randomized Clinical Trials ', ' Training ', ' Physical activity ', ' Individual ', ' adult youth ', ' young adulthood ', ' young adult ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Genetic ', ' lightweight ', ' light weight ', ' Morphology ', ' machine learned ', ' Machine Learning ', ' Evidence Based Medicine ', ' Knowledge ', ' Life ', ' programs ', ' Dimensions ', ' Complex ', ' Event ', ' System ', ' Services ', ' behavioral prediction ', ' behavior prediction ', ' Performance ', ' success ', ' Modeling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Pharmacogenomics ', ' Bio-Informatics ', ' Bioinformatics ', ' Tissue Sample ', ' preventing ', ' prevent ', ' Address ', ' fitness ', ' Data ', ' Motor ', ' Molecular ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' environmental change ', ' injured ', ' Behavioral Model ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' stem ', ' treatment strategy ', ' complex biological systems ', ' adolescent man ', ' adolescent men ', ' young man ', ' adolescent woman ', ' adolescent women ', ' young woman ', ' Combinatorial Optimization ', ' precision-based medicine ', ' precision medicine ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' personalized genetics ', ' precision genetics ', ' precision therapies ', ' precision treatment ', ' Precision therapeutics ', ' healthy life-style ', ' healthy lifestyle ', ' genomic effort ', ' genomic strategy ', ' Genomic approach ', ' behavioral plasticity ', ' mixed reality ', ' multi-modal data ', ' multi-modal datasets ', ' multimodal datasets ', ' multimodal data ', ' data fusion ', ' recovery after injury ', ' recovery following injury ', ' recovery post injury ', ' injury recovery ', ' ']",NIBIB,UNIV OF NORTH CAROLINA CHAPEL HILL,R21,2020,312918,NC-04,0.011773487032144444
"Machine learning for fast motion compensated quantitative abdominal DCE-MRI Project Summary: Functional imaging with dynamic contrast-enhanced MRI (DCE-MRI) provides important physiological markers of permeability, perfusion and glomerular filtration rate (GFR), a measure of kidney function, without exposing patients to ionizing radiation. DCE-MR images are at the same time used for evaluation of anatomy. Functional markers from DCE-MRI, if computed accurately, would play a critical role in diagnosing and assessing the progression of a number of pediatric diseases including those compromising kidney function, liver diseases, tumors, and Crohn's disease. One of the most important applications of DCE-MRI is assessing kidney function (GFR) in hydronephrosis patients with obstruction. In the absence of GFR information, children who stand to benefit from immediate surgical reconstruction might be overlooked or delayed in receiving treatment, and those who might benefit from a more conservative approach (i.e., watchful waiting) might receive an unnecessary surgical intervention. While the current reference standard, nuclear renography (MAG3), yields some useful diagnostic information, it is slow, provides low resolution, does not offer anatomic detail, and delivers potentially harmful ionizing radiation. There is a clinical need for accurate computation of quantitative functional markers. Unfortunately, current methods of DCE-MRI in neonates and children are less than optimal, and therefore, DCE-MRI is underutilized in clinical practice. The technical challenges include insufficient temporal resolution to capture fast arterial input function (AIF) dynamics (which are required for accurate computation of quantitative markers), unavoidable respiratory motion and bulk motion (which reduce image quality and significantly lower the accuracy of parameter estimates), and a lack of robust, fast, automated post processing techniques for accurate computation of markers. Thus, there is an urgent, unmet need to develop a motion-compensated, high spatiotemporal resolution DCE-MRI method addressing these challenges. The primary objective of this exploratory, three-year study, is three-fold: first, to develop and evaluate a new bulk and respiratory motion-compensated, high spatiotemporal resolution DCE-MRI technique for accurate estimation of functional markers; second, to further improve the robustness and speed of DCE-MRI using a fast, deep learning (DL) technique with integrated temporal prior for the reconstruction of motion-compensated, higher quality, high temporal resolution images; and third, to develop an automatic quantitative analysis pipeline including segmentation and tracer kinetic model-fitting using DL techniques for fast, robust and accurate quantification of functional markers. The successful completion of these aims will provide new, clinically important abdominal imaging capabilities, with real-time, motion-compensated image reconstruction and reliable real-time parameter estimation from high temporal and spatial resolution DCE-MRI. This work will extend the usefulness of DCE-MRI to pediatric patients who are unable to remain still in the scanner, and eliminate the need for repeated scans and sedation in infants. ! ! Project Narrative: This project addresses the need to develop advanced methods of magnetic resonance imaging (MRI) to provide new, clinically important abdominal imaging capabilities, with real-time, motion-compensated image reconstruction and reliable real-time estimation of clinically important quantitative imaging markers from high temporal and spatial resolution DCE-MRI. These markers will be used to evaluate the extent of several disorders and would play a critical role in diagnosing and assessing the progression of a number of pediatric diseases including those compromising kidney function, liver diseases, tumors, and Crohn's disease. This work will extend the usefulness of DCE-MRI to pediatric patients who are unable to remain still in the scanner, and eliminate the need of repeated scans, sedation and anesthesia when imaging newborns with congenital abnormalities such as congenital hydronephrosis, which if left untreated, can result in permanent damage to the child's kidneys.",Machine learning for fast motion compensated quantitative abdominal DCE-MRI,9957672,R21EB029627,"['developmental ', ' Development ', ' imaging ', ' Image ', ' neonate ', ' reconstruction ', ' time use ', ' tumor ', ' spatiotemporal ', ' clinical practice ', ' clinical decision-making ', ' child patients ', ' pediatric patients ', ' anxious ', ' quantitative imaging ', ' contrast enhanced ', ' temporal resolution ', ' time measurement ', ' temporal measurement ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' bulk motion ', ' imaging capabilities ', ' recursive neural network ', ' deep learning ', ' neural net architecture ', ' neural network architecture ', ' analysis pipeline ', ' realtime image ', ' real-time images ', ' kinetic model ', ' Abdomen ', ' Abdominal ', ' Congenital Abnormality ', ' Birth Defects ', ' Congenital Anatomic Abnormality ', ' Congenital Anatomical Abnormality ', ' Congenital Defects ', ' Congenital Deformity ', ' Congenital Malformation ', ' Affect ', ' Algorithms ', ' Anatomy ', ' Anatomic ', ' Anatomic Sites ', ' Anatomic structures ', ' Anatomical Sciences ', ' Anesthesia procedures ', ' Anesthesia ', ' Breathing ', ' Respiratory Aspiration ', ' Respiratory Inspiration ', ' inspiration ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', "" Crohn's disease "", ' Crohn disease ', "" Crohn's "", "" Crohn's disorder "", ' Granulomatous Enteritis ', ' eleocolitis ', ' regional enteritis ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Glomerular Filtration Rate ', ' Hydronephrosis ', ' image reconstruction ', ' image construction ', ' image generation ', ' Infant ', ' Newborn Infant ', ' 0-4 weeks old ', ' Newborns ', ' newborn child ', ' newborn children ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Liver diseases ', ' Hepatic Disorder ', ' hepatic disease ', ' hepatopathy ', ' liver disorder ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Methods ', ' Motion ', ' Discipline of Nuclear Medicine ', ' Atomic Medicine ', ' Nuclear Medicine ', ' Radiology / Radiation Biology / Nuclear Medicine ', ' Obstruction ', ' Patients ', ' Perfusion ', ' Permeability ', ' Play ', ' Ionizing radiation ', ' Ionizing Electromagnetic Radiation ', ' Radiation-Ionizing Total ', ' ionizing output ', ' Reference Standards ', ' Role ', ' social role ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Time ', ' Work ', ' Imaging Techniques ', ' Imaging Procedures ', ' Imaging Technics ', ' Measures ', ' base ', ' Organ ', ' improved ', ' Left ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Series ', ' Compensation ', ' Financial compensation ', ' Evaluation ', ' Failure ', ' pediatric ', ' Childhood ', ' kidney function ', ' Renal function ', ' Measurement ', ' radiologist ', ' sedation ', ' Sedation procedure ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Scanning ', ' Techniques ', ' respiratory ', ' Nuclear ', ' Operative Procedures ', ' Surgical ', ' Surgical Interventions ', ' Surgical Procedure ', ' surgery ', ' Operative Surgical Procedures ', ' Performance ', ' Speed ', ' Watchful Waiting ', ' Patient observation ', ' Modeling ', ' Ureteropelvic junction obstruction ', ' image-based method ', ' imaging method ', ' imaging modality ', ' Address ', ' Detection ', ' Disease Marker ', ' Resolution ', ' Physiologic Imaging ', ' physiological imaging ', ' Functional Imaging ', ' Tracer ', ' ']",NIBIB,BOSTON CHILDREN'S HOSPITAL,R21,2020,708000,MA-07,0.047197638679742006
"In-Office, Ultrasound-Based Breakage and Removal of Urinary stones OVERALL SUMMARY  The main focus of this Program Project Grant is to discover the foundational and translational knowledge needed to create an office-based handheld ultrasound device to target, detach, break, and expel stones and stone fragments from the urinary space to facilitate natural clearance. This system will obviate costly and inefficient emergency department visits that typically include repetitive exposure to ionizing radiation from diagnostic imaging, and will significantly reduce the often lengthy (days to weeks) wait time patients must endure before procedures for stone removal can be scheduled and performed. As the proposed therapy system is entirely noninvasive, patients will be treated on an outpatient basis. Further, as the system is designed to efficiently and painlessly break stones of any size and expel the fragments from the kidney, the treatment of both symptomatic and asymptomatic stones using this technology will reduce the high retreatment and stone event recurrence rates associated with current surgical interventions for stone removal.  In this effort, we will combine stone breakage by burst wave lithotripsy (BWL), clearance of fragments by ultrasonic propulsion (UP), and stone-specific ultrasound imaging (S-mode) into an integrated system in which exposure strategies are adapted during treatment in response to real-time acoustic feedback to enhance comminution efficiency and patient safety. We will tailor treatment by investigating numerically and in lab tests the primary mechanisms - cavitation and elastic waves - involved in the comminution process over a broad parameter space. We will develop acoustics-based feedback including model- based, machine learning and passive acoustic mapping (PAM) of the bubble field to signal the need to adjust the energy output. We will investigate the morphological and functional response of the kidney in living animals and in ex vivo perfused porcine kidneys, and pursue tissue protective treatment strategies such as power ramping.  These studies will include the first in-human test of BWL in which we will compare the comminution effectiveness and safety of treatment with and without adaptive output control in response to acoustic feedback. In addition, we will conduct a randomized controlled trial of the benefits and risks of fragmenting and expelling symptomatic and asymptomatic stones in the clinic. Toward application of the system for use in humans, we will refine and validate the use of UP and S-mode together to improve stone and fragment detection. With our eye on the future of stone management, we will develop and validate in vivo an extracorporeal acoustic tractor beam to grasp and carry fragments through the complex three- dimensional path of the urinary space and out of the kidney. OVERALL NARRATIVE Urinary stone disease, which affects 1 in 11 Americans, is one of the most painful diseases and also the costliest non-malignant urologic disease, because current management is limited to observation for the stone to pass or performing surgery. The main focus of this Program Project Grant is to discover the foundational and translational knowledge needed to create an office-based, handheld ultrasound device to target, detach, break, and expel stones and stone fragments from the urinary space to facilitate natural clearance. This system will obviate costly and temporizing emergency department visits and radiation exposing imaging while the patient waits in pain for days to weeks for the stone to pass or be surgically removed.","In-Office, Ultrasound-Based Breakage and Removal of Urinary stones",10005352,P01DK043881,"['Acoustics ', ' Acoustic ', ' Affect ', ' Anatomy ', ' Anatomic ', ' Anatomic Sites ', ' Anatomic structures ', ' Anatomical Sciences ', ' Animals ', ' Calibration ', ' Diagnostic Imaging ', ' Disease ', ' Disorder ', ' Engineering ', ' Eye ', ' Eyeball ', ' Feedback ', ' Foundations ', ' Fracture ', ' bone fracture ', ' Future ', ' Health ', ' Human ', ' Modern Man ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Lithotripsy ', ' Litholapaxy ', ' Methodology ', ' Outpatients ', ' Out-patients ', ' Pain ', ' Painful ', ' Patients ', ' Productivity ', ' Publications ', ' Scientific Publication ', ' Ionizing radiation ', ' Ionizing Electromagnetic Radiation ', ' Radiation-Ionizing Total ', ' ionizing output ', ' Ramp ', ' Recurrence ', ' Recurrent ', ' Research ', ' Research Design ', ' Study Type ', ' study design ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Safety ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Family suidae ', ' Pigs ', ' Suidae ', ' Swine ', ' porcine ', ' suid ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Ultrasonography ', ' Echography ', ' Echotomography ', ' Medical Ultrasound ', ' Ultrasonic Imaging ', ' Ultrasonogram ', ' Ultrasound Diagnosis ', ' Ultrasound Medical Imaging ', ' Ultrasound Test ', ' diagnostic ultrasound ', ' sonogram ', ' sonography ', ' sound measurement ', ' ultrasound ', ' ultrasound imaging ', ' ultrasound scanning ', ' Urinary Calculi ', ' Urinary Stones ', ' Urinary Tract Stones ', ' Urolith ', ' Urologic Diseases ', ' Urinary Tract Diseases ', ' Urologic Disorder ', ' Urological Diseases ', ' Urological Disorders ', ' urinary tract disorder ', ' Measures ', ' Schedule ', ' Dataset ', ' Data Set ', ' Calcified ', ' calcification ', ' base ', ' improved ', ' Procedures ', ' Clinical ', ' Ensure ', ' Grips ', ' grasp ', ' Urinary Space ', "" Bowman's space "", ' non-painful ', ' nonpainful ', ' not painful ', ' Painless ', ' Sample Size ', ' Collaborations ', ' Randomized Controlled Trials ', ' Exposure to ', ' Morphology ', ' machine learned ', ' Machine Learning ', ' re-treatment ', ' Retreatment ', ' Knowledge ', ' programs ', ' Complex ', ' Event ', ' Clinic ', ' Techniques ', ' System ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Operative Procedures ', ' Surgical ', ' Surgical Interventions ', ' Surgical Procedure ', ' surgery ', ' Operative Surgical Procedures ', ' American ', ' success ', ' simulation ', ' Benefits and Risks ', ' Modality ', ' Devices ', ' Reporting ', ' Abscission ', ' Extirpation ', ' Removal ', ' Surgical Removal ', ' resection ', ' Excision ', ' Statistical Methods ', ' Modeling ', ' response ', ' patient safety ', ' Effectiveness ', ' Address ', ' Ultrasonic ', ' Ultrasonics ', ' Biostatistics Core ', ' Detection ', ' NIDDK ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' P01 Mechanism ', ' P01 Program ', ' Program Project Grant ', ' Research Program Projects ', ' Program Research Project Grants ', ' Renal Tissue ', ' in vivo ', ' nonmalignant ', ' Non-Malignant ', ' Tissue Model ', ' Monitor ', ' Process ', ' imaging ', ' Image ', ' safety study ', ' Output ', ' cost ', ' designing ', ' design ', ' next generation ', ' treatment strategy ', ' ED visit ', ' ER visit ', ' Emergency care visit ', ' Emergency hospital visit ', ' Emergency room visit ', ' Emergency department visit ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' biomechanic modeling ', ' biomechanic simulation ', ' biomechanical modeling ', ' biomechanical simulation ', ' biomechanical model ', ' Radiation exposure ', ' experiment ', ' experimental research ', ' experimental study ', ' Wait Time ', ' first in man ', ' first-in-human ', ' structured data ', ' complex data  ', ' ']",NIDDK,UNIVERSITY OF WASHINGTON,P01,2020,1567293,WA-07,0.08013196363928765
"A Systems Biology and Patient Stratification Approach to Improve Outcomes of Patients with Hypoxic Injury in Renal Tubular Cells in Chronic Kidney Diseases ABSTRACT  Chronic Kidney Disease (CKD) is a global health epidemic and patients with CKD suffer from increased mortality and cardiovascular disease. Despite the severity of the disease, there are limited treatment options to hinder its progression. Tubular injury (TI) is a common finding on many kidney biopsies from patients with CKD, and there is mechanistic data supporting that TI can lead to interstitial fibrosis and tubular atrophy. While interstitial fibrosis and tubular atrophy are the strongest known pathologic predictor of progression of CKD, we have limited understand of how TI contributes to this progression. Hypoxia Inducible Factor-1 (HIF-1) has been shown in animal studies to impact the severity of TI and is also known to trigger a fibrotic cascade, but there is limited data regarding its overall activity in kidney tissue, its cell type specific activity, its association with pathologic features or patient outcomes. It is of utmost importance to better understand this pathway as several Prolyl Hydroxylase inhibitors, which are novel therapeutic agents that increase the expression of HIF- 1, are currently in clinical trial testing to treat anemia of CKD. The first aim of this proposal is to develop a measure of HIF-1 pathway activity that enables evaluation of clinical and morphologic features and cell-type specificity. Specifically, the candidate will a) Identify clinical and pathologic descriptors associated with increased HIF-1 pathway activity score and b) Determine the cell-type specific expression level of HIF-1 and its downstream components in tubular cells using single-cell RNA-sequencing. The second aim of this proposal is to determine the association of increased HIF-1 activity with outcomes and identify patients with increased HIF-1 activity non-invasively using biomarkers. Specifically, the candidate will a) Determine the association of increased HIF-1 activity score with patient outcomes and b) Identify serum or urine biomarkers that detect increased HIF-1 pathway activity in patients. The candidate will analyze data from 3 cohorts to accomplish these aims: Nephrotic Syndrome Study Network (NEPTUNE), Clinical Phenotyping Resource and Biobank Core (C-PROBE) and the Native Americans with Type 2 Diabetes cohort (formerly known as the Pima Indian cohort). These investigations will allow us to monitor HIF-1 activity non-invasively in trials where patients receive novel drug agents, such as Prolyl Hydroxylase Inhibitors.  The candidate will obtain formal training in analysis of gene expression data, single cell RNA- sequencing and machine learning techniques during the course of the award period to successfully integrate gene expression data, pathology data and clinical data. She will be mentored by an expert team with complementary experience in nephrology, tubular injury biology, systems biology and bioinformatics. The long-term goal of these investigations is to ultimately be able to better sub-type patients with tubular injury based on mechanistic terms. NARRATIVE Chronic Kidney Disease is a global health epidemic and is associated with increased mortality, but we do not have a detailed understanding of why this disease progresses. Identifying sub-types of patients who progress by the same molecular mechanism is important to identify patients for future clinical trials. This project aims to use gene expression data from kidney biopsies to identify patients who will respond differently to medications that increase the expression of Hypoxia Inducible Factor-1 alpha.",A Systems Biology and Patient Stratification Approach to Improve Outcomes of Patients with Hypoxic Injury in Renal Tubular Cells in Chronic Kidney Diseases,9948349,K08DK124449,"['Anemia ', ' Animals ', ' inhibitor/antagonist ', ' inhibitor ', ' Atherosclerosis ', ' Atheroscleroses ', ' Atherosclerotic Cardiovascular Disease ', ' atheromatosis ', ' atherosclerotic disease ', ' atherosclerotic vascular disease ', ' Award ', ' Beds ', ' Biology ', ' Biopsy ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cells ', ' Cell Body ', ' Clinical Trials ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemic ', ' Erythropoietin ', ' ECSF ', ' Epoetin ', ' erythrocyte colony stimulating factor ', ' hematopoietin ', ' Fibrosis ', ' Future ', ' Gene Expression ', ' Glomerular Filtration Rate ', ' Goals ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Mentors ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' mortality ', ' Nephrology ', ' Nephrotic Syndrome ', ' Pathology ', ' Patients ', ' Production ', ' Procollagen-Proline Dioxygenase ', ' Peptidyl Prolyl Hydroxylase ', ' Procollagen Prolyl 4-Hydroxylase ', ' Proline Hydroxylase ', ' Proline,2-Oxoglutarate 4-Dioxygenase ', ' Prolyl 4-Hydroxylase ', ' Prolyl Hydroxylase ', ' Protocollagen Prolyl Hydroxylase ', ' Resources ', ' Research Resources ', ' Specificity ', ' Testing ', ' Tissues ', ' Body Tissues ', ' transcription factor ', ' Basal Transcription Factor ', ' Basal transcription factor genes ', ' General Transcription Factor Gene ', ' General Transcription Factors ', ' Transcription Factor Proto-Oncogene ', ' Transcription factor genes ', ' Urine ', ' Urine Urinary System ', ' Measures ', ' Dataset ', ' Data Set ', ' injuries ', ' Injury ', ' base ', ' glomerular sclerosis ', ' glomerulosclerosis ', ' improved ', ' Chronic ', ' Clinical ', ' HIF 1 ', ' HIF-1 protein ', ' HIF1 ', ' HIF1 protein ', ' hypoxia inducible factor 1 ', ' Training ', ' Blood Serum ', ' Serum ', ' kidney function ', ' Renal function ', ' Hypoxic ', ' Oxygen Deficiency ', ' Hypoxia ', ' Disease Progression ', ' Native Americans ', ' Descriptor ', ' Therapeutic ', ' Therapeutic Agents ', ' Tubular ', ' Tubular formation ', ' Morphology ', ' Atrophy ', ' Atrophic ', ' machine learned ', ' Machine Learning ', ' Investigation ', ' Severities ', ' Complex ', ' cell type ', ' Techniques ', ' disease severity ', ' Severity of illness ', ' experience ', ' interstitial ', ' cohort ', ' novel ', ' Gene Expression Monitoring ', ' Gene Expression Pattern Analysis ', ' Transcript Expression Analyses ', ' Transcript Expression Analysis ', ' gene expression analysis ', ' gene expression assay ', ' transcriptional profiling ', ' Gene Expression Profiling ', ' intervention therapy ', ' Therapeutic Intervention ', ' Sampling ', ' response ', ' Bio-Informatics ', ' Bioinformatics ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Address ', ' Systems Biology ', ' global health ', ' Data ', ' Molecular Fingerprinting ', ' molecular profile ', ' molecular signature ', ' Molecular Profiling ', ' Reproducibility ', ' Clinical Data ', ' Clinical Evaluation ', ' Clinical Testing ', ' clinical test ', ' research clinical testing ', ' trial regimen ', ' trial treatment ', ' Clinical Treatment ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Pathologic ', ' Monitor ', ' Molecular ', ' Process ', ' Pima Indian ', ' pathway ', ' Pathway interactions ', ' clinical phenotype ', ' Outcome ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' Hypoxia Inducible Factor ', ' new marker ', ' novel biomarker ', ' novel marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' biorepository ', ' biobank ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' predictive biomarkers ', ' predictive molecular biomarker ', ' predictive marker ', ' phase 3 trial ', ' phase III trial ', ' stratified patient ', ' patient stratification ', ' improved outcome ', ' patient subgroups ', ' patient subpopulations ', ' patient subtypes ', ' patient subsets ', ' Expression Profiling ', ' scRNA-seq ', ' single cell RNA-seq ', ' single cell RNAseq ', ' single-cell RNA sequencing ', ' death risk ', ' mortality risk ', ' renal biopsy ', ' kidney biopsy ', ' statistical and machine learning ', ' ']",NIDDK,UNIVERSITY OF MICHIGAN AT ANN ARBOR,K08,2020,168955,MI-12,0.16455580393412753
"Integrative Molecular Epidemiology Approach to Identify Nephrotic Syndrome Subgroups ABSTRACT Although patients with Nephrotic Syndrome (NS) present with shared clinical signs and symptoms (proteinuria, hypoalbuminemia, hyperlipidemia and edema), there is dramatic variability in prognosis and response to therapy, frustrating patients, families and their clinicians. Even within the histopathologic categories used in the current diagnostic approach (e.g. minimal change disease, focal segmental glomerulosclerosis), there is dramatic variability in disease progression and response to therapy, highlighting the underlying biological heterogeneity within the groups. Small studies with broad, clinical patient inclusion criteria have demonstrated that a subset of patients respond well to anti-TNF therapy, but accurate pre-treatment response of those individuals is not possible based on routine clinical parameters. This project will leverage the Nephrotic Syndrome Study Network (NEPTUNE) cohort study, a multi-center prospective study of 600 patients with FSGS, MCD and MN with rich clinical data, kidney biopsy tissue and gene expression profiles. This study will leverage the kidney tissue gene expression data to identify a subgroup of patients with TNF-alpha pathway activation, assess associated clinical outcomes and identify non- molecular predictors of the subgroup. The aims are:  Aim 1: To identify a subgroup of Nephrotic Syndrome patients with homogeneous activation of the  TNF-alpha transcriptional pathway.  Aim 2: To compare molecular subgroups with conventional clinical-pathologic classification in  clinical outcome prediction.  Aim 3: To identify non-invasive markers (e.g. demographics, blood and urine markers), standard  pathology features and novel pathologic biopsy descriptors associated with the TNF-alpha subgroup. To accomplish this project, the applicant will pursue formal training in systems biology, genetic epidemiology and bioinformatics. She will be mentored by a multi-disciplinary team with expertise in systems biology, epidemiology and bioinformatics. The long term objective is to improve the clinical care of patients with Nephrotic Syndrome by improved understanding of the underlying biology, identifying novel biomarkers and potential therapeutic targets for future validation in animal models and mechanistic-based interventional clinical trials. PROJECT NARRATIVE Nephrotic Syndrome, caused by several rare kidney diseases, is characterized by an abnormal amount of protein in the urine, swelling and kidney failure. Patients affected by the syndrome suffer complications of the disease as well as the toxicity of the immunosuppressive therapy used to treat it, but their individual presentations, response to treatment and prognosis can vary markedly. This project aims to use gene expression levels from kidney biopsy tissue to identify the subgroup patients most likely to respond to TNF- alpha blocking medications, an approach which, if validated, may help to inform targeted therapy selections for these patients.",Integrative Molecular Epidemiology Approach to Identify Nephrotic Syndrome Subgroups,9926246,K08DK115891,"['Affect ', ' Award ', ' Biology ', ' Biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Classification ', ' Systematics ', ' Clinical Trials ', ' Cohort Studies ', ' Concurrent Studies ', ' Complement ', ' Complement Proteins ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Edema ', ' Dropsy ', ' Hydrops ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Family ', ' Future ', ' Gene Expression ', ' Patient Care ', ' Patient Care Delivery ', ' Genotype ', ' Membranous Glomerulonephritis ', ' Extramembranous Glomerulopathy ', ' Membranous Glomerulonephropathy ', ' Membranous Glomerulopathy ', ' Membranous Nephropathy ', ' Grant ', ' Heterogeneity ', ' Hyperlipidemia ', ' Hyperlipemia ', ' Therapeutic immunosuppression ', ' Anti-Rejection Therapy ', ' Antirejection Therapy ', ' Immunosuppressive Therapy ', ' artificial immunosuppression ', ' immunosuppression therapy ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Kidney Glomerulus ', ' Malpighian Tuft ', ' kidney glomeruli ', ' renal glomerulus ', ' Leadership ', ' Mentors ', ' Nephrotic Syndrome ', ' Pathology ', ' Patients ', ' Phenotype ', ' Probability ', ' outcome forecast ', ' Prognosis ', ' Prospective Studies ', ' Proteins ', ' Proteinuria ', ' Publications ', ' Scientific Publication ', ' Kidney Failure ', ' Kidney Insufficiency ', ' Renal Failure ', ' Renal Insufficiency ', ' Resources ', ' Research Resources ', ' Signs and Symptoms ', ' Diagnostic Findings ', ' Swelling ', ' Syndrome ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Urine ', ' Urine Urinary System ', ' Work ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' Histologically ', ' Histologic ', ' Molecular Epidemiology ', ' Training ', ' Individual ', ' Hypoalbuminemia ', ' Disease Progression ', ' Patient Selection ', ' R-Series Research Projects ', ' R01 Mechanism ', ' R01 Program ', ' Research Grants ', ' Research Projects ', ' Research Project Grants ', ' Glomerular disease ', ' Renal Glomerular Diseases and Syndromes ', ' Renal glomerular disease or syndrome ', ' Renal glomerular disorder ', ' Renal glomerular syndrome ', ' Renal glomerular disease ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' anti-TNF therapy ', ' anti-TNF-alpha therapy ', ' Anti-Tumor Necrosis Factor Therapy ', ' Descriptor ', ' Genetic ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' FSGS ', ' Focal segmental glomerular sclerosis ', ' Focal Segmental Glomerulosclerosis ', ' Complex ', ' Clinical Course of Disease ', ' Techniques ', ' cohort ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' Toxicities ', ' Toxic effect ', ' Histopathology ', ' Structure ', ' skills ', ' novel ', ' Participant ', ' member ', ' Categories ', ' Position ', ' Positioning Attribute ', ' (TNF)- ', ' Cachectin ', ' Macrophage-Derived TNF ', ' Monocyte-Derived TNF ', ' TNF ', ' TNF A ', ' TNF Alpha ', ' TNF- ', ' TNFA ', ' TNF ', ' Tumor Necrosis Factor ', ' Tumor Necrosis Factor-alpha ', ' TNF gene ', ' response ', ' genetic epidemiologic study ', ' genetic epidemiology ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Bio-Informatics ', ' Bioinformatics ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Systems Biology ', ' Data ', ' Molecular Fingerprinting ', ' molecular profile ', ' molecular signature ', ' Molecular Profiling ', ' predict therapeutic response ', ' predict therapy response ', ' predict treatment response ', ' therapy prediction ', ' treatment prediction ', ' treatment response prediction ', ' Prediction of Response to Therapy ', ' Subgroup ', ' Clinical Data ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Validation ', ' Pathologic ', ' Characteristics ', ' Molecular ', ' pathway ', ' Pathway interactions ', ' Outcome ', ' multidisciplinary ', ' inclusion criteria ', ' demographics ', ' therapeutic target ', ' clinical epidemiology ', ' clinical care ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' new marker ', ' novel biomarker ', ' novel marker ', ' clinical practice ', ' biological systems ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' biological heterogeneity ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' patient subgroups ', ' patient subpopulations ', ' patient subtypes ', ' patient subsets ', ' clinical outcome prediction ', ' predictor of clinical outcome ', ' predict clinical outcome ', ' Prospective cohort study ', ' Expression Profiling ', ' Molecular Disease ', ' patient specific response ', ' responsive patient ', ' patient response ', ' renal biopsy ', ' kidney biopsy ', ' ']",NIDDK,UNIVERSITY OF MICHIGAN AT ANN ARBOR,K08,2020,169560,MI-12,0.11701062357598033
"Predictive Analytics in Hemodialysis: Enabling Precision Care for Patient with ESKD ABSTRACT End stage kidney disease (ESKD) is a complex disease with individuals having variable life- expectancies, with 25% dying within 1 year and 41% surviving at least 5 years. While providers recognize that patients are different  and ought to be differently  there are no tools to reliably forecast individual life expectancy and aid in treatment individualization. Instead, providers are left with often unclear or incomplete guidelines on how best to manage patients. In order to provide precision care for patients on hemodialysis (HD), there is a critical need to be able to (1) dynamically assess life expectancy for medical decision-making; and (2) identify distinct clinical phenotypes to enhance clinical monitoring and care planning. Our central hypothesis is that there is heterogeneity in patient survivorship and disease trajectory that, when known, can be used to provide more personalized and effective care. By coupling novel machine learning approaches for survival prediction with granular clinical data on HD patients, we will be able to develop the analytic tools necessary to support precision care. At the completion of this proposal we will have tools to dynamically assess a patient's life expectancy and insights into heterogeneous disease phenotypes for patients with ESKD. These tools will allow providers to make informed treatment decisions as well as lay the groundwork for further precision research into optimized patient care. NARRATIVE End stage kidney disease (ESKD) is a complex disease with individuals having variable life- expectancies. However, there are no tools to reliably forecast individual life expectancy. In this proposal we will develop an analytic framework for predicting patient life-expectancy allowing for the personalized study and and ultimately treatment of individuals with ESKD.",Predictive Analytics in Hemodialysis: Enabling Precision Care for Patient with ESKD,10050938,R01DK123062,"['Clinical Research ', ' Clinical Study ', ' Cessation of life ', ' Death ', ' Decision Making ', ' Dialysis procedure ', ' Dialysis ', ' dialysis therapy ', ' Disease ', ' Disorder ', ' Future ', ' Patient Care ', ' Patient Care Delivery ', ' Health ', ' Hemodialysis ', ' Hemodialyses ', ' hemodynamics ', ' Heterogeneity ', ' Hospitalization ', ' Hospital Admission ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Hypotension ', ' Low Blood Pressure ', ' Vascular Hypotensive Disorder ', ' Infection ', ' Laboratories ', ' Life Expectancy ', ' Longevity ', ' Length of Life ', ' life span ', ' lifespan ', ' Methods ', ' mortality ', ' Patients ', ' Phenotype ', ' outcome forecast ', ' Prognosis ', ' Research ', ' Risk ', ' Supervision ', ' survivorship ', ' Testing ', ' Time ', ' Translations ', ' Transplantation ', ' transplant ', ' Weight Gain ', ' Weight Increase ', ' body weight gain ', ' body weight increase ', ' wt gain ', ' Work ', ' Risk Assessment ', ' Caring ', ' Nutritional Deficiency ', ' Undernutrition ', ' dietary deficiency ', ' malnourished ', ' nutrition deficiency ', ' nutrition deficiency disorder ', ' nutritional deficiency disorder ', ' Malnutrition ', ' Guidelines ', ' base ', ' Left ', ' Chronic ', ' Clinical ', ' Medical ', ' insight ', ' Individual ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Quality-of-Life Assessment ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' Companions ', ' tool ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Life ', ' Complex ', ' Event ', ' System ', ' experience ', ' novel ', ' member ', ' Abscission ', ' Extirpation ', ' Removal ', ' Surgical Removal ', ' resection ', ' Excision ', ' Modeling ', ' Provider ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Preventive ', ' Data ', ' Clinical Data ', ' Clinical Management ', ' Update ', ' Monitor ', ' Cardiac ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' clinical phenotype ', ' disease phenotype ', ' Outcome ', ' prospective ', ' Coupled ', ' Coupling ', ' innovate ', ' innovative ', ' innovation ', ' analytical tool ', ' usability ', ' clinical care ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' clinical decision-making ', ' Precision care ', ' individualized care ', ' individualized patient care ', ' personalized patient care ', ' personalized care ', ' learning activity ', ' learning method ', ' learning strategy ', ' Predictive Analytics ', ' individual patient ', ' Preventative care ', ' Preventive care ', ' individualized clinical decision ', ' individualized decision ', ' personalized clinical decision ', ' personalized data-driven decision ', ' personalized decision ', ' predictive tools ', ' co-morbid symptom ', ' co-occuring symptom ', ' comorbid symptom ', ' concurrent symptom ', ' cooccuring symptom ', ' symptom association ', ' symptom comorbidity ', ' associated symptom ', ' predict survival ', ' predictor of survival ', ' survival prediction ', ' deep learning ', ' ']",NIDDK,DUKE UNIVERSITY,R01,2020,745259,NC-04,0.06602737221417206
"Extracellular Vesicles as a Link Between Placental and Renal Dysfunction in Preeclampsia PROJECT SUMMARY Preeclampsia (PE) is a devastating hypertensive disorder of pregnancy that is a leading cause of maternal and fetal mortality and morbidity worldwide. It affects 2-10% of women and accounts for 16% of maternal deaths related to childbirth in developed countries. PE is difficult to study because it is a multifactorial disorder with varying molecular mechanisms associated with the development of the spectrum of clinical symptoms associated with early onset, late onset, and severe PE. A personalized medicine approach applied to dissecting the underlying mechanisms of PE may be beneficial to reduce clinical incidence of this devastating syndrome. The placenta plays a key role in the development of PE, leading to widespread maternal endothelial dysfunction, hypertension, and systemic multi-organ failure in PE. Extracellular vesicles (EVs) containing protein, RNA, and lipid cargo are continuously extruded from the placenta, and are capable of interacting with maternal organs including the kidney. PE is primarily associated with placental and renal dysfunction, and PE is the most common cause of acute kidney injury during pregnancy. However, no studies have investigated the potential of placenta-derived RNA cargo as a link between placental and renal dysfunction in PE. Urinary EVs are derived from multiple tissue types and represent a trove of biomarkers that are increasingly being utilized to diagnose renal disorders. Further, urine samples can be obtained throughout pregnancy non-invasively and could potentially be utilized to identify biomarkers related to placental dysfunction in PE. In the proposed research, during the mentored phase, cutting-edge RNA-Seq technology coupled with computational biological and machine learning approaches will be applied to profile the transcriptome of urinary EVs in women with PE compared to normal pregnancy. Preliminary data indicates that it is possible to isolate and profile the transcriptome of urinary EVs from maternal urine throughout normal gestation, and that placenta-derived and placenta-specific mRNA and miRNA can be detected within the urinary EV population. This presents a novel technique that has potential to identify biomarkers as well as provide information on placental dysfunction in PE in a non-invasive manner. During the independent phase, the candidate will utilize an in vitro approach to investigate the effect of uptake of placenta-derived EVs with miRNA cargo associated with PE on the function of proximal tubule epithelial cells and cortical collecting duct cells. These two renal-specific cell types are involved in tubular reabsorption in the nephron, a process that is compromised leading to increased excretion of protein in the urine in some preeclamptic pregnancies. This proposal is multidisciplinary, utilizing basic biology, clinical research, and high-performance computing applied to investigating placental dysfunction in PE. These experiments are significant because they will generate novel information on the role of placenta- derived EVs in renal dysfunction in PE, as well as point the way towards preventative and therapeutic targets that may be transformative and clinically relevant. PROJECT NARRATIVE The proposed research will examine the transcriptome of urinary extracellular vesicles obtained non-invasively as a source of placenta-derived nucleic acids reflective of the development of preeclampsia (PE), and will con- duct in vitro experiments to determine the role of placental extracellular vesicles in renal dysfunction in PE.",Extracellular Vesicles as a Link Between Placental and Renal Dysfunction in Preeclampsia,10266768,K99HD096125,"['Affect ', ' Biology ', ' Blood Circulation ', ' Bloodstream ', ' Circulation ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Cells ', ' Cell Body ', ' Chromosomes ', ' Clinical Research ', ' Clinical Study ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Epithelial Cells ', ' Gestational Age ', ' Chronologic Fetal Maturity ', ' Fetal Age ', ' Goals ', ' Human ', ' Modern Man ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Immunohistochemistry ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry Staining Method ', ' In Vitro ', ' Incidence ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Libraries ', ' Lipids ', ' Liver ', ' hepatic body system ', ' hepatic organ system ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Maternal Mortality ', ' maternal death ', ' Mentors ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Nephrons ', ' Uriniferous Tube ', ' Nucleic Acids ', ' Pathology ', ' Placenta ', ' Cells Placenta-Tissue ', ' Normal Placentoma ', ' Placenta Embryonic Tissue ', ' Placentome ', ' Play ', ' Pre-Eclampsia ', ' EPH Gestosis ', ' Preeclampsia ', ' Pregnancy Toxemias ', ' Proteinuria-Edema-Hypertension Gestosis ', ' pregnancy toxemia/hypertension ', ' Pregnancy ', ' Gestation ', ' Proteins ', ' Proteinuria ', ' Research ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' Messenger RNA ', ' mRNA ', ' Role ', ' social role ', ' Stress ', ' Syndrome ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Urine ', ' Urine Urinary System ', ' Woman ', ' Health Care Costs ', ' Health Costs ', ' Healthcare Costs ', ' diverse populations ', ' heterogeneous population ', ' population diversity ', ' Population Heterogeneity ', ' pregnancy disorder ', ' Apoptosis Pathway ', ' Programmed Cell Death ', ' Apoptosis ', ' injuries ', ' Injury ', ' Organ ', ' improved ', ' Clinical ', ' prematurity ', ' premature ', ' Phase ', ' Biological ', ' Link ', ' excretion ', ' Excretory function ', ' Failure ', ' Hypoxic ', ' Oxygen Deficiency ', ' Hypoxia ', ' uptake ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Industrialized Countries ', ' Industrialized Nations ', ' developed country ', ' developed nation ', ' developed nations ', ' Developed Countries ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Tubular ', ' Tubular formation ', ' machine learned ', ' Machine Learning ', ' Source ', ' cell type ', ' Techniques ', ' acute kidney injury ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' stillborn ', ' stillbirth ', ' Cellular injury ', ' cell damage ', ' cellular damage ', ' damage to cells ', ' injury to cells ', ' cell injury ', ' high-end computing ', ' High Performance Computing ', ' novel ', ' Pathogenesis ', ' Sampling ', ' response ', ' Micro RNA ', ' miRNA ', ' miRNAs ', ' MicroRNAs ', ' child birth ', ' Childbirth ', ' preventing ', ' prevent ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Small RNA ', ' Fetal Mortality ', ' Fetal Mortality Statistics ', ' Data ', ' Disease Pathway ', ' Ductal Cell ', ' Ductal Epithelial Cell ', ' Transcript ', ' Pathologic ', ' Characteristics ', ' Molecular ', ' Process ', ' urinary ', ' developmental ', ' Development ', ' early onset ', ' neonatal morbidity ', ' Population ', ' Coupled ', ' innovate ', ' innovative ', ' innovation ', ' transcriptomics ', ' clinical relevance ', ' clinically relevant ', ' multidisciplinary ', ' maternal serum ', ' therapeutic target ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' biorepository ', ' biobank ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' endothelial dysfunction ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' co-morbid symptom ', ' co-occuring symptom ', ' comorbid symptom ', ' concurrent symptom ', ' cooccuring symptom ', ' symptom association ', ' symptom comorbidity ', ' associated symptom ', ' extracellular vesicles ', ' experiment ', ' experimental research ', ' experimental study ', ' Molecular Disease ', ' renal dysfunction ', ' kidney dysfunction ', ' ']",NICHD,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",K99,2020,60858,CA-52,0.0302676147727873
"Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery PROJECT SUMMARY In the United States over 500,000 cardiac surgeries are performed annually. Postoperative acute kidney injury (AKI) occurs in ~20% of cardiac surgical patients. Several cohort and registry studies have reported that AKI defined by rise in serum creatinine after cardiac surgery associates with development of chronic kidney disease and cardiovascular events. However, it is unclear which patients will develop long-term adverse kidney events, adverse cardiovascular events, or both. In recent years blood and urine AKI biomarkers have been identified that reflect different aspects of AKI biology and that detect serum creatinine defined AKI earlier than rise in serum creatinine or detect subclinical AKI that is not revealed by traditional serum creatinine assessment. Clinical outcomes and biomarker research has focused mainly on detecting cardiac surgery- associated AKI itself, but not on predicting which patients are at greatest risk for long-term adverse kidney and cardiovascular outcomes after AKI. The central hypothesis of this proposal is that perioperative blood and urine AKI biomarkers significantly associate with increased long-term (2 to 5 years) postoperative major adverse kidney events (MAKE) and major adverse cardiovascular events (MACE). MAKE is defined as the composite of dialysis, death, renal hospitalization, or  30 day postoperative eGFR decline >25% from preoperative baseline. MACE is defined as the composite of death or hospitalizations for heart failure, myocardial infarction, coronary revascularization, arrhythmia, or stroke. We propose a prospective observational cohort study of 610 patients undergoing cardiac surgery at UT Southwestern Medical Center who will be followed for a minimum of 2 years and up to 5 years following cardiac surgery. Based on preliminary data we will assess plasma NT-pro- B-type natriuretic peptide, plasma intact fibroblast growth factor 23, serum cystatin C, urine TIMP-2*IGFBP7, and urine Kidney Injury Molecule-1 AKI biomarkers preoperatively and at 5 postoperative time points. This proposal will address three specific aims: 1) To determine the association between in-hospital AKI biomarkers and occurrence of MAKE during long-term follow-up; 2) To determine the association between in-hospital AKI biomarkers and occurrence of MACE during long-term follow-up; and 3) To develop clinical prediction models for long-term MAKE and MACE after cardiac surgery. In addition to traditional regression modeling, we will use machine learning that leverages detailed perioperative data including time-varying intraoperative and intensive care unit clinical data and blood and urine AKI biomarker data to create high performing prediction models. Our proposal is significant because knowing what blood and urine AKI biomarkers and clinical parameters accurately predict long-term major adverse kidney and cardiovascular outcomes after cardiac surgery provides the foundation for clinical trials that will identify effective short and long-term interventions for patients at highest risk. Our proposal is innovative because clinical and biomarker data has not been leveraged in this way to predict long-term MAKE and MACE after cardiac surgery. PROJECT NARRATIVE The proposed research is relevant to public health because combining blood and urine acute kidney injury biomarkers and clinical data to identify cardiac surgical patients at highest risk for long-term major adverse kidney and cardiovascular outcomes will allow interventional studies to better individualize clinical management to prevent these outcomes. While acute kidney injury after cardiac surgery is associated with increased long-term adverse kidney and cardiovascular outcomes (~25% incidence), it remains unclear which patients with postoperative acute kidney injury are at highest risk. Thus, the proposed research is relevant to the NIH's mission to develop fundamental knowledge that can be applied to enhancing health, lengthening life, and reducing illness and disability.",Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery,9930135,R01HL148448,"['Anesthesiology ', ' Angiotensin-Converting Enzyme Inhibitors ', ' ACE Inhibitors ', ' Angiotensin I-Converting Enzyme Inhibitors ', ' Angiotensin-Converting Enzyme Antagonists ', ' Kininase II Antagonists ', ' Kininase II Inhibitors ', ' Arrhythmia ', ' Cardiac Arrhythmia ', ' Heart Arrhythmias ', ' Biology ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cardiology ', ' Cardiopulmonary Bypass ', ' Heart-Lung Bypass ', ' heart bypass ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Clinical Informatics ', ' Clinical Trials ', ' Cohort Studies ', ' Concurrent Studies ', ' Creatinine ', ' Cessation of life ', ' Death ', ' Dialysis procedure ', ' Dialysis ', ' dialysis therapy ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Foundations ', ' Foxes ', ' Future ', ' Goals ', ' Grant ', ' Health ', ' Heart failure ', ' cardiac failure ', ' Cardiac Surgery procedures ', ' Cardiac Surgery ', ' Cardiac Surgical Procedures ', ' Heart Surgical Procedures ', ' heart surgery ', ' hemodynamics ', ' Hospitalization ', ' Hospital Admission ', ' Hospitals ', ' Incidence ', ' Information Systems ', ' Data Systems ', ' IT Systems ', ' Information Technology Systems ', ' Intensive Care Units ', ' Intervention Studies ', ' intervention research ', ' interventional research ', ' interventional study ', ' interventions research ', ' Intraoperative Care ', ' Peroperative Care ', ' intra-operative care ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Literature ', ' Methods ', ' Mission ', ' mortality ', ' Myocardial Infarction ', ' Cardiac infarction ', ' Myocardial Infarct ', ' cardiac infarct ', ' coronary attack ', ' coronary infarct ', ' coronary infarction ', ' heart attack ', ' heart infarct ', ' heart infarction ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Nephrology ', ' Patients ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Postoperative Period ', ' Post-Operative ', ' Postoperative ', ' Prospective Studies ', ' Public Health ', ' Publishing ', ' Questionnaires ', ' Angiotensin Receptor ', ' Records ', ' Registries ', ' Regression Analysis ', ' Regression Analyses ', ' Regression Diagnostics ', ' Statistical Regression ', ' Research ', ' Risk ', ' Sensitivity and Specificity ', ' Stroke ', ' Apoplexy ', ' Brain Vascular Accident ', ' Cerebral Stroke ', ' Cerebrovascular Apoplexy ', ' Cerebrovascular Stroke ', ' brain attack ', ' cerebral vascular accident ', ' cerebrovascular accident ', ' Time ', ' United States ', ' Urine ', ' Urine Urinary System ', ' Brain natriuretic peptide ', ' BNP Gene Product ', ' BNP-32 ', ' Brain Natriuretic Peptide-32 ', ' Natriuretic Factor-32 ', ' Nesiritide ', ' Type-B Natriuretic Peptide ', ' brain Natriuretic factor ', ' post gamma-globulins ', ' cystatin C ', ' post-gamma-protein ', ' Measures ', ' base ', ' Transfusion ', ' Clinical ', ' Medical ', ' Blood Serum ', ' Serum ', ' disability ', ' kidney function ', ' Renal function ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' Funding ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Hour ', ' Event ', ' Source ', ' Operative Procedures ', ' Surgical ', ' Surgical Interventions ', ' Surgical Procedure ', ' surgery ', ' Operative Surgical Procedures ', ' Medical center ', ' acute kidney injury ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' cohort ', ' kidney injury molecule 1 ', ' renal KIM-1 ', ' rat KIM-1 protein ', ' novel ', ' health record ', ' Reporting ', ' Modeling ', ' Sampling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' FGF23 gene product ', ' fibroblast growth factor 23 ', ' preventing ', ' prevent ', ' Address ', ' Dose ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' Clinical Data ', ' Clinical Management ', ' enroll ', ' Enrollment ', ' Long-term Follow-up ', ' long-term followup ', ' longterm followup ', ' Longterm Follow-up ', ' Perioperative ', ' Coronary ', ' Cardiac ', ' developmental ', ' Development ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' Computational Science ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' multidisciplinary ', ' high risk ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' biorepository ', ' biobank ', ' cardiac rehab ', ' Cardiac rehabilitation ', ' predictive biomarkers ', ' predictive molecular biomarker ', ' predictive marker ', ' clinically useful biomarkers ', ' clinical biomarkers ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' Prospective cohort study ', ' ']",NHLBI,UT SOUTHWESTERN MEDICAL CENTER,R01,2020,797215,TX-30,0.0957863801598272
"A Machine Learning Alternative to Beamforming to Improve Ultrasound Image Quality for Interventional Access to the Kidney Project Summary  Despite the widespread prevalence of ultrasound imaging in hospitals today, the clinical utility of ultrasound guidance is severely hampered by clutter and reverberation artifacts that obscure structures of interest and com- plicate anatomical measurements. Clutter is particularly problematic in overweight and obese individuals, who account for 78.6 million adults and 12.8 million children in North America. Similarly, interventional procedures of- ten require insertion of one or more metal tools, which generate reverberation artifacts that obfuscate instrument location, orientation, and geometry, while obscuring nearby tissues, thus additionally hampering ultrasound im- age quality. Although artifacts are problematic, ultrasound continues to persist primarily because of its greatest strengths (i.e., mobility, cost, non-ionizing radiation, real-time visualization, and multiplanar views) in comparison to existing image-guidance options, but it would be signicantly more useful without problematic artifacts.  Our long-term project goal is to use state-of-the-art machine learning techniques to provide interventional radiologists with artifact-free ultrasound-based images. We will initially develop a new framework alternative to the ultrasound beamforming process that removes needle tip reverberations and acoustic clutter caused by multipath scattering in near-eld tissues when guiding needles to the kidney to enable removal of painful kidney stones. Our rst aim will test convolutional neural networks (CNNs) that input raw channel data and output human readable images with no artifacts caused by multipath scattering and reverberations. A secondary goal of the CNNs is to learn the minimum number of parameters required to create these new CNN-based images. Our second aim will validate the trained algorithms with ultrasound data from experimental phantom and ex vivo tissue. Our third aim will extend our evaluation to ultrasound images of in vivo porcine kidneys. This work is the rst to propose bypassing the entire beamforming process and replacing it with machine learning and computer vision techniques to remove traditionally problematic noise artifacts and create a fundamentally new type of artifact-free, high-contrast, high-resolution, ultrasound-based image for guiding interventional procedures.  This work combines the expertise of an imaging scientist, a computer scientist, and an interventional ra- diologist to explore an untapped, understudied area that is only recently made feasible through improvements in computing power, advances in computer vision capabilities, and new knowledge about dominant sources of image degradation. Translation to in vivo cases is enabled by our clinical collaboration with the Department of Radiology at the Johns Hopkins Hospital. With support from the NIH Trailblazer Award, our team will be the rst to develop these tools and capabilities to eliminate noise artifacts in interventional ultrasound, opening the door to a new paradigm in ultrasound image formation, which will directly benet millions of patients with clearer, easier-to-interpret ultrasound images. Subsequent R01 funding will customize our innovation to addi- tional application-specic ultrasound procedures (e.g., breast biopsies, cancer detection, autonomous surgery). Project Narrative Artifacts in ultrasound images, specically artifacts caused by multipath scattering and acoustic reverberations (which occur when imaging through the abdominal tissue of overweight and obese patients or visualizing metallic surgical tools), remain as a major clinical challenge. There are no existing solutions to eliminate these artifacts based on today's signal processing techniques. The goal of this project is to step away from conventional signal processing models and instead learn from raw data examples with state-of-the-art machine learning techniques that differentiate artifacts from true signals, and thereby deliver clearer, easier-to-interpret images.",A Machine Learning Alternative to Beamforming to Improve Ultrasound Image Quality for Interventional Access to the Kidney,9913520,R21EB025621,"['Abdomen ', ' Abdominal ', ' Acoustics ', ' Acoustic ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Age ', ' ages ', ' Algorithms ', ' Anatomy ', ' Anatomic ', ' Anatomic Sites ', ' Anatomic structures ', ' Anatomical Sciences ', ' Architecture ', ' Engineering / Architecture ', ' Award ', ' Back ', ' Dorsum ', ' Biopsy ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Computer Vision Systems ', ' computer vision ', ' Computers ', ' Cyst ', ' Diagnosis ', ' Elements ', ' Environment ', ' Fatty Liver ', ' Liver Steatosis ', ' hepatic steatosis ', ' Goals ', ' Hospitals ', ' Human ', ' Modern Man ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Calculi ', ' Kidney Stones ', ' Renal Calculi ', ' Renal Stone ', ' Learning ', ' Liver diseases ', ' Hepatic Disorder ', ' hepatic disease ', ' hepatopathy ', ' liver disorder ', ' Metals ', ' Methods ', ' Methodology ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Needles ', ' Noise ', ' North America ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Pain ', ' Painful ', ' Patients ', ' Nonionizing Radiation ', ' Non-Ionizing Electromagnetic Radiation ', ' Non-Ionizing Radiation ', ' Nonionizing Electromagnetic Radiation ', ' Radiation-Non-Ionizing Total ', ' Radiology Specialty ', ' General Radiology ', ' Radiology ', ' Retroperitoneal Space ', ' Retroperitoneal ', ' Retroperitoneal Cavity ', ' Retroperitoneum ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Surgical Instruments ', ' Family suidae ', ' Pigs ', ' Suidae ', ' Swine ', ' porcine ', ' suid ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Translations ', ' Ultrasonography ', ' Echography ', ' Echotomography ', ' Medical Ultrasound ', ' Ultrasonic Imaging ', ' Ultrasonogram ', ' Ultrasound Diagnosis ', ' Ultrasound Medical Imaging ', ' Ultrasound Test ', ' diagnostic ultrasound ', ' sonogram ', ' sonography ', ' sound measurement ', ' ultrasound ', ' ultrasound imaging ', ' ultrasound scanning ', ' United States ', ' Work ', ' Measures ', ' Morphologic artifacts ', ' Artifacts ', ' Custom ', ' base ', ' improved ', ' Procedures ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Interventional Ultrasound ', ' Interventional Ultrasonography ', ' Evaluation ', ' Training ', ' Individual ', ' Measurement ', ' Funding ', ' radiologist ', ' Collaborations ', ' Imaging Phantoms ', ' tool ', ' instrument ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Scientist ', ' Source ', ' Techniques ', ' Location ', ' Over weight ', ' Overweight ', ' fetal ', ' Operative Procedures ', ' Surgical ', ' Surgical Interventions ', ' Surgical Procedure ', ' surgery ', ' Operative Surgical Procedures ', ' interest ', ' Structure ', ' novel ', ' Abscission ', ' Extirpation ', ' Removal ', ' Surgical Removal ', ' resection ', ' Excision ', ' Bypass ', ' Modeling ', ' Readability ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' intra-operative imaging ', ' intraoperative imaging ', ' surgical imaging ', ' Image-Guided Surgery ', ' Thickness ', ' Thick ', ' Data ', ' Resolution ', ' in vivo ', ' Cancer Detection ', ' Process ', ' Cardiac ', ' imaging ', ' Image ', ' Output ', ' cost ', ' image guided intervention ', ' Prevalence ', ' innovate ', ' innovative ', ' innovation ', ' clinical effect ', ' Network-based ', ' lenses ', ' lens ', ' Geometry ', ' signal processing ', ' image guidance ', ' image guided ', ' Breast biopsy ', ' metallicity ', ' imaging scientist ', ' deep learning ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' machine learned algorithm ', ' machine learning algorithm ', ' Visualization ', ' algorithm training ', ' ']",NIBIB,JOHNS HOPKINS UNIVERSITY,R21,2020,235027,MD-07,0.10676809805586455
"Identifying Personalized Risk of Acute Kidney Injury with Machine Learning PROJECT SUMMARY/ABSTRACT Acute Kidney Injury (AKI) is a common and highly lethal health problem, affecting 10-15% of all hospitalized patients and >50% of patients in intensive care units (ICUs). It has been shown that a small increase in serum creatinine (SCr) of 0.5 mg/dl was associated with a 6.5-fold increase in the odds of death, a 3.5-day increase in length of stay, and nearly $7,500 in excess hospital costs. Unfortunately, no specific treatment exists to cure AKI once it has developed. The ability to predict AKI in hospitalized patients would provide clinicians the opportunity to modify care pathways and implement interventions, which could in turn prevent AKI and yield better outcomes. Although electronic medical record (EMR) based monitoring systems for AKI have led to expedited interventions and may increase the percentage of patients returning to baseline kidney function, most of these systems are reactive rather than proactive, with little or no contribution to AKI prevention. Moreover, our current knowledge of AKI risk factors is far from complete, especially in the ICU and general inpatient populations, characterized by numerous deficiencies and systematic failings that may be avoidable To transform the reactive AKI care to proactive and personalized care, early identification of high risk patients and better understanding of individual modifiable risk factors for AKI is the key. In Aim 1, to discover novel risk factors predictive of AKI, we propose to develop an ensemble multi-view feature selection framework to simultaneously consider the differences and interrelations between feature spaces and obtain robust knowledge by synthesizing findings from diverse patient populations across multiple institutions in nine US states. In Aim 2, to discover general modifiable causes of AKI to help physicians design more effective AKI prevention policies, we propose to develop a novel multi-cause inference method to identify causal relationships between modifiable factors and AKI for susceptible patient subgroups. In Aim 3, to explain what caused AKI in individual patients to support physicians in designing personalized AKI intervention, we propose to develop a new causal explanation method by integrating causal inference and case based reasoning to quantify patient-level causal significance of modifiable factors. The proposed study will have a significant clinical impact by not only expanding the capacity of clinicians to identify high risk patients for AKI early and advancing the general knowledge on causal and modifiable risk factors for AKI but also supporting personalized AKI intervention with suggestions on potential patient-specific actionable items. The work will not only advance AKI but also the machine learning and clinical research informatics community and the methodology developed is generalizable to other clinical domains. PROJECT NARRATIVE The proposed research is to identify clinical risk factors of acute kidney injury (AKI) in hospitalized patients from electronic medical records (EMRs) with machine learning. AKI risk factors discovered from EMR of diverse populations from multiple institutions across nine US states will be reliable and robust and can assist clinicians in providing proactive and personalized care to high-risk patients.",Identifying Personalized Risk of Acute Kidney Injury with Machine Learning,10003227,R01DK116986,"['Affect ', ' Elderly ', ' advanced age ', ' elders ', ' geriatric ', ' late life ', ' later life ', ' older adult ', ' older person ', ' senior citizen ', ' Algorithms ', ' inhibitor/antagonist ', ' inhibitor ', ' Clinical Research ', ' Clinical Study ', ' Communities ', ' Creatinine ', ' Cessation of life ', ' Death ', ' Diabetes Mellitus ', ' diabetes ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Patient Care ', ' Patient Care Delivery ', ' Geographic Locations ', ' Geographic Area ', ' Geographic Region ', ' Geographical Location ', ' geographic site ', ' Health ', ' Hospitals ', ' Incidence ', ' Inpatients ', ' Intensive Care Units ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Learning ', ' Length of Stay ', ' Number of Days in Hospital ', ' hospital days ', ' hospital length of stay ', ' hospital stay ', ' Methods ', ' Methodology ', ' Patients ', ' Physicians ', ' Physiology ', ' Research ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Suggestion ', ' Time ', ' Work ', ' Computerized Medical Record ', ' Electronic Medical Record ', ' Hospital Mortality ', ' In-house Mortalities ', ' Inhospital Mortality ', ' Outcomes Research ', ' diverse populations ', ' heterogeneous population ', ' population diversity ', ' Population Heterogeneity ', ' Risk Assessment ', ' Caring ', ' injury prevention ', ' kidney injury ', ' renal injury ', ' Injury to Kidney ', ' base ', ' improved ', ' Clinical ', ' Series ', ' Hospitalization cost ', ' Hospital Costs ', ' Link ', ' Blood Serum ', ' Serum ', ' kidney function ', ' Renal function ', ' Individual ', ' Policies ', ' Exposure to ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Event ', ' Pattern ', ' System ', ' acute kidney injury ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' Informatics ', ' Nephrotoxic ', ' kidney toxicity ', ' nephrotoxicity ', ' novel ', ' adjudicative process and procedure ', ' adjudication ', ' Predictive Factor ', ' Early identification ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Institution ', ' preventing ', ' prevent ', ' US State ', ' Geographic state ', ' Health system ', ' Data ', ' Clinical Data ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Monitor ', ' Myocardial ', ' pathway ', ' Pathway interactions ', ' designing ', ' design ', ' blood infection ', ' bloodstream infection ', ' Sepsis ', ' Outcome ', ' Population ', ' case-based ', ' modifiable risk ', ' high risk ', ' patient population ', ' clinical risk ', ' clinical predictors ', ' Precision care ', ' individualized care ', ' individualized patient care ', ' personalized patient care ', ' personalized care ', ' individual patient ', ' patient subgroups ', ' patient subpopulations ', ' patient subtypes ', ' patient subsets ', ' high dimensionality ', ' machine learned algorithm ', ' machine learning algorithm ', ' death risk ', ' mortality risk ', ' data heterogeneity ', ' data set heterogeneity ', ' dataset heterogeneity ', ' heterogeneous data ', ' heterogeneous data sets ', ' heterogeneous datasets ', ' heterogenous data sets ', ' heterogenous datasets ', ' heterogenous data ', ' feature selection ', ' ']",NIDDK,UNIVERSITY OF KANSAS MEDICAL CENTER,R01,2020,506170,KS-03,0.10904054565217873
"Development and Validation of Computational Algorithms to Assess Kidney Health in Electronic Health Records Project Summary A key aim of this proposal is to equip the candidate, Dr.Ozrazgat Baslanti, with the necessary protected time and additional training and resources to develop her skillset on quantitative methods and understanding of underlying mechanism of progression of kidney disease and facilitate her transition to an independent translational researcher in health care. The long-term career goal is to become an independent data scientist, with a focus on hospital care for acute disease and complications arising from that care. The overall objective of this application is to build the foundation of the analytical approach for identifying patients health trajectories during episode of acute hospitalization and quantifying the transitions in health states that can be applied to any acute illness. Our central hypothesis is that using kidney health as a paradigm for this approach we can determine individual states of change in kidney health during hospitalization using longitudinal, highly granular temporal data in electronic health records, determine transition probabilities to more severe stages of acute and chronic kidney disease, and improve understanding of the underlying processes influencing these transitions. Current diagnosis and risk evaluation for acute kidney injury (AKI) are focused on determination of severity of AKI episode and an integrated framework for assessing renal recovery does not exist. There is a clear lack of research on estimating transition probabilities among different states of kidney health through nonlinear and non-normal time- dependent domains using longitudinal electronic health records data. The complexity of underlying processes influencing the transition probabilities from renal risk to more severe stages of acute and chronic kidney disease requires application of advanced computational models in sufficiently large and granular datasets. The specific aims of the proposal are: Aim 1- Expand and validate computable phenotypes of kidney health in large-scale medical data. Aim 2- Determine the epidemiology and clinical outcomes of changes in kidney health. Aim 3- Develop and validate probabilistic graphical models to predict transition through the states of kidney health and identify risk factors for progression. The proposed research is significant as we will have phenotyping algorithms of kidney health, validated in multi-center study, that can enhance their inter-institutional sharing and that enable to study epidemiology and outcomes of changes in kidney health. The approach is innovative because it implements technological advances in data science and statistics in innovative steps to develop and validate a phenotyping algorithm that determines computable phenotypes of changes in kidney health and graphical models to predict transition through the states of kidney health through nonlinear and non-normal time- dependent domains using highly granular electronic health records. This will provide foundation for changes in the care of patients with AKI, through identification of those patients at risk of developing AKI and progressing to acute and chronic kidney disease. On completion of the proposed investigations the deliverables will be new knowledge and a diagnosis and prognostication tool for kidney health. Project Narrative Acute kidney injury (AKI) is one of the most common complication among hospitalized patients and is central to the subsequent development of chronic kidney disease and increased mortality. Besides the severity of an initial episode of acute kidney injury, the timing and duration of renal recovery are required to characterize the natural history of this complex condition and its effect on overall kidney health. Thus, the proposed research is relevant to the part of NIHs mission that pertains to developing fundamental knowledge that will help to enhance health, since our research may provide diagnosis and prediction tools for changes in kidney health using electronic records data that contain wealth of clinical data that could be used to identify all dimensions of AKI episode as well as key determinants of undesired outcomes.",Development and Validation of Computational Algorithms to Assess Kidney Health in Electronic Health Records,9891542,K01DK120784,"['Acute Disease ', ' acute disease/disorder ', ' acute disorder ', ' Algorithms ', ' Award ', ' Complication ', ' Decision Making ', ' Diagnosis ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Foundations ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Health ', ' Hospitalization ', ' Hospital Admission ', ' Hospitals ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Mentors ', ' Methods ', ' Mission ', ' mortality ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Patients ', ' Phenotype ', ' Probability ', ' Records ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' statistics ', ' Testing ', ' Time ', ' Training Programs ', ' Treatment Protocols ', ' Treatment Regimen ', ' Treatment Schedule ', ' health care ', ' Healthcare ', ' Dataset ', ' Data Set ', ' Caring ', ' Guidelines ', ' Natural History ', ' base ', ' career ', ' improved ', ' Acute ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Medical ', ' Series ', ' Evaluation ', ' Training ', ' kidney function ', ' Renal function ', ' Individual ', ' Recovery ', ' Multi-center studies ', ' Multicenter Studies ', ' tool ', ' Knowledge ', ' Investigation ', ' Dimensions ', ' Severities ', ' Complex ', ' acute kidney injury ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' adjudicative process and procedure ', ' adjudication ', ' Admission ', ' Admission activity ', ' Modeling ', ' Data ', ' Clinical Data ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Validation ', ' Process ', ' developmental ', ' Development ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' computer algorithm ', ' Computational algorithm ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' adverse consequence ', ' adverse outcome ', ' prognostic tool ', ' inter-institutional ', ' Data Science ', ' improved outcome ', ' Preventative therapy ', ' Preventive therapy ', ' translational investigator ', ' translational researcher ', ' translational scientist ', ' Data Banks ', ' Databanks ', ' data depository ', ' data repository ', ' data warehouse ', ' Data Scientist ', ' Bayesian Network ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' acute care ', ' phenotyping algorithm ', ' statistical and machine learning ', ' computable phenotypes ', ' machine learning method ', ' ']",NIDDK,UNIVERSITY OF FLORIDA,K01,2020,130488,FL-03,0.2282208421977275
"Refining repeat screening for coronary artery disease in kidney transplant candidates 7. Project Summary This K23 proposal will provide Xingxing S. Cheng, MD, MS with the protected time, mentorship, training, and research experience to become an independent clinical investigator. Dr. Cheng is a board-certified nephrologist and accredited transplant nephrologist, with a long-term vision of improving the effectiveness of health care for kidney transplant patients. She seeks to combine patient-oriented research and decision science to find innovative solutions to clinical problems. Skills she will acquire in this grant, under the guidance of a strong mentorship team, include 1) integration of patient-oriented research and decision analytic models; 2) assessing the heterogeneity of response in different patient subgroups; and 3) advanced modelling skills. This grant proposes to refine the process of screening of coronary artery disease in patients with chronic kidney disease on the wait-list awaiting kidney transplantation. Currently, patients undergo repeat cardiac screening tests at frequent intervals, few of which result in interventions. These tests impose a high treatment burden on patients and potentially delay time to transplant, while bringing unclear benefit to the patient. This grant proposes to refine the cardiac screening strategy and personalize it for specific patient subgroups (e.g. elderly patients with diabetes mellitus). It will examine strategies that vary the frequency of cardiac testing and risk stratification for cardiac testing based on a simple, inexpensive, and non-invasive test that can be performed in routine clinical settings, a 6-minute walk test (6MWT). This project will achieve this broad aim by three specific aims: 1) to characterize the 6MWT in identifying low-risk patients who do not additional cardiac testing; 2) to model strategies varying the frequency of cardiac testing and use of 6MWT; 3) to design strategies personalized for specific patient subgroups and model them in the entire kidney transplant candidate population of the United States (US). The first two aims will arise from a well-characterized cohort of patients at Dr. Chengs institution. Machine-learning systems will be used to identify which patient subgroups are best served by which strategies (i.e. the heterogeneity of response). The third aim will leverage the US Renal Data System, which Dr. Chengs mentors and institution has a track record of leveraging for innovative research. The proposed work has high potential to make a significant clinical impact. Its completion will enable the identification and characterization of rational strategies for pre-transplant screening of coronary artery disease that may be incorporated into clinical practice or pave the way for a future multi-center comparative effectiveness trial. The proposed work is realistic and feasible within the award period, and will allow Dr. Cheng to build research skills, advance and disseminate scientific knowledge, create additional collaborative networks, and compete for R01 or equivalent funding. In summary, the K23 award will provide the support to enable Dr. Cheng to become a successful independent clinical investigator. 8. Project Narrative Currently, patients on the kidney transplant waitlist undergo repeat cardiac screening tests at frequent intervals, but relatively few interventions result. This project proposes to refine the cardiac screening strategy and personalize it for specific patient subgroups (e.g. elderly patients without diabetes mellitus), by examining strategies that reduce the frequency of cardiac testing and use performance-based risk stratification to reduce the number of patients who need cardiac testing. If successful, this project will reduce the cardiac testing burden and facilitate activation for transplant for patients on the kidney transplant waitlist.",Refining repeat screening for coronary artery disease in kidney transplant candidates,9871208,K23DK123410,"['Specificity ', ' Testing ', ' Time ', ' Transplantation ', ' transplant ', ' United States ', ' Vision ', ' Sight ', ' visual function ', ' Waiting Lists ', ' waitlist ', ' Work ', ' Measures ', ' Quality-Adjusted Life Years ', ' QALY ', ' Quality-Adjusted Life Expectancy ', ' Walking ', ' health care ', ' Healthcare ', ' Caring ', ' Guidelines ', ' analytical method ', ' base ', ' career ', ' improved ', ' Clinical ', ' Phase ', ' Evaluation ', ' Training ', ' Funding ', ' machine learned ', ' Machine Learning ', ' transplant patient ', ' Transplant Recipients ', ' Knowledge ', ' Frequencies ', ' Event ', ' System ', ' Cardiopulmonary ', ' experience ', ' Performance ', ' cohort ', ' skills ', ' Interventional trial ', ' Intervention Trial ', ' Modeling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' patient oriented study ', ' patient oriented research ', ' Institution ', ' Effectiveness ', ' fitness ', ' K23 Award ', ' K23 Mechanism ', ' K23 Program ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' Mentored Patient-Oriented Research Career Development Award ', ' Sum ', ' Characteristics ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Cardiac ', ' cost ', ' designing ', ' design ', ' elderly patient ', ' older patient ', ' Outcome ', ' Population ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' high risk ', ' clinical practice ', ' clinical risk ', ' screening ', ' prognostic ability ', ' prognostic power ', ' prognostic utility ', ' prognostic value ', ' individualized strategies ', ' personalized strategies ', ' Physical Performance ', ' patient subgroups ', ' patient subpopulations ', ' patient subtypes ', ' patient subsets ', ' relative effectiveness ', ' Risk stratification ', ' recruit ', ' Wait Time ', ' predictive assay ', ' predictive test ', ' comparative effectiveness trial ', ' Accreditation ', ' Age ', ' ages ', ' Award ', ' Clinical Investigator ', ' Coronary Arteriosclerosis ', ' Coronary Artery Disease ', ' Coronary Artery Disorder ', ' Coronary Atherosclerosis ', ' atherosclerotic coronary disease ', ' coronary arterial disease ', ' Diabetes Mellitus ', ' diabetes ', ' Eligibility Determination ', ' Eligibility ', ' Protocol Screening ', ' Future ', ' Goals ', ' Grant ', ' Heterogeneity ', ' Hybrids ', ' Information Systems ', ' Data Systems ', ' IT Systems ', ' Information Technology Systems ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Kidney Transplantation ', ' Kidney Grafting ', ' Kidney Transplants ', ' Renal Grafting ', ' Renal Transplantation ', ' Renal Transplants ', ' kidney tx ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Mentors ', ' Mentorship ', ' Patients ', ' Research ', ' Risk ', ' Risk Factors ', ' Science ', ' ']",NIDDK,STANFORD UNIVERSITY,K23,2020,166536,CA-18,0.0278042327543747
"Enhanced Diagnosis of Antibody-Mediated Kidney Rejection by Machine Learning and Hybrid Targeted-Shotgun Proteomics Kidney transplantation offers the best quality of life for patients with chronic kidney failure. Antibody and T-cell mediated rejection (ABMR and TCMR) are key factors that determine graft survival. Currently, the diagnosis and differential diagnosis of rejection relies on histopathologic examination which has known limitations such as subjective interpretations, limited reproducibility, and the need for expert transplant pathologists. There is an unmet need to develop more specific and quantitative molecular tests that can complement and enhance conventional histologic assessment. Among the molecular assays, proteome profiling is more attractive than genomic and transcriptomic profiling which are subjected to numerous post-translational and epigenetic regulatory mechanisms. Moreover, morphologic changes form the basis of classifying different allograft diseases. Therefore, the transplant community needs to invest in biopsy-based assays in addition to the blood/urine-based assays that are being developed by others. This study is aimed to fully map the proteomic changes in routinely processed formalin fixed paraffin embedded (FFPE) biopsies using a liquid chromatographytandem mass spectrometry (LC-MS/MS) platform. To meet the needs of personalized medicine, this platform uses a novel strategy and machine learning to simultaneously measure the absolute expression levels of a panel of targeted biomarkers as well as thousands of untargeted proteins. The central hypothesis is that LC-MS/MS can be used to define disease-specific biomarkers using a discovery data set, which can then be followed up by a validation data set to determine if LC-MS/MS based tests can be implemented in clinical practice. In the current project, we will focus on developing molecular assays for ABMR since antibody contributes to graft loss in 60% of patients. Two Aims are proposed. In Aim #1, quantitative proteomic strategies will be used to map proteome-level changes in a discovery set of biopsies with ABMR and its mimics, such as acute tubular injury (ATI), TCMR, BK virus nephropathy (BKVN), interstitial fibrosis/tubular atrophy (IFTA), and stable renal function (STA). The goal is to identify potential protein biomarkers that can distinguish ABMR from its mimics. In Aim #2, the potential ABMR biomarkers obtained in Aim #1 will be validated and optimized in an independent validation data set. Using a hybrid proteomic platform combing targeted, shotgun proteomics and machine learning, information on absolute quantitation of potential protein biomarkers and thousands of other proteins will be collected to build a kidney transplant Protein Atlas for assay development. Successful completion of this study has great potential to be translated into clinical tests that will enhance the diagnosis of ABMR from other diseases that can mimic that pathology. It will also serve as a model for developing a new generation of clincal diagnositc tests that will use routinely fixed biopsy materials. This will eliminate the need for intense biobanking efforts, which have hampered the more widespread implementation of molecular diagnostics into the transplant clinic. PROJECT NARRATIVE This research is aimed at devising more accurate and reliable tests for diagnosing rejection of transplanted kidneys. Better tests will lead to more effective treatment, prolong graft life, and improve the quality of life for patients with chronic kidney failure.",Enhanced Diagnosis of Antibody-Mediated Kidney Rejection by Machine Learning and Hybrid Targeted-Shotgun Proteomics,10055012,R21AI148776,"['Algorithms ', ' Amino Acids ', ' aminoacid ', ' Antibodies ', ' Atlases ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biopsy ', ' BK Virus ', ' BK Polyomavirus ', ' BKV virus ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cell Culture Techniques ', ' cell culture ', ' Cell physiology ', ' Cell Function ', ' Cell Process ', ' Cellular Function ', ' Cellular Physiology ', ' Cellular Process ', ' Subcellular Process ', ' Liquid Chromatography ', ' Communities ', ' Complement ', ' Complement Proteins ', ' Diagnosis ', ' Differential Diagnosis ', ' Disease ', ' Disorder ', ' Fibrosis ', ' Goals ', ' Gold ', ' Graft Rejection ', ' Transplant Rejection ', ' Transplantation Rejection ', ' Graft Survival ', ' Histology ', ' Hybrids ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Kidney Transplantation ', ' Kidney Grafting ', ' Kidney Transplants ', ' Renal Grafting ', ' Renal Transplantation ', ' Renal Transplants ', ' kidney tx ', ' Longevity ', ' Length of Life ', ' life span ', ' lifespan ', ' Maps ', ' Methods ', ' Nucleic Acids ', ' Pathology ', ' Patients ', ' Phenotype ', ' outcome forecast ', ' Prognosis ', ' Proteins ', ' Quality of life ', ' QOL ', ' Research ', ' Risk ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' Messenger RNA ', ' mRNA ', ' Running ', ' Sensitivity and Specificity ', ' Shotguns ', ' shot gun ', ' Survival Rate ', ' T-Lymphocyte ', ' T-Cells ', ' thymus derived lymphocyte ', ' Technology ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Transplantation ', ' transplant ', ' Urine ', ' Urine Urinary System ', ' complement C4d ', ' C 4d ', ' C4d ', ' complement 4d ', ' Generations ', ' Measures ', ' Tissue Embedding ', ' Paraffin Embedding ', ' Diagnostic tests ', ' Mediating ', ' Dataset ', ' Data Set ', ' Caring ', ' injuries ', ' Injury ', ' base ', ' Label ', ' improved ', ' Procedures ', ' Acute ', ' Clinical ', ' Diffuse ', ' Histologically ', ' Histologic ', ' Lesion ', ' kidney function ', ' Renal function ', ' clinical Diagnosis ', ' Tubular ', ' Tubular formation ', ' Morphology ', ' Inflammatory ', ' Atrophy ', ' Atrophic ', ' Pathologist ', ' Diagnostic ', ' Combs ', ' Comb animal structure ', ' machine learned ', ' Machine Learning ', ' Life ', ' Clinic ', ' Reaction ', ' Techniques ', ' Allografting ', ' interstitial ', ' Performance ', ' synthetic peptide ', ' tandem mass spectrometry ', ' knowledgebase ', ' knowledge base ', ' novel ', ' Reporting ', ' Proteome ', ' Molecular Diagnostic Testing ', ' Modeling ', ' Sampling ', ' assay development ', ' Proteomics ', ' RNA analysis ', ' Genomics ', ' Formalin ', ' Bio-Informatics ', ' Bioinformatics ', ' protein expression ', ' Stable Isotope Labeling ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Tissue Sample ', ' Address ', ' Data ', ' Protein Analysis ', ' Reproducibility ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Validation ', ' Monitor ', ' Molecular ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' pathway ', ' Pathway interactions ', ' cost ', ' burden of disease ', ' disease burden ', ' years of life lost to disability ', ' years of life lost to disease ', ' burden of illness ', ' designing ', ' design ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' transcriptomics ', ' noninvasive monitor ', ' non-invasive monitor ', ' candidate biomarker ', ' candidate marker ', ' effective treatment ', ' effective therapy ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' clinical practice ', ' biorepository ', ' biobank ', ' screening ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' differentially expressed ', ' transcriptional differences ', ' differential expression ', ' Data Discovery ', ' targeted biomarker ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' marker panel ', ' biomarker panel ', ' biomarker discovery ', ' specific biomarkers ', ' protein markers ', ' protein biomarkers ', ' histopathologic examination ', ' histopathological examination ', ' histological samples ', ' histology samples ', ' histology specimens ', ' histological specimens ', ' molecular diagnostics ', ' proteomic signature ', ' preservation ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NIAID,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R21,2020,234008,PA-18,0.1414705071847124
"A Deep Learning Model to Improve Pathologist Interpretation of Donor Kidney Biopsies ABSTRACT More people die every year from kidney disease than breast or prostate cancer. Kidney transplantation is life-saving, yet the donor organ shortage and high organ discard rate contributes to 13 deaths daily among patients awaiting transplant. The decision to use or discard a donor kidney relies heavily on microscopic quantitation of chronic damage by pathologists. The current standard of care relies on a manual process that is subject to significant human variability and inefficiency, resulting in potentially healthy kidneys being discarded and potentially damaged kidneys being transplanted inappropriately. Our team developed the first Deep Learning model to quantify percent global glomerulosclerosis in donor kidney frozen section biopsy whole slide images. We developed a cloud-based platform to apply the Deep Learning model to analyze kidney biopsy whole slide images in under 6 minutes with accuracy and precision equal to or greater than current standard of care pathologists. We have also developed a Deep Learning model to quantify interstitial fibrosis on donor kidney biopsy whole slide images. This innovative approach has the potential to transform donor kidney biopsy evaluation by improving pathologist efficiency, accuracy, and precision ultimately resulting in optimized donor organ utilization, improved patient outcomes, and diminished health care costs. The goal of this project is to establish our Deep Learning automated techniques as the standard for evaluating donor kidneys prior to transplantation. This will be achieved by assembling a team of expert pathologists and computer scientists specializing in machine learning. The proposal will evaluate the accuracy and precision of the interstitial fibrosis Deep Learning model, use the automated quantitation of key microscopic findings to develop an outcome-based chronic damage score that predicts graft outcome, and test the ability of the Deep Learning models to withstand variations encountered using different scanners and processing in different laboratories. The functionality of the Trusted Kidney software platform will be improved beyond the current usable product into a commercially viable solution for multiple laboratories. PUBLIC HEALTH RELEVANCE STATEMENT Before kidneys can be transplanted, they must be examined using a microscope to ensure the kidney is healthy enough for transplant. A limitation of microscopic examination by pathologists is the inherent human variability in quantifying the amount of scar tissue, or chronic damage, present. The result is potentially healthy organs being discarded or damaged kidneys being used inappropriately. This funding will support developing artificial intelligence tools to assist pathologists with quantifying scar tissue in donor kidneys prior to transplantation, resulting in more consistent and objective biopsy evaluations, minimizing discard of potentially healthy kidneys, and optimizing placement of kidneys for transplant.",A Deep Learning Model to Improve Pathologist Interpretation of Donor Kidney Biopsies,10138826,R42DK120253,"['Personal Satisfaction ', ' well-being ', ' wellbeing ', ' Reproducibility of Results ', ' Reproducibility of Findings ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Savings ', ' Computer software ', ' Software ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Transplantation ', ' transplant ', ' Universities ', ' Washington ', ' Work ', ' Trichrome stain ', ' Health Care Costs ', ' Health Costs ', ' Healthcare Costs ', ' Specialist ', ' base ', ' glomerular sclerosis ', ' glomerulosclerosis ', ' image processing ', ' Organ ', ' Microscope ', ' improved ', ' Chronic ', ' Clinical ', ' Microscopic ', ' Phase ', ' Variation ', ' Variant ', ' Ensure ', ' Evaluation ', ' Trust ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' Funding ', ' Letters ', ' Contracting Opportunities ', ' Contracts ', ' Pathologist ', ' tool ', ' machine learned ', ' Machine Learning ', ' Malignant Tumor of the Prostate ', ' Malignant prostatic tumor ', ' Prostate CA ', ' Prostate Cancer ', ' Prostatic Cancer ', ' Malignant neoplasm of prostate ', ' Knowledge ', ' Life ', ' Scientist ', ' Scanning ', ' Slide ', ' Techniques ', ' System ', ' Services ', ' interstitial ', ' Performance ', ' Speed ', ' technological innovation ', ' Modeling ', ' Trichrome ', ' Trichrome stain method ', ' Data ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' STTR ', ' Small Business Technology Transfer Research ', ' Process ', ' developmental ', ' Development ', ' cost ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' UNOS ', ' United Network for Organ Sharing ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' analytical tool ', ' function improvement ', ' functional improvement ', ' commercial application ', ' public health relevance ', ' standard of care ', ' Phase I Study ', ' phase 1 study ', ' Secure ', ' cloud based ', ' imaging marker ', ' imaging-based biological marker ', ' imaging-based biomarker ', ' imaging-based marker ', ' imaging biomarker ', ' learning activity ', ' learning method ', ' learning strategy ', ' clinically useful biomarkers ', ' clinical biomarkers ', ' cloud server ', ' cloud platform ', ' whole slide imaging ', ' pathology imaging ', ' deep learning ', ' renal biopsy ', ' kidney biopsy ', ' damage to kidney ', ' kidney damage ', ' renal damage ', ' FHIR ', ' Fast Healthcare Interoperability Resources ', ' shared data base ', ' shared database ', ' Adoption ', ' Americas ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Biopsy ', ' malignant breast neoplasm ', ' Breast Cancer ', ' malignant breast tumor ', ' Canada ', ' Cicatrix ', ' Scars ', ' Computers ', ' Cessation of life ', ' Death ', ' Fibrosis ', ' Frozen Sections ', ' Freeze Sectioning ', ' Goals ', ' Gold ', ' Graft Survival ', ' Human ', ' Modern Man ', ' Interobserver Variability ', ' Inter-Observer Variability ', ' Inter-Observer Variation ', ' Interobserver Variations ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Kidney Transplantation ', ' Kidney Grafting ', ' Kidney Transplants ', ' Renal Grafting ', ' Renal Transplantation ', ' Renal Transplants ', ' kidney tx ', ' Laboratories ', ' Manuals ', ' Midwestern United States ', ' Midwest ', ' Midwest U.S. ', ' Midwest US ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Online Systems ', ' On-Line Systems ', ' online computer ', ' web based ', ' Organ Donor ', ' Organ Procurements ', ' Pathology ', ' Patients ', ' ']",NIDDK,"NEWVENTUREIQ, LLC",R42,2020,811695,MO-01,0.19098004809758348
"Low- and Zero-dose Contrast-enhanced MRI Using Deep Learning Project Summary Motivation: Gadolinium-based contrast agents (GBCAs) are used in approximately a third of all MRI scans. The unique relaxation parameters of GBCAs create indispensable image contrast for a wide range of clinical applications, such as angiography and tumor detection. However, the usage of GBCAs has been linked to the development of nephrogenic systemic fibrosis (NSF). NSF can be painful, cause severe disability, and even death. The risk of developing NSF prevents millions of patients with advanced chronic kidney disease (CKD) from receiving contrast-enhanced MRI exams. The recent identification of gadolinium deposition within the brain and body has raised additional safety concerns about the usage of GBCAs. Studies have demonstrated increased signal intensity on the unenhanced T1-weighted MR images that is correlated with previous GBCA exposure, and this gadolinium retention is independent of renal function. While initial reports focused on linear GBCAs, more recent reports show that gadolinium deposition occurs with macrocyclic GBCAs as well, albeit at lower levels. FDA has recently issued warnings about gadolinium retention following contrast-enhanced MRI, and required GBCA manufacturers to conduct human and animal studies to further assess the safety of these contrast agents. This project addresses these concerns by developing low-dose and zero-dose contrast-enhanced MRI using artificial intelligence (AI) and deep learning (DL). Approach: This fast-track project has two phases and three aims. Aim 1 (Phase I) is to develop a DL method that can synthesize full-dose contrast-enhanced MR images using pre-contrast images and contrast-enhanced images acquired with only 10% of standard GBCA dose. A software infrastructure will be constructed to seamlessly integrate the DL software between MR scanners and PACS. Aim 2 (Phase II) is to develop a DL method that can synthesize full-dose contrast-enhanced MR images using GBCA-free acquisitions with different image contrast. In Aim 3 (Phase II), we will clinically validate and evaluate both low-dose and zero-dose DL methods, including on patients with mild- to-moderate CKD. Non-inferiority tests and diagnostic performance of the synthesized full-dose images compared to the true full-dose images will be performed. Significance: This work will lead to safer contrast-enhanced MRI. The low-dose and zero-dose contrast-enhanced MRI method will benefit not only millions of patients with advanced CKD, who cannot currently undergo contrast-enhanced MRI, but many more patients with normal kidney function, who are at the risk of gadolinium retention after contrast-enhanced MRI. Project Narrative Gadolinium-based contrast agents (GBCAs) are widely used in MRI exams to create indispensable image contrast for monitoring treatment and investigating pathology and function. However, the usage of GBCAs has been linked to the development of nephrogenic systemic fibrosis, preventing patients with advanced chronic kidney disease from receiving contrast-enhanced MRI exams, as well as potential gadolinium deposition in the body and brain for patients with normal kidney function. This project aims to address these problems by developing and validating low-dose and zero-dose contrast-enhanced MRI using deep learning.",Low- and Zero-dose Contrast-enhanced MRI Using Deep Learning,10140491,R44EB027560,"['Affect ', ' Angiography ', ' Angiogram ', ' angiographic imaging ', ' Animals ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Clinical Research ', ' Clinical Study ', ' Contrast Media ', ' Contrast Agent ', ' Contrast Drugs ', ' Radiopaque Media ', ' Cessation of life ', ' Death ', ' Gadolinium ', ' Gd element ', ' Goals ', ' Hospitals ', ' Human ', ' Modern Man ', ' Image Enhancement ', ' image reconstruction ', ' image construction ', ' image generation ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Medical Imaging ', ' Methods ', ' Motivation ', ' Pain ', ' Painful ', ' Pathology ', ' Patients ', ' Relaxation ', ' Kidney Failure ', ' Kidney Insufficiency ', ' Renal Failure ', ' Renal Insufficiency ', ' Research ', ' Risk ', ' Safety ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Software Validation ', ' Software Verification ', ' Testing ', ' Work ', ' Dataset ', ' Data Set ', ' base ', ' Clinical ', ' Phase ', ' Link ', ' Evaluation ', ' Training ', ' disability ', ' kidney function ', ' Renal function ', ' Deposit ', ' Deposition ', ' Diagnostic ', ' System ', ' experience ', ' Performance ', ' Reporting ', ' Modeling ', ' develop software ', ' developing computer software ', ' software development ', ' Magnetic Resonance Imaging Scan ', ' MRI Scans ', ' Manufacturer ', ' Manufacturer Name ', ' preventing ', ' prevent ', ' Address ', ' Dose ', ' Detection ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' Monitor ', ' developmental ', ' Development ', ' Health Care Professional ', ' Healthcare professional ', ' Health Professional ', ' imaging ', ' Image ', ' clinical applicability ', ' clinical application ', ' tumor ', ' contrast enhanced ', ' contrast imaging ', ' learning activity ', ' learning method ', ' learning strategy ', ' deep learning ', ' Infrastructure ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' deep learning algorithm ', ' Nephrogenic Systemic Fibrosis  ', ' software infrastructure ', ' ']",NIBIB,"SUBTLE MEDICAL, INC.",R44,2020,742405,CA-18,0.03764938747015583
"Organ Procurement and Information Process Optimization Project Summary: Organ Procurement and Information Process Optimization A recent White House initiative titled Advancing American Kidney Health outlines the current administration's plans to increase the supply of kidneys in the US, along with other measures that attempt to correct the imbalance between supply and demand for kidneys. In alignment with this White House initiative, the principal investigator (PI) of this project will develop algorithms to assist Organ Procurement Organizations (OPOs) make donor disposition decisions with the goal of increasing the supply of transplantable organs. The PI will harness the vast amount of data collected by OPOs, and customize as well as develop new Articial Intelligence (AI) algorithms to identify good donors. These algorithms will reduce case coordinators workload and improve the accuracy of their decisions. The PI's objective is to quantity the impact of AI-assisted decision-making on increasing the supply of kidneys by nding missed opportunities on account of the current manual processes. Even a few more potential donors per OPO will help reduce the organ shortage problem when scaled to all 58 OPOs across the country.  This project will leverage unique data sets to generate and test hypotheses concerning which fac- tors aect donor disposition decisions, and which information processing protocols produce greater referral-to-donor conversion rate. It will also customize classication algorithms to assist case co- ordinators make donor disposition decisions. The focus will be on improving both the accuracy and speed of such decisions. As a follow up of this project, the PI will conduct a broader study involving at least ve additional OPOs. The ve OPOs will be selected to represent the diversity in size, population, and geography among the 58 OPOs across the country. Results of this and the follow-up study will be shared freely with all OPOs. The proposed research has the potential to increase the number of donors, free up sta time, and lower OPO labor costs.  The potential impact of this project lies in the formulation and testing of hypotheses that can benet OPO decision-making and people on transplant wait list, customization of existing machine learning algorithms and computational techniques for sequential decision-making in a novel setting, and laying the groundwork for the development of new methods in the future.  The PI has the necessary disciplinary expertise, and management and leadership experience to succeed in the proposed eorts. He has access to advanced computing resources and administrative help from the University of Texas. Finally, he has obtained the necessary IRB approval to proceed with this project. 1 Project Narrative: Organ Procurement and Information Process Optimization The widespread use of electronic medical record systems by hospitals, and electronic capture of referrals data by the organ procurement organizations (OPOs) makes it possible to harness large amounts of data to augment human decision-making and ask whether this can increase the supply of organs, specically kidneys. The PI in this project will focus on improving the speed and accuracy of case coordinators' donor-disposition decisions by developing and testing customized machine learning and sequential decision-making algorithms using data from two OPOs. These eorts will help quantify the potential benet of leveraging OPO data to increase kidney supply and pave the way for a larger study focusing on multiple OPOs.",Organ Procurement and Information Process Optimization,10042096,R03HS027671,[''],AHRQ,"UNIVERSITY OF TEXAS, AUSTIN",R03,2020,41981,TX-10,0.11741494017867271
"A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles In the United States, 2.8 million people every year seek medical attention for traumatic brain injury (TBI), of which 80% are considered to have a mild TBI (i.e. concussion). Even in those with mild injuries, 10-20% of individuals will suffer long-term disability including seizures and emotional and behavioral issues. One of the primary challenges in TBI care is appropriately classifying this heterogeneous injury and identifying patients at risk for these chronic impairments. Conventional imaging studies, including magnetic resonance imaging (MRI) and computed tomography (CT), are commonly used to classify TBI, but do not reliably capture the full extent of the injury, particularly in those patients with mild injuries. Currently, there are few molecular markers to assist in the assessment of an individual's unique injury and subsequent recovery and biomarkers are desperately needed in the field that correlate with these varied endophenotypes, track the progress of the disease, and predict clinical outcomes. To address this challenge, we propose to develop a microchip-based platform that can be used to characterize TBI and its recovery using the RNA cargo found in brain-derived circulating extracellular vesicles (EVs), including exosomes. Unlike prior work that has mainly focused on single biomarkers, our approach measures a panel of circulating EV miRNA markers processed with machine learning algorithms, to more comprehensively capture the state of the injured and recovering brain. Our proposal combines surface marker-specific nanomagnetic isolation of brain-derived EVs from a variety of cell types, biomarker discovery using RNA sequencing, and machine learning processing of EV miRNA cargo to measure the state of injury and recovery in TBI. Nanoscale exosomes are known to shed from brain cells into the blood stream, carrying with them the molecular signatures that can be used to better diagnose and treat injuries, such as traumatic brain injury. We propose an innovative, clinically practical approach to probe the RNA contained within these nanoscale vesicles to better understand a patient's injury and recovery to better guide treatment. Our rapid and easily multiplexed platform has great potential for non-invasive diagnostics and monitoring of both secondary injury progression and drug efficacy, offers tremendous benefits for patients.",A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles,10019696,R33MH118170,"['Archives ', ' Astrocytes ', ' Astrocytus ', ' Astroglia ', ' astrocytic glia ', ' Axon ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Volume ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Brain Concussion ', ' Cerebral Concussion ', ' Commotio Cerebri ', ' concussion ', ' Calibration ', ' Cell Line ', ' CellLine ', ' Strains Cell Lines ', ' cultured cell line ', ' Classification ', ' Systematics ', ' Color ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Elements ', ' Goals ', ' Gold ', ' Recording of previous events ', ' History ', ' Human ', ' Modern Man ', ' Inflammation ', ' Laboratories ', ' Magnetic Resonance Imaging ', ' MR Imaging ', ' MR Tomography ', ' MRI ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' NMR Imaging ', ' NMR Tomography ', ' Nuclear Magnetic Resonance Imaging ', ' Zeugmatography ', ' Methods ', ' Biological Models ', ' Biologic Models ', ' Model System ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Nucleic Acids ', ' Patients ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Production ', ' outcome forecast ', ' Prognosis ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' RNA Probes ', ' RNA Gene Probes ', ' Seizures ', ' Technology ', ' Testing ', ' Time ', ' X-Ray Computed Tomography ', ' CAT scan ', ' CT X Ray ', ' CT Xray ', ' CT imaging ', ' CT scan ', ' Computed Tomography ', ' Tomodensitometry ', ' X-Ray CAT Scan ', ' X-Ray Computerized Tomography ', ' Xray CAT scan ', ' Xray Computed Tomography ', ' Xray computerized tomography ', ' catscan ', ' computed axial tomography ', ' computer tomography ', ' computerized axial tomography ', ' computerized tomography ', ' United States ', ' Work ', ' Measures ', ' Blinded ', ' Caring ', ' injuries ', ' Injury ', ' base ', ' improved ', ' Surface ', ' Chronic ', ' Clinical ', ' Evaluation ', ' prognostic ', ' disability ', ' Individual ', ' Recovery ', ' non-invasive diagnosis ', ' non-invasive diagnostic ', ' noninvasive diagnostic ', ' noninvasive diagnosis ', ' Acquired brain injury ', ' brain damage ', ' brain-injured ', ' Brain Injuries ', ' Vesicle ', ' Inflammatory ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Severities ', ' Stream ', ' cell type ', ' System ', ' Best Practice Analysis ', ' Benchmarking ', ' innovative technologies ', ' brain cell ', ' Performance ', ' drug efficacy ', ' tech development ', ' technology development ', ' Devices ', ' sorting ', ' Sorting - Cell Movement ', ' Emotional ', ' Modeling ', ' Sampling ', ' nucleic acid detection ', ' Brain Trauma ', ' traumatic brain damage ', ' Traumatic Brain Injury ', ' neuropathology ', ' microchip ', ' Micro RNA ', ' miRNA ', ' miRNAs ', ' MicroRNAs ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' Mobile Phones ', ' Car Phone ', ' Address ', ' Data ', ' Molecular Fingerprinting ', ' molecular profile ', ' molecular signature ', ' Molecular Profiling ', ' Clinical Evaluation ', ' Clinical Testing ', ' clinical test ', ' research clinical testing ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' Brain Swelling ', ' Intracranial Edema ', ' wet brain ', ' Brain Edema ', ' point of care ', ' Behavioral ', ' imaging ', ' Image ', ' nano magnetic ', ' nanomagnetic ', ' injury and repair ', ' cost ', ' injured ', ' digital ', ' Advanced Development ', ' designing ', ' design ', ' next generation ', ' nano meter scale ', ' nano meter sized ', ' nano scale ', ' nanometer scale ', ' nanometer sized ', ' nanoscale ', ' injury response ', ' response to injury ', ' Outcome ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' Impairment ', ' endophenotype ', ' murine model ', ' mouse model ', ' medical attention ', ' molecular biomarker ', ' molecular marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' ratiometric ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' precision-based medicine ', ' precision medicine ', ' MTBI ', ' mild TBI ', ' mild brain trauma ', ' mild traumatic brain injury ', ' biomarker discovery ', ' exosome ', ' extracellular vesicles ', ' clinical outcome prediction ', ' predictor of clinical outcome ', ' predict clinical outcome ', ' miRNA biomarkers ', ' miRNA markers ', ' microRNA markers ', ' microRNA biomarkers ', ' imaging study ', ' manufacturability ', ' individualized response ', ' individual response ', ' machine learned algorithm ', ' machine learning algorithm ', ' injury to the vasculature ', ' vascular injury ', ' recovery after injury ', ' recovery following injury ', ' recovery post injury ', ' injury recovery ', ' ']",NIMH,UNIVERSITY OF PENNSYLVANIA,R33,2020,603187,PA-03,0.024048001331914613
"A new approach to predict graft outcome from histology in children undergoing kidney transplantation using machine learning methods Abstract Although the overall renal graft survival has dramatically improved over the last several decades, almost half of pediatric patients lose their transplant within 10 years. Epidemiology, immunology and histology are all key elements in understanding post-transplant complications and in predicting clinical outcomes, however accurate prediction of transplant outcomes remains challenging and understudied among pediatric kidney transplant recipients. Machine learning technology is rapidly advancing and has demonstrated remarkable predictive accuracy surpassing classical predictive models in several biomedical applications. The goal of this research proposal is to develop machine learning methods to improve prediction of transplant outcomes through analysis of histology, assemble data sufficient to describe the incidence of different types of rejection and histological findings on pediatric kidney transplant biopsies, and to assess their impact on graft outcome. To achieve these goals, we will assemble an international multicenter cohort of over 700 pediatric kidney transplant recipients and develop and validate machine-learning models combining clinical, immunological and histological data for predicting short-term pediatric graft outcomes. This study will enable accurate, reproducible, and standardized assessment of histopathological findings in pediatric transplant recipients and provide a new method to predict graft outcome. This will pave the way to future large, prospective study assessing the feasibility and potential impact of machine-learning methods in transplant biopsy analysis, with the goal of improving clinical management and resource utilization by identifying patients with high risk of graft loss. Finally, this study will provide critical information for efficient and effective design of clinical trials focused on improving outcomes of pediatric kidney transplant recipients, with an emphasis on individualized treatment. Project Narrative: Accurate prediction of graft outcome in pediatric kidney transplant patients is critical to individualize patients' management and treatment and to design efficient and effective clinical trials focused on improving outcomes of these patients. Our long-term goal is to improve the assessment of histopathological findings in pediatric transplant recipients and create a new systematic methodology to predict graft outcomes that can be applied nationally and internationally. The goal of this research proposal is to develop machine learning methods to improve prediction of transplant outcomes through analysis of histology, assemble data sufficient to describe the incidence of different types of rejection and histological findings on pediatric kidney transplant biopsies, and to assess their impact on graft outcome.",A new approach to predict graft outcome from histology in children undergoing kidney transplantation using machine learning methods,10007806,R21DK122229,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Antibodies ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Biopsy ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Classification ', ' Systematics ', ' Clinical Trials ', ' Elements ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Europe ', ' Future ', ' Goals ', ' Graft Rejection ', ' Transplant Rejection ', ' Transplantation Rejection ', ' Graft Survival ', ' Histology ', ' Human ', ' Modern Man ', ' Incidence ', ' Interobserver Variability ', ' Inter-Observer Variability ', ' Inter-Observer Variation ', ' Interobserver Variations ', ' Kidney Transplantation ', ' Kidney Grafting ', ' Kidney Transplants ', ' Renal Grafting ', ' Renal Transplantation ', ' Renal Transplants ', ' kidney tx ', ' Manuals ', ' Methods ', ' Methodology ', ' Pathology ', ' Patients ', ' Prospective Studies ', ' Research Proposals ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Standardization ', ' Technology ', ' Time ', ' Transplantation ', ' transplant ', ' United States ', ' Dataset ', ' Data Set ', ' Immunology ', ' base ', ' improved ', ' Acute ', ' Chronic ', ' Clinical ', ' Histologically ', ' Histologic ', ' Kidney Replacement Therapy ', ' Renal Replacement Therapy ', ' pediatric ', ' Childhood ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Therapeutic ', ' Pathologist ', ' machine learned ', ' Machine Learning ', ' transplant patient ', ' Transplant Recipients ', ' programs ', ' Event ', ' Scanning ', ' Techniques ', ' American ', ' cohort ', ' Reporting ', ' Pathology Report ', ' Modeling ', ' depository ', ' repository ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Histologic Grade ', ' Histopathologic Grade ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Address ', ' Data ', ' International ', ' Reproducibility ', ' Clinical Management ', ' Clinical Trials Design ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Risk Estimate ', ' Update ', ' Pathologic ', ' Immunochemical Immunologic ', ' Immunologic ', ' Immunological ', ' Immunologically ', ' Immunologics ', ' Modification ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' digital ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Outcome ', ' Prevalence ', ' multidisciplinary ', ' transplant medicine ', ' transplantation medicine ', ' high risk ', ' risk benefit ratio ', ' allograft rejection ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' child patients ', ' pediatric patients ', ' individualized management ', ' individualized patient management ', ' personalized clinical management ', ' personalized disease management ', ' precision management ', ' personalized management ', ' improved outcome ', ' clinical outcome prediction ', ' predictor of clinical outcome ', ' predict clinical outcome ', ' Retrospective cohort ', ' transplant centers ', ' Infrastructure ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' Pediatric cohort ', ' post-transplantation ', ' posttransplant ', ' posttransplantation ', ' post-transplant ', ' machine learning method ', ' Multi-center clinical study ', ' Multicenter clinical study ', ' Multisite clinical study ', ' Multi-site clinical study ', ' ']",NIDDK,EMORY UNIVERSITY,R21,2020,191618,GA-05,0.11968963525426282
"Prediction of Major Adverse Kidney Events and Recovery (Pred-MAKER) in COVID-19 Patients PROJECT SUMMARY  Major adverse kidney events (MAKE) are common in individuals hospitalized with COVID-19, particularly in the United States. Our data from Mount Sinai show that ~40% of hospitalized patients develop acute kidney injury (AKI); 20% of those need renal replacement therapy, and the mortality rate in patients that experience COVID-19 associated AKI is several-fold greater than patients without AKI. Furthermore, we have seen that the rate of non-recovery is also significantly higher compared to those observed in non-COVID AKI, highlighting the potential long-term effects of SARS-CoV-2-associated kidney damage. We propose to utilize the highly coordinated tissue and biospecimen collection machinery that has been initiated at the Mount Sinai Health System. As the largest hospital system at the epicenter of the crisis, Mount Sinai treated and discharged nearly 10,000 COVID-19 patients and created a central IRB approval and data coordination system under the auspices of the newly formed Mount Sinai COVID Informatics Center. As part of biospecimen and clinical data collation efforts, we have consented and obtained blood, urine or clinically indicated kidney biopsy samples from over 700 patients at the time of admission.  Using these samples, we propose (1) to use a multipronged approach to determine the biomarkers that are associated with MAKE; (2) to develop a machine learning-based predictive algorithm using a combination of multiplexed biomarker expression levels and clinical metrics; and, (3) to determine cellular pathways that are responsible for COVID-associated AKI by combining multiomics interrogation of SARS-CoV-2 positive patient urine and kidney biopsies as well as the time-dependent transcriptomic signatures of in vitro primary proximal tubule cells.  First, our results will have an immediate translational outcome, which will help focus clinical efforts on high risk patients and triage low risk patients quicker. In addition, our proposal will lead to improved understanding of the complex disease mechanisms that cause the unique kidney injury signatures in COVID-19 and may lead to development of novel biomarkers and therapeutics that may prove beneficial during post-COVID clinical care. Our rigorous approach is innovative, and it is supported by established complementary assays. We have assembled an experienced multidisciplinary team encompassing bioengineers, nephrologists, basic scientists, informaticians and virologists that will help improve the understanding of the landscape of kidney outcomes during COVID-19 hospitalizations. PROJECT NARRATIVE  Kidney podocytes play an important role in kidney filtration. In order to perform this key biological function, the podocyte has to maintain a specialized structure that depends on a number of proteins. We identified a previously unknown protein, called nebulette, as a key component of the podocyte filtration machinery, and we propose to test its role in maintenance of the specialized structure of podocytes during health and disease. Our results will improve our understanding of podocyte biology and may identify new drug targets to treat kidney diseases such as diabetic nephropathy.",Prediction of Major Adverse Kidney Events and Recovery (Pred-MAKER) in COVID-19 Patients,10216732,R01DK118222,"['Algorithms ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biomedical Engineering ', ' bio-engineered ', ' bio-engineers ', ' bioengineering ', ' Biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cells ', ' Cell Body ', ' Coca ', ' Erythroxylon ', ' Consultations ', ' Data Collection ', ' Dialysis procedure ', ' Dialysis ', ' dialysis therapy ', ' Discrimination ', ' Cognitive Discrimination ', ' Disease ', ' Disorder ', ' Disease Outbreaks ', ' Outbreaks ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Future ', ' Hospitalization ', ' Hospital Admission ', ' Hospitals ', ' Human ', ' Modern Man ', ' In Vitro ', ' Incidence ', ' Infection ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Long-Term Effects ', ' Longterm Effects ', ' Lung diseases ', ' Pulmonary Diseases ', ' Pulmonary Disorder ', ' Respiratory Disease ', ' Respiratory System Disease ', ' Respiratory System Disorder ', ' disease of the lung ', ' disorder of the lung ', ' lung disorder ', ' Molecular Biology ', ' DNA Molecular Biology ', ' mortality ', ' Nephrology ', ' New York ', ' New York City ', ' Patients ', ' Phenotype ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Proteinuria ', ' Risk ', ' Sampling Studies ', ' Time ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Triage ', ' United States ', ' Urine ', ' Urine Urinary System ', ' Vaccines ', ' virology ', ' Measures ', ' Hospital Mortality ', ' In-house Mortalities ', ' Inhospital Mortality ', ' kidney injury ', ' renal injury ', ' Injury to Kidney ', ' injuries ', ' Injury ', ' base ', ' improved ', ' specimen collection ', ' sample collection ', ' Site ', ' Clinical ', ' Phase ', ' Biological ', ' Logistic Regressions ', ' Kidney Replacement Therapy ', ' Renal Replacement Therapy ', ' Survivors ', ' Coronaviridae ', ' corona virus ', ' Coronavirus ', ' Link ', ' insight ', ' Individual ', ' Recovery ', ' Measurement ', ' Disease Progression ', ' Early Intervention ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Therapeutic ', ' Tubular ', ' Tubular formation ', ' machine learned ', ' Machine Learning ', ' cell biology ', ' Cellular biology ', ' Scientist ', ' Hour ', ' Severities ', ' Complex ', ' Event ', ' In Situ ', ' Techniques ', ' System ', ' acute kidney injury ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' experience ', ' Informatics ', ' Biopsy Sample ', ' Biopsy Specimen ', ' Disease Outcome ', ' Reporting ', ' Admission ', ' Admission activity ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' response ', ' Proteomics ', ' SARS ', ' SARS coronavirus disease ', ' SARS-CoV disease ', ' Severe Acute Respiratory Syndrome CoV disease ', ' Severe Acute Respiratory Syndrome coronavirus disease ', ' Severe Acute Respiratory Syndrome ', ' Visceral Epithelial Cell ', ' glomerular visceral epithelial cell ', ' podocyte ', ' Systems Biology ', ' Health system ', ' Symptoms ', ' Consent ', ' Data ', ' Predictive Value ', ' Clinical Data ', ' Collection ', ' Molecular ', ' urinary ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' transcriptomics ', ' multidisciplinary ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' spatiotemporal ', ' high risk ', ' clinical care ', ' new marker ', ' novel biomarker ', ' novel marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' IRB ', ' IRBs ', ' Institutional Review Boards ', ' Patient Triage ', ' clinical predictors ', ' prognostic ability ', ' prognostic power ', ' prognostic utility ', ' prognostic value ', ' multiomics ', ' multiple omics ', ' stratified patient ', ' patient stratification ', ' marker panel ', ' biomarker panel ', ' biomarker discovery ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' proteomic signature ', ' translational impact ', ' machine learned algorithm ', ' machine learning algorithm ', ' renal biopsy ', ' kidney biopsy ', ' damage to kidney ', ' kidney damage ', ' renal damage ', ' multiple omic data ', ' Multiomic Data ', ' COVID19 ', ' corona virus disease 2019 ', ' coronavirus disease 2019 ', ' COVID-19 ', ' 2019 novel coronavirus ', ' SARS-CoV-2 ', ' SARS-CoV2 ', ' SARS-associated coronavirus 2 ', ' SARS-coronavirus-2 ', ' SARS-related coronavirus 2 ', ' Severe acute respiratory syndrome coronavirus 2 ', ' Wuhan coronavirus ', ' 2019-nCoV ', ' MERS ', ' MERS coronavirus disease ', ' MERS-CoV disease ', ' Middle East Respiratory Syndrome CoV disease ', ' Middle East Respiratory Syndrome coronavirus disease ', ' Middle Eastern Respiratory Syndrome ', ' Middle Eastern Respiratory Syndrome CoV disease ', ' Middle Eastern Respiratory Syndrome coronavirus disease ', ' Middle East Respiratory Syndrome ', ' COVID-19 epidemic ', ' COVID19 epidemic ', ' COVID19 pandemic ', ' corona virus disease 2019 epidemic ', ' corona virus disease 2019 pandemic ', ' coronavirus disease 2019 epidemic ', ' coronavirus disease 2019 pandemic ', ' COVID-19 pandemic ', ' COVID ', ' CoV disease ', ' corona virus disease ', ' coronavirus disease ', ' ']",NIDDK,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2020,468762,NY-13,0.24742058614395326
"Adiposity-obesity-related subgroups discovery and metabolomics analysis for chronic kidney disease Project Summary Chronic kidney disease (CKD) is prevalent in the U.S. population and is a major cause of end-stage renal disease (ESRD), cardiovascular disease morbidity, and mortality. Current gaps exist in characterizing the heterogeneity of CKD population. Obesity further increases the risks of adverse outcomes among people with impaired kidney function. However, the mechanism between obesity and CKD is not fully understood, and numerous studies have observed obesity paradox or survival advantage being associated with higher body fat among advanced CKD patients. In this context, the Chronic Renal Insufficiency Cohort (CRIC) Study provides an ideal opportunity to study the mechanism of CKD with its rich clinical information and population characteristics, as well as its availability of non-targeted high-dimensional metabolomics data. To better understand the adiposity-obesity-related (AOR) mechanisms of CKD and to discover novel biomarkers, we propose to identify distinct subgroups based on AOR attributes and to perform metabolomics analysis on the identified subgroups and CKD outcomes. The overall goal of this research and the training plan is to execute three studies as the subjects of a doctoral dissertation in metabolomics analysis and CKD epidemiology. First, in Aim 1, we will identify latent AOR subgroups in the CRIC CKD population using the data-driven approach of consensus clustering. We will also evaluate the utility and the independent risk discrimination performance of the AOR subgroups with key CKD outcomes (CKD progression, CVD, and death), using Cox regression model with adjustment for known CKD risk factors. Next, in Aim 2, we will perform metabolomics analysis and identify metabolites and metabolomic patterns that are associated with the different AOR subgroups. In response to the statistical challenges in analyzing the high-dimensional metabolomics data, we will implement both the machine learning random-forest algorithm and the conventional univariate and multivariate regression analysis. Finally, in Aim 3, we will investigate the relationship between CKD outcomes and the metabolites and metabolomic patterns identified in Aim 2, using Cox regression model, extended by pathway analysis and mediation analysis. Mining high-dimensional metabolomics data with AOR phenotypes in the CRIC Study holds promise to expand our knowledge of pathophysiology and molecular characterization of CKD. Future studies can be built upon these findings to improve more effective and personalized CKD management in the setting of the obesity epidemic. A rigorous curriculum including didactic and experiential learning in biomedical data mining, statistics, and advanced epidemiology will round out the applicant's training, preparing her to be an independent and collaborative investigator and a kidney disease epidemiologist at the completion of his PhD. Project Narrative Chronic kidney disease (CKD) and its risk factors of obesity, diabetes, and hypertension are prevalent in the United States. To better understand the mechanism between adiposity-obesity-related CKD mechanism, the proposed research will implement machine learning algorithms, and identify distinct patient subgroups and discover novel CKD biomarkers, using the clinical and high-dimensional metabolomics data from a diverse cohort of CKD patients. The findings of our study hold promise to expand our knowledge of pathophysiology and molecular characterization of CKD, and facilitate personalized disease management.",Adiposity-obesity-related subgroups discovery and metabolomics analysis for chronic kidney disease,9964494,F31DK122683,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Albuminuria ', ' Algorithms ', ' Blood Pressure ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cohort Studies ', ' Concurrent Studies ', ' Educational Curriculum ', ' Curriculum ', ' lesson plans ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Cessation of life ', ' Death ', ' Diabetes Mellitus ', ' diabetes ', ' Discrimination ', ' Cognitive Discrimination ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Fatty acid glycerol esters ', ' Fats ', ' Future ', ' Glomerular Filtration Rate ', ' Glucose ', ' D-Glucose ', ' Dextrose ', ' Goals ', ' Glycosylated hemoglobin A ', ' Glycohemoglobin A ', ' Hb A1 ', ' Hb A1a+b ', ' Hb A1c ', ' HbA1 ', ' HbA1c ', ' Hemoglobin A(1) ', ' hemoglobin A1c ', ' Heterogeneity ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Insulin Resistance ', ' insulin resistant ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Kynurenine ', ' Methods ', ' Mining ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Patients ', ' Phenotype ', ' Population Characteristics ', ' Regression Analysis ', ' Regression Analyses ', ' Regression Diagnostics ', ' Statistical Regression ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Risk Factors ', ' statistics ', ' Tryptophan ', ' L-Tryptophan ', ' Levotryptophan ', ' United States ', ' Weight ', ' Troponin T ', ' tropomyosin binding protein troponin T ', ' Outcome Assessment ', ' base ', ' improved ', ' Clinical ', ' Training ', ' kidney function ', ' Renal function ', ' Measurement ', ' Disease Progression ', ' Cooperative Learning ', ' Experiential Learning ', ' Active Learning ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Metabolic ', ' tool ', ' Body fat ', ' Research Specimen ', ' Specimen ', ' machine learned ', ' Machine Learning ', ' Consensus ', ' Knowledge ', ' Disorder Management ', ' Disease Management ', ' Chronic Renal Insufficiency ', ' Chronic Kidney Insufficiency ', ' Pattern ', ' Techniques ', ' Height ', ' Performance ', ' cohort ', ' Disease Outcome ', ' novel ', ' Negotiating ', ' Negotiation ', ' Mediation ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' response ', ' FGF23 gene product ', ' fibroblast growth factor 23 ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' datamining ', ' data mining ', ' Mediator ', ' Mediator of Activation ', ' Mediator of activation protein ', ' Parathyrin ', ' Parathyroid Hormone ', ' parathormone ', ' PTH gene ', ' Data ', ' Ph.D. ', ' PhD ', ' Doctor of Philosophy ', ' Research Training ', ' Subgroup ', ' Epidemiologist ', ' Characteristics ', ' Molecular ', ' pathway ', ' Pathway interactions ', ' Population ', ' Impairment ', ' population based ', ' new marker ', ' novel biomarker ', ' novel marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' adverse consequence ', ' adverse outcome ', ' Patient risk ', ' targeted biomarker ', ' individualized management ', ' individualized patient management ', ' personalized clinical management ', ' personalized disease management ', ' precision management ', ' personalized management ', ' patient subgroups ', ' patient subpopulations ', ' patient subtypes ', ' patient subsets ', ' high dimensionality ', ' preservation ', ' random forest ', ' machine learned algorithm ', ' machine learning algorithm ', ' high dimensional data ', ' multidimensional datasets ', ' multidimensional data ', ' Obesity Epidemic ', ' ']",NIDDK,UNIVERSITY OF PENNSYLVANIA,F31,2020,45520,PA-03,0.07815903712809812
"Identifying Healthy and High-Risk Weight Loss Phenotypes to Optimize Obesity Management in End Stage Kidney Disease Project Summary/Abstract  In 2016, 47,000 individuals who initiated dialysis in the United States (~42% of all incident dialysis patients that year) had obesity, with a body mass index (BMI) of  30 kilograms per meters squared. Across the BMI spectrum, individuals with kidney disease commonly lose weight after initiating dialysis treatment. However, whereas body weight typically stabilizes after the first several months of dialysis among patients without obesity, those with obesity often continue to lose weight. Both people with and without obesity who are on dialysis may lose weight due to muscle wasting and malnutrition, and recent studies have identified weight loss as a risk factor for death among people on dialysis, independent of BMI. Yet, some of the weight loss observed among obese dialysis patients may also reflect deliberate attempts to improve health, mobility, or access to kidney transplantation. Currently, there are no guidelines to help clinicians to differentiate between healthy and high-risk weight loss among people with obesity on dialysis. Further, typical obesity management paradigms are not easily transferrable to obese people with end-stage kidney disease, given factors such as chronic malnutrition, inflammation, and sarcopenia in this population that may modify the risks and benefits of different weight loss strategies. Therefore, the overarching goal of this five-year research proposal is to define healthy and high-risk weight loss phenotypes among people with obesity who are on dialysis, and to provide clinically feasible tools to improve obesity management in the setting of end-stage kidney disease. We will accomplish this goal by conducting three distinct but interrelated studies. In the first study, we will qualitatively determine patient-prioritized endpoints of weight loss, in addition to patient, physician and other stakeholder perspectives on the key factors that differentiate healthy from high-risk weight loss on dialysis. In the second study, we will leverage a national dataset of 23,000 obese dialysis patients and apply constructs of high and low physiologic reserve to derive healthy and high-risk weight loss phenotypes. We will then develop a weight- loss risk calculator tool that predicts the risks of hospitalization and death that are associated with each weight loss phenotype, using dynamic predictive joint models and machine learning techniques. In the third study, we will enroll 250 obese dialysis patients in a prospective, longitudinal study across five regions in the United States to evaluate the association between nutritional, inflammatory, and hemodynamic biomarkers and measures of health trajectory that are not typically captured in registry data, such as sarcopenia, dynapenia, body composition, and patient-prioritized endpoints such as quality of life. In accomplishing its aims, this research will provide urgently needed knowledge and tools that will improve the medical management of tens of thousands of people with end-stage kidney disease and obesity, ensuring that clinicians will be better able to incorporate patient-prioritized outcomes into assessments of weight loss interventions, and recognize and mitigate the effects of high-risk weight loss. Project Narrative Although over 40,000 obese individuals with end-stage kidney disease initiate dialysis each year in the United States, there are no guidelines on optimal obesity management in the setting of dialysis care. Obese dialysis patients may lose weight due to chronic illness or due to intentional weight loss attempts, though it is difficult to differentiate between healthy and unhealthy weight loss in these patients. This proposal seeks to advance the science of obesity management in dialysis settings by providing new tools to differentiate between healthy and unhealthy weight loss trajectories among obese dialysis patients.",Identifying Healthy and High-Risk Weight Loss Phenotypes to Optimize Obesity Management in End Stage Kidney Disease,9943129,R01DK124388,"['Blood Pressure ', ' Body Composition ', ' Body Weight ', ' Chronic Disease ', ' Chronic Illness ', ' chronic disorder ', ' Confidence Intervals ', ' Cessation of life ', ' Death ', ' Dialysis procedure ', ' Dialysis ', ' dialysis therapy ', ' Foundations ', ' Goals ', ' Health ', ' Health Status ', ' Level of Health ', ' Hemodialysis ', ' Hemodialyses ', ' hemodynamics ', ' Hospitalization ', ' Hospital Admission ', ' Inflammation ', ' Interview ', ' Joints ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Kidney Transplantation ', ' Kidney Grafting ', ' Kidney Transplants ', ' Renal Grafting ', ' Renal Transplantation ', ' Renal Transplants ', ' kidney tx ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' mortality ', ' Muscular Atrophy ', ' Muscle Atrophy ', ' muscle breakdown ', ' muscle degradation ', ' muscle deterioration ', ' muscle loss ', ' muscle wasting ', ' Nephrology ', ' nutrition ', ' Obesity ', ' adiposity ', ' corpulence ', ' corpulency ', ' corpulentia ', ' obese ', ' obese people ', ' obese person ', ' obese population ', ' Patients ', ' Phenotype ', ' Physicians ', ' Quality of life ', ' QOL ', ' Research ', ' Research Proposals ', ' Risk ', ' Risk Factors ', ' Science ', ' United States ', ' Body Weight decreased ', ' Weight Loss ', ' Weight Reduction ', ' body weight loss ', ' wt-loss ', ' Weight ', ' Measures ', ' Dataset ', ' Data Set ', ' Caring ', ' Nutritional Deficiency ', ' Undernutrition ', ' dietary deficiency ', ' malnourished ', ' nutrition deficiency ', ' nutrition deficiency disorder ', ' nutritional deficiency disorder ', ' Malnutrition ', ' Guidelines ', ' improved ', ' Chronic ', ' Clinical ', ' Physiologic ', ' Physiological ', ' Medical ', ' Link ', ' Ensure ', ' Muscle function ', ' Individual ', ' muscle bulk ', ' muscle mass ', ' muscle form ', ' Patient-Centered Care ', ' Inflammatory ', ' tool ', ' machine learned ', ' Machine Learning ', ' Consensus ', ' transplant patient ', ' Transplant Recipients ', ' Knowledge ', ' Dietitian ', ' Kilogram ', ' Techniques ', ' meter ', ' muscle strength ', ' Services ', ' experience ', ' hazard ', ' cohort ', ' Structure ', ' novel ', ' Benefits and Risks ', ' Reporting ', ' Modeling ', ' sarcopenic ', ' sarcopenia ', ' vulnerable group ', ' Vulnerable Populations ', ' Provider ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' preventing ', ' prevent ', ' BMI percentile ', ' BMI z-score ', ' Quetelet index ', ' Body mass index ', ' Data ', ' Intake ', ' enroll ', ' Enrollment ', ' nutritious ', ' Nutritional ', ' Characteristics ', ' Process ', ' obesity management ', ' health related quality of life ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Dialysis patients ', ' Outcome ', ' Nonobese ', ' Non obese ', ' Population ', ' prospective ', ' weight loss intervention ', ' patient centered ', ' patient oriented ', ' high risk ', ' clinical care ', ' patient population ', ' inflammation marker ', ' inflammatory marker ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' mobility enhancement ', ' mobility improvement ', ' optimized mobility ', ' improved mobility ', ' adverse consequence ', ' adverse outcome ', ' data registry ', ' healthy weight ', ' clinical predictors ', ' decreased muscle strength ', ' dynapenia ', ' low muscle strength ', ' muscle strength decline ', ' reduced muscle strength ', ' predictive tools ', ' Prospective cohort study ', ' quality of sleep ', ' sleep quality ', ' machine learned algorithm ', ' machine learning algorithm ', ' death risk ', ' mortality risk ', ' ']",NIDDK,DREXEL UNIVERSITY,R01,2020,301998,PA-03,0.07213451266325567
"Prediction of Chronic Kidney Disease by Simulation Modeling to Improve the Health of Minority Populations Project Summary/Abstract Significant health disparities exist in chronic kidney disease (CKD), CKD progression, and end stage renal disease (ESRD) in ethnically diverse populations. African Americans (AAs) have ~25% higher prevalence of CKD, 3-fold higher rate of ESRD, and the highest risk of mortality among those with estimated glomerular filtration rate (eGFR) 45-95mL/min/1.73m2. The most significant traditional risk factors for CKD and ESRD are diabetes and hypertension accounting for >60% CKD and >70% of new ESRD cases, respectively. Non- traditional risk factors for CKD such as environmental, cultural-behavioral factors, geographic, education, insurance coverage, socioeconomic status and unequal access to optimal healthcare, disproportionately affect CKD health in ethnic minorities. The unique combination of these factors on CKD progression in the real world remains poorly defined. Identification of modifiable risk factors that may reduce CKD disparities would be invaluable to improve quality of life, life expectancy, and decrease economic burden. Simulation models have been successfully applied in other clinical domains, but are limited in CKD development and CKD progression, due to small datasets and the absence of modeling techniques using longitudinal observational health data. Further, no models have been tested in a real-world minority population to uncover the potential for interventional studies that would reduce CKD disparities on a larger scale. To our knowledge, we have created the largest, comprehensive database from electronic health records of >10 million individuals seen between 2006-2016 from a 2-year partnership between UCLA (1.8 million) and Providence St. Joseph Health (PSJH; 9.2 million) systems. From the UCLA Registry population, we identified significant differences in eGFR trajectory decline between AAs and non-AAs according to baseline eGFR, indicating a pattern shift from a higher to a lower, steeper eGFR trajectory suggesting there may be critical windows for interventions to reduce CKD disparities in AAs. Race/ethnicity differences from linear mixed models of all ethnic cohorts persisted even after controlling for demographic and clinical variables known to influence eGFR trajectories. We hypothesize that the use of ethnically diverse populations in the joint UCLA PSJH CKD/At-risk CKD Registry can identify a novel combination of CKD risk factors; and improve the performance of existing simulation models to predict CKD progression. The specific aims are to: 1) develop and test a machine learning-based simulation model for CKD and eGFR trajectories using the UCLA PSJH CKD/At-risk CKD Registry; and conduct internal validation of the models and comparisons with existing CKD risk models, 2) stratify and test simulation models based on different racial/ethnic groups, including external validation based on cross-institution comparisons, and 3) conduct focus groups with UCLA primary care physicians, who manage racial/ethnic patients, to elicit their perspectives on existing and designed simulation models to reduce CKD health disparities. These innovative approaches will facilitate our long-term goal to inform clinical decision support methods to reduce/eliminate CKD health disparities. Project Narrative Disparities in chronic kidney disease (CKD) disproportionately affect the development of CKD and CKD progression in ethnic minorities. The ability to use large datasets of patient information to reduce these disparities is greatly lacking. We will conduct simulation modeling to identify a unique set of risk factors that predict CKD and CKD progression, that can be targeted for individualized treatment in patients with highest risk of kidney function decline, with valuable input on the potential utility of this resource from focus groups consisting of primary care physicians.",Prediction of Chronic Kidney Disease by Simulation Modeling to Improve the Health of Minority Populations,9848452,R01MD014712,"['Accounting ', ' Affect ', ' Behavior ', ' Diabetes Mellitus ', ' diabetes ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Education ', ' Educational aspects ', ' Engineering ', ' Ethnic group ', ' ethnicity group ', ' Focus Groups ', ' Foundations ', ' Future ', ' Patient Care ', ' Patient Care Delivery ', ' Geography ', ' Glomerular Filtration Rate ', ' Goals ', ' Health ', ' Medicare ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Title 18 ', ' health insurance for disabled ', ' Health Planning ', ' plan health ', ' Health Policy ', ' health care policy ', ' healthcare policy ', ' Hypertension ', ' Vascular Hypertensive Disease ', ' Vascular Hypertensive Disorder ', ' high blood pressure ', ' hyperpiesia ', ' hyperpiesis ', ' hypertensive disease ', ' Intervention Studies ', ' intervention research ', ' interventional research ', ' interventional study ', ' interventions research ', ' Joints ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Laboratories ', ' Life Expectancy ', ' Methods ', ' Patients ', ' Population Statistics ', ' Primary Care Physician ', ' Quality of life ', ' QOL ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Registries ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Social Environment ', ' social climate ', ' social context ', ' socioenvironment ', ' socioenvironmental ', ' Testing ', ' Urban Health ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' health care ', ' Healthcare ', ' diverse populations ', ' heterogeneous population ', ' population diversity ', ' Population Heterogeneity ', ' Socio-economic status ', ' socio-economic position ', ' socioeconomic position ', ' Socioeconomic Status ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Area ', ' Clinical ', ' Ensure ', ' kidney function ', ' Renal function ', ' insight ', ' Discipline ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' Disease Progression ', ' machine learned ', ' Machine Learning ', ' Insurance Status ', ' Insurance Coverage ', ' Disorder Management ', ' Disease Management ', ' Education Level ', ' Educational Background ', ' Pattern ', ' Techniques ', ' System ', ' Physical environment ', ' Performance ', ' cohort ', ' novel ', ' model-based simulation ', ' models and simulation ', ' ethnicity difference ', ' ethnic difference ', ' disease risk ', ' disorder risk ', ' Predictive Factor ', ' Modeling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' disease registry ', ' model development ', ' disparity in health ', ' health disparity ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Institution ', ' Address ', ' Health system ', ' Data ', ' Economic Burden ', ' High Prevalence ', ' Validation ', ' developmental ', ' Development ', ' ED care ', ' ER care ', ' Emergency Department care ', ' Emergency Room care ', ' Emergency health care ', ' Emergency healthcare ', ' Emergency medical care ', ' Emergency Care ', ' beneficiary ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' Behavioral ', ' minority health ', ' cost ', ' designing ', ' design ', ' Minority ', ' Outcome ', ' Population ', ' Prevalence ', ' innovate ', ' innovative ', ' innovation ', ' modifiable risk ', ' ethnic minority ', ' ethnic minority population ', ' combinatorial ', ' racial and ethnic ', ' high risk ', ' population health ', ' data registry ', ' BigData ', ' Big Data ', ' precision-based medicine ', ' precision medicine ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' health data ', ' ethnically diverse ', ' ethnic diversity ', ' reduce disparity ', ' disparity reduction ', ' clinical translation ', ' clinical decision support ', ' clinical implementation ', ' death risk ', ' mortality risk ', ' large data sets ', ' large datasets ', ' ']",NIMHD,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2020,389501,CA-33,0.05200822752805067
"Understanding the role of the Complement Proteome in progressive Diabetic Kidney Disease PROJECT SUMMARY / ABSTRACT There is a critical need to identify novel mechanisms of diabetic kidney disease (DKD) that will provide targets for new interventions. Chronic inflammation is one plausible mechanism. Using untargeted high-throughput aptamer proteomics, our recently published study has shed new light on specific, key inflammatory drivers of DKD. This was a large prospective three-cohort study that identified a novel and extremely robust circulating signature (KRIS) associated with risk of ESRD in diabetes. Our pilot study points to the data-driven connection between circulating KRIS and urinary profiles of the Complement pathway. Our hypothesis is that the Complement involvement in the kidney is a downstream effect of the systemic inflammatory processes mediating an increased DKD risk. The overarching goal of this proposal is to provide a high-resolution view of the involvement of the Complement proteome in progressive diabetic kidney disease. Aim 1 will comprehensively evaluate the etiological role of the urinary Complement proteome in progressive DKD leading to ESRD. This evaluation will leverage a prospective two-cohort population of Joslin Kidney Study (JKS) participants with an overt DKD at baseline followed for 10 years (primary outcome  incident ESRD). Measurements will utilize an aptamer proteomic technology (SOMAscan). Aim 2 will extend generalizability of the urinary Complement proteome to earlier DKD stages. The proposed study will be conducted in participants of the Preventing Early Renal Loss (PERL) clinical trial with predominantly normal renal function at baseline followed for 3 years (primary outcome - renal slope). Aim 3 proposes to gain direct insight into the intra-renal Complement proteome by targeted and untargeted protein studies in diabetic kidney tissue (Susztaklab Biobank). This project focuses on a significant public health problem, leverages the progressiveness of the disease, employs an innovative proteomic technology and stems from strong preliminary data. Advances in this project will pinpoint missing key components of DKD etiology, thereby accelerating drug development strategies for patients with diabetes. PROJECT NARRATIVE Diabetes accounts for approximately 45% of prevalent ESRD cases in the United States, therefore new interventions to prevent or decelerate development of kidney failure are critical in order to improve the health of patients with diabetes who comprise a large sector of the US population. This study will advance our knowledge regarding the etiology of diabetic kidney complications evaluating specific components of systemic (KRIS) and local, kidney inflammation (Complement). These advances offer long-term potential for the development of new therapies that will ultimately improve clinical outcomes of patients with diabetes.",Understanding the role of the Complement Proteome in progressive Diabetic Kidney Disease,9866226,R01DK123459,"['Clinical Trials ', ' Cohort Studies ', ' Concurrent Studies ', ' Complement ', ' Complement Proteins ', ' Data Reporting ', ' data representation ', ' Diabetes Mellitus ', ' diabetes ', ' Diabetic Nephropathy ', ' Diabetic Kidney Disease ', ' Goals ', ' Health ', ' Histology ', ' Immunoglobulin G ', ' 7S Gamma Globulin ', ' IgG ', ' indexing ', ' Inflammation ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Light ', ' Photoradiation ', ' Medicine ', ' Nested Case-Control Study ', ' Patients ', ' Phenotype ', ' Pilot Projects ', ' pilot study ', ' Proteins ', ' Public Health ', ' Publishing ', ' Kidney Failure ', ' Kidney Insufficiency ', ' Renal Failure ', ' Renal Insufficiency ', ' Risk ', ' Role ', ' social role ', ' Technology ', ' Tissue Banks ', ' Tissue Collection ', ' Tissue repository ', ' Tissues ', ' Body Tissues ', ' United States ', ' Tumor Necrosis Factor Receptor ', ' Cachectin Receptors ', ' TNF Receptor Family Protein ', ' TNF Receptor Superfamily ', ' TNF Receptors ', ' TNFR ', ' Tumor Necrosis Factor Receptor Family ', ' Tumor Necrosis Factor Receptor Superfamily ', ' Mediating ', ' kidney injury ', ' renal injury ', ' Injury to Kidney ', ' improved ', ' Chronic ', ' Clinical ', ' Evaluation ', ' kidney function ', ' Renal function ', ' insight ', ' diabetic ', ' Measurement ', ' Disease Progression ', ' Ethnicity ', ' Ethnic Origin ', ' Tubular ', ' Tubular formation ', ' Inflammatory ', ' tool ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Complex ', ' Source ', ' Pattern ', ' disease severity ', ' Severity of illness ', ' aptamer ', ' cohort ', ' novel ', ' Participant ', ' member ', ' Negotiating ', ' Negotiation ', ' Mediation ', ' disease risk ', ' disorder risk ', ' Proteome ', ' drug development ', ' Proteomics ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' kidney development ', ' nephrogenesis ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' preventing ', ' prevent ', ' complement pathway ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Progressive Disease ', ' Signaling Factor Proto-Oncogene ', ' Signaling Pathway Gene ', ' Signaling Protein ', ' CCL2 ', ' Chemokine, CC Motif, Ligand 2 ', ' MCAF ', ' MCP-1 ', ' MCP1 ', ' Monocyte Chemoattractant Protein-1 ', ' Monocyte Chemotactic Protein-1 ', ' Monocyte Chemotactic and Activating Factor ', ' Monocyte Chemotactic and Activating Protein ', ' Monocyte Chemotactive and Activating Factor ', ' Monocyte Secretory Protein JE ', ' SCYA2 ', ' Small Inducible Cytokine A2 ', ' CCL2 gene ', ' Address ', ' Data ', ' Resolution ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Characteristics ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' urinary ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' Population ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' transcriptomics ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' stem ', ' nondiabetic ', ' non-diabetic ', ' primary outcome ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' biorepository ', ' biobank ', ' complement system ', ' study population ', ' random forest ', ' ']",NIDDK,JOSLIN DIABETES CENTER,R01,2020,498936,MA-07,0.10678749518903195
"Single Cell Analysis of Kidney Transplant Antibody Mediated Rejection PROJECT SUMMARY/ABSTRACT Kidney transplantation offers the greatest survival advantage to patients with end stage kidney disease and is vastly more cost effective than dialysis. Long-term survival of kidney transplants has not improved in recent decades. Antibody mediated rejection (AMR) has been identified as a major cause of transplant failure. Currently, management of patients with AMR is inconsistent among centers and frequently fails. We hypothesize that the cell types and cell states unique to AMR can be resolved by single cell RNA sequencing (scRNA-seq) of biopsy samples taken from patients at the time of diagnosis. This approach uses an unsupervised framework for dissecting transcriptional heterogeneity within complex tissues such as the kidney. This allows for the interrogation of cell states and subpopulations using an unbiased clustering approach that is independent of previous knowledge and can provide unprecedented resolution. To test our hypothesis we propose the following aims: In Aim 1, we will perform scRNA-seq of 40 research biopsy cores (20 AMR and 20 non-AMR). From this data we will identify genes expressed in endothelial cells and antibody secreting cells that define AMR specific phenotypes. We have demonstrated feasibility of this approach by generating single cell data from human biopsy samples as outlined in the research plan. For Aim 2, we will use immunohistochemistry to validate these AMR specific markers on a set of independent tissue samples. For Aim 3, we will use publicly available Affymetrix microarray datasets from kidney transplant biopsies with associated outcomes data to determine which cell types are associated with allograft outcome. This proposal logically builds on the principal investigators previous research experience and clinical training. To date he has been working full time in clinical transplantation and continuing his research endeavors on an out of hours basis. Despite this his research output and experience continue to grow and he has recently published a report on the first successful application of this technology to human kidney biopsy tissue (co-first author). This proposal now focuses on expanding his scientific skills by attaining additional knowledge and practical research experience in single cell methods, bioinformatics and immunology. The career development goals will be achieved through a multi-faceted approach involving mentoring by Dr. Benjamin Humphreys and an advisory committee consisting of Drs. Barbara Murphy (transplant genomics), Phil Payne (biomedical informatics and translational science), Rob Mitra (single cell applications) and Paul Allen (translational immunology), didactic coursework, scientific investigation, and training in scientific communication and research ethics. This work will take place in Washington University which has a rich history of mentoring successful physician-scientists. Successful completion of this career development award will result in a better understanding of AMR, result in the principal investigators transition to an independent physician- scientist, and provide a solid foundation from which he will apply for RO1-level funding. PROJECT NARRATIVE Antibody mediated rejection is a major cause of kidney transplant failure. The pathophysiology of antibody mediated rejection is poorly understood and current treatment strategies frequently fail. Successful completion of this project has the potential to identify new markers of disease and novel targets for treatment.",Single Cell Analysis of Kidney Transplant Antibody Mediated Rejection,9908076,K08DK120953,"['Antibodies ', ' Archives ', ' Arteritis ', ' B-Lymphocytes ', ' B blood cells ', ' B cell ', ' B cells ', ' B-Cells ', ' B-cell ', ' Biopsy ', ' Cell Survival ', ' Cell Viability ', ' Cells ', ' Cell Body ', ' Diagnosis ', ' Dialysis procedure ', ' Dialysis ', ' dialysis therapy ', ' Disease ', ' Disorder ', ' Endothelium ', ' Foundations ', ' Future ', ' Gene Expression ', ' Genes ', ' Goals ', ' Heterogeneity ', ' Recording of previous events ', ' History ', ' Human ', ' Modern Man ', ' Immunohistochemistry ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry Staining Method ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Transplantation ', ' Kidney Grafting ', ' Kidney Transplants ', ' Renal Grafting ', ' Renal Transplantation ', ' Renal Transplants ', ' kidney tx ', ' Masks ', ' Mentors ', ' Methods ', ' Patients ', ' Phenotype ', ' Physicians ', ' Pilot Projects ', ' pilot study ', ' Plasma Cells ', ' Blood Plasma Cell ', ' Plasmacytes ', ' plasmocyte ', ' Publishing ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Stains ', ' Staining method ', ' Technology ', ' Testing ', ' Thromboplastin ', ' Blood Coagulation Factor III ', ' CD142 Antigens ', ' Coagulation Factor III ', ' Coagulin ', ' Factor III ', ' Glomerular Procoagulant Activity ', ' Prothrombinase ', ' Tissue Factor ', ' Tissue Factor Procoagulant ', ' Tissue Thromboplastin ', ' Urothromboplastin ', ' Time ', ' Tissues ', ' Body Tissues ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Transplantation ', ' transplant ', ' Universities ', ' Washington ', ' Work ', ' Antibody-Secreting Cells ', ' Immunoglobulin-Secreting Cells ', ' Mediating ', ' Dataset ', ' Data Set ', ' Immunology ', ' Task Forces ', ' advisory team ', ' Advisory Committees ', ' base ', ' career ', ' improved ', ' Solid ', ' Clinical ', ' Histologically ', ' Histologic ', ' Link ', ' prognostic ', ' Training ', ' Endothelial Cells ', ' Failure ', ' Bayesian Methodology ', ' Bayesian Statistical Method ', ' Bayesian approaches ', ' Bayesian classification method ', ' Bayesian classification procedure ', ' Bayesian posterior distribution ', ' Bayesian Method ', ' Measurement ', ' Funding ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' Inflammatory ', ' tool ', ' Diagnostic ', ' Research Specimen ', ' Specimen ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Scientist ', ' Investigation ', ' Hour ', ' Complex ', ' Event ', ' Source ', ' cell type ', ' Allografting ', ' experience ', ' human data ', ' single cell analysis ', ' Accuracy of Diagnosis ', ' diagnostic accuracy ', ' Biopsy Sample ', ' Biopsy Specimen ', ' skills ', ' novel ', ' Reporting ', ' Abscission ', ' Extirpation ', ' Removal ', ' Surgical Removal ', ' resection ', ' Excision ', ' FYN ', ' FYN oncogene related to SRC, FGR, YES ', ' SLK gene ', ' SLK protein ', ' SYN gene ', ' SYN protein ', ' FYN gene ', ' Research Ethics ', ' Sampling ', ' career development ', ' Genomics ', ' Bio-Informatics ', ' Bioinformatics ', ' activated B cells ', ' B-Cell Activation ', ' Molecular Interaction ', ' Binding ', ' protein expression ', ' fluidic ', ' Microfluidics ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Tissue Sample ', ' Core Needle Biopsy ', ' Core Biopsy ', ' Candidate Gene ', ' Candidate Disease Gene ', ' IBP3 ', ' IGFBP3 ', ' IGFBP3 gene ', ' Data ', ' Disease Marker ', ' Reproducibility ', ' Career Development Awards ', ' Career Development Awards and Programs ', ' Career Development Programs K-Series ', ' K-Awards ', ' Research Career Program ', ' K-Series Research Career Programs ', ' Resolution ', ' Retrieval ', ' in vivo ', ' Communication Research ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Principal Investigator ', ' Output ', ' Benlysta ', ' belimumab ', ' biomed informatics ', ' biomedical informatics ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Outcome ', ' cost effective ', ' Population ', ' transcriptomics ', ' new diagnostics ', ' next generation diagnostics ', ' novel diagnostics ', ' treatment strategy ', ' new marker ', ' novel biomarker ', ' novel marker ', ' B-Cell Maturation Factor ', ' BCM gene ', ' BCM protein ', ' BCMA gene ', ' BCMA protein ', ' TNFRSF17 ', ' tumor necrosis factor receptor superfamily, member 17 ', ' TNFRSF17 gene ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' XBP1 ', ' XBP1 gene ', ' experiment ', ' experimental research ', ' experimental study ', ' scRNA-seq ', ' single cell RNA-seq ', ' single cell RNAseq ', ' single-cell RNA sequencing ', ' random forest ', ' renal biopsy ', ' kidney biopsy ', ' ']",NIDDK,WASHINGTON UNIVERSITY,K08,2020,164258,MO-01,0.1378357981313671
"Identification of Sub-phenotypes in Sepsis Associated Acute Kidney Injury PROJECT SUMMARY/ABSTRACT Acute kidney injury (AKI) occurs in over 50% of patients with sepsis and is associated with increased risk of mortality and other complications, including longer hospital length of stay and the development or progression of chronic kidney disease. To date, therapies for sepsis associated AKI (SA-AKI) remain largely supportive. One possible reason for the failure of targeted therapies may be the currently limited understanding of the pathophysiology of the condition. Traditionally, SA-AKI has been thought to be largely due to renal ischemia secondary to hypoperfusion. However, animal models show that SA-AKI is actually a state characterized by hyperdynamic circulation, and review of histological changes in septic patients shows a lack of acute tubular necrosis, a pathological finding often associated with renal ischemia. Rather, it appears that a combination of immunologic, toxic and inflammatory factors likely leads to SA-AKI, and intervening along these pathways may improve patient outcomes for SA-AKI. We hypothesize that within a population with SA-AKI, there are subgroups who have particular inflammatory and immunological profiles that are associated with differential outcomes and response to therapies. In the fields of asthma and the acute respiratory distress syndrome, the use of clinical data and biomarkers to identify such subpopulations, or sub-phenotypes, of disease, has led to new treatment paradigms, where individuals with a specific biological profile receive and benefit from a targeted therapy. We propose to use data from a large, established cohort of patients admitted to the Intensive Care Unit (the Early Assessment of Renal and Lung Injury [EARLI] cohort) to define sub-phenotypes of SA-AKI using latent class analysis. Latent class analysis is an established method that uses mixture models to identify sub- phenotypes within a heterogenous population in an unbiased manner. Prior work using this methodology has allowed for discovery of new disease entities that inform biological pathways of cellular injury leading to organ failure. Our specific aims are: Aim 1: To identify novel sub-phenotypes of patients with SA-AKI and discover molecular targets for therapy through the incorporation of clinical and biomarker data into our latent class analysis. Aim 2: To determine whether certain sub-phenotypes are associated with differential outcomes with regards to mortality, need for renal replacement therapy, or duration of AKI. Through the studies outlined in this F32 proposal, Dr. Kwong will learn how to rigorously conduct latent class analysis as well as other unbiased analytic techniques (e.g., machine learning) and to apply these techniques to AKI. This work will effectively position Dr. Kwong for her future research studies, where she wants to identify appropriate patients for clinical trials of AKI therapies and to better define the pathophysiology of human AKI. PROJECT NARRATIVE Sepsis has been shown to be a key contributing factor for the development of acute kidney injury (AKI). To date, there are no available targeted therapies for sepsis-associated AKI besides supportive care with antibiotics and fluids. The long-term goal of this project is to find new therapeutics for sepsis-associated AKI by first identifying sub-phenotypes based on clinical and biomarker profiles that may inform the molecular pathways of injury and then determining their association with adverse outcomes.",Identification of Sub-phenotypes in Sepsis Associated Acute Kidney Injury,9833437,F32DK118870,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Anti-Inflammatory Agents ', ' Anti-Inflammatories ', ' Anti-inflammatory ', ' Antiinflammatories ', ' Antiinflammatory Agents ', ' antiinflammatory ', ' Antibiotics ', ' Antibiotic Agents ', ' Antibiotic Drugs ', ' Miscellaneous Antibiotic ', ' Aspirin ', ' Acetylsalicylic Acid ', ' Asthma ', ' Bronchial Asthma ', ' Blood Circulation ', ' Bloodstream ', ' Circulation ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Clinical Trials ', ' Dialysis procedure ', ' Dialysis ', ' dialysis therapy ', ' Disease ', ' Disorder ', ' Electrolyte Balance ', ' Fibrinolysis ', ' Fibrinolyses ', ' Fluid Balance ', ' Foundations ', ' Goals ', ' Heterogeneity ', ' Hospitals ', ' Human ', ' Modern Man ', ' Inflammation ', ' Intensive Care Units ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Acute Kidney Tubular Necrosis ', ' Acute Renal Failure with Tubular Necrosis ', ' Lower Nephron Nephrosis ', ' acute tubular necrosis ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Learning ', ' Length of Stay ', ' Number of Days in Hospital ', ' hospital days ', ' hospital length of stay ', ' hospital stay ', ' Medicine ', ' Methods ', ' Methodology ', ' mortality ', ' Oliguria ', ' Patients ', ' Phenotype ', ' Physicians ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' outcome forecast ', ' Prognosis ', ' Adult Respiratory Distress Syndrome ', ' ARDS ', ' Acute Respiratory Distress ', ' Acute Respiratory Distress Syndrome ', ' Adult ARDS ', ' Adult RDS ', ' Da Nang Lung ', ' Shock Lung ', ' Stiff lung ', ' wet lung ', ' Resuscitation ', ' Risk Factors ', ' Septic Shock ', ' Syndrome ', ' Urine ', ' Urine Urinary System ', ' Work ', ' Caring ', ' tubular necrosis ', ' Allergic asthma ', ' atopic asthma ', ' extrinsic allergic asthma ', ' Extrinsic asthma ', ' kidney injury ', ' renal injury ', ' Injury to Kidney ', ' Secondary to ', ' injuries ', ' Injury ', ' base ', ' career ', ' improved ', ' Acute ', ' Clinical ', ' Biological ', ' Histologically ', ' Histologic ', ' Kidney Replacement Therapy ', ' Renal Replacement Therapy ', ' Failure ', ' kidney function ', ' Renal function ', ' Individual ', ' Measurement ', ' Lung damage ', ' lung injury ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Industrialized Countries ', ' Industrialized Nations ', ' developed country ', ' developed nation ', ' developed nations ', ' Developed Countries ', ' fluid ', ' liquid ', ' Liquid substance ', ' Metabolic ', ' Inflammatory ', ' Supportive Therapy ', ' Supportive care ', ' machine learned ', ' Machine Learning ', ' Immunes ', ' Immune ', ' Complex ', ' Protocol ', ' Protocols documentation ', ' Techniques ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' acute kidney injury ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' Cellular injury ', ' cell damage ', ' cellular damage ', ' damage to cells ', ' injury to cells ', ' cell injury ', ' cohort ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' novel ', ' research study ', ' Pathogenesis ', ' Allergic ', ' Position ', ' Positioning Attribute ', ' Deterioration ', ' Modeling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' kidney ischemia ', ' renal ischemia ', ' Organ failure ', ' Data ', ' Subgroup ', ' Apoptotic ', ' Clinical Data ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Pathologic ', ' Immunochemical Immunologic ', ' Immunologic ', ' Immunological ', ' Immunologically ', ' Immunologics ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' blood infection ', ' bloodstream infection ', ' Sepsis ', ' adjudicate ', ' Outcome ', ' Population ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' adverse consequence ', ' adverse outcome ', ' hypoperfusion ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' clinically useful biomarkers ', ' clinical biomarkers ', ' improved outcome ', ' molecular targeted therapeutics ', ' molecular targeted treatment ', ' molecular targeted therapies ', ' Prospective cohort ', ' sepsis patients ', ' septic patients ', ' death risk ', ' mortality risk ', ' ']",NIDDK,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",F32,2020,81571,CA-12,0.09565326447876465
"Transforming Kidney Care in the Emergency Department using Artificial Intelligence Driven Clinical Decision Support PROJECT SUMMARY/ABSTRACT The objective of this proposal is to determine best-practice methods for incorporating artificial intelligence (AI)- derived insights into emergency care. This investigation will use the iterative development and evaluation of an AI-driven clinical decision support (CDS) system to prevent or mitigate acute kidney injury (AKI) as a reference use-case. We are responding to the AHRQ Special Emphasis Notice: Health Services Research Priorities for Achieving a High Value Healthcare System (NOT-HS-18-015), calling for research on prevention of disease through incorporation of AI into healthcare and on interventions to prevent kidney disease progression. Emergency departments (EDs) deliver high-volume patient care in hazardous decision-making environments fraught with excessive cognitive loading and time-pressure. AI has potential to support ED clinician decisions by exploiting large-scale electronic health record (EHR) data to aid prognosis, extract signal from noise, and reduce untoward variability in practice. Despite AIs fervent promotion, translation to practice is rare and means to incorporate AI that is trustworthy, transparent, and explainable in the ED are unknown. AKI is an important target for AI-driven predictive modeling. It is prevalent and strongly associated with adverse outcomes including dialysis and death, yet is under-recognized and therefore under-treated. In addition, many ED treatments inadvertently promote the progression of AKI and kidney disease. AKI prevention is achievable with evidence-based CDS at the point of care. We will use our AI-driven model, with proven capacity for early and reliable AKI risk estimation, to achieve the following Specific Aims: Aim 1: Develop an AI-driven algorithm for promotion of AKI-focused clinical decision-making in the ED. We will leverage previously developed AKI surveillance and prediction tools to generate a unified EHR-based algorithm that empowers ED clinician prevention of kidney disease progression. Aim 2: Translate the AI algorithm to an AKI-CDS system to enable in-depth study of Clinician-AI interactions in the ED. We will establish end-user requirements while creating data collection instruments to examine AI in the ED. Both efforts will support the development of the AKI-CDS system to pilot and investigate ED clinician perceptions of AI trustworthiness and explainability in preparation for multi-site implementation. Aim 3: Perform a multi-site effectiveness-implementation evaluation of the AKI-CDS system in the ED. We will implement the AI-driven CDS system across three ED study sites using a pragmatic investigational framework to perform effectiveness and implementation evaluations in parallel. The research proposed will generate new knowledge and tools to advance the study of AI in the ED, and will result in a scalable CDS product with the capacity to improve the quality of kidney care delivered to more than 1 million patients affected by AKI in the US each year. PROJECT NARRATIVE The research project Transforming Kidney Care in the Emergency Department (ED) using Artificial Intel- ligence Driven Clinical Decision Support is to determine best-practice methods for incorporating artificial intelligence (AI)-derived insights into emergency care delivery. This investigation will use the iterative develop- ment and evaluation of an AI-driven clinical decision support (CDS) system to prevent or mitigate acute kidney injury (AKI) as a reference use-case. The proposed research aims to increase our understanding of human-AI interactions in the emergency care setting through the development and evaluation of a novel AI-driven deci- sion support system for kidney disease.",Transforming Kidney Care in the Emergency Department using Artificial Intelligence Driven Clinical Decision Support,10096632,R01HS027793,[''],AHRQ,JOHNS HOPKINS UNIVERSITY,R01,2020,386137,MD-07,0.08220589558241431
"Defining the Pathogenesis and Prognosis of Human Acute Interstitial Nephritis Acute interstitial nephritis (AIN), resulting from drug exposure, infection or autoimmune disease, is the cause of acute kidney injury (AKI) in up to 20% of patients who undergo a kidney biopsy. Even though we currently have 2 clinical interventions available to treat patients with AIN (withdrawal of the offending drug and corticosteroids), 40-60% of patients with AIN go on to develop chronic kidney disease (CKD) even when appropriately treated. Kidney damage in AIN is believed to result from immune-mediated tubular injury that eventually leads to fibrosis and permanent kidney damage.  The recent dileniation of the immune underpinnings of multiple autoimmune diseases and cancers has led to the development of targeted therapies that exhibit improved efficacy and less toxicity compared to corticosteroids. Therefore, an analysis of the immune infiltrate and resulting resident cell (tubular and vascular) responses that provides pathogenic understanding of the specific immune events that initiate and propogate AIN should lead to development and/or repurposing of targeted therapies that are more effective at resolving AIN and preventing the progression to CKD, as well as potentially less toxic.  Data from several groups, including our own, suggest that CD4+ T-helper cells (particularly the TH2/TH9 subsets) are potential drivers of AIN. We have found that TH2/TH9 cytokines IL-5 and IL-9 and some cells of type 2 immunity, mast cells and eosinophils, are higher in the urine or kidneys of patients with AIN. Based on these data, it is our hypothesis that TH2/TH9 T-helper cells in the kidney itself play an important pathogenic role in promoting tubular or vascular injury in AIN. We will test this hypothesis by performing a quantitative evaluation of the kidney immune infiltrate and accompanying tubular and vascular response in humans with AIN. We will use existing kidney biopsies, adjudicated by 3 nephropathologists as exhibiting AIN, from two university health centers (Yale and Johns Hopkins), as discovery and validation cohorts for this study. To perform the quantitative analysis we will use an imaging technique called Imaging Mass Cytometry (IMC) that supports the simultaneous, spatially-preserved quantification of up to 42 antibodies on a single tissue section. We have an existing library of 27 validated kidney and immune antibodies and have developed a machine learning protocol to rapidly and accurately quantify and localize all cells in the human kidney identified using IMC.  We will first increase our validated antibody panel and optimize our IMC protocol for use in the study of AIN (SA 1). We will then use IMC to identify, quantify and localize the immune and resident cell responses in 30 AIN cases and 60 non-AIN control biopsies from Yale (discovery cohort), followed by 30 AIN cases and 60 non-AIN controls from JHU (validation cohort, SA 2). Finally, we will define the relationship between cellular determinants of AIN and recovery of kidney function as well as response to steroids (SA3). Our findings will not only lead to identification of novel druggable targets in AIN, but also lead to improving clinical histological diagnosis of AIN. Acute Interstitial Nephritis (AIN) is an important cause of kidney dysfunction, and can lead to chronic kidney disease in many patients. We know that AIN occurs as an immune response in the kidney to certain drugs or infections, but do not have a clear understanding of the cell sources of the inflammation or the tubular and vascular responses. This proposal is designed to define these immune events in human kidney biopsy samples left over after clinical diagnosis has been completed, and to determine how they relate to the development of chronic kidney disease.",Defining the Pathogenesis and Prognosis of Human Acute Interstitial Nephritis,10096452,R01DK126815,"['Adrenal Cortex Hormones ', ' Corticoids ', ' Corticosteroids ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Antibiotics ', ' Antibiotic Agents ', ' Antibiotic Drugs ', ' Miscellaneous Antibiotic ', ' Antibodies ', ' Antigens ', ' immunogen ', ' Archives ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Vessels ', ' vascular ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cell Communication ', ' Cell Interaction ', ' Cell-to-Cell Interaction ', ' Cells ', ' Cell Body ', ' Cohort Studies ', ' Concurrent Studies ', ' Diagnosis ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' eosinophil ', ' Blood Eosinophil ', ' Eosinophilic Granulocyte ', ' Eosinophilic Leukocyte ', ' Marrow Eosinophil ', ' Exhibits ', ' Fibrosis ', ' Health ', ' Helper-Inducer T-Lymphocyte ', ' Helper Cells ', ' Helper T-Cells ', ' Helper T-Lymphocytes ', ' Helper-Inducer T-Cells ', ' Inducer Cells ', ' Inducer T-Lymphocytes ', ' Human ', ' Modern Man ', ' Delayed Hypersensitivity ', ' Delayed-Type Hypersensitivity ', ' Tuberculin-Type Hypersensitivity ', ' Type IV Hypersensitivity ', ' cell mediated hypersensitivity ', ' delayed-type hypersensitivity response ', ' Immunity ', ' Infection ', ' Inflammation ', ' Interleukin-5 ', ' B Cell Differentiation Factor I ', ' B cell growth factor 2 ', ' B-Cell Growth Factor-II ', ' BCGF-II ', ' BCGF2 ', ' Eo-CSF ', ' Eosinophil Differentiation Factor ', ' IL-5 ', ' IgA enhancing factor ', ' Interleukin 5 Precursor ', ' T cell replacing factor ', ' T-Cell Replacing Factor ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Libraries ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' mast cell ', ' Marrow Mast Cell ', ' Tissue Basophils ', ' mastocyte ', ' Neighborhoods ', ' Interstitial Nephritis ', ' Optics ', ' optical ', ' Patients ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Quantitative Evaluations ', ' Role ', ' social role ', ' Steroids ', ' Steroid Compound ', ' CD4 Positive T Lymphocytes ', ' CD4 Cells ', ' CD4 T cells ', ' CD4 helper T cell ', ' CD4 lymphocyte ', ' CD4+ T-Lymphocyte ', ' CD4-Positive Lymphocytes ', ' T4 Cells ', ' T4 Lymphocytes ', ' Testing ', ' Tissue Preservation ', ' Tissues ', ' Body Tissues ', ' Universities ', ' Urine ', ' Urine Urinary System ', ' Virus Diseases ', ' Viral Diseases ', ' viral infection ', ' virus infection ', ' virus-induced disease ', ' cytokine ', ' Imaging Techniques ', ' Imaging Procedures ', ' Imaging Technics ', ' Paraffin Embedding ', ' Interleukin-9 ', ' HP40 ', ' Homolog of Mouse T Cell and Mast Cell Growth Factor 40 ', ' IL-9 ', ' IL9 Protein ', ' Interleukin 9 Precursor ', ' T-Cell Growth Factor P40 ', ' T-Cell/Mast Cell Growth Factor p40 ', ' p40 Cytokine ', ' p40 Protein ', ' Mediating ', ' injuries ', ' Injury ', ' base ', ' exhaust ', ' Organ ', ' improved ', ' Left ', ' Site ', ' Acute ', ' Clinical ', ' Histologically ', ' Histologic ', ' Evaluation ', ' kidney function ', ' Renal function ', ' Recovery ', ' Withdrawal ', ' inflammatory mediator ', ' Inflammation Mediators ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' clinical Diagnosis ', ' Tubular ', ' Tubular formation ', ' Proton Pump Inhibitors ', ' machine learned ', ' Machine Learning ', ' Immunes ', ' Immune ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Reaction ', ' Source ', ' cell type ', ' Techniques ', ' 3-D ', ' 3D ', ' three dimensional ', ' 3-Dimensional ', ' Location ', ' acute kidney injury ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' cohort ', ' functional recovery ', ' Recovery of Function ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' Toxicities ', ' Toxic effect ', ' Biopsy Sample ', ' Biopsy Specimen ', ' novel ', ' Participant ', ' Pathogenesis ', ' Drug Exposure ', ' Cytometry ', ' Sampling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Formalin ', ' Skin ', ' Pathogenicity ', ' preventing ', ' prevent ', ' Data ', ' Clinical Data ', ' Validation ', ' Pathologic ', ' Characteristics ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' injured ', ' designing ', ' design ', ' adjudicate ', ' new drug target ', ' new druggable target ', ' new pharmacotherapy target ', ' new therapy target ', ' novel drug target ', ' novel druggable target ', ' novel pharmacotherapy target ', ' novel therapeutic target ', ' novel therapy target ', ' new therapeutic target ', ' biorepository ', ' biobank ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' multi-photon imaging ', ' multiphoton imaging ', ' Checkpoint inhibitor ', ' immune check point inhibitor ', ' Immune checkpoint inhibitor ', ' Immune infiltrates ', ' T cell infiltration ', ' T cell tumor trafficking ', ' immune cell infiltrate ', ' immune infiltration ', ' intratumoral immune cell ', ' tumor immune cell ', ' Tumor-infiltrating immune cells ', ' preservation ', ' scRNA-seq ', ' single cell RNA-seq ', ' single cell RNAseq ', ' single-cell RNA sequencing ', ' adverse event risk ', ' renal biopsy ', ' kidney biopsy ', ' renal dysfunction ', ' kidney dysfunction ', ' damage to kidney ', ' kidney damage ', ' renal damage ', ' injury to the vasculature ', ' vascular injury ', ' ']",NIDDK,YALE UNIVERSITY,R01,2020,564483,CT-03,0.19223044846663206
"Machine Learning and Network Science for Predicting Kidney Transplant Survival  Chronic kidney disease affects about 10% of adults in the United States and 7-12% of the population worldwide. It may lead to irreversible loss of kidney function, known as end-stage renal disease (ESRD). For patients with ESRD, kidney transplantation is the preferred treatment compared to dialysis in terms of patient survival, quality of life and cost. Despite the advantages of kidney transplants, most patients with ESRD are treated with dialysis primarily because there exist an insufficient number of compatible donors for patients. The human leukocyte antigens (HLAs) of the organ donor and recipient are known to be a significant contributing factor to transplanted organ survival times due to immunogenicity, the immune response of the recipient to the transplanted organ. Mismatches between donor and recipient HLAs are associated with shorter survival times; however, it is extremely rare to identify donors that have a perfect match with recipients, so most transplants involve mismatched HLAs. Our main objective is to accurately predict survival times for kidney transplants by incorporating both data- driven models of HLA compatibility based on outcomes of past transplants and biologically-driven models of HLA immunogenicity. Accurate prediction of survival times can improve patient transplant outcomes by enabling more efficient allocation of donors and recipients, particularly by reducing the number of repeat transplants due to graft failure with a poorly matched donor. We propose to estimate HLA compatibilities using high-dimensional variable selection techniques applied to outcomes of past transplants and through a novel donor-recipient latent space model for the HLA compatibility network. We then propose to incorporate these predicted compatibilities along with biologically-driven models of HLA immunogenicity using amino acid sequences and epitopes into a multi-task classification-based survival prediction algorithm. Our proposed approach for learning integrated data- and biologically-driven models of transplant survival generalizes broadly to organ transplantation (liver, heart, pancreas, lungs) and possibly to bone marrow transplantation. Finding better methods for human leukocyte antigen (HLA) matching between donor and recipient may redefine and improve clinical outcomes for organ and tissue transplants. In fact, new approach may revolutionize the selection of donors with recipients, thereby producing significantly improved long-term organ and tissue transplant survivals.",Machine Learning and Network Science for Predicting Kidney Transplant Survival ,9985180,R01LM013311,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Affect ', ' Amino Acid Sequence ', ' Primary Protein Structure ', ' protein sequence ', ' Epitopes ', ' Antigenic Determinants ', ' Binding Determinants ', ' Antigens ', ' immunogen ', ' Anus ', ' Anal ', ' Bone Marrow Transplantation ', ' Bone Marrow Grafting ', ' Bone Marrow Transplant ', ' Marrow Transplantation ', ' Classification ', ' Systematics ', ' Dialysis procedure ', ' Dialysis ', ' dialysis therapy ', ' Heart ', ' HLA Antigens ', ' HL-A Antigens ', ' Human Leukocyte Antigens ', ' Leukocyte Antigens ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Kidney Transplantation ', ' Kidney Grafting ', ' Kidney Transplants ', ' Renal Grafting ', ' Renal Transplantation ', ' Renal Transplants ', ' kidney tx ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Learning ', ' Liver ', ' hepatic body system ', ' hepatic organ system ', ' Lung ', ' Lung Respiratory System ', ' pulmonary ', ' Methods ', ' Organ Donor ', ' Organ Survival ', ' Organ Transplantation ', ' Grafting Procedure ', ' Organ Transplants ', ' organ allograft ', ' organ graft ', ' organ xenograft ', ' Pancreas ', ' Pancreatic ', ' Patients ', ' Plants ', ' Quality of life ', ' QOL ', ' Research ', ' Science ', ' Time ', ' Transplantation ', ' transplant ', ' United States ', ' Tissue Transplantation ', ' base ', ' improved ', ' Clinical ', ' Biological ', ' kidney function ', ' Renal function ', ' Space Models ', ' Immunological response ', ' host response ', ' immunoresponse ', ' Immune response ', ' machine learned ', ' Machine Learning ', ' transplant patient ', ' Transplant Recipients ', ' Techniques ', ' hazard ', ' novel ', ' Modeling ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Donor Screening ', ' Donor Selection ', ' Data ', ' cost ', ' immunogenicity ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Outcome ', ' Population ', ' multi-task ', ' multitask ', ' graft failure ', ' learning network ', ' discrete time ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' predict survival ', ' predictor of survival ', ' survival prediction ', ' high dimensionality ', ' model of human ', ' human model ', ' transplant model ', ' compare treatment ', ' treatment comparison ', ' ']",NLM,UNIVERSITY OF TOLEDO,R01,2020,277764,OH-09,0.1316692082596502
"Artificial intelligence-enabled, real-time communication software for optimizing clinical decision making during the allocation, procurement, and transplantation of donated organs Project Abstract for HealthTech Solutions Kidney transplantation is a clinically effective and cost-effective treatment for patients suffering from end-stage renal disease (ESRD) and diabetes. Twenty-two patients die each day waiting for a transplant and 30% of all deaths in the US could be prevented by organ transplant. Despite the obvious clinical and cost-effective advantages of kidney transplantation, there has been a decades-long rise in the kidney discard rate from 5.1% in 1988 to 19.2% in 2015. During a successful Phase I grant and to address the need for a dedicated communications system to help improve transplant patient outcomes and achieve greater donated organ utilization, HealthTech Solutions (HTS), Inc. developed a proprietary mobile application for secure team communication tailored specifically for kidney transplant teams. To further improve communication efficiency and augment critical decision making in healthcare, specifically for surgeons, HTS will employ machine learning (ML) powered clinical decision support. Clinical decision support (CDS) may significantly increase access, increase quality, and reduce the cost of kidney transplantation. The proposed project is designed to further test and quantify the improvement of the donor management, coordination process, and kidney utilization outcomes using the companys CDS and communication infrastructure for medical team communication. The aims are; 1) Develop CDS models specifically for transplant professionals aimed at improving decision times and decision confidence. Develop the CDS infrastructure capable of handling medical data and serving insights safely, securely, and rapidly; 2) Asses usability by working with a test group to exceed usability criteria and ensure that CDS meets clinician needs through user feedback iterations. Verification of utility from a diversified testing group (n=10) that represent every type of professional involved in transplant cases. 3) Measure the effects of TXP Chat enhanced with CDS after live clinical implementation in the kidney offer and procurement processes for more than 3,000 offers (1,500 with CDS and 1,500 control) over a period of 365 days with multiple partner institutions (n=3). TXP Chat and CDS will demonstrate to be reliable, secure, trustworthy and useful by the clinical/technical community, increase kidney acceptance practices resulting in an increase in kidney transplants, reduction in cold ischemic time, and reduction in time from offer to transplant. Ultimately, these metrics have been demonstrated in the literature to improve patient outcomes, reduce expensive chronic treatment costs (e.g. dialysis), reduce patient deaths from lack of kidney availability, and significantly improve human health and productivity. Study results will be disseminated via publication in a peer-reviewed journal. Aim 1 will lay the foundation for further development to enable wider CDS in the Phase IIB. Aim 2 will prove physician support and steady adoption trend as we roll into commercialization. Aim 3 will provide multi-center pilot study data used to prove increased efficiency of the process in terms of time, money, and total number of kidneys transplanted. Project Narrative Despite the obvious clinical and cost-effectiveness advantages of kidney transplantation for many patients, nearly 1 in 5 kidneys authorized for donation are discarded. This project addresses the need for an efficient communications software technology enhanced with clinical decision support tailored for organ procurement organizations and transplant centers. Combined with enhanced communication efficiency, clinical decision support powered by machine learning may significantly improve donated kidney utilization and increase the number of viable, but currently unused organs that could otherwise be successfully transplanted, reducing waste and saving lives.","Artificial intelligence-enabled, real-time communication software for optimizing clinical decision making during the allocation, procurement, and transplantation of donated organs",10017295,R44LM012575,"['Adoption ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Communication ', ' Communities ', ' cost effectiveness ', ' Cessation of life ', ' Death ', ' Decision Making ', ' Dialysis procedure ', ' Dialysis ', ' dialysis therapy ', ' Feedback ', ' Foundations ', ' Renal Glycosuria ', ' Renal Diabetes ', ' Goals ', ' Grant ', ' Health ', ' Human ', ' Modern Man ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Transplantation ', ' Kidney Grafting ', ' Kidney Transplants ', ' Renal Grafting ', ' Renal Transplantation ', ' Renal Transplants ', ' kidney tx ', ' Literature ', ' Multiple Partners ', ' Organ Procurements ', ' Organ Transplantation ', ' Grafting Procedure ', ' Organ Transplants ', ' organ allograft ', ' organ graft ', ' organ xenograft ', ' Patients ', ' Peer Review ', ' Physicians ', ' Pilot Projects ', ' pilot study ', ' Privatization ', ' Productivity ', ' Publications ', ' Scientific Publication ', ' Savings ', ' Computer software ', ' Software ', ' Surveys ', ' Survey Instrument ', ' Technology ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' Transplantation ', ' transplant ', ' Waiting Lists ', ' waitlist ', ' Work ', ' Measures ', ' Tissue Transplantation ', ' health care ', ' Healthcare ', ' Decision Support Model ', ' Treatment Cost ', ' Magazine ', ' Journals ', ' Organ ', ' improved ', ' Chronic ', ' Clinical ', ' Phase ', ' Medical ', ' Ensure ', ' Evaluation ', ' insight ', ' wasting ', ' satisfaction ', ' Donkey ', ' Equus asinus ', ' Asses ', ' machine learned ', ' Machine Learning ', ' transplant patient ', ' Transplant Recipients ', ' Life ', ' Hour ', ' System ', ' burn-out ', ' burnout ', ' Surgeon ', ' experience ', ' Performance ', ' cohesion ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' response ', ' Enhancement Technology ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Institution ', ' preventing ', ' prevent ', ' Address ', ' Data ', ' Direct Costs ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Transmission ', ' transmission process ', ' trend ', ' Process ', ' developmental ', ' Development ', ' cost ', ' designing ', ' design ', ' Clinical effectiveness ', ' Outcome ', ' cost effective ', ' usability ', ' commercial application ', ' commercialization ', ' effective treatment ', ' effective therapy ', ' clinical decision-making ', ' Secure ', ' operation ', ' mobile app ', ' mobile application ', ' transplant centers ', ' clinical decision support ', ' clinical implementation ', ' Infrastructure ', ' ']",NLM,ORGANIZER,R44,2020,975104,IA-02,0.1930198988985972
"Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy ABSTRACT Acute kidney injury (AKI) affects up to half of critically ill patients admitted to intensive care units (ICU). In patients with AKI and hemodynamic instability, continuous renal replacement therapy (CRRT) is the preferred dialysis modality for solute and volume control. ICU mortality in this vulnerable population is high (~75%) but kidney recovery occurs in up to two-thirds of survivors. Fluid overload is a potentially modifiable risk factor associated with these outcomes. However, there are currently no universally accepted approaches for predicting kidney recovery, survival or individual response to fluid removal during CRRT. Due to recent advances in computer science and widespread big data usage, deep learning (DL) has emerged as a valuable approach. DL allows construction of risk prediction models using time-series data that incorporate thousands of variables and dynamic changes in these variables derived from multi-dimensional sources and not only static values of these variables. We propose to develop and validate innovative DL approaches to dynamically predict these outcomes using multi-modal data from electronic health records and CRRT machines. We demonstrated superiority of DL models without a-priori variable selection compared to optimized logistic regression (C-Statistic of 0.72 vs. 0.62) for prediction of RRT liberation. We also showed that mortality prediction improved by incorporating changes in clinical data within 6-hour intervals after CRRT initiation. In addition, we identified distinctive mortality risk according to quintiles of achieved net ultrafiltration rates, after adjustment by patients weight, duration of CRRT, and other clinical parameters: OR 8.0 (95% CI: 2.7-25.1) when the highest quintile (>36 ml/kg/day) was compared to the lowest quintile (<13 ml/kg/day). We hypothesize that innovative DL approaches integrating time- series data will generate accurate and generalizable risk prediction models that can impact CRRT delivery. We will utilize a multi-institutional dataset that encompasses clinical data and CRRT programmatic and therapy data (CRRTnet registry, n=1500 patients) for model development and an independent multi-institutional dataset for validation (n=1500 patients) to: 1) continuously predict short-term (7-day) and medium-term (28-day) liberation from RRT due to kidney recovery; 2) continuously predict 24-hour mortality; and 3) identify and validate sub- phenotypes of patients with AKI on CRRT with differing achieved net ultrafiltration rates. This innovative research will assist 1) the development of novel clinical decision support platforms for guiding informed CRRT delivery and promoting kidney recovery; 2) the identification of sub-phenotypes of patients that can benefit from precision- medicine approaches to fluid removal during CRRT; and 3) the design of interventional studies focusing on fluid removal during CRRT to impact patient-centered outcomes. PROJECT NARRATIVE Continuous renal replacement therapy (CRRT) is the preferred dialysis treatment for critically ill patients with acute kidney injury and hemodynamic instability, yet mortality is high (~75%). Presently, there are no universally accepted approaches for predicting kidney recovery, survival or individual response to fluid removal during CRRT. We propose to develop and validate innovative deep learning approaches to dynamically predict these outcomes, which could guide CRRT decision-making including intensification, de-escalation, and enrich clinical trials focusing on fluid removal during CRRT.",Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy,10261059,R56DK126930,"['Affect ', ' Algorithms ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Critical Illness ', ' Critically Ill ', ' Decision Making ', ' Dialysis procedure ', ' Dialysis ', ' dialysis therapy ', ' Goals ', ' hemodynamics ', ' Intensive Care Units ', ' Intervention Studies ', ' intervention research ', ' interventional research ', ' interventional study ', ' interventions research ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' mortality ', ' Patients ', ' Phenotype ', ' Registries ', ' Research ', ' Risk Factors ', ' Time ', ' Ultrafiltration ', ' Weight ', ' Measures ', ' Hospital Mortality ', ' In-house Mortalities ', ' Inhospital Mortality ', ' Dataset ', ' Data Set ', ' improved ', ' Acute ', ' Clinical ', ' Series ', ' Logistic Regressions ', ' Kidney Replacement Therapy ', ' Renal Replacement Therapy ', ' Survivors ', ' Recovery ', ' Measurement ', ' fluid ', ' liquid ', ' Liquid substance ', ' Hour ', ' Event ', ' Source ', ' hypervolemia ', ' Fluid overload ', ' acute kidney injury ', ' Acute Renal Failure with Renal Papillary Necrosis ', ' Performance ', ' solute ', ' computer science ', ' novel ', ' Predictive Factor ', ' Modality ', ' Abscission ', ' Extirpation ', ' Removal ', ' Surgical Removal ', ' resection ', ' Excision ', ' Modeling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' model development ', ' vulnerable group ', ' Vulnerable Populations ', ' Dose ', ' Data ', ' Reproducibility ', ' Resolution ', ' Clinical Data ', ' Clinical Trials Design ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Validation ', ' developmental ', ' Development ', ' electronic data ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' time use ', ' Outcome ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' modifiable risk ', ' intervention design ', ' treatment design ', ' therapy design ', ' multi-modality ', ' multimodality ', ' clinical decision-making ', ' Statistics Algorithm ', ' Statistical Algorithm ', ' BigData ', ' Big Data ', ' precision-based medicine ', ' precision medicine ', ' individual patient ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' clinical outcome prediction ', ' predictor of clinical outcome ', ' predict clinical outcome ', ' clinical decision support ', ' patient specific response ', ' responsive patient ', ' patient response ', ' individualized response ', ' individual response ', ' deep learning ', ' multi-modal data ', ' multi-modal datasets ', ' multimodal datasets ', ' multimodal data ', ' risk prediction model ', ' death risk ', ' mortality risk ', ' ']",NIDDK,UNIVERSITY OF KENTUCKY,R56,2020,100000,KY-06,0.15187078559725298
"DUET: Rapid dual-mode microscopy for quantitative slide-based renal fibrosis evaluation Contact PD/PI: Fereidouni, Farzad Abstract Kidneys, like other organs, have an inherent capacity to recover from acute injury; however, severe or recurrent injury can result in chronic kidney disease (CKD), the sequelae of which result in 82,000 deaths annually in the US alone. Regardless of the etiology of the initial injury, the common final pathway leading to- end stage renal disease is closely connected to fibrosis(excess or aberrant collagen distribution), one of the most important determinants of renal disease severity and prognosis. Histology is the gold standard for evaluation, typically through the use of histochemical stains such as trichrome and PAS that highlight the presence of collagens and basement membrane, respectively. Nevertheless, these stains are not completely specific, can be technically challenging to perform well and reproducibly, and thus contribute to interobserver variability and a concomitant decrease in diagnostic precision. Moreover, they also require the preparation of extra slides and additional staining procedures, and thus increase cost and can prolong the diagnostic process. We propose to optimize, deploy and test a new kind of microscope, DUET (DUal mode Emission and Transmission microscopy), developed at UC Davis, that will be a low-cost and very rapid solution for detection and digital characterization of the presence and distribution of collagen and other macromolecules, directly from standard formalin-fixed, paraffin-embedded hematoxylin and eosin-stained slides. Specifically, we will finalize the design of the hardware and software components of the instrument itself, validate imaging performance against standard histology and immunohistochemical stains for collagen and other components, and with the assistance of scientists at our partnering institutions (John Hopkins University and University of Buffalo) develop robust tools for analysis and quantitation of fibrosis. DUET instrument hardware will be shared with JHU to ensure that the methods are technically reproducible across multiple sites. The application leverages the expertise across three institutions in optics, biomedical engineering, renal pathology and novel artificial intelligence approaches. The goal of the project is development and validation of DUET, which promises to be a robust, inexpensive and practical approach for the rapid and accurate evaluation of fibrosis, extensible to other renal pathologies, and indeed across other organs systems, with significant positive impact on disease research, clinical practice, and patient outcomes. Page 6 Project Summary/Abstract Project Narrative Evaluation of fibrosis and tubular atrophy from chemically stained kidney biopsies are essential for diagnosis and disease-severity assessment, but current techniques are time-consuming, somewhat non-specific and contribute to interobserver variability and imprecision, affecting care. We propose to optimize and test a new kind of microscope (DUET) that can visualize fibrosis (scarring) and other tissue abnormalities directly from standard slides to enable high-quality reproducible fibrosis scoring and evaluation. This multi-site project will also provide a unique opportunity to perform a retrospective study from hundreds of existing H&E slides with associated months to years of clinical follow-up data, and to create a method with demonstrated utility in more than one institution.",DUET: Rapid dual-mode microscopy for quantitative slide-based renal fibrosis evaluation,10261643,R56DK124873,"['Staging ', ' Atrophy ', ' Atrophic ', ' Pathologist ', ' tool ', ' instrument ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Scientist ', ' Slide ', ' Techniques ', ' System ', ' Organ System ', ' body system ', ' disease severity ', ' Severity of illness ', ' Allografting ', ' H and E ', ' Hematoxylin and Eosin ', ' Hematoxylin and Eosin Staining Method ', ' Performance ', ' cohort ', ' novel ', ' Agreement ', ' Property ', ' develop software ', ' developing computer software ', ' software development ', ' Formalin ', ' Fibrillar Collagen ', ' ESRD ', ' End-Stage Kidney Disease ', ' End-Stage Renal Disease ', ' End stage renal failure ', ' Institution ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' Trichrome ', ' Trichrome stain method ', ' Data ', ' Detection ', ' Quantitative Microscopy ', ' Reproducibility ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Validation ', ' Transmission ', ' transmission process ', ' Preparation ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' cost ', ' digital ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' cost effective ', ' Consumption ', ' clinical significance ', ' clinically significant ', ' stem ', ' clinical care ', ' clinical practice ', ' personalized diagnosis ', ' precise diagnostics ', ' precision diagnostics ', ' personalized diagnostics ', ' prognostic ability ', ' prognostic power ', ' prognostic utility ', ' prognostic value ', ' Data Science ', ' histologic stains ', ' histological stains ', ' clinical outcome prediction ', ' predictor of clinical outcome ', ' predict clinical outcome ', ' digital pathology ', ' renal biopsy ', ' kidney biopsy ', ' renal fibrosis ', ' kidney fibrosis ', ' Affect ', ' Algorithms ', ' Archives ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Basement membrane ', ' Biomedical Engineering ', ' bio-engineered ', ' bio-engineers ', ' bioengineering ', ' Biopsy ', ' Buffaloes ', ' Cicatrix ', ' Scars ', ' Collagen ', ' Computers ', ' Data Sources ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Fibrosis ', ' Fluorescence ', ' Goals ', ' Gold ', ' Histology ', ' instrumentation ', ' Interobserver Variability ', ' Inter-Observer Variability ', ' Inter-Observer Variation ', ' Interobserver Variations ', ' Kidney ', ' Kidney Urinary System ', ' renal ', ' Kidney Diseases ', ' Nephropathy ', ' Renal Disease ', ' kidney disorder ', ' renal disorder ', ' Chronic Kidney Failure ', ' Chronic Renal Disease ', ' Chronic Renal Failure ', ' chronic kidney disease ', ' Laboratories ', ' Manuals ', ' Methods ', ' Microscopy ', ' Optics ', ' optical ', ' Pathology ', ' Patients ', ' outcome forecast ', ' Prognosis ', ' Recurrence ', ' Recurrent ', ' Kidney Failure ', ' Kidney Insufficiency ', ' Renal Failure ', ' Renal Insufficiency ', ' Research ', ' Retrospective Studies ', ' Running ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Stains ', ' Staining method ', ' Standardization ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Universities ', ' Sirius Red F3B ', ' picrosirius red ', ' sirius red F 3B ', ' Measures ', ' Tissue Embedding ', ' Paraffin Embedding ', ' Caring ', ' injuries ', ' Injury ', ' Natural History ', ' base ', ' macromolecule ', ' Organ ', ' Microscope ', ' Procedures ', ' Image Analyses ', ' image evaluation ', ' image interpretation ', ' Image Analysis ', ' Site ', ' Acute ', ' Clinical ', ' Histologically ', ' Histologic ', ' Kidney Replacement Therapy ', ' Renal Replacement Therapy ', ' Link ', ' Ensure ', ' Chemicals ', ' Evaluation ', ' prognostic ', ' kidney function ', ' Renal function ', ' Individual ', ' Therapeutic ', ' Tubular ', ' Tubular formation ', ' ']",NIDDK,UNIVERSITY OF CALIFORNIA AT DAVIS,R56,2020,91725,CA-03,0.1052419359088852
